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Abstract 
Incorporating the Host-Pathogen Kinetics of Time-Dose-Response into Epidemic Outbreaks 
Bidya Prasad 
Charles N. Haas, PhD 
 
 
 
 
Mathematical models charting disease outbreaks have been a central tenant of epidemiology since 
its inception. Pathogens responsible for these outbreaks replicate in the host, leading to adverse 
reactions over time. It may be concluded, therefore, that the incubation period is a function of 
pathogen reproduction, which is time-dependent. Yet no outbreak model has considered the 
effects of in-vivo kinetics to date. It is postulated that outbreak models which consider host-
pathogen kinetics can provide better fits to outbreak data than models that do not consider this 
system. This dissertation demonstrates the relationship between the incubation function of a host-
pathogen system and outbreak models. 
 
To examine this relationship, this work is divided into two categories: (1) derivations and model 
development, which includes (a) deriving time-dose-response (TDR) models, (b) deriving 
primary (common-source) and secondary (person-to-person spread) outbreak models that 
incorporate the TDR equations, and (c) developing a Matlab code which models a convolution of 
the exposure and incubation distributions; and (2) data modelling, which includes (a) mining the 
literature to find appropriate TDR and outbreak datasets for each respective pathogen, (b) 
generating dose-response model fits for each respective pathogen, (c) generating TDR model fits 
for each pathogen, and (d) generating fits for the TDR and non-time-dependent outbreak models. 
This methodology was partially verified using data from a Cryptosporidium parvum outbreak that 
occurred in Milwaukee. The pathogens modelled using this method are (1) Legionella spp.; (2) 
Giardia lamblia; (3) Salmonella spp.; (4) Shigella spp.; (5) Escherichia coli O157:H7; and (6) 
Campylobacter jejuni.  
xvii 
 
The results of this work suggest good support for the TDR incorporation into the outbreak model. 
In several cases, the TDR outbreak had the lowest deviance values among time-dependent and 
non-time-dependent models, which was the metric that was used to determine the best-fit model. 
However, since the TDR contained extra parameters, it did not necessarily have the lowest 
Akaike information criterion (AIC) and Bayesian information criterion (BIC) values. Parameter 
estimates were generally consistent across different species.  
 
This work seeks to characterize the relationship between the time-dose-response functions, which 
reflect the in-vivo kinetics of the host-pathogen system, and the models that predict the number of 
ill persons per day of an outbreak, based on available data from epidemiological studies.
 
 
1 
 
 
 
Chapter 1: Introduction 
 
1.1. Epidemiology History and Motivations 
Throughout history, outbreaks caused by microbial infections have had devastating effects on 
global communities. Since 500 CE, infection from Yersinia pestis, the causative agent of the 
plague, led to millions of deaths, including that of 10 million people in China, 100 million people 
in Europe, and 50 million people in the Middle East, Asia and the Mediterranean basin 
(Williamson and Oyston 2012). Between 1519-1521, a smallpox virus brought to Mexico by the 
explorer Hernando Cortés initially killed between 5 and 8 million indigenous peoples, and by 
1620, European diseases caused the native population to dwindle from 25 million to less than 2 
million (Brooks 1993). More recently, the great influenza pandemic of 1918-1919 is estimated to 
have killed 50 million people worldwide, including 675,000 Americans (Taubenberger and 
Morens 2006). Despite vaccine developments and improved sanitation in the 20th century, 
microbial infections remain the most common cause of morbidity and mortality globally (Wilson 
1995). Emerging infectious disease (EID) events, the prevalence of which has been well-
documented through surveillance efforts in the United States (U.S.), have risen since the 1940s, 
peaking in the mid-1980s with the HIV pandemic (Jones et al. 2008).  
 
In addition to the morbidity and mortality associated with natural outbreaks, microbial agents 
have been used as biological weapons for thousands of years (DaSilva 1999, Rotz et al. 2002). 
Records of poisoned water supplies date back to the 6th century BCE, with the contamination of 
enemy drinking wells by the Assyrians with ergot fungi (Romano Jr et al. 2007). During the 
French and Indian War, British forces gave blankets containing live smallpox virus to Native 
Americans tribes who aligned themselves with French forces (Anderson and Bokor 2012). During 
World War II, Hitler’s army diverted sewage in the Bohemia region of the Czech Republic to 
weaken the country. In 1984, the Rajneeshee cult attempted to influence local elections in The 
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Dallas, Oregon by contaminating salad bars with Salmonella typhimurium, thereby restricting 
voter turnout (Tokgöz 2012). And notably in 2001, letters containing Bacillus anthracis spores 
were mailed to journalists and senators in the U.S., infecting seventeen people and killing five 
victims (Jacobs 2004). The severity of these weaponized biologics further necessitates the need 
for an understanding of pathogen activity. 
 
1.2. Basic epidemiological concepts 
Epidemiology is a discipline which investigates the pathogenic infection of a host and the 
resulting illness. These pathogens are generally microorganisms, such as bacteria and viruses, and 
are thus distinguished from diseases caused by chemical or toxicological agents (Giesecke 2002). 
The associated disease can be (1) endemic, where the microorganism becomes established in a 
population and remains at a baseline level, or (2) epidemic, where a sudden outbreak of a disease 
affects a substantial portion of the population for a short time before diminishing (Giesecke 
2002).  
 
There are two major types of epidemics: (1) a primary, common (point) source and (2) a 
secondary, person-to-person (propagated). Common source epidemics are caused by the direct 
infection of numerous people from a common source, such as contaminated food or water. Many 
foodborne and waterborne common source epidemics originate from pathogen presence in fecal 
material. The fecal matter comes in contact with food or water supplies, and then enters the 
intestinal tract of susceptible individuals through the oral or nasal route (Madigan et al. 2012). 
The common source outbreak graph is characterized by a distinct peak: a small number of people 
become ill per day in the beginning of the outbreak, with illness rates increasing daily until it 
reaches a peak period (Figure 1.1, left). If the contaminated source is discovered and removed, 
the incidence of a common source illness may decline rapidly (Madigan et al. 2012). Cases tend 
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to be reported for a period of time approximately equal to the duration of one incubation period of 
the disease (Madigan et al. 2012).  
 
In a secondary person-to-person epidemic, the disease incidence shows a uniform appearance 
(Figure 1.1, right). Cases continue to be reported over a period of time equivalent to several 
incubation periods of the disease (Madigan et al. 2012). A person-to-person epidemic can be 
initiated by the introduction of a single infected individual into a susceptible population, with this 
individual infecting one or more people (Giesecke 2002). The pathogen then replicates in 
susceptible persons, reaches a communicable stage, and is transferred to other susceptible 
persons, where it again replicates and becomes communicable (Giesecke 2002). Chicken pox is 
an example of a disease that is typically spread in person-to-person epidemics (Madigan et al. 
2012). 
 
 
  
 
Figure 1.1 (left) Point source outbreak of Cryptosporidium parvum in Milwaukee during the spring of 1993 
(MacKenzie 1995). (right) Person-to-person transmission outbreak of Salmonella newport that occurred in Northern 
Ireland during September and October 2004 (Irvine et al. 2009). 
 
 
 
The pathogen’s mode of transmission from source to host is an important factor in the infection 
process. There are several routes of transmission, broadly categorized as direct or indirect 
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transmission (Gupta 1999).  Direct transmission occurs when there is physical contact between 
infected and susceptible persons, such as kissing, touching or contact with blood from an infected 
person. Conversely, indirect transmission occurs when there is no physical contact between 
infected and susceptible persons. Examples of indirect transmissions include the inhalation of 
aerosols (sneezing), vectors such as mosquitos or fleas, and fomites.  
 
The progression of clinical symptoms for a typical acute infectious disease can be divided into 
stages as shown in Figure 1.2. The latent period is the period from infection to the beginning of 
the infectious period, defined as the time period in which a person can transmit a disease 
(Giesecke 2002). The incubation period is the period between infection and the appearance of 
disease symptoms (Giesecke 2002). Some diseases, like influenza, have very short incubation 
periods, measured in days; others, like AIDS, have longer ones, sometimes extending for years 
(Giesecke 2002). Some factors that determine incubation period for a given disease include 
inoculum size, virulence, microbial life cycle, host immune resistance, and distance of the site of 
entrance from the focus of infection (Giesecke 2002). It is important to note that not all 
susceptible individuals will become symptomatically ill from exposures. This individual may be a 
carrier, or may remain uninfected (Giesecke 2002). 
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Figure 1.2 Disease natural history and the relationship between time periods. The first patient transmits the infection to 
a second patient (Giesecke 2002). 
 
 
 
 
1.3. Mathematical models 
The infection process is complex and individualistic, and therefore it is difficult to predict the 
exact outcome of an epidemic. For example, children, the elderly, and immunocompromised 
persons are generally more susceptible to illness than healthy adults. Experiments in 
epidemiology are often difficult to design, and present ethical concerns (Krugman 1986). 
Sometimes data may be obtained from outbreak reports, but this data may be incomplete. In an 
ideal scenario, all diseased individuals would report their illness to their doctors, and the doctors 
would send stool or blood samples out for laboratory confirmation. Many ill people, however, 
don’t have access to healthcare, so their illnesses go unreported. Still others may be infected 
carriers, who are infectious but do not exhibit symptoms, and are therefore omitted from outbreak 
reports. Despite these limitations, outbreak models are important tools for assessing the risk 
posed by the release of microorganisms into an environment and are the best means of containing 
an outbreak (Ferguson et al. 2003, Grassly and Fraser 2008). Good models can balance biological 
realism against any limitations of knowledge (Ferguson et al. 2003).  
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1.3.1. Early deterministic and stochastic models  
Mathematical modeling of infectious diseases began to take root in the early 20th century, when 
John Brownlee fitted Pearsonian frequency distribution curves to large-scale epidemics 
(Anderson and May 1991, Brownlee 1907, Daley and Gani 1999). He attributed the rise and 
decline of epidemics to changes in the infectiousness of pathogenic agents (Anderson and May 
1991, Brownlee 1907, Fine 1979). Brownlee’s contemporaries, Ronald Ross and William Hamer, 
ushered in an era of deterministic modelling with their work. Ross discovered that malaria was 
transmitted through mosquito vectors, and in 1911, he published a model that determined 
parameter values for malaria transmission (Bailey 1975, Fine 1979, Gani 2010, Ross 1916, Ross 
and Hudson 1917, b). Hamer proposed an explanation for the regular recurrence of the measles 
epidemics by theorizing that outbreaks are dependent upon the number of susceptible individuals 
and the contact rate between this group and those who ultimately become infected (Bailey 1975, 
Fine 1979, Hamer 1906). Beginning in 1927, W.O. Kermack and A.G. McKendrick collaborated 
on three seminal papers in which they describe a threshold theory for the spread of infectious 
diseases (Kermack and McKendrick 1927, Kermack and McKendrick 1932, 1933). They 
proposed the Susceptible-Infective-Recovered (SIR) compartment model, a deterministic model 
in which there is a closed population of size 𝑁 consisting of 𝑆(𝑡) susceptibles, 𝐼(𝑡) infectives and 
𝑅(𝑡) removals (individuals who had died, or had recovered and were immune) at time 𝑡. This SIR 
model remains a cornerstone in modern mathematical epidemiology (Figure 1.3). 
 
 
 
Figure 1.3 Susceptible-Infective-Recovered (SIR) model  
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The deterministic models described above provide a firm theoretical framework for observed 
outbreaks, and work quite well with large populations because the number of cases are treated as 
a continuous function (Bailey 1975, Anderson and May 1991). However, for small populations, 
the number of cases can no longer be considered to be continuous. A stochastic model, in which 
randomness associated with a small population is considered, may give a more satisfactory 
explanation of observed phenomena (Baily 1975). Here, variable states are not described by 
unique values, but rather by probability distributions. Stochastic models are generally more 
complex, and often utilize coupled difference equations (Bailey 1975, Haas et al. 2014).  
 
In 1949, M.S. Bartlett modelled a stochastic epidemic with continuous time in his seminal paper 
presented at the Symposium on Stochastic Processes of the Royal Statistical Society, London. He 
derived a partial differential equation for the probability function of a general stochastic epidemic 
in continuous time. This was the stochastic equivalent of Kermack and McKendrick’s 
deterministic model (Gani 2010). In 1950, Norman Bailey published a simple stochastic epidemic 
in continuous time, and was later able to provide a complete solution to the problem in terms of 
known functions (Gani 2010).  
 
1.3.2. Modern modifications to the SIR compartment model 
In 1950, P.E. Sartwell fit lognormal distributions to the incubation periods of 37 outbreak cases, 
and found that these distributions provided a much better fit than a simple linear fit. This brought 
to light a deficiency in the standard SIR model, which had implied an exponential distribution of 
incubation times (Sartwell 1950). In order to reconcile the incubation period discrepancies within 
the SIR model, Joe Eisenberg developed a compartment process disease model in 1996 that used 
sub-stages within the infection process, fitting a gamma distribution to the incubation period 
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(Eisenberg et al. 1996). Although the sub-stage approach was able to bridge the gap between the 
deficiency in the standard model and Sartwell’s conclusions, there are simpler and more 
systematic approaches that can be used without having to modify the compartmental model solely 
for the purpose of reaching this end. One such approach is to postulate an incubation time 
function and reformulate the SIR model using a theoretical basis; this approach was taken by 
Mukul Gupta in his 1999 doctoral dissertation (Gupta 1999).  
 
 
Gupta’s method was demonstrated in his 2004 paper, in which he showed that his reformulated 
SIR model provided an acceptable fit to a Cryptosporidium outbreak in Milwaukee (Gupta and 
Haas 2004, Mac Kenzie et al. 1994). He did note, however, one drawback of this method, which 
was that it left the incubation time sensitive to assumed distributions. This means that the shape 
and scale parameter values of his assumed distributions (which included the lognormal, gamma, 
Weibull and inverse Gaussian functions) widely differed, making it difficult to determine which 
of the distributions is the most plausible (Gupta and Haas 2004). Gupta suggested an ideal 
approach that would circumvent this issue would be to utlize data from the uninfected fraction. 
However, serological information from susceptible populations is not generally available. The 
question arises then, what is a plausible alternative to determine a fitted incubation distribution 
that is less sensitive to assumed distributions? The answer may lie in the incorporation of a time-
dose-response (TDR) model. To examine this further, we take a look at dose-response before 
returning to the compartment models. 
 
1.3.3. Dose-response  
Dose-response models are generally based on datasets acquired from animal or human studies, 
and quantify the probability of adverse effects from microbial infection as a function of 
administered doses (Pepper et al. 2011). Responses in hosts may vary from no observable effect 
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to illness and death. These models are beneficial because by quantifying how individuals respond 
to various dosages of microorganisms, the model can be used to predict the probability of a 
susceptible person becoming adversely affected given a particular dosing level. 
 
 
In 2009, Yin Huang published a series of papers that built upon these traditional dose-response 
equations by modelling a distribution of cases over time from the initial infection (Huang and 
Haas 2009). In Huang’s new model, exponential and beta-Poisson dose-response equations were 
modified to include the time-post-inoculation (TPI), the time between infection and the onset of 
symptoms. These time-dose-response (TDR) models take into account the kinetics of in-vivo 
microbial growth.  
 
 
 
1.3.4. Incorporation of TDR into SIR models  
Huang’s time-dependent dose-response models can be used to model the incubation distribution 
of Gupta’s compartmental SIR model. If the TDR models are differentiated, a conversion 
between the incubation period and recovery can be obtained. These differential equations can be 
used to find the total number of ill persons each day of an outbreak dataset. This method may 
provide a solution to the incubation distribution sensitivity of Gupta’s model, and may provide 
further insight into the in-vivo kinetics of the host-pathogen system. The question then arises if 
this approach can offer better fits to outbreak data than models that do not consider time 
dependency. 
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1.4. Objectives and framework 
The overall goal of this work is to demonstrate the relationship between the TDR-based outbreak 
models, and to compare these results with non-time-dependent models. The outbreak model 
developed in this work is mechanistically-based and fits epidemic data from reported outbreaks 
found in literature.  
 
The objectives of this thesis work are as follows: 
1. To construct a dynamic model of the disease transmission process that integrates Huang’s 
time-dose-response equations into Gupta’s outbreak model. 
2. To apply these models to common source and person-to-person outbreaks. 
3. To determine model parameters that define exposure and incubation distributions. 
 
1.4.1. Hypothesis I  
It is hypothesized that the Huang et al. time-dose-response model can provide acceptable fits to 
the dose-response datasets of several pathogens responsible for common source and person-to-
person outbreaks (Hypothesis I).  
 
In his 2010 dissertation, Huang applied his TDR framework to four pathogens: Bacillus 
anthracis, Yersinia pestis, Francisella tularensis, and Scrapie agent. However, it remains to be 
seen if these models can be applied to a broader range of pathogens successfully. A partial 
validation of the Huang TDR models is performed as it applies to six pathogens: Giardia, 
Legionella, Salmonella, E. coli, Shigella, and Campylobacter. This portion of the thesis is 
motivated by the need for TDR models for the pathogens that are studied in this work.  
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1.4.2. Hypothesis II 
It is hypothesized that for a common source outbreak, incorporating TDR into the incubation 
distribution of an outbreak model provides a better fit to the outbreak data than models that do not 
take time-based distributions into account (Hypothesis II).  
 
The focus for this hypothesis is on primary environmental exposures, and we neglect secondary 
cases. In order to test the hypothesis, rescaled time derivatives of the TDR equations were derived 
and incorporated into the incubation distribution of the basic SIR model (Huang and Haas 2009). 
Since bacteria and viruses replicate in the host, infection is generally accepted as a time-
dependent process, and it is therefore expected that the incubation distributions that incorporate 
TDR equations provide better fits than those that do not. The common source outbreak models 
are applied to Giardia, Legionella, Salmonella, E. coli, Shigella, and Campylobacter outbreaks. 
These TDR oubreak models are then be compared with other generated non-TDR models.  
 
Figure 1.4 presents a flow chart that documents the undertaken work. 
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Figure 1.4 Flow chart of proposed TDR-incorporated epidemic model.  
 
 
 
The first step in the method was to re-develop Gupta’s derivations and Matlab code, which 
modeled the number ill per day by convoluting exposure and incubation distributions, and to 
validate this code using outbreak data obtained from the literature. Next, TDR models, which 
were originally in the form of cumulative distribution functions (CDFs), were modified to form 
probability distribution functions (PDFs) so that they could directly be used in the incubation 
function of the outbreak model. Once these models were established, they could be applied to 
each pathogen. Data sets for dose-response and corresponding outbreaks were found in the 
literature. The dose-response data was fit to the (CDF) TDR models, and the model which gave 
the best fit was used as the incubation distribution of the outbreak: depending on the TDR model 
that gave the best fit, the corresponding TDR-based PDF incubation distribution was chosen. 
Plugging this incubation TDR model distribution into the outbreak model yields a fit with TDR 
dependency. Non-TDR models were generated, and comparison of the TDR model fits with non-
TDR models were made. Among these, the best-fit models were highlighted.  
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1.4.3. Hypothesis III  
Attention is now turned to the secondary cases that were neglected in Hypothesis II. In order to 
model the scenario of secondary attacks, the SIR framework equations must be modified. 
Secondary transmissions were initially modeled by Kermack and McKendrick as the product of 
susceptible and infected individuals multiplied by a transmission factor (Kermack and 
McKendrick 1927, Kermack and McKendrick 1932, 1933). This was expanded upon by 
Anderson and May who incorporated demographic and epidemiological parameters such as age-
specific death rate and recovery rates (Anderson and May 1991).   
 
It is hypothesized that for the onset of a propagated (person-to-person) outbreak, in which the 
onset of secondary cases is clearly distinguishable from primary waves, incorporating TDR 
dependency into the incubation distribution of the full outbreak model predicts the behavior of the 
secondary wave that is comparable with non-time-dependent models (Hypothesis III). 
 
The methodology from Hypothesis II is repeated here. An outbreak model that is appropriate for 
person-to-person spread was first derived. The pathogens that were considered were the same as 
from Hypothesis II. However, some of those pathogens are not communicable, and for others, 
usable data could not be found. Therefore, the pathogens considered in the secondary spread are 
Legionella, Salmonella, E. coli, Shigella. 
 
In order to execute these objectives, it is beneficial to list the data that would ideally be available 
for each of the outbreak models: 
1. Appropriate TDR data. This dataset includes the doses each subject was given, and the 
number of subjects that experienced adverse effects on each respective day. 
2. In the outbreak model, the number of people who are susceptible to infection is known.  
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3. All members of this susceptible population who became symptomatically ill were tested 
for the pathogen. 
4. All outbreak cases that are identified have the same case definition. Throughout the 
years, many case definitions have evolved over time. For example, the case definition for 
Legionella is currently a 4-fold increase in titer (OSHA 2013). Ideally, this would be the 
same case definition that was used to confirm disease in the TDR data. 
5. The beginning and end of the exposure time is known.  
6. In the case of a common source outbreak, there should be no secondary spread of disease. 
Or, if there is some secondary spread, there is a clear distinction between the primary and 
secondary spread. 
7. In the case of a person-to-person outbreak, this secondary wave should be close in time 
and space to the primary outbreak. However, this secondary wave should be clearly 
distinct from the primary one.  
 
It is emphasized that these are ideal characteristics of outbreaks, and it may not necessarily 
preclude fitting of the data. 
 
1.5. Pathogens of interest 
The pathogens studied in this work include: (1) Legionella spp.; (2) Giardia lamblia; (3) 
Salmonella spp.; (4) Shigella spp.; (5) Escherichia coli O157:H7; and (6) Campylobacter jejuni.  
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1.5.1. Legionella spp.  
Legionella is a Gram-negative bacterium found in freshwater environments that includes L. 
pneumophila and L. longbeachae. It is the causative agent of legionellosis, a respiratory disease 
that infects susceptible populations when it is inhaled through aerosolized water. Legionnaires’ 
disease, a pneumonia caused by Legionella spp., and Pontiac fever, a milder, flu-like infection 
can also occur (Ellis 1993, Glick et al. 1978, Heyman 2004, Wharton et al. 1990). Most 
legionellosis cases are linked to human-made water environments where Legionella rapidly 
multiply in temperatures between 25°C and 45°C (Fields et al. 2002). Since water delivery 
systems (Atlas 1999), such as cooling towers, whirlpools, indoor fountains, air conditioning, and 
indoor plumbing often operate within these ranges, they provide ideal conditions for Legionella 
growth, and have been implicated in several outbreaks (Bartram 2007). Due to their ubiquitous 
presence in built-water environments, legionellosis has emerged as an important disease in the 
last half of the 20th century (Fields et al. 2002).  
 
1.5.2. Giardia lamblia  
Giardia lamblia is a zoonotic flagellated parasite that infects a wide variety of mammalian hosts 
through the fecal-oral route. Transmissions commonly occur when the fecal matter of an infected 
person or animal is ingested through foodstuffs and drinking water (Erlandsen and Meyer 1984, 
Ortega-Pierres 2009). Giardia cysts are immediately infectious once they are shed in feces, and 
are protected by a hard outer shell that allows them to survive outside the body for several weeks 
or months (Cole et al. 1989, Olson et al. 1999). Due to its stability and widespread distribution, 
Giardia is considered to be one of the most common causes of protozoan diarrhea in the world 
(Baldursson and Karanis 2011, Karanis et al. 2007).  
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1.5.3. Salmonella spp.  
Salmonella is a Gram-negative bacteria belonging to the Enterobacteriaceae family (Su and Chiu 
2007). Salmonellosis, the illness caused by non-typhoid Salmonella (NTS) primarily results in 
gastroenteritis (Heymann 2008). NTS causes diarrhea in some infected persons, while others may 
remain asymptomatic carriers who pass the pathogen in stool (Atlas 1999). Annually, an 
estimated 61.8 to 131.6 million cases (5th to 95th percentile) of gastroenteritis are due to 
Salmonella infections, causing between 39,000 to 303,000 deaths (Majowicz et al., 2010). 
Though the Salmonella family includes over 2,500 serotypes, S. enterica subsp. enterica serotype 
Typhimurium and S. enterica subsp. enterica serotype Newport rank in the top 
three Salmonella serotypes associated with foodborne outbreaks in the United States (CDC 2014). 
Therefore, in this work, attention is given to these pathogens. 
 
1.5.4. Shigella spp.  
Shigellosis, or bacillary dysentery, is an acute enteric infection spread directly or indirectly 
through the fecal-oral route of the genus Shigella (Heymann 2008, Scallan et al. 2011). Shigella 
are Gram-negative, non-motile bacilli belonging to the family Enterobacteriacae (Jin et al. 2002, 
WHO 2005). S. sonnei accounts for about 80% and 90% of Shigella infections in the U.S. and the 
United Kingdom (U.K.), respectively (Nygren et al. 2013, Pond and Organization 2005).  S. 
flexneri is the second most common species in the United States, accounting for 18% of Shigella 
isolates from 1989 to 2002 (Gupta et al. 2004). 
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1.5.5. Escherichia coli O157:H7 
Escherichia coli are rod-shaped, Gram-negative bacteria that are the predominant facultative 
anaerobe of the human intestinal tract (Nataro and Kaper 1998). E. coli O157:H7 is responsible 
for the greatest number of gastrointestinal cases in the U.S. (Mead et al. 1999) – over 96,000 
illnesses and 30 deaths due to E. coli O157:H7 occur annually (Scallan et al. 2011). Between 
1982 and 2002 there were 350 reported outbreaks of O157:H7 in the country (Rangel et al. 2005). 
 
1.5.6. Campylobacter jejuni  
Campylobacter bacteria are motile, non–spore-forming, Gram-negative rods (Garrity et al. 2006). 
They are the causative agent of campylobacteriosis, a disease of varying intensity characterized 
by gastroenteritis. Symptoms include loose bloody stools, abdominal pain, malaise, fever, nausea 
and vomiting (Heymann 2008, Ketley and Konkel 2005). C. jejuni, and to a much lesser extent C. 
coli, account for 90% of all reported cases (Wagenaar et al. 2015). Campylobacteriosis is one of 
the most widespread and commonly reported infectious diseases of the last century (Kaakoush et 
al. 2015), with 1.3 million reported cases in the U.S. in 2011 (Scallan et al. 2011). 
 
1.6. Dissertation structure 
The dissertation work is presented in nine chapters. Chapter 1 is a general introduction which 
provides background on epidemiology, dose-response, time-dose-response, and pathogens of 
interest. Chapter 2 provides a detailed development of time-dose-response models, mathematical 
models of outbreaks, fitting methods and evaluation criteria, and a partial validation of the model 
using Cryptosporidium. Chapters 3 through 8 apply the methodology discussed in Chapter 2 to 
the aforementioned pathogens, and provides the following results for each respective pathogen: 
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(1) non-time-dependent dose-response models; (2) time-dose-response models; (3) outbreak 
models containing time-dependent incubation periods; (4) outbreak models containing non-time-
dependent incubation periods; and (5) model criteria and parameter values for time-dependent- 
and non-time-dependent models. Chapter 9 summarizes the conclusions for this work and 
proposes potential future work in this field. It is to be noted that each pathogen chapter is 
designed to be a stand-alone piece of work; therefore, certain aspects, particularly the Methods 
section may be redundant.  
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Chapter 2: Mathematical models 
 
2.1. Introduction 
Each pathogen case studied in this dissertation follows the same general methodology: (1) a 
literature search is performed to obtain dose-response and outbreak data; (2) the dose-response 
data is modeled with the traditional (non-time-dependent) dose-response models; (3) the dose-
response data is modeled with the time-dose-response (TDR) models; and (4) the outbreak data is 
modeled with the TDR and non-time-dependent outbreak models. This chapter discusses each of 
the three models in detail, and provides a derivation of the outbreak model. 
  
2.2. Dose-response  
Traditional dose-response models predict the probability of adverse effects such as illness or 
death from the infection of a particular dose (Haas 1999). Two commonly used dose-response 
models are the exponential and beta-Poisson model (Haas 1999): 
 
𝑃(𝑑) = 1 − 𝑒−𝑘𝑑     Eq. 2.1 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 2.2 
In these expressions, 𝑃(𝑑) is the probability of positive response (illness, death, etc.), 𝑑 is dose, 
and 𝑘, 𝑁50 and 𝛼 are parameters of the exponential and beta-Poisson models. The exponential 
model assumes that each organism has an independent and identical probability of surviving and 
replicating in a host body; this probability is represented by the parameter 𝑘. If 𝑘 value is much 
less than 1, then the probability of infection is approximately 𝑃(𝑑) = 𝑘×𝑑. If 𝑘 is much greater 
than 1, then the exponential expression goes toward zero, and the probability of infection 
becomes very large. The beta-Poisson model introduces variability in the pathogen-host 
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interaction through the 𝛼 parameter. 𝑁50 is the dose at which 50% of the population is expected to 
be adversely affected. Both models have a mechanistic biological basis and exhibit linearity at 
low dose (Haas 1999). These models are beneficial because they can help predict how individual 
hosts respond to various levels of pathogens. 
 
Before a dosing study is used in the dose-response models, a Cochran-Armitage test of trend 
needs to be applied to determine whether there is an association between increasing dosages and 
adverse effects (Haas et al. 2014, Neuhäuser and Hothorn 1999). If such an association is 
determined, the data can be utilized in the dose-response models. Written formally, the Z-statistic 
is calculated by 
𝑍𝐶𝐴 =
∑ (𝑥𝑖−?̅?)
𝑘
𝑖=1 𝑝𝑖
√?̅?(1−?̅?) ∑ 𝑛𝑖(𝑥𝑖−?̅?)2
𝑘
𝑖=1
                                                   Eq. 2.3 
where  
?̅? =
∑ 𝑛𝑖𝑥𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
  and ?̅? =
∑ 𝑝𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
                                                  Eq. 2.4 
with 𝑥𝑖 the natural logarithm of the mean dose in group 𝑖, the 𝑛𝑖 total subjects and 𝑝𝑖 positive 
subjects. The null hypothesis of lack of trend is rejected if 𝑍𝐶𝐴 is greater than the upper 5
th 
percentile of the normal distribution, which is 1.64 for a one-tailed test. 
 
To fit a dose-response model to the data, a legacy code written in the R programming platform 
(www.r-project.org) was used. The minimized deviance (𝑌) of the respective model fits is given 
by: 
𝑌 = −2 ∑ [𝑝𝑖𝑙𝑛
𝜋𝑖
𝜋𝑖
0 + (𝑛𝑖 − 𝑝𝑖)𝑙𝑛
1−𝜋𝑖
1−𝜋𝑖
0]
𝑘
𝑖=1                                             Eq. 2.5 
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The parameters 𝜋𝑖  and 𝜋𝑖
0 are the predicted and observed responses of 𝑝𝑖 positive subjects within 
𝑛𝑖 number of subjects in the set (Haas et al. 2014). Goodness-of-fit is determined by comparing 
minimized deviance from maximum likelihood estimations (MLE) to the critical 2 distribution. 
The optimized deviance has a 2 distribution with (𝑚 –  𝑛) degrees of freedom, where m is the 
number of doses and n is the number of model parameters. The dose-response model is rejected if 
the minimized deviance is greater than the critical 2 value at 95% confidence level for (𝑚 –  𝑛) 
degree of freedom (𝑌 >  𝑚−𝑛,0.95
2 ). If both models provide acceptable fits, the beta-Poisson 
model may be selected as the best-fit model only if the difference in minimized deviances 
between the beta-Poisson and exponential models is greater than the critical 2 value for a one 
degree of freedom (the difference between the exponential and beta-Poisson degrees of freedom). 
Confidence intervals of the models were determined via bootstrapping with 10,000 iterations. The 
source code for the dose-response models are documented in Appendices A and B. 
 
Eight time-dose-response models were developed by Huang et al. (2009) by modifying the 
exponential and beta-Poisson dose-response models to include a time dependency that quantified 
the onset of symptoms from infection time. These TDR models describe the development of 
adverse host response over time. The eight models were tested to determine if they were true 
cumulative distribution functions (CDFs). The criteria for determining true CDF distributions is 
if: 
 
1. The function at time zero is zero (𝐹(𝑡 → 0) = 0), and the function at time approaches 
infinity is one (𝐹(𝑡 → ∞) = 1). 
2. The functions are monotonic, which means that for all 𝑎 and b, 𝑤𝑖𝑡ℎ 𝑎 ≤ 𝑏, 𝐹(𝑎) ≤
𝐹(𝑏), and the derivative of the function is greater than or equal to zero for all of time 
(
𝑑𝐹
𝑑𝑡
≥ 0 for all t).  
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Of the original 8 models, only 4 were true CDFs, and are presented in Table 2.1. The models that 
were not true CDFs were excluded from the study (Mendenhall, Beaver et al. 2012).  
 
Table 2.1 True CDF time-dependent dose-response models 
Model Name Expression 
Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 
Eq. 2.6 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 2.7 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 2.8 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 2.9 
 
𝑃(𝑑) is the probability of positive response, 𝑑 is the administered dose, 𝑘 is the parameter of 
exponential-time, and 𝑗 and 𝛼 are the parameters of the beta-Poisson-time model.  
 
The dose-response datasets were fit to the TDR models in Table 2.1. MLE was used to obtain 
deviance values in R. The likelihood ratio for the incidence occurring on the jth day with i dose 
groups is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋
𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1    Eq. 2.10 
where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made (generally recorded in day-long segments), 𝑝𝑖,𝑗 is the number of 
positive response observed during time period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the 
beginning of time period 𝑗. The predicted response is 𝜋𝑖, and the response for each set based on 
observations are 𝜋𝑖
°. The corresponding deviance is  
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𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1   Eq. 2.11 
This expression is similar to the traditional dose-response, in which only the long-term endpoint 
is known (Haas et al. 2014).  The difference between this expression and the expression normally 
used in dose-response modeling is that the number of positive responses corresponds to a specific 
time period rather than at the end of observations (Haas et al. 2014). The source code for the TDR 
models are documented in Appendix C. 
 
2.4. Outbreak model  
Attention is now turned from the dose-response models to the outbreak model. In his 1999 
dissertation, Mukul Gupta developed a compartment model that included susceptible, latent, 
asymptomatic and symptomatically ill persons (Gupta 1999) (Figure 2.1).  
 
 
 
 
Figure 2.1 Modified SIR Model proposed by Gupta (Kermack and McKendrick 1927, Gupta and Haas 2004) 
 
 
 
The number of susceptible individuals in a population is given by the function 𝑋(𝑡). A fraction of 
these individuals pass into the latent state 𝑌(𝑡) at a rate of 𝛽(𝑡). The individuals in the latent state 
can either become asymptomatic 𝐼(𝑡) at a rate 𝑅(𝑡), or symptomatically ill 𝑍(𝑡) at a rate of 𝑄(𝑡). 
24 
 
 
 
Recovery is omitted in this particular scenario. The differential equations governing this 
compartment model states are summarized in Table 2.2. 
 
Table 2.2. The equations governing the primary spread SIR model. 
SIR Compartment Description SIR Compartment Expression 
Eq’n 
number 
Rate of change of Susceptible individuals 
𝑑𝑋
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡) Eq. 2.12 
Rate of change of Latent individuals 
𝑑𝑌
𝑑𝑡
= 𝛽(𝑡)𝑋(𝑡) − 𝑄(𝑡) − 𝑅(𝑡) Eq. 2.13 
Rate of change of Symptomatically Ill individuals 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡) Eq. 2.14 
Rate of change of Asymptomatically Ill individuals 
𝑑𝐼
𝑑𝑡
= 𝑅(𝑡) Eq. 2.15 
 
 
 
In the case of a common source outbreak, we are more concerned with 𝑄(𝑡) rather than 𝑅(𝑡) for 
practical purposes, as individuals who do not exhibit any symptoms of disease do not seek 
professional care, although for contagious diseases, some of the asymptomatic individuals may be 
the source of secondary cases. Therefore, these data are also more readily available.  
 
In Figure 2.1, the change in the susceptible population with respect to time 
𝑑𝑋
𝑑𝑡
 is defined as 
𝑑𝑋
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), 𝑜𝑟 
1
𝑋
𝑑𝑋
𝑑𝑡
= −𝛽(𝑡)                                               Eq. 2.16 
𝛽(𝑡) is the force of infectivity, or the transfer rate constant for the movement of individuals from 
the susceptible to infected state. Solving this differential equation yields 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
       Eq. 2.17 
Similarly, the movement of individuals form infected to ill can also be given by the differential 
equation 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡)𝑌(𝑡)      Eq. 2.18 
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where 𝑄(𝑡) is transfer rate constant for the movement of individuals from the infected to the 
diseased state. Continuous probability density distribution functions can be used for modeling the 
exposure and incubation times of a common source outbreak. The instantaneous rate of new 
illnesses 
𝑑𝑍
𝑑𝑡
 can also be written as the convolution integral 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡)𝑌(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
                                        Eq. 2.19 
where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). 𝑄(𝑡) is a function of 
the attack distribution 𝛽 and the incubation time distribution 𝑓. The function 𝑓 is a probability 
density function (PDF) which may have parameters that need to be estimated, while the force of 
infection 𝛽(t) has units of inverse time, and is a versatile parameter. In the case of a rectangular 
distribution for infectivity, 𝛽(t) would be a constant for the exposure duration. However, common 
source outbreaks are frequently caused by time variable microbial exposures, which means that 
the parameter takes the form of a density distribution, generally of the following form: 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)    
   Eq. 2.20 
where 𝑏0 is the background infectivity level, 𝑏1 is the scaling factor for the statistical distribution 
used to model the increased infectivity above background, and 𝑔 is the exposure PDF with 
parameters that need to be estimated. Substituting Eq. 2.17 into Eq. 2.19 we then obtain: 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝑋0𝛽(𝜏)exp [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 2.21 
where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the cumulative distribution function (CDF) 
corresponding to the PDF 𝑔(𝑡). Integrating Eq. 2.21 directly, we can solve for Z and obtain a 
direct result: 
𝑍(𝑡) = ∫ ∫ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑  Eq. 2.22 
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where 𝑋0 is the number of initial susceptible persons and 𝜏 is the actual time of infection. The 
𝑔(𝑡) and 𝑓(𝑡) functions are the exposure and incubation functions, respectively. These 
parameters can be determined through inverse calibration by fitting the model to observed 
epidemic curves. For illustrative purposes, Figure 2.2 shows the full outbreak model in which a 
Weibull exposure distribution is convoluted with a lognormal incubation distribution. 
 
 
 
Figure 2.2 Weibull exposure distribution convoluted with lognormal incubation distribution for the primary source 
outbreak. 
 
 
 
Attention is now turned to the person-to-person cases. In order to model the scenario of secondary 
attacks, the SIR framework equations must be modified. Secondary transmissions were initially 
modeled by Kermack and McKendrick as the product of susceptible and infected individuals 
multiplied by a transmission factor (Kermack 1927, Kermack 1932, Kermack 1933). This was 
extended by Anderson and May who incorporated demographic and epidemiological parameters 
such as age-specific death rate and recovery rates (Anderson and May 1991). 
 
Anderson and May described the number of newly infected persons per unit time in a secondary 
infection as 𝛾(𝑡)𝑥(𝑡)𝑧(𝑡) (Anderson and May 1992). As defined previously, X(t) is the number 
of susceptibles, and Z(t) is the number of symptomatically ill individuals. Here, γ(t) is a 
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parameter that is dependent upon the physical properties of a given outbreak, such as the contact 
rate and dose that is transmitted from one contact to another. The inclusion of the individuals in 
the asymptomatically and symptomatically ill states accounts for the fact that they have the ability 
to transfer infection to other susceptible individuals, given the physical parameter value 𝛾(𝑡). 
This expression for the number of newly infected due to secondary exposure can be incorporated 
into the original SIR expressions, which had originally neglected this case. If we are at the latter 
stages after the primary contamination has decreased, we expect that the force of infectivity 𝛽 is 
approximately 0, and is negligable. The new SIR expressions are listed below in Table 2.3. 
 
Table 2.3. The equations governing the secondary spread SIR model. 
SIR Compartment Description SIR Compartment Expression 
Eq’n 
number 
Rate of change of Susceptible individuals 
𝑑𝑋
𝑑𝑡
= −𝛾(𝑡)𝑋(𝑡)𝑍(𝑡) Eq. 2.23 
Rate of change of Latent individuals 
𝑑𝑌
𝑑𝑡
= 𝛾(𝑡)𝑋(𝑡)𝑍(𝑡) Eq. 2.24 
Rate of change of Symptomatically Ill individuals 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡) Eq. 2.25 
Rate of change of Asymptomatically Ill individuals 
𝑑𝐼
𝑑𝑡
=
1 − 𝜆
𝜆
𝑄(𝑡) Eq. 2.26 
 
The number of newly symptomatically ill individuals per unit time (Z) must be determined. We 
can re-derive this expression using a similar method we used to derive primary infection spread.  
𝑑𝑥
𝑑𝑡
= −
𝑑𝑦
𝑑𝑡
     Eq. 2.27 
Separating the variables and solving, 
𝑥(𝑡) = 𝑥0 + (𝑦0 − 𝑦(𝑡))    Eq. 2.28 
Then, 
𝑑𝑧
𝑑𝑡
= 𝑄(𝑡)𝑌(𝑡) = ∫ [𝛾(𝜏)𝑥(𝜏)𝑧(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
   Eq. 2.29 
Plugging in x(t), 
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𝑑𝑧
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝛾(𝜏)𝑧(𝜏)[𝑥0 + (𝑦0 − 𝑦(𝜏))] ∗ 𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
  Eq. 2.30 
And 
𝑍(𝑡) = ∫ ∫ 𝛾(𝜏)𝑧(𝜏)[𝑥0 + (𝑦0 − 𝑦(𝜏))] ∗ 𝑓(𝑡 − 𝜏)
𝑡
0
𝑑𝜏𝑑𝜑
𝑡
0
  Eq. 2.31 
Eq. 2.31 is analogous to Eq. 2.22, which models common source outbreaks. Recall that 𝑍(𝑡) is 
the number of individuals who are symptomatically ill at time 𝑡. For this expression, there are 
functions that not present in the common source outbreak: 𝑦(𝜏), the PDF which describes the 
number of latent individuals at time of infection 𝜏; and 𝑧(𝜏), the PDF which describes the number 
of symptomatically ill individuals at the time of infection 𝜏. These 2 PDFs along with the 
parameter 𝛾 are components of the exposure distribution, while 𝑓(𝜑 − 𝜏) is the density function 
for the incubation distribution.  
 
Figure 2.3 shows an example of the person-to-person outbreak model, in which a Weibull 
exposure distribution is convoluted with a lognormal incubation distribution. 
 
 
Figure 2.3 Weibull exposure distribution convoluted with lognormal incubation distribution for the primary source 
outbreak. 
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2.5. Incorporation of TDR in SIR models  
The time-dose-response functions from Table 2.1 cannot be immediately used as incubation 
distributions because they are CDFs. To derive a time dose-response based incubation 
distribution to fit epidemiologic curves, the distributions must be PDFs. To get a PDF from a 
CDF, the derivative must be taken. In the case of the beta-Poisson time dose-response with 
inverse time dependency, we have the following equation:  
𝑅(𝑑, 𝑡) = 1 − [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 2.32 
𝑅(𝑑, 𝑡) is the probability of adverse effect; α is a fitting parameter; θ is a time parameter; 
𝑗0
𝑡
+ 1 
is the dose that elicits a positive response in 50% of the hosts, after infinite time. Taking the first 
partial derivative with respect to time, we get 
𝑟(𝑑, 𝑡) = −𝛼 [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼−1
×𝑑 (2
1
𝛼 − 1)
𝑗0
𝑡2
           Eq. 2.33 
However, we want that to make sure that our function is a true PDF. Probability density functions 
satisfy the following conditions: 
1. 𝑓(𝑥) ≥ 0 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑥 
2. ∫ 𝑓(𝑥)𝑑𝑥 = 1
∞
−∞
 
As time goes to infinity, we want the integral of our distribution to be exactly 1.  So we must 
divide by a certain value that ensures that this is true. As 𝑡 → ∞, the maximum response is 
reached for the time dose response. Then Eq. 2.33 no longer becomes time-dependent, and we 
refer to the parameter TDR dependency equation in Table 2.1, which assumed that 𝑁50 =
𝑗0
𝑡
+ 1. 
Plugging in 𝑁50 for the expression in the denominator returns us back to the regular beta-Poisson 
dose-response model. 
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𝑅(𝑑, 𝑡 → ∞) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
   Eq. 2.34 
This expression can be used as the constant for which Eq. 2.33 can be divided. If we divide Eq. 
2.33 by Eq. 2.34, we get the following function: 
𝑓(𝑡|𝑑) =
𝛼[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼−1
×𝑑(2
1
𝛼−1)𝑗0
𝑡2(−1+[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼
)
   Eq. 2.35 
We now have a proper PDF 𝑓(𝑡|𝑑) that characterizes the distribution. This PDF based on the 
beta-Poisson time dose-response function distribution can now be used as a potential incubation 
distribution 𝑓(𝑡) to use in the probability density function used to calculate the number of ill, 
𝑍(𝑡). The functions used to model the exposure distributions (𝑔(𝑡) that is embedded in 𝛽(𝜏) and 
𝐵(𝜏) in Eq. 2.22 for common source outbreaks; 𝑦(𝜏) and 𝑧(𝜏) in Eq. 2.31 for person-to-person 
spread) include the Weibull, gamma, lognormal and uniform distributions. The incubation 
distribution (𝑓(𝜑 − 𝜏) in Eq. 2.22 for common source outbreaks and in Eq. 2.31 for person-to-
person spread) is fit by the Weibull, gamma, lognormal and uniform distributions and the 
corresponding PDF for the best-fit TDR model. 
 
In Figure 2.4 below, the effects of varying several of the parameters on the beta-Poisson with 
inverse time dependency CDF (Eq. 2.35) were examined.  
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Figure 2.4 Effect of parameters 𝑗0; 𝑗1; 𝛼; and 𝑑 on 𝑓(𝑡|𝑑). (top, left) The 𝑗0 parameter is varied from 3 to 20. (top, 
right) The 𝑗1 parameter is varied from 0.001 to 10. (bottom, left) The 𝛼 parameter is varied from 0.1 to 10. (bottom, 
right) The 𝑑 is varied from 5 to 25. 
 
 
 
The 𝑗0 parameter was varied from 3 to 20, at constant 𝑗1, 𝛼, and 𝑑. The parameter 𝑗1 was varied 
from 0.001 to 10, 𝛼 was varied from 0.1 to 10, and finally, 𝑑 was varied from 0.01 to 5, keeping 
the other respective parameters constant. Interestingly, as the parameter 𝑗0 increases, the curve 
becomes more peaked, with a greater response value in an earlier time span. When the 𝑗1 value 
increases, the density curves shift to the right, and when 𝑑 increases, the density curves shift left. 
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Similar derivations for the remaining CDF time-dependent models were made to transform the 
equations to PDFs. The distributions used for the exposure and incubation functions are presented 
in Table 2.4. As described earlier, the (i) Weibull, (ii) gamma, (iii) lognormal, and (iv) uniform 
density functions were used for both exposure 𝑔(𝑡) and incubation 𝑓(𝑡 − 𝜏) distributions. In 
addition, the TDR models were used as the incubation 𝑓(𝑡 − 𝜏) distributions: (i) exponential 
model with exponential reciprocal dependency, (ii) beta-Poisson model with exponential 
reciprocal dependency, (iii) beta-Poisson model with exponential dependency, and the (iv) beta-
Poisson model with inverse dependency. 
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Table 2.4 Distributions used to model the exposure and incubation periods. 
Function Expression 
Equation 
number 
E
x
p
o
su
re
 a
n
d
 I
n
cu
b
at
io
n
 
D
is
tr
ib
u
ti
o
n
s 
Weibull 𝑓(𝜏|𝑎, 𝑏) =
𝑏
𝑎
(
𝜏
𝑎
)
𝑏−1
𝑒−(
𝜏
𝑎
)𝑏
 Eq. 2.36 
Gamma 𝑓(𝜏|𝑎, 𝑏) =
1
𝑏𝑎Γ(𝑎)
𝜏𝑎−1𝑒−
𝜏
𝑏 Eq. 2.37 
Lognormal 𝑓(𝜏|𝜇, 𝜎) =
1
𝜏𝜎√2𝜋
𝑒
−(𝑙𝑛𝜏−𝜇)2
2𝜎2  Eq. 2.38 
Uniform 𝑓(𝜏|𝑎, 𝑏) =
𝜏 − 𝑎
𝑏 − 𝑎
𝐼[𝑎,𝑏](𝜏) Eq. 2.39 
In
cu
b
at
io
n
 D
is
tr
ib
u
ti
o
n
s 
Exponential 
Model with 
Exponential 
Reciprocal 
Time 
Dependency 
𝑓(𝑡|𝑑) = 𝑒−𝑒
(−
𝑘0
𝑡 )𝑑 Eq. 2.40 
Beta-Poisson 
Model with 
Exponential 
Reciprocal 
Time 
Dependency 
𝑓(𝑡|𝑑) =
−∝ [1 + 𝑑×𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
∝ − 1)]
−∝−1
×𝑑 (2
1
∝ − 1) 𝑗0𝑒
𝑗0
𝑡+𝑗1
(𝑡 + 𝑗1)2 (1 − [1 +
𝑑
𝑁50
× (2
1
∝ − 1)]
−∝
)
 Eq. 2.41 
Beta-Poisson 
Model with 
Exponential 
Time 
Dependency 
𝑓(𝑡|𝑑)
=
−∝ [1 + 𝑑×𝑒(𝑗0×𝑡+𝑗1)× (2
1
∝ − 1)]
−∝−1
×𝑑 (2
1
∝ − 1) 𝑗0𝑒
(𝑗0×𝑡+𝑗1)
(𝑡 + 𝑗1)2 (1 − [1 +
𝑑
𝑁50
× (2
1
∝ − 1)]
−∝
)
 
Eq. 2.42 
Beta-Poisson 
Model with 
Inverse Time 
Dependency 
𝑓(𝑡|𝑑)
=
−∝ [1 + 𝑑× (
𝑗0
𝑡 + 1) × (2
1
∝ − 1)]
−∝−1
×𝑑 (2
1
∝ − 1) 𝑗0 (
𝑗0
𝑡 + 1)
(𝑡 + 𝑗1)2 (1 − [1 +
𝑑
𝑁50
× (2
1
∝ − 1)]
−∝
)
 
Eq. 2.43 
 
In the common source outbreak model (Eq. 2.22), we have several parameters that need to be 
optimized: the attack parameters 𝑏0 and  𝑏1, the two PDF parameters for the exposure distribution 
and between two and four PDF parameters for the incubation distribution (Weibull, gamma, 
lognormal and uniform distributions all contain two parameters; the TDR models contain between 
two and four). In the person-to-person outbreak (Eq. 2.31), we must determine the contact rate 
parameter 𝛾, the four parameters in the attack distribution, and between two and four PDF 
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parameters in the incubation distribution (again, the Weibull, gamma, lognormal and uniform 
distributions all contain two parameters; the TDR models contain between two and four). 
 
To compare the results of the outbreak models, deviance, Akaike information criterion (AIC) and 
Bayesian information criterion (BIC) values are examined: 
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 2.44 
𝐴𝐼𝐶 = 2𝑘 − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]                   Eq. 2.45 
𝐵𝐼𝐶 = 𝑘 ∗ 𝑙𝑛(𝑛) − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]           Eq. 2.46 
The parameters 𝜃?̂? are the values of the full model (observed values), and 𝜃0̂ are the values of the 
predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and thus we can see that 
the AIC and BIC is the deviance plus a complexity parameter. BIC penalizes model complexity 
more than AIC does (Ruppert 2011). The outbreak model with the lowest deviance, AIC and BIC 
are the best-fit. Since some TDR models have extra parameters, they will have higher AIC and 
BIC values. 
 
 
2.6. Matlab code  
Since Gupta’s original outbreak code had been written in 1999, it could no longer run on newer 
versions of Matlab and needed to be redeveloped. A new model was written in Matlab to fit the 
outbreak dataset. An optimization algorithm was used to evaluate an objective function using 
input from a set of assumed values for the model parameters.  
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Assuming Poisson distribution, the likelihood of newly ill cases 𝑍(𝑡) is defined by 
𝐿 =
exp (−𝜂)𝜂𝑁
𝑁!
       Eq. 2.47 
where 𝐿 is the maximum likelihood function, 𝜂 is the predicted number of new cases, and 𝑁 is 
observed number of cases. The maximum likelihood for the full model is defined by 
?̂? =
exp (−𝑁)𝑁𝑁
𝑁!
     Eq. 2.48 
where the observed case is the same as the predicted number of cases and 𝜂 = 𝑁. The likelihood 
ratio (𝐿/?̂?) is the objective function 
−2𝑙𝑛 (
𝐿
?̂?
) = 2 [(𝜂 − 𝑁) − 𝑁𝑙𝑛 (
𝜂
𝑁
)]      Eq. 2.49 
The objective function was minimized by varying the assumed parameters in search of a global 
minimum value. Each unique combination of assumed values corresponds to a calculated value 
for the predicted number of cases per day 𝑍(𝑡), from which a corresponding value for the daily 
likelihood ratio objective function is calculated. An overall objective function is then calculated, 
which is the sum total of all the individual daily objective functions −2𝑙𝑛 (
𝐿
?̂?
) throughout the 
entire outbreak. The routine function ‘fmins,’ which has the ability to minimize functions with 
several parameters and uses a Nelder-Mead simplex, was utilized to fit the dataset. 
 
Figure 2.5 shows a flow chart illustrating the sequence of procedure calls within the computer 
model.  
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Figure 2.5 Flowchart of procedure calls in the optimization model 
 
 
 
This entire process was iterative. For each exposure-incubation combination, the following 
process was applied. A set of assumed parameter values were first input into the simulation 
model, and the corresponding predicted daily ill cases 𝑍(𝑡) was evaluated using the function 
‘quad2d.’ The summation of the daily objective function −2𝑙𝑛 (
𝐿
?̂?
) over the entire duration of the 
outbreak was then calculated. The program varied the initial guesses, and continued to calculate 
the deviance objective function until convergence was assumed, which was assumed to be less 
than 10−3. Appendix D contains the computer optimization program based on the mathematical 
equations underlying this model. 
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The parameter values obtained by the Gupta and new codes do have slight variation. For 
example, Gupta modeled the 1990-91 Shigella outbreak in Crete (Samonis, Elting et al. 1994) 
using a Weibull incubation distribution, and for comparison, the author modeled the same 
outbreak, also using a Weibull incubation distribution. Gupta reports only the incubation 
distribution parameters 𝑎 and 𝑏, which are presented alongside the 𝑎 and 𝑏 parameters from the 
new code (Table 2.5).  
  
 
Table 2.5 Comparison of new and Gupta output for Shigella model 
 Incubation distribution parameter 𝑎 Incubation distribution parameter 𝑏 
New code 19.51 13.30 
Gupta code 4.24 3.29 
 
 
 
It can be seen that 𝑎 and 𝑏 vary considerably. Parameter 𝑎 = 19.51 in the new code, and 𝑎 =
4.24 in the Gupta code. In the new code, 𝑏 = 13.30 while 𝑏 = 3.29 in the Gupta code. A plot 
was generated in Matlab that graphs the Weibull density function using the curve using the 𝑎 and 
𝑏 distribution parameters from the new and Gupta code, respectively (Figure 2.6). 
 
 
Figure 2.6 Visual comparison of Gupta and new code parameters. 
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The new parameters are shifted toward the right compared to the Gupta parameters. The 
discrepancies are likely due to differences in the code. In Gupta’s code, the function that is 
minimized is 𝑄(𝑡), the rate at which persons became symptomatically ill; in the new code, 𝑍(𝑡), 
the number of ill persons per day, is minimized. Also in Gupta’s code, the 𝑄(𝑡) integral is 
evaluated using trapezoidal numerical integration using the function ‘trapz’; in the new code, we 
have a double integral in 𝑍(𝑡) that is evaluated by the Matlab function ‘quad2d.’ 
 
Figure 2.7 shows the Weibull incubation fit to the Shigella outbreak. Visually from the graphs, 
the two model fits appear to have differences, which may be due to the differences in the two 
distribution parameters. However, both models are comparable, and give acceptable fits for the 
number of data points. 
 
 
 
Figure 2.7 (left) Gupta and (right) new output for Shigella model 
 
 
 
 
2.6.1. Partial method validation 
Gupta’s outbreak methodology was validated in his paper, in which the model provided an 
acceptable fit to a Cryptosporidium outbreak in Milwaukee (Mac Kenzie, Hoxie et al. 1994, 
Gupta and Haas 2004). In order to partially validate the new outbreak methodology, and to 
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compare these results with Gupta’s work, the same Milwaukee Cryptosporidium outbreak was 
modelled in this work, along with dose-response and TDR models for the Cryptosporidium 
pathogen. 
2.6.1.1. Introduction 
Cryptosporidium parvum is a pathogenic protozoan that is the causative agent of 
cryptosporidiosis, which can result in gastrointestinal illness in humans (Heyman 2004). C. 
parvum is spread through the fecal-oral route, and its tough outer shell enables it to survive 
outside a host at length. Symptoms often include stomach cramps, dehydration, nausea, vomiting 
and fever, although some of those infected with the pathogen will exhibit no symptoms (Heyman 
2004). It is one of the most common causes of waterborne disease in humans in the United States, 
where an estimated 748,000 cases of cryptosporidiosis occur each year (Scallan, Hoekstra et al. 
2011).  
 
2.6.1.2. Dose-response and outbreak datasets 
A literature search was first performed to find usable C. parvum dose-response and outbreak 
datasets. Dupont et al. (1995) inoculated 29 human volunteers with oocysts concentrations 
ranging between 30 to 1 million, sourced from fresh calf stool samples. The oocysts were 
administered orally through gelatin capsule vehicles within one hour of preparation, along with 
250 ml of buffered saline. The volunteers, who were divided in groups of three to six, were then 
monitored for oocyst excretion and clinical illness for eight weeks. The positive detections for 
each respective day were documented, making it suitable to be analyzed by maximum likelihood 
estimation. The Milwaukee occurred in the spring of 1993 (MacKenzie et al. 1994) and 
documented 254 laboratory-confirmed cases of cryptosporidiosis with no secondary spread. It 
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was estimated that 419,000 residents suffered from watery diarrhea, which was caused by oocyst 
contamination in one of the city’s water treatment plants (MacKenzie et al. 1994). 
 
2.6.1.3. Dose-response and time-dose-response models 
The dosages administered to the human volunteers and the adverse responses are recorded in 
Table 2.6. Individuals exposed to doses as low as 100 oocysts were infected. Infection was 
defined to be the appearance of oocysts in stool samples. The incubation period of the fecal 
oocysts post-inoculation ranged from 4 to 22 days, with a mean of 9 days.  
 
 
Table 2.6 Daily infection of humans exposed to Cryptosporidium parvum via the oral route (DuPont, Chappell et al. 
1995). 
 Day post-inoculation 
Doseb 1 2 3 4 5 6 7 8 9 10 11 20 25 Total 
30 0 0 0 0 0 0 0 0 0 0 0 20 20 20 
100 0 0 0 0 12 12 25 25 37.5 37.5 37.5 37.5 37.5 37.5 
300 0 0 0 0 0 0 0 0 0 0 33 33 66 66 
500 0 0 17 50 67 83 83 83 83 83 83 83 83 83 
𝟏×𝟏𝟎𝟑 0 0 0 0 0 0 50 50 100 100 100 100 100 100 
𝟏×𝟏𝟎𝟒 0 0 0 0 67 67 100 100 100 100 100 100 100 100 
𝟏×𝟏𝟎𝟓 0 0 0 100 100 100 100 100 100 100 100 100 100 100 
𝟏×𝟏𝟎𝟔 0 100 100 100 100 100 100 100 100 100 100 100 100 100 
 
 
 
Results of the non-time-dependent dose-response model fits to the DuPont et al. (1995) dataset 
are provided in Table 2.7 The difference in the minimized deviance between two models is 
compared to the critical 𝜒2 value at its degree of freedom. The deviance values in Table 2.7 show 
that the best-fit model in this case is the exponential model, since it has the lowest deviance value 
of 0.503, less than the 𝜒2 value of 14.1 at that degree of freedom. The 𝑘 value is  
4.19×10−3, an order of magnitude less than the previously published value for humans (Enger 
2013).  The plot showing the best-fit model with confidence intervals is presented in Figure 2.8. 
 
 
41 
 
 
 
 
 
 
 
Table 2.7 Dose-response model parameter and criterion values 
Model 
Parameter 
Deviance dfa 𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 Conclusions Best fit modelc 
type value 
Expd k 4.19×10−3 0.503 7 14.1 Exp and BP 
provide 
acceptable fit 
Exponential 
BPe 
α 3.16 
0.371 6 12.6 
N50 148 
a df - degrees of freedom for dataset and model 
b  critical values of the 𝜒2 distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, m is the 
number of doses, n is the number of parameters 
c Best fit model criteria - the lowest deviance of candidate models was chosen compared to the critical values of 𝜒2  
distribution  
d Exponential Model 
e beta-Poisson Model 
 
 
 
 
 
Figure 2.8 (left) Exponential (dotted line) and beta-Poisson (solid line) models; (right) Best-fit exponential model and 
confidence intervals.  
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The dosing study dataset was next fit to the time-dependent dose-response models in Table 2.1. 
Goodness-of-fit was evaluated by comparing the minimized deviance values to the critical 2 
value at significance level 0.05 and with degrees of freedom equal to the number of observations 
minus the number of parameters used in the model. AIC values were additionally examined. 
Results from the TDR models are summarized in Table 2.8. The best-fit TDR model with the 
lowest minimized deviance and AIC values is the beta-Poisson model with exponential time 
dependency, with values of 62.93 and 68.93, respectively. The plot of this model is presented in 
Figure 2.9. 
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Table 2.8 Summary of fits to time-dependent dose-response data to oral exposure to Cryptosporidium 
Time Dependence Model 
Best fit 
parameters 
AIC 
Minimized 
deviance 
2
,05.0 df  Acceptable fit 
Beta-Poisson model with 
exponential time 
dependency 
∝= 0.647 
68.93 62.93 107.5 Yes 𝑗0 = 17.96 
𝑗
1
= 4.082 
Beta-Poisson model with 
exponential-reciprocal 
time dependency 
∝= 4.27 
150.35 144.35 107.5 No 𝑗0 = 0.0473 
𝑗
1
= 4.082 
Beta-Poisson model with 
inverse time dependency 
∝= 4.278 
77.41 73.41 108.6 Yes 
𝑗
0
= 0.047 
Exponential model with 
exponential-reciprocal 
time dependency 
𝑘0 = 0.0473 75.41 73.41 109.8 Yes 
 
 
 
Figure 2.9 Cumulative response data and beta-Poisson with exponential time dependency model predictions for the 
DuPont et al. dataset 
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2.6.1.4. Outbreak model 
Confirmed cases of illness from the C. parvum outbreak, documented by MacKenzie et al. (1994) 
are listed in Table 2.9. 
 
Table 2.9 Confirmed cases in Cryptosporidium outbreak, by date of symptom onset (Mac Kenzie, Hoxie et al. 1994). 
Start Day End Day Number of Cases 
1 2 1 
2 3 2 
3 4 3 
4 5 4 
5 6 3 
6 7 5 
7 8 5 
8 9 8 
9 10 7 
10 11 12 
11 12 22 
12 13 7 
13 14 22 
14 15 25 
15 16 22 
16 17 18 
17 18 19 
18 19 9 
19 20 12 
20 21 11 
21 22 5 
22 23 5 
23 24 3 
 
 
 
The CDF of the best-fit TDR model (Table 2.4) was next inserted into the incubation distribution 
𝑓(𝜑 − 𝜏) in Eq. 2.22 and convoluted with Weibull, gamma, lognormal and uniform exposure 
distributions, respectively. Sixteen additional non-time-dependent exposure-incubation 
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convolutions were run for a total of twenty combinations. Models were generated using Matlab to 
predict a best fit to the overall epidemic curve by utilizing a MLE approach.  
 
Table 2.10 summarizes the 6 model parameters of the outbreak optimization code. The first and 
second column are the optimized 𝑏0 and 𝑏1 attack rate parameters, generally on the order of 10
−3 
and 10−1, respectively. These low levels indicate that a low incidence rate of Cryptosporidium 
among this particular susceptible population. The 3rd and 4th columns are referred to as “PDF 
param 1” and “PDF param 2,” and they differ according to the distributions used. For the gamma 
distribution, PDF param 1 and PDF param 2 are the mean and variance. In the lognormal 
distributions, PDF param 1 and PDF param 2 are the log transform of the mean and variance. In 
the Weibull distribution, PDF param 1 and PDF param 2 are the scale parameter 𝑎 and shape 
parameter 𝑏 for the function. The uniform similarly follows the Weibull, and uses parameters 
𝑎 and 𝑏 in the PDF, with 𝑎 being a lower endpoint (minimum) and 𝑏 being an upper endpoint 
(maximum).  
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 2.10 Summary of parameter values for Exposure/Incubation distribution model. 
  Model Parameters  
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
param 
b1 
Expos dist 
PDF param 
1 
Expos dist 
PDF param 
2 
Incub dist 
PDF param 
1 
Incub dist 
PDF param 
2 
Incub dist 
PDF param 
3 
Incub dist 
PDF param 
4 
Weibull 
Weibull 4.53×10−3 0.523 20.3a 5.59b 1.77a 3.14b n/a n/a 
Gamma 4.94×10−3 0.531 20.3a 5.73b 1.41c 5.22d n/a n/a 
Lognormal 5.14×10−3 0.518 19.4a 5.94b 6.68×10−2e 7.17f n/a n/a 
Uniform 6.02×10−3 0.552 20.2a 6.10b 1.26g 2.54h n/a n/a 
BP with exp 1.95×10−8 0.257 20.9a 4.59b 5.96i 9.02×10−3 j 5.34k 1.07l 
Gamma 
Weibull 6.08×10−3 0.524 18.8c 13.2d 1.86a 5.49b n/a n/a 
Gamma 5.48×10−3 0.500 19.6c 16.2d 1.47c 3.32d n/a n/a 
Lognormal 6.00×10−3 0.496 18.2c 13.9d 1.28e 5.79f n/a n/a 
Uniform 7.43×10−3 0.395 18.7c 8.71d 1.29g 6.35h n/a n/a 
BP with exp 9.11×10−3 15.5 36.7c 1.42d 1.12i 3.25j 2.45k 3.76l 
Lognormal 
Weibull 5.10×10−3 0.518 19.4e 5.94f 6.68×10−2a 1.17b n/a n/a 
Gamma − − − − − − − − 
Lognormal 6.02×10−3 0.552 20.2e 6.10f 1.26e 6.54f n/a n/a 
Uniform − − − − − − − − 
BP with exp 8.52×10−3 0.947 3.03e 0.22f 2.49i 6.82×10−43j 5.38k 4.84l 
Uniform 
Weibull 3.69×10−2 0.150 3.37g 4.27h 15.3a 2.24b n/a n/a 
Gamma 9.28×10−2 6.04×10−19 0.50g 0.62h 21.9c 235d n/a n/a 
Lognormal 9.39×10−2 1.00×10−4 1.31g 1.31h 2.93e 0.91f n/a n/a 
Uniform 2.90×10−3 3.79 3.81g 0.34h 1.39g 21.3h n/a n/a 
BP with exp 1.40×10−4 4.46×10−63 1.15g 1.47h 6.83i 0.72j 3.59k 2.47l 
a mean 
b variance 
c log transform of 
mean 
d log transform of variance 
e lower endpoint 
f upper endpoint 
g scale parameter 
h shape parameterr 4
6
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To determine which distribution convolution fit the data best, we look to the deviance values 
(Table 2.11). The lowest criterion value was for the Weibull exposure-beta-Poisson incubation 
distributions at 18.3, closely followed by the gamma exposure-beta-Poisson incubation 
distribution at 18.6. The uniform exposure distributions have the highest deviance values.  
 
 
 
Table 2.11 Criterion values for Exposure/Incubation distribution models. 
Exposure Distribution Incubation Distribution Deviance 
Weibull 
Weibull 19.4 
Gamma 18.9 
Lognormal 19.3 
Uniform 22.6 
BP with exp time dep 18.3 
Gamma 
Weibull 21.5 
Gamma 20.2 
Lognormal 21.5 
Uniform 30.8 
BP with exp time dep 18.6 
Lognormal 
Weibull 21.8 
Gamma -- 
Lognormal 24.2 
Uniform -- 
BP with exp time dep 21.4 
Uniform 
Weibull 80.3 
Gamma 83.7 
Lognormal 92.3 
Uniform 83.7 
BP with exp time dep 123 
 
 
 
In his work, Gupta (1999) modelled a Weibull exposure period convoluted with an inverse 
Gaussian incubation period. He reported infectivity and baseline levels of the pathogen to be 
0.0021 and 0.048, respectively. These values are of the same order of magnitude with our 𝑏0 and 
𝑏1 parameters, which are generally of the order of 10
−3 and  10−1, respectively. Both models 
imply a low base level of Cryptosporidium in the Milwaukee area prior to the outbreak. Gupta 
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reported a deviance level of 20.02, which is comparable to the values that were generated with the 
new model. 
 
Figure 2.10 plots the outbreak data each of the model runs.  
 
 
 
Figure 2.10 Summary of curve fits for Exposure/Incubation distribution models. 
 
 
 
The methodology described in this chapter will be applied to the following pathogens: Legionella, 
Giardia, Salmonella, Shigella, Escherichia coli O157:H7, and Campylobacter. 
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Chapter 3: Legionella1 
 
3.1. Abstract 
A novel method was used to incorporate in-vivo host-pathogen dynamics into a new robust 
outbreak model for legionellosis. Dose-response and time-dose-response (TDR) models were 
generated for Legionella longbeachae exposure to mice via the intratracheal route using a 
maximum likelihood estimation approach. TDR models were then incorporated into two L. 
pneumophila outbreak models: (1) an outbreak that occurred at a spa in Japan, and (2) one that 
occurred in a Melbourne aquarium. The best-fit TDR from the murine dosing study was the beta-
Poisson with exponential reciprocal dependency model, which had a minimized deviance of 32.9. 
This TDR was inserted into the incubation period of the Japan outbreak, and tested against other 
incubation distributions, performing consistently well, with reported deviances ranging from 32 
to 35. In the Melbourne outbreak, the exponential model with exponential dependency was tested 
against non-time-dependent distributions to explore the performance of the time-dependent model 
with the lowest number of parameters. This exponential model reported low minimized deviances 
around 8 when convoluted with the Weibull, gamma and lognormal exposure distribution cases. 
This work shows that the incorporation of a time factor can be a useful tool in modelling, and can 
simultaneously provide insight into the in-vivo dynamics of the host-pathogen system.  
 
3.2. Keywords 
Legionella, mathematical epidemiology, time-dose-response, outbreak model, in-vivo kinetics, 
epidemic modeling 
                                                          
 
1 This chapter is published in Risk Analysis: Prasad, B., Hamilton, K.A. and Haas, C.N. (2016) 
Incorporating Time‐Dose‐Response into Legionella Outbreak Models. Risk Analysis. 
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3.3. Introduction 
Legionellosis is a disease contracted through the inhalation of the opportunistic waterborne 
pathogen Legionella in aerosolized water (Fields 1996, Muder et al. 1986). Legionella spp. 
include the causative agent of Legionnaires’ disease, a severe pneumonia with a fatality rate 
between 5–10% (Benin et al. 2002) and characterized by fever, nonproductive cough, headache, 
myalgia, rigors, dyspnea, diarrhea, and delirium (Fraser et al. 1977, Wharton et al. 1990). 
Legionella is also responsible for the milder Pontiac fever, a non-fatal influenza-like disease. 
Symptoms including headache, nausea, vomiting, aching muscles, general malaise, and cough 
(Ellis 1993, Glick et al. 1978, Heyman 2004, Wharton et al. 1990). Legionnaire’s disease and 
Pontiac fever usually occur in separate outbreaks, although documented studies have shown them 
to occur simultaneously (Benin et al. 2002). An estimated 8,000 to 18,000 persons are 
hospitalized for legionellosis each year in the U.S. (Farnham et al. 2014), with reportable cases 
increasing 217%, from 1,110 in 2000 to 3,522 in 2009 (Adams et al. 2013, CDC 2011). 
 
Of the 48 Legionella species (Fields et al. 2002), L. pneumophila is attributed to being the 
causative agent for approximately 90% of all reported cases of legionellosis in the U.S. (Marston 
et al. 1994), and 95% of cases in Europe (Whiley and Bentham 2011). L. pneumophila bacteria 
are naturally found in freshwater systems (Fliermans et al. 1981), in groundwater (Lye et al. 
1997), marine waters (Arnow et al. 1985), and in engineered aquatic systems (Lye et al. 1997), 
where they have been detected in 22.6% of domestic hot water samples (Borella et al. 2004). L. 
pneumophila have an optimal temperature range of 32- 42°C, but can survive and multiply in 
water at temperatures between 25°C and 45°C (Yee and Wadowsky 1982). Water delivery 
systems, including cooling towers (Bentham 2000, Nguyen et al. 2006), whirlpools (Benkel et al. 
2000, Campese et al. 2010, Jernigan et al. 1996), indoor fountains (Palmore et al. 2009), air 
conditioning (Goutziana et al. 2008), and indoor plumbing (Arnow et al. 1985, Bollin et al. 1985, 
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Donohue et al. 2014, Tobin et al. 1980) often operate within these ranges, providing ideal 
conditions for Legionella growth, and have been implicated in several outbreaks (Bartram 2007). 
Such water delivery systems often produce aerosols, which facilitate the spread of the pathogen. 
Transmission to human hosts occurs when contaminated water containing the pathogen is 
aerosolized, inhaled by the host, and deposited into respiratory airways (Fitzgeorge et al. 1983). 
Legionella bacteria are 0.3-0.9 µm wide and 2-20 µm long (Bartram 2007), generally falling 
within the respirable range of 2-6 µm (Berk et al. 1998). In the last decade, drinking water has 
emerged as a source of L. pneumophila outbreaks, with L. pneumophila recently becoming the 
single most common cause of reported disease outbreaks involving drinking water, responsible 
for 58% of all outbreaks (CDC 2013b). There have been no documented cases of person-to-
person transmission of either Legionnaires’ disease or Pontiac fever (Bartram 2007).  
 
In Australia, New Zealand, Japan and Thailand, L. longbeachae bacteria have been widely 
reported in potting soil, and cases have been on the rise throughout Europe and Asia in the last 
decade (Benin et al. 2002, Koide et al. 2001, Montanaro-Punzengruber et al. 1999, O'connor et al. 
2007, Phares et al. 2007, Whiley and Bentham 2011). Little, however, is known about the spread 
of L. longbeachae infections because they have not been as well-documented as L. pneumophila. 
The mode of transmission remains unclear.  
 
Although Legionella has been responsible for numerous outbreaks in the past decade, few 
outbreak models have been generated for the pathogen. Egan et al. (2011) convoluted an 
infection-time distribution with an incubation distribution and fit this model to an outbreak at the 
Melbourne Aquarium in Australia. This method could be further improved upon by assuming an 
infection-time distribution that closely models the actual time to infection for Legionella. The 
time-dose-response (TDR) modeling methodology, which quantifies a relationship between 
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pathogen kinetics and host response through the time to infection, provides the means in which 
data from dosing studies can be incorporated into the outbreak model (Huang et al. 2009, Huang 
and Haas 2009, 2011). Infection is a time-dependent process, since pathogen populations in the 
host vary with time, yet no outbreak model has ever considered the effects of in-vivo kinetics of 
various pathogens on hosts to date.  
 
A key research gap that remains is whether models that consider host-pathogen kinetics can 
provide robust fits to outbreak data.  The purpose of this study is to utilize data mined from 
published literature to determine the best-fit TDR model for Legionella, and to incorporate this 
model into the incubation distribution of an outbreak model. 
 
3.4. Materials and methods 
3.4.1. Datasets for time-dose-response and outbreak models 
3.4.1.1. Dose-response datasets 
A literature search was conducted to identify and collect appropriate datasets to develop a 
Legionella time dose-response model. Our approach was contingent upon finding time-dose-
response data in the literature, and therefore our inclusion criteria was not limited to any 
particular species of Legionella, animal host, route of administration, or endpoint. The inclusion 
criteria for choosing the time-dose-response model was that article included (i) a clear description 
of dosing methods; (ii) reported mode of exposure; (iii) the administered dose to each subject; 
(iv) the number of subjects that experienced adverse effects on each respective day; (v) stated 
criteria used to define a positive endpoint; (vi) detailed descriptions of the pathogen (i.e. source 
and strain); (vii) at least one observation where a fraction of the dosing groups is infected 
(0 < 𝑝 < 1); and (viii) the time-to-adverse response for each individual subject (Haas 1999).  
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3.4.1.2. Outbreak datasets 
The literature was then searched for published outbreak data that met the following criteria: (i) 
the outbreak occurred among a sufficiently large cluster of individuals to mitigate the effects of 
random variation that applies when analyzing small populations; (ii) members of this susceptible 
population who became symptomatically ill were tested for the pathogen; (iii) all outbreak cases 
that are identified have the same case definition2; (iv) the beginning and end of the source of 
pathogen contamination is known; (v) all infection comes from a common (primary) source. 
 
3.4.2. Dose-response models 
3.4.2.1. Non-time-dependent dose-response models 
The inoculation study dataset was initially modeled using traditional dose-response equations 
widely used in quantitative microbial risk assessment (QMRA), which only considers the host 
response and not time of occurrence (Haas et al. 2014). Traditional dose-response predicts the 
probability of adverse effects, such as illness or death, from the infection of a given dose (Haas et 
al. 2014). Dose-response equations are usually expressed mathematically, often in the form of an 
exponential or beta-Poisson model (Haas et al. 2014) (Table 3.1). 
 
 
 
Table 3.1 Exponential and beta-Poisson dose-response models 
Model Expression Eq’n number 
Exponential 𝑃(𝑑) = 1 − 𝑒−𝑘𝑑 8.1 
Beta-Poisson 𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
 8.2 
 
                                                          
 
2 Throughout the years, many case definitions have evolved over time. For example, the case definition for 
Legionella is currently a 4-fold increase in titer OSHA (2013) Legionnaires' Disease - Appendix 1B: 
Diagnostic Methods, U.S. Department of Labor, OSHA, Washington, DC. Ideally, this would be the same 
case definition that was used to confirm infection in the TDR data. 
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These expressions and assume that (1) the host ingests one or more organisms capable of causing 
an adverse response; and (2) that only a fraction of these pathogens reach a site of infection. 
Because these models are predictive models, we look at the probability of adverse response in the 
host. P(d) is the probability of response at dose d, and k is the exponential rate parameter 
describing the probability that a single organism can survive and initiate infection in the host. 𝑁50 
is the median infective dose and 𝛼 is the slope parameter for the beta-Poisson model. The 
exponential model and the beta-Poisson model both have a mechanistic biological basis and 
exhibit linearity at low dose (Haas et al. 2014).   
 
A Cochran-Armitage test of trend was applied to determine whether there was an association 
between increasing dosages and adverse effects (Haas et al. 2014, Neuhäuser and Hothorn 1999). 
Written formally, the Z-statistic is calculated by 
𝑍𝐶𝐴 =
∑ (𝑥𝑖−?̅?)
𝑘
𝑖=1 𝑝𝑖
√?̅?(1−?̅?) ∑ 𝑛𝑖(𝑥𝑖−?̅?)2
𝑘
𝑖=1
                                                   Eq. 3.3 
where  
?̅? =
∑ 𝑛𝑖𝑥𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
  and ?̅? =
∑ 𝑝𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
                                                  Eq. 3.4 
with 𝑛𝑖 total subjects and 𝑝𝑖 positive subjects. The null hypothesis of lack of trend is rejected if 
𝑍𝐶𝐴 is above the upper 5
th percentile of the normal distribution, which is 1.64 for a one-tailed test.  
 
If such an association is determined, the data can be modeled. A code written in R programming 
language (www.r-project.org) minimized the deviance (𝑌) of each of these model fits: 
𝑌 = −2 ∑ [𝑝𝑖𝑙𝑛
𝜋𝑖
𝜋𝑖
0 + (𝑛𝑖 − 𝑝𝑖)𝑙𝑛
1−𝜋𝑖
1−𝜋𝑖
0]
𝑘
𝑖=1                                     Eq. 3.5 
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The parameters 𝜋𝑖  and 𝜋𝑖
0 are the predicted and observed responses of 𝑝𝑖 positive subjects within 
𝑛𝑖 number of subjects in the set (Haas et al. 2014). Goodness-of-fit was determined by comparing 
minimized deviance from maximum likelihood estimations (MLE) to the critical 2 distribution. 
The optimized deviance has a 2 distribution with m – n degrees of freedom, where m is the 
number of doses and n is the number of model parameters. The dose-response model is rejected if 
𝑌 >  𝑚−𝑛,0.95
2 , at a 95% confidence level. If, however, both models provide acceptable fits, the 
beta-Poisson model can be selected as a best-fit model only if the difference in minimized 
deviances between the beta-Poisson and the exponential model was greater than the critical chi-
square value for a single parameter (one degree of freedom). Confidence intervals of the 
parameters for the models were determined via bootstrapping with 10,000 iterations.  
 
3.4.2.2. Dose-response-time models 
These traditional dose-response models were modiﬁed by Huang and Haas (2009) to incorporate 
a time dependency by including additional parameters of time-post-inoculation (TPI). The 
additional time parameter quantifies the time of onset of the effect associated with the kinetics of 
in-vivo pathogen growth. Huang developed eight separate time-dependent equations (Huang et al. 
2009, Huang and Haas 2009, 2011); of the original eight models, only four were true cumulative 
density functions (CDFs). These models are presented in Table 3.2. The models that were not true 
CDFs were excluded from this study.  
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Table 3.2 True CDF time-dependent dose-response models 
Model Name Expression 
Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 
Eq. 3.6 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 3.7 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 3.8 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 3.9 
 
 
 
The TDR models were ﬁt to the dose-response data, deviances were optimized, and model 
parameters were determined using maximum likelihood estimation (MLE) in the R programming 
language (www.r-project.org, ver. 3.0.3).  
 
The likelihood ratio for the incidence occurring for 𝑖 dose groups on day 𝑗 is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1            Eq. 3.10 
where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made, 𝑝𝑖,𝑗 is the number of positive response observed during time 
period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the beginning of time period 𝑗.  The predicted 
response is 𝜋𝑖, and the response for each set based on observations are 𝜋𝑖
°. 
 
The corresponding deviance is  
𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1  Eq. 3.11 
 
57 
 
 
 
 
3.4.3. Outbreak model 
The standard Susceptible-Infective-Recovered (SIR) compartment model proposed by Kermack 
and McKendrick in 1927 is a deterministic model for a closed population of size 𝑁 consisting of 
𝑆(𝑡) susceptibles, 𝐼(𝑡) infectives and 𝑅(𝑡) removals, namely individuals who had died, or had 
recovered and were immune at time 𝑡 (Kermack & McKendrick 1927). In his 1999 thesis, Gupta 
proposed a modified SIR model for water and foodborne infections (Gupta 1999), which includes 
a latent period and accounts for individuals being either symptomatically or asymptomatically ill 
(Figure 3.1).  
 
 
 
 
Figure 3.1 Modified SIR model proposed by Gupta (Gupta and Haas 2004, Kermack and McKendrick 
1927). 
 
 
 
In this model, populations are compartmentalized into groups, moving through the compartments 
as they become infected. The number of people in the compartments, as well as the rates that of 
transfer are described by a system of differential equations. The four states in this model are (1) 
the susceptible populations 𝑋(𝑡); (2) latent individuals 𝑌(𝑡) who have been exposed to the 
pathogen and will ultimately become infected; (3) those who become symptomatically ill 𝑍(𝑡); 
and (4) those who have become infected but will remain Asymptomatic 𝐼(𝑡). The force of 
infectivity, 𝛽(𝑡), is the rate of transfer from susceptible to the latent, and 𝑄(𝑡) models the rate of 
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newly symptomatic cases. For our purposes, only the symptomatically ill population will be 
considered, since generally data is only available for these groups through epidemic studies. The 
compartment model then reduces to the following equations: 
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), or 
1
𝑋
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)    Eq. 3.12 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡)      Eq. 3.13 
The force of infection 𝛽(t) has units of inverse time, and is a versatile parameter. In the case of a 
rectangular distribution for infectivity, 𝛽(t) would be a constant for the exposure duration. 
However, common source outbreaks are frequently caused by time variable microbial exposures, 
which means that the parameter takes the form of a density distribution, generally of the 
following form: 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)     Eq. 3.14 
 
where 𝛽(t) is the force of infection; b0 is the background infectivity level, which may account for 
any endemic cases in the population; 𝑔(𝑡) is the ratio of susceptible persons ultimately becoming 
infected at time t; and b1 is the scaling factor for increased infectivity above background. Here, 
𝑔(𝑡) is modeled as a probability density function for the exposure case. The density functions in 
this case that we have used are the Weibull, gamma, and lognormal, and uniform, all which are 
standard functions which have historically been used to fit observed epidemic curves. Each of 
these density functions have parameter values that determine the shape and scale of the function. 
Integrating Eq. (3.12) gives: 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
   Eq. 3.15 
The rate of newly ill people at any time t is given by the parameter 𝑄(t). At any time t, the 
instantaneous rate of new illnesses can be obtained by the convolution integral: 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
    Eq. 3.16 
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where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). The function 𝑓 is a 
probability density function (PDF) which has parameters that need to be estimated.  
 
Substituting Eq. 3.15 into Eq. 3.16 we then obtain: 
𝑑𝑍
𝑑𝑡
= ∫ 𝑋0𝛽(𝜏)exp [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 3.17 
where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the CDF corresponding to the PDF 𝑔(𝑡). Since we are 
using the Weibull, gamma, lognormal and uniform PDFs to model 𝑔(𝑡), we necessarily must use 
the corresponding CDFs for 𝐺(𝑡) in each respective case.  
 
Integrating Eq. 3.17 directly, we can solve for the number of symptomatically ill patients per day 
𝑍(𝑡): 
𝑍(𝑡) = ∬ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑     Eq. 3.18 
In Eq. 3.18, the exposure time distribution is represented by the expression 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)], 
while the incubation distribution is represented by the expression 𝑓(𝜑 − 𝜏). The incubation 
distribution that will be used here will be the best-fit time-dose-response equation. 
 
The time-dose-response functions from Table 3.2 cannot be immediately used as incubation 
distributions because they are CDFs. To derive a time dose-response based incubation 
distribution to fit epidemiologic curves, the distributions must be PDFs. To get a PDF from a 
CDF, the derivative must be taken. In the case of the beta-Poisson time dose-response with 
inverse time dependency, we have the following equation:  
𝑅(𝑑, 𝑡) = 1 − [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 3.19 
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𝑅(𝑑, 𝑡) is the probability of adverse effect; α is a fitting parameter; θ is a time parameter; 
𝑗0
𝑡
+ 1 
is the dose that elicits a positive response in 50% of the hosts, after infinite time. Taking the first 
partial derivative with respect to time, we get 
𝑟(𝑑, 𝑡) = −𝛼 [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼−1
×𝑑 (2
1
𝛼 − 1)
𝑗0
𝑡2
                      Eq. 3.20 
However, we want that to make sure that our function is a true PDF. Probability density functions 
satisfy the following conditions: 
1. 𝑓(𝑥) ≥ 0 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑥 
2. ∫ 𝑓(𝑥)𝑑𝑥 = 1
∞
−∞
 
 As time goes to infinity, we want the integral of our distribution to be exactly 1.  So we must 
divide by a certain value that ensures that this is true. As 𝑡 → ∞, the maximum response is 
reached for the time dose-response. Then Eq. 3.19 no longer becomes time-dependent, and we 
refer to the TDR dependency equation in Table 3.2, which assumed that 𝑁50 =
𝑗0
𝑡
+ 1. Plugging 
in 𝑁50 for the expression in the denominator returns us back to the regular beta-Poisson dose-
response model. 
𝑅(𝑑, 𝑡 → ∞) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 3.21 
This expression can be used as the constant for which Eq. 3.20 can be divided. If we divide Eq. 
3.20 by Eq. 3.21, we get the following function: 
𝑓(𝑡|𝑑) =
𝛼[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼−1
×𝑑(2
1
𝛼−1)𝑗0
𝑡2(−1+[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼
)
   Eq. 3.22 
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We now have a proper PDF 𝑓(𝑡|𝑑) that characterizes the distribution. This PDF based on the 
beta-Poisson time dose-response function distribution can now be used as a potential incubation 
distribution 𝑓(𝑡) to use in the probability density function used to calculate the number of ill, 
Z(t). The functions used to model the exposure distributions include the Weibull, gamma, 
lognormal and uniform distributions, and the best-fit time-dose-response model will be used as 
the incubation distribution. 
 
For the Weibull, gamma, lognormal and uniform incubation scenarios, we have six parameters for 
𝑍(𝑡): the attack parameters  𝑏0 and  𝑏1, two PDF parameters for the attack distribution, and two 
PDF parameters for the incubation distribution (Weibull, gamma, lognormal and uniform 
distributions all contain two parameters). In the case of the beta-Poisson model with exponential 
time dependency, we have eight parameters total, as this model contains four parameters: 𝛼, 𝑗0,
𝑗1, and 𝑑.  
 
To compare the results of the outbreak models, deviance, Akaike information criterion (AIC) and 
Bayesian information criterion (BIC) values are examined: 
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 3.23 
𝐴𝐼𝐶 = 2𝑘 − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]                   Eq. 3.24 
𝐵𝐼𝐶 = 𝑘 ∗ 𝑙𝑛(𝑛) − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]           Eq. 3.25 
The parameters 𝜃?̂? are the values of the full model (observed values), and 𝜃0̂ are the values of the 
predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and thus we can see that 
the AIC and BIC is the deviance plus a complexity parameter. BIC penalizes model complexity 
more than AIC does (Ruppert 2011). The outbreak model with the lowest deviance, AIC and BIC 
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are the best-fit. Since some TDR models have extra parameters, they will have higher AIC and 
BIC values. 
 
To compare the parameters in the epidemic and dosing parameter studies to see if the differences 
between corresponding parameters were significant, the two-sample Kolmogorov–Smirnov (KS) 
test and the Anderson–Darling (AD) test were utilized. In both tests, we wanted to see if the 
parameters came from the same distribution. The KS test states that 𝐷∗ =
𝑠𝑢𝑝
𝑥
| 𝐹1(𝑥) − 𝐹2(𝑥)|, 
where 𝐹1(𝑥) and 𝐹2(𝑥) are the empirical distribution functions of the two samples respectively, 
and 𝑠𝑢𝑝 is the supremum function (Sheskin 2003). The null hypothesis is rejected if the following 
equation holds true: 𝐷∗ > 𝑐(𝛼)√
𝑛+𝑛1
𝑛𝑛1
. For 𝛼 = 0.05, 𝑐(𝛼) = 1.36. The AD is a refinement of the 
KS test. The statistic that was used was of the form 
𝐴2 = −𝑛 − ∑
2𝑖−1
𝑛
[ln(Φ(𝑌𝑖)) + ln(1 − Φ(𝑌𝑛+1−𝑖))]
𝑛
𝑖=1  (D’Agostino et al. 1986). The parameter 
𝑛 is the number of data points in the sample, and the test statistic measures the distance between 
the hypothesized and empirical. The null hypothesis of normality is rejected if A2 exceeds 0.752 
for α = 0.05. 
 
3.5. Results and discussion 
3.5.1. Dose-response  
Several Legionella dosing studies have been performed using animal hosts, including guinea pigs 
(Berendt et al. 1980, Breiman and Horwitz 1987, Davis et al. 1982, Doyle et al. 2001, Edelstein et 
al. 1999), rhesus monkeys (Fitzgeorge et al. 1983) and mice (Gobin et al. 2009, Susa et al. 1998). 
An experiment performed by Gobin et al. (2009) was the only one which met the inclusion 
criteria for the time-dependent dose-response models. The authors exposed graded doses of 
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Legionella longbeachae serogroup 1 to A/J mice intratracheally in order to determine survival 
rates. The strains were obtained from clinical isolates in the U.S. The mice were 6-10 weeks old, 
and dosed at mean values between 103 and 109 CFU. All of the mice receiving the lowest dose 
survived, while the mortality rates of the groups dosed at 104 and 105 CFUs were found to be 
30% and 90%, respectively. The mortality of the mice dosed from 106 to 109 CFUs was 100%. 
The adverse response for the study is shown in Table 3.3 (Gobin et al. 2009).   
 
 
 
Table 3.3 Cumulative infection percentages of mice exposed to graded doses of Legionella via 
intratracheal exposure (Gobin et al. 2009). 
Day 
Dose 
(CFU) 
1 2 3 4 5 6 15 total 
𝟏𝟎𝟑 0 0 0 0 0 0 0 0 
𝟏𝟎𝟒 0 0 0 0 0 30 30 30 
𝟏𝟎𝟓 0 0 0 10 40 90 90 90 
𝟏𝟎𝟔 0 0 0 50 80 100 100 100 
𝟏𝟎𝟕 0 0 20 100 100 100 100 100 
𝟏𝟎𝟖 0 40 100 100 100 100 100 100 
𝟏𝟎𝟗 0 80 100 100 100 100 100 100 
 
 
 
Dose-response data showed positive trends when subjected to the Cochran-Armitage test of trend. 
Z critical was greater than 1.64 (𝑍𝑐𝑟 > 1.64), so the null hypothesis of lack of trend is rejected 
and data can be analyzed using R. The adverse responses for the data set was best fit by the 
exponential dose-response model. Predictive model results from conventional dose-response 
studies are provided in Table 3.4 and Figures 3.2 - 3.3.  
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Table 3.4 Dose-response modeling results for Legionella inoculation  
Model 
Parameter 
Deviance dfa 𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 Conclusions Best fit modelc 
type value 
Expd k 1.95×10−5 4.85 2 5.99 
Exp provides 
acceptable fit 
Exponential 
BPe 
α 4.00×105 
4.85 1 3.84 
N50 3.55×104 
a df - degrees of freedom for dataset and model 
b  critical values of the chi-squared distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, 
m is the number of doses, n is the number of parameters 
c Best fit model criteria - the lowest deviance of candidate models was chosen compared to the critical values of chi-
squared distribution  
d Exponential Model 
e beta-Poisson Model 
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Figure 3.2 Dose-response data by Gobin et al. (2009) on CFUs administered to chickens generated into 
predictive exponential and beta-Poisson model results. The best-fitting mechanistic model was the 
exponential (𝐤 = 𝟏. 𝟗𝟓×𝟏𝟎−𝟓;𝛘𝟐 = 𝟒. 𝟖𝟓). 
 
 
 
 
Figure 3.3 Dose-response data and best-fit bootstrapped exponential model with confidence intervals for 
CFUs administered orally to mice via the intratracheal route (Table 3.3), along with the frequency diagram 
of exponential model parameter 𝐤.  
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The exponential is the best-fitting mechanistic model because it was the only one whose 
minimized deviance of 4.85 was lower than the critical chi-square 𝜒𝑐𝑟
2  distribution for one degree 
of freedom, at 5.99. The bootstrapped data set with 10,000 iterations from this model is plotted 
with optimized parameters for the exponential model. 
 
Estimates for LD50 values were calculated from the traditional dose-response models. The LD50 
value at the lower bound of the 95th percentile confidence interval was determined to be 
2.87×104 CFUs, and 4.34×104 CFUs at the upper bound. This range of LD50 values for L. 
longbeachae is comparable to LD50 values in L. pneumophila published in literature. Huang 
(2012) reported LD50 values in mice and guinea pigs administered via the inhalation route to be 
1.07×104 and 1.66×104 CFUs respectively. Armstrong and Haas (2007) additionally reported 
LD50 values for L. pneumophila on the same magnitude, at 5×104 CFUs. The similar LD50 values 
for L. longbeachae and L. pneumophila do not lead to the conclusion that there would be a 
significant difference between using the results of the L. longbeachae time-dose-response 
datasets, and a L. pneumophila dataset, which could not be found in the literature.  
 
3.5.2. Time-Dose-Response  
The time-dose-response models in Table 3.2 were ﬁtted to the survival data presented in Table 
3.3 using MLE. Figure 3.4 presents the best-fit models, and Table 3.5 summarizes the parameter 
estimates and the minimized deviances. The three-parameter beta-Poisson with exponential 
reciprocal time dependency was found to be the best-fit model for the time-dependent data. It 
provided the lowest deviance at 32.9, lower than the critical chi square of 54.6, and gave a 
statistically signiﬁcant improvement in ﬁt over the other models. None of the other models 
provided acceptable fits to the data.  
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Figure 3.4 Best-fit time-dose-response model.  
 
 
Table 3.5 Time-dose-response (TDR) modeling results for L. longbeachae inoculation   
Time Dependence Model 
Best fit 
parameters 
AIC 
Minimized 
deviance 
2
,05.0 df  Acceptable fit 
Beta-Poisson model with 
exponential time 
dependency 
α = 0.71 
126.5 118.5 54.6 no j0 = -1.0 
j1 = 18.6 
Beta-Poisson model with 
exponential-reciprocal 
time dependency 
α = 2.7 
40.9 32.9 54.6 Yes j0 = 24.7 
j1 = 7.5 
Beta-Poisson model with 
inverse time dependency 
α = 0.013 
63.9 53.9 55.8 No 
j0 = 109.2 
Exponential model with 
exponential-reciprocal 
time dependency 
k0 = 4.69×10-5 109.9 99.9 56.9 No 
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3.5.3. Outbreak models 
Two data sets were chosen for the outbreak models. The first outbreak occurred in a spa in Japan 
(Okada et al. 2005). On July 18, 2002, a medical institution in the Miyazaki Prefecture reported 
that three inpatients who used the same spa reported symptoms associated with legionellosis. On 
July 25, the same Legionella serogroup was detected in both the ill patients and the shared 
bathwater. Five days later, health officials found that the genotypes of the detected bacteria were 
identical, indicating that these bacteria were likely derived from the same source. The health 
center determined that the spa was the source of the pathogen and ordered it to be shut down. In 
total, 295 confirmed and suspected cases were reported, with 90% of reported cases having an 
onset of symptoms from July 7 to 31. The estimated lag phase ranged from 2 to 15 days for the 
majority of cases, peaking on day 5. 
 
The second dataset that was modeled was the April 2000 outbreak in Melbourne documented by 
Greig et al. (2004), first modeled by Egan et al. (2011). In this outbreak, Legionnaires’ disease 
caused by L. pneumophila was confirmed in 125 people who visited the Melbourne Aquarium 
between April 11 and 25. This dataset was chosen so that comparisons could be drawn between 
the time-dose-response based models and the conclusions presented by Egan et al. (2011). 
 
Since the beta-Poisson with exponential reciprocal time dependency was the best-fit model, this 
was the time-dependent kinetic model that was chosen to be used as incubation distributions. The 
static Weibull, gamma, lognormal and uniform distributions were also incorporated into the 
incubation distribution for comparison. The model fits are summarized in Figure 3.5. Table 3.6 
summarize the model parameters and criteria values of all generated models.  
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To determine which distribution convolution fit the data best, the deviance, AIC and BIC output 
were compared (Table 3.6). The Weibull-uniform exposure/incubation convolution has the lowest 
deviance at 30.59, consistent with a visual inspection (Figure 3.5). It appears that the convoluted 
Weibull exposure distributions give the lowest deviances for each respective incubation 
distribution. The TDR-based models perform well, and give low deviances with a median of 33. 
However, due to the additional parameters of the TDR model, the AIC and BIC are slightly larger 
than they would be in a 6-parameter system. The models with the lowest deviances for each of the 
exposure distribution categories are as follows: the Weibull-uniform (deviance = 30.6),  the 
gamma-BP with exponential reciprocal (deviance = 35.1); the lognormal-BP with exponential 
reciprocal (deviance = 32.1); and the uniform-gamma (deviance = 32.6).  
 
The first and second column are the results for the 𝑏0 and 𝑏1 attack rate values. There is a trend 
for attack parameter 𝑏0 to be small, indicating that there is a low baseline level of this disease in 
the population before the outbreak. The third and fourth columns are referred to as “Exposure 
Distribution PDF param 1” and “Exposure Distribution PDF param 2,” which correspond to the 
respective exposure distributions. For the Weibull distribution, PDF Param 1 and PDF Param 2 
refer to the scale parameter a, and shape parameter b in the probability distribution function. For 
the gamma exposure distribution, PDF Param 1 and 2 are the mean and variance. In the 
lognormal distributions, PDF Param 1 and PDF Param 2 are the log transform of the mean and 
variance. The uniform distribution refers to parameters a and b in the PDF, with a being a lower 
endpoint (minimum) and b being an upper endpoint (maximum), respectively.  The remaining 
columns correspond to the respective incubation distributions, and follow the same pattern as 
described previously. For the beta-Poisson with exponential reciprocal time dependency, 
parameters 5, 6, 7 and 8 refer to 𝛼, 𝑗0, 𝑗1, and 𝑑, respectively.   
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Figure 3.5 Model fits for the Legionella primary outbreak in a Japan spa. The gamma, lognormal, uniform, 
and Weibull exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, and beta-
Poisson with reciprocal incubation distributions for a total of 20 data fits. The abscissa is time of symptom 
onset in days, and the ordinate is the number of cases reported. 
 
  
  
 
 
Table 3.6 Parameter and criteria values for the Legionella spa outbreak model.  
 
  Model Parameters  Criterion Values 
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
para
m 
b1 
Expos 
dist 
PDF 
param 1 
Expos 
dist 
PDF 
param 2 
Incub 
dist 
PDF 
param 1 
Incub 
dist 
PDF 
param 2 
Incub 
dist 
PDF 
param 3 
Incub 
dist 
PDF 
param 4 
Deviance AIC BIC 
Weibull 
Weibull 3.44×10−3 0.65 29.0a 4.24b 1.12a 0.668b n/a n/a 35.95 47.95 58.08 
Gamma 3.19×10−3 0.67 29.6a 4.05b 1.07c 0.314d n/a n/a 35.74 47.74 57.88 
Lognormal 4.26×10−3 0.64 26.6a 4.00b 1.12e 0.704f n/a n/a 37.16 49.16 59.30 
Uniform 8.47×10−3 0.49 16.2a 9.13b 0.48g 20.91h n/a n/a 30.59 42.59 52.72 
BP with exp 4.34×10−3 0.57 19.8a 3.35b 1.96i 10.6j 7.47k 1.01l 33.27 45.27 55.40 
Gamma 
Weibull 2.80×10−3 0.69 28.0c 77.1d 1.09a 0.866b n/a n/a 38.65 50.65 60.78 
Gamma 2.95×10−3 0.70 28.3c 81.5d 1.09c 0.89d n/a n/a 38.77 50.77 60.90 
Lognormal 3.95×10−3 0.68 25.0c 62.5d 1.08e 0.867f n/a n/a 40.32 52.32 62.45 
Uniform 1.19×10−2 0.47 8.73c 1.00d 0.48g 27.7h n/a n/a 51.57 63.57 73.70 
BP with exp 3.52×10−3 0.65 16.2c 34.1d 2.73i 24.7j 1.27k 3.72l 35.15 47.15 57.28 
Lognormal 
Weibull 2.69×10−3 0.79 3.36e 0.37f 1.00a 5.85b n/a n/a 39.25 51.25 61.38 
Gamma 2.57×10−3 0.87 3.30e 0.36f 2.34c 8.99d n/a n/a 42.77 54.77 64.90 
Lognormal 3.10×10−3 0.73 3.28e 0.35f 0.43e 0.85f n/a n/a 40.65 52.65 62.78 
Uniform 3.00×10−2 0.44 19.7e 8.97f 0.49g 26.2h n/a n/a 80.84 92.84 103.0 
BP with exp 3.95×10−3 0.68 25.0e 62.5f 1.08i 12.9j 6.95k 2.63l 32.15 44.15 54.29 
Uniform 
Weibull 4.37×10−3 0.54 13.4g 37.5h 1.26a 3.61b n/a n/a 41.34 53.34 63.48 
Gamma 4.22×10−3 0.62 13.6g 34.7h 3.75c 22.2d n/a n/a 32.55 44.55 54.68 
Lognormal 4.81×10−3 0.60 12.3g 33.0h 1.33e 0.84f n/a n/a 32.60 44.60 54.73 
Uniform 5.36×10−3 0.53 12.3g 33.4h 1.16g 6.44h n/a n/a 34.84 46.84 56.97 
BP with exp 7.88×10−3 0.51 15.3g 3.89h 0.42i 11.0j 18.6k 21.2l 33.15 47.15 58.97 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1
7
1
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The Melbourne aquarium outbreak was similarly modeled with a time-dependent incubation 
distribution, in this case, the exponential model with exponential-reciprocal time dependency. 
This time-dependent distribution was chosen to explore the performance of the TDR model with 
the lowest number of parameters against other results that were published in literature. The 
Weibull, gamma, lognormal and uniform incubation and exposure distributions were also 
modelled.  
 
Figure 3.6 plots the observed outbreak data (number ill) as point values and the predicted values 
of the model as the curve fit. In each graph, the abscissa is time in days, and the ordinate is the 
number of cases reported.  
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Figure 3.6 Model fits for the Legionella primary outbreak in a Melbourne aquarium. The gamma, 
lognormal, uniform, and Weibull exposure functions are convoluted with the gamma, lognormal, uniform, 
Weibull, and beta-Poisson with reciprocal incubation distributions for a total of 20 data fits. The abscissa is 
time of symptom onset in days, and the ordinate is the number of cases reported. 
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In Figure 3.6, if we look across the first row, it appears that given a Weibull exposure 
distribution, the curves become broader (less peaked) as the incubation distribution changes from 
Weibull to gamma. In terms of qualitative fit, the lognormal and uniform appear to fall in 
between the Weibull and gamma in terms of their broad curves. The TDR distribution here seems 
to fit across many of the data points better especially the points on the descending side of the 
curve, and the last few data points.  
 
The gamma exposure distribution seems to be more peaked and left-skewed than the Weibull 
PDFs, which is notable because the Weibull-gamma combination in the previous row had the 
broadest functions. This left-skew is probably due to the large increase in the number of cases on 
day 5-6 when (𝑡, 𝑖𝑙𝑙)  =  (5 − 6,16). However, the behavior of the incubation distributions in this 
row seem to mimic the previous one; the curves become more broad as the incubation distribution 
changes from Weibull to gamma, while the lognormal and uniform seem to fall somewhere in 
between. Again, here it appears that the TDR model is especially good at fitting the data points in 
the descending side of the curve, especially the last few data points.  
 
The lognormal-Weibull distributions in Row 3 exhibit different behavior than the previous rows, 
in that this combination is the most centered and has the broadest peak of the distributions in its 
row. The lognormal-gamma, lognormal-lognormal, and lognormal-uniform all seem to increase 
skew much more to the left. The lognormal-uniform seems be the most peaked, which is 
interesting because the uniform distribution is a rectangular distribution, and so one would expect 
to see a peak that was not as sharp. The TDR incubation distribution performs very well here, and 
of all the exposure distributions with uniform exposures, seems to model the observed data points 
best.  
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The uniform exposure distributions are the most unique distributions in Figure 3.6, each 
exhibiting a continuous rectangular distribution shape in fitting the data set. The uniform 
exposure distribution dominated the fit, and there is little variability between the incubation 
distributions here, except in the case of the TDR models. Here it is very clear that the TDR 
distribution modeled the data points best, retaining a standard density curve shape, where the 
other distributions were unable to do so.  
 
The estimated parameter values for the Melbourne outbreak are summarized in Table 3.7. We see 
that there is a trend for attack parameter 𝑏0 to be small, indicating that there is a low baseline 
level of this disease in the population before the outbreak. The gamma exposure distributions 
generally give a mean 𝜇 range around 7-8 days, with 𝜎 values that are an order of magnitude less. 
This is consistent with the assumed incubation time of approximately 11 days for Legionella 
(Egan et al. 2011). The gamma incubation distribution similarly gives mean values of 1.9, 8.4, 2.4 
and 0.43 days, with corresponding 𝜎 values of 4.7, 1.8, 7.6, and 0.16 days respectively. This is 
also consistent with the assumed incubation distribution of 2-10 days, most often 5-6 for 
Legionella (Heymann 2008).  
 
 
 
 
 
 
  
  
 
 
Table 3.7 Parameter and criteria values for the Legionella aquarium outbreak model. 
  Model Parameters Criterion Values 
Exposure 
Dist 
Incubation 
Dist 
Expos param 
b0 
Expos 
param 
b1 
Expos dist 
PDF 
param 1 
Expos dist 
PDF 
param 2 
Incub dist 
PDF 
param 1 
Incub dist 
PDF param 
2 
Incub dist 
PDF param 
3 
Dev AIC BIC 
Weibull 
Weibull 5.2×10−3 0.22 8.4a 2.7b 1.1a 1.6b n/a 4.62 16.62 21.62 
Gamma 3.0×10−3 0.28 7.8a 2.2b 1.9c 4.7d n/a 10.16 22.16 27.16 
Lognormal 1.7×10−28 0.28 0.28a 8.0b 2.2e 1.1×10−28 f n/a 10.60 22.60 27.60 
Uniform 3.3×10−3 0.23 8.9a 2.6b 5.0×10−4 g 1.0h n/a 9.47 21.47 26.47 
Exp w exp 0.45 1.54 2.56a 2.06b 0.13i 0.33 j 2.01k 8.44 22.44 28.27 
Gamma 
Weibull 3.4×10−3 0.12 8.1c 0.72d 17.0a 14.0b n/a 6.90 18.90 23.90 
Gamma 9.8×10−49 0.29 0.34c 0.47d 8.4c 18.0d n/a 13.31 25.31 30.31 
Lognormal 2.3×10−4 0.29 7.3c 17.0d 6.5×10−2 e 1.1f n/a 14.87 26.87 31.87 
Uniform 3.8×10−3 0.22 8.3c 13.0d 6.0×10−3 g 9.9×10−1 h n/a 13.46 25.46 30.46 
Exp w exp 0.45 1.56 2.32c 1.34d 0.13i 0.60j 0.78k 8.31 22.31 28.14 
Lognormal 
Weibull 4.3×10−3 0.21 0.21e 2.1f 2.1a 0.44b n/a 15.69 27.69 32.69 
Gamma 2.0×10−4 0.97 15.0e 14.0f 24.0c 7.6d n/a 23.45 35.45 40.45 
Lognormal 6.10×10−101 0.32 0.48e 1.1f 1.8e 0.70f n/a 20.07 32.07 37.06 
Uniform 3.2×10−3 0.24 2.0e 0.66f 0.14g 1.9h n/a 19.94 31.94 36.93 
Exp w exp 1.34 66.15 4.31e 2.04f 0.15i 2.23j 13.65k 8.18 22.18 28.01 
Uniform 
Weibull 5.7×10−3 0.19 1.7g 12.0h 1.2a 17.0b n/a 9.32 21.32 26.32 
Gamma 4.9×10−3 0.20 3.2g 13.0h 0.43c 0.16d n/a 7.48 19.48 24.48 
Lognormal 7.0×10−3 0.17 3.2g 13.0h 0.43e 0.16f n/a 6.02 18.02 23.02 
Uniform 5.2×10−3 0.19 2.9g 12.0h 9.4×10−2 g 1.3h n/a 7.46 19.46 24.46 
Exp w exp 0.39 0.71 1.21g 1.49h 0.10i 0.51j 0.83k 13.64 27.64 33.47 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 7
6
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As with the Japan spa outbreak, deviance, AIC and BIC output were compared to determine 
which distribution convolution fit the data best (Table 3.7). The Weibull-Weibull 
exposure/incubation convolution has the lowest deviance at 4.6, consistent with a qualitative 
inspection. Looking at the trends, it appears that the convoluted Weibull incubation distributions 
give the lowest deviances for each respective exposure distribution. For example, looking at the 
gamma exposure PDFs, we see that the lowest deviance is 6.90, which corresponds to the 
gamma-Weibull PDF. The only time this does not seem to be the case, however, is in the uniform 
exposure PDFs. Here, the uniform-Weibull distribution actually has the poorest fit for all uniform 
exposures, at 9.32. This may be due to the broad peaks of the Weibull distributions, combined 
with the rectangular shape of the uniform distributions. The TDR models perform well, and give 
low deviances with a median of 8, with the uniform-TDR distribution at 13.6. However, due to 
the additional parameter of the TDR model, the AIC and BIC are slightly larger than they would 
be in a 6-parameter system. Still, the TDR model performed second-best in the Weibull and 
gamma exposure distributions respectively, and best in the lognormal exposure distribution.  
 
After comparing various generated models with each other, the models that Egan generated were 
examined. Egan reported a maximized log-likelihood for the uniform exposure convoluted with 
the gamma, lognormal, and Weibull incubation distributions were -272.66, -272.83, and -278.27, 
respectively (Egan et al. 2011). This corresponds to deviance values of 136.33, 136.42 and 
139.15. Our model produced deviances of 7.48, 6.02 and 9.32, respectively for those same 
distributions. The discrepancies in deviances are attributed to the different approaches of deriving 
the expression for the number of symptomatically ill at a given time. In this work, the number of 
symptomatically ill for a common-source outbreak was based on the SIR model. Egan’s approach 
was more direct, and in the appendix of his paper, he detailed his method of simple convolution 
of the uniform and gamma distribution functions to fit the data (Egan et al. 2011).  
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It is noted that the exponential model with exponential time dependency did not provide an 
acceptable fit for the time-dose-response models, but when this time-dependent distribution was 
incorporated in the outbreak model as incubation distributions, the fits of the outbreak model 
provided acceptable fits. The method we typically use is to incorporate the the best-fit TDR 
models to the outbreak data. However, we observe that the non-time-dependent dose-response 
best-fit model was the exponential. Additionally, the QMRA Wiki website, run through Michigan 
State University posts four dose-response models for Legionella infection on mice and guinea 
pigs via the inhalation route, with endpoints ranging from illness to death (Huang 2013). In all 
dose-response case scenarios, the best-fit model was the exponential model. Finally, in their study 
of Legionella on guinea pigs, Armstrong and Haas (2007) completed dose-response modeling for 
the beta-Poisson, exponential, probit, logistic, and Weibull models for inhalation, mortality, and 
infection. For the endpoint of infection, all models listed passed the goodness-of-ﬁt, and none of 
the models gave a significantly improved ﬁt (Armstrong and Haas 2007).  Using the findings of 
these studies, the assumption was made that the exponential TDR models in Table 3.2 could 
adequately describe the incubation distribution if another dataset was used.   
 
The data was further analyzed by comparing the parameters of the incubation distribution of the 
outbreak model with those from the dosing experiment to see if there was a significant difference 
between the distributions of the two systems. The two-sample Kolmogorov–Smirnov (KS) test 
and the Anderson–Darling (AD) test were utilized towards this end. We took the best-fit time-
dependent distributions in each outbreak case to see if the parameters in these cases were drawn 
from the same distribution as the dosing experiment administered to mice. The KS value that was 
calculated for the Japanese spa outbreak was between the parameters of the beta-Poisson model 
with exponential-reciprocal time dependency and the mouse challenge, and was determined to be 
0.58. The null hypothesis cannot be rejected, and it is accepted that the parameters from the TDR 
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and outbreak models came from the same distribution. The KS value for the Melbourne outbreak 
was calculated between the parameters of the exponential model with exponential time 
dependency incubation period, and was determined to be 3.37. The null hypothesis is rejected, 
and it is concluded that Melbourne outbreak parameters were not drawn from the same 
distribution.  
 
The parameters from the dosing studies were used as initial guesses in the Matlab computer 
outbreak models. In the case of the Japan spa outbreak, the time-dependent dose-response model 
that was incorporated into the incubation distribution of the outbreak model was the beta-Poisson 
with exponential-reciprocal time dependency, a model that provided an acceptable fit in the TDR 
dataset. However, in the case of the Melbourne outbreak, the TDR model that was incorporated 
into the outbreak model was the exponential model with exponential-reciprocal time dependency, 
which failed to provide an acceptable fit for the dataset. This may provide an explanation for why 
the Japanese outbreak converged to the beta-Poisson dose-response parameters, while the 
Melbourne outbreak was not able to converge with the parameters in the exponential TDR model. 
 
3.6. Conclusion 
In this study, a TDR model was incorporated into an incubation distribution. It was convoluted 
with an exposure distribution, then plugged into an SIR compartment model via a process derived 
by Gupta et al. to get a fitted epidemic curve (Gupta and Haas 2004). To this end, dose-response 
and time-dose-response models were generated for Legionella longbeachae exposure to mice via 
the intratracheal route, and subsequently incorporated into the incubation period of a L. 
pneumophila outbreak in order to capture the in-vivo dynamics between pathogen and host. In the 
dose-response model, 50% predictive infectious dose was estimated to be 3.55×104 CFUs, and 
the best-fit time-dose-response model was the beta-Poisson with exponential reciprocal 
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dependency, which had a minimized deviance of 32.9. A TDR model was chosen to be 
incorporated into two L. pneumophila outbreak models: an outbreak that occurred at a spa in 
Japan, and one that occurred in a Melbourne aquarium. In the outbreak that occurred at a spa in 
Japan, the convolution of the Weibull distribution with the uniform incubation distribution was 
the best-fit for the model, with a minimized deviance value of 30.59, but the models that 
incorporated the beta-Poisson with exponential reciprocal time distributions performed 
consistently well compared with other incubation distributions. In the case of the Melbourne 
outbreak, the Weibull-Weibull distribution performed the best, with a minimized deviance value 
of 4.62. Again, however, the exponential model with exponential dependency performed well, 
with deviance values of 8.44, 8.31, and 8.18 for the Weibull, gamma and lognormal exposure 
distribution cases, respectively. Analysis of the parameters from the dose-response model and the 
epidemic study showed that the parameters were taken from the same distribution in the Japan 
case, as they passed the KS test, but this null hypothesis was rejected in the case of the Melbourne 
outbreak.  
 
The outbreak models gave better results that are more mechanistically based than other methods 
in the literature.  They compared well against Egan et al.’s work, in which the release times were 
convoluted with an incubation distribution to model the epidemic.  This work suggests that the 
incorporation of a time factor into outbreak models may provide an approach to modelling that 
adequately describes realistic in-vivo dynamics of the host-pathogen system.  
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Chapter 4: Giardia lamblia3 
 
4.1. Abstract 
Experimental time-to-infection data is a useful, but often underutilized, material for examining 
the mechanics of in-vivo pathogen growth. In this paper, the authors incorporate a time-dose-
response (TDR) equation into a model which predicts the number of ill persons per day in a 
Giardia lamblia epidemic using data collected from a Pittsfield, Massachusetts outbreak. To this 
end, dose-response and time-dose-response models were generated for Giardia exposure to 
beaver and human volunteers, and a maximum likelihood estimation (MLE) approach was used to 
ensure that the models provided acceptable fits. The TDR equation that best-fit the dosing study 
was the beta-Poisson with exponential reciprocal dependency model. The outbreak model is an 
expanded probability model that convolutes an assumed incubation distribution of the infectious 
agent with an exposure distribution. Since the beta-Poisson with exponential reciprocal 
dependency models the time-to-infection density distribution best, it is input as the incubation 
distribution. Several density functions, including the Weibull, lognormal, gamma, and uniform 
functions served as exposure distributions. The convolution of the time-dependent probability 
distribution with the lognormal distribution yielded the best-fit for the outbreak model.  
 
4.2. Keywords 
Dose-response; epidemiology; Giardia lamblia; outbreak model; time-dose-response 
  
                                                          
 
3 This chapter is published: Prasad, B., Haas, C.N., Ryan, M. (2017). A method for incorporating a time-
dose-response model into a Giardia lamblia outbreak. Journal of Water and Health, in press. 
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4.3. Introduction 
Giardia lamblia (syn. duodenalis or intestinalis), referred to herein as Giardia, is a zoonotic 
flagellated parasite that infects a wide variety of mammalian hosts through the fecal-oral route. 
Common transmissions occur either through direct contact with the fecal matter of an infected 
person, or through cyst ingestion, which often occurs through the vehicle of contaminated food or 
water (Erlandsen and Meyer 1984). Giardia cysts are immediately infectious once they are shed, 
and are protected by a hard outer shell that allows them to survive outside the body for several 
weeks or even months (Olson et al. 1999). Human dosing studies have shown that the median 
infectious dose for Giardia via the oral route is between 10 and 100 cysts; conversely an infected 
person might shed 1-10 billion cysts daily for several months (Rendtorff 1954). Giardiasis may be 
acute or chronic, with susceptible populations such as children and the elderly often having 
difficulty in clearing the cysts. Although carriers can be asymptomatic, gastroenteritis in ill 
patients normally begins 1 to 3 weeks after infection, leading to severe diarrhea and life-
threatening sickness (Heyman 2004).  
 
Due to its stability and widespread distribution, Giardia is considered to be one of the most 
common causes of protozoan diarrhea in the world. In a 2007 review of waterborne outbreaks 
caused by parasitic protozoa in developed countries, Karanis et al. (2007) found that Giardia was 
the etiological agent responsible for 32% of total outbreaks. In 2008, it was reported that the total 
number of Giardia cases was 19,140 in the United States (U.S.) (Yoder et al. 2010), but since 
infected populations may be asymptomatic or lack access to sufficient health care, some experts 
estimate that the actual number of giardiasis in the U.S. is on the order of 2×106 (Mead et al. 
1999). Annual global incidences of giardiasis are estimated to be 2.8×108 infections per year. In 
2004, Giardia was added to the WHO Neglected Diseases Initiative (Savioli et al. 2006). 
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Despite such prevalence, there have been few outbreak models for Giardia that forecast 
transmission of the pathogen into susceptible populations. The Susceptible-Infected-Recovered 
(SIR) compartment model proposed by Kermack-McKendrick in 1927 remains the cornerstone of 
disease modeling (Kermack and McKendrick 1927), and has been expanded upon numerous 
times since its inception (Anderson and May 1991, Hethcote 1996). In 1999, Gupta et al. 
reworked the compartment model so that density distributions were assumed for parameters that 
had historically been point estimates (Gupta 1999). Gupta’s method could be further improved 
upon by assuming a density distribution that closely models the incubation time (the period 
between infection and clinical disease) for Giardia. The assumed incubation density distribution 
would come from time-dose-response (TDR) modeling.  
 
The TDR model, which quantifies a relationship between pathogen kinetics and host response, 
provides the means by which dosing study equations can be incorporated into outbreak models 
(Huang and Haas 2009). Between 2009 and 2011, Huang et al. published a series of papers that 
aimed to quantify the onset time for clinical disease by building incubation time into the 
framework of traditional exponential and beta-Poisson dose-response equations (Huang et al. 
2009, Huang and Haas 2009, 2011). These TDR equations can be incorporated into the SIR 
compartment model. To date, a time-dose-response model has not been generated for Giardia, 
nor has a formal incubation distribution been incorporated into a disease model. Such a model is 
needed to determine if the host-pathogen dynamic can appropriately describe a public health risk 
in a meaningful way.  
 
The purpose of this study is to (i) generate and discuss the results stemming from a non-time-
dependent DR model for Giardia; (ii) determine the best-fit TDR model for Giardia; (iii) to 
incorporate this model into the incubation distribution of an outbreak model; and (iv) to compare 
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the results of the time-dependent model with other non-time-dependent models. Criteria and 
parameter values are also investigated.  
 
4.4. Materials and methods 
This study was broken down into four parts, each which builds upon the previous section, as 
illustrated in Figure 4.1. These parts include: (i) a literature review of dose-response and outbreak 
datasets; (ii) modeling of non-time-dependent dose-response using animal and human studies; 
(iii) time-dose-response models using animal and human studies; and (iv) the development and 
utilization of an outbreak model which incorporates a selected time-dose-response equation into 
the model.  
 
A literature search for usable datasets for the dose-response and outbreak models was first 
performed. The dose-response datasets from the literature search were then modeled using the 
non-time-dependent dose-response and TDR equations. From the initial literature search, a usable 
Giardia outbreak dataset was found, and this dataset was modeled by convoluting an exposure 
density function with an incubation density function. The exposure density functions that were 
explored were the Weibull, gamma, lognormal and uniform. The incubation density function that 
was used was the best-fit TDR model (in the form of a probability density function). The work 
builds upon the time-dose-response models developed by Huang et al. (Huang et al. 2009, Huang 
and Haas 2009, 2011), and the outbreak model developed by Gupta et al. (1999). 
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Figure 4.1 The methods are divided into four parts: (i) the literature search; (ii) the dose-response (DR) 
model; (iii) the time-dose-response model (TDR); and (iv) the outbreak model. 
 
 
 
 
4.4.1. Datasets for time-dose-response and outbreak models 
4.4.1.1. Dose-response datasets 
The inclusion criteria for choosing the time-dose-response model was that article included: (i) a 
clear description of dosing methods; (ii) reported mode of exposure; (iii) the administered dose to 
each subject; (iv) the number of subjects that experienced adverse effects on each respective day; 
(v) stated criteria used to define a positive endpoint; (vi) detailed descriptions of the pathogen 
(i.e. source and strain); (vii) at least one observation where a fraction of the dosing groups is 
infected (0 < 𝑝 < 1); and (viii) the time-to-adverse response for each individual subject (Haas 
1999).  
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4.4.1.2. Outbreak datasets 
The inclusion criteria for selecting an appropriate outbreak dataset included: (i) that the size of 
population susceptible to infection was known or could be estimated; (ii) members of this 
susceptible population who became symptomatically ill were confirmed cases; (iii) the beginning 
and end of the pathogen contamination is known; (iv) there is incubation data for the pathogen; 
(v) the outbreak occurred over a defined period of time; (vi) the exposure period is short 
compared to the length of the outbreak; (vii) each confirmed case comes from the original source 
and there is no secondary spread of disease; or, if there is some secondary spread, there is a clear 
distinction between the primary and secondary spread; and that (viii) all outbreak cases that are 
identified have the same case definition. The final criterion is necessary because case definitions 
have evolved over the years, and a case of infection defined decades ago may not be the same as 
today. A laboratory confirmed case of giardiasis is defined as the detection of Giardia organisms, 
antigen, or DNA in stool or other fluid and tissue sample, while a probable case of giardiasis is a 
case linked epidemiologically to a confirmed case, where an individual experiences similar 
clinical symptoms (Wharton et al. 1990). 
 
4.4.2. Dose-response Models 
4.4.2.1. Non-time-dependent dose-response models 
Datasets that met this inclusion criteria were initially modeled using traditional dose-response 
analysis widely used in quantitative microbial risk assessment (QMRA), which neglects the time-
to-infection process. Traditional dose-response predicts the probability of adverse effects, such as 
illness or death, from the infection of a given dose (Haas et al. 2014). Dose-response equations 
are usually expressed mathematically, often in the form of an exponential or beta-Poisson model 
(Haas et al. 2014): 
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𝑃(𝑑) = 1 − 𝑒−𝑘𝑑     Eq. 4.1 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 4.2 
The approximate beta-Poisson (Eq. 4.2) was developed from the exponential (Eq. 4.1) by 
replacing the parameter 𝑘 with a beta distribution (Haas et al. 2014). Both expressions assume 
that (i) a single surviving pathogen is sufficient to initiate infection; (ii) the host ingests one or 
more organisms capable of causing an adverse response; (iii) only a fraction of these pathogens 
reach a site of infection; (iv) individuals ingest a number of microorganisms representing a 
random sample from a Poisson distribution; (v) within the host, the survival of any 
microorganism is independent of the survival of any other microorganism (Haas et al. 2014).  
 
Because these models are predictive models, we look at the probability of adverse response in the 
host. 𝑃(𝑑) is the probability of adverse response at dose 𝑑, and 𝑘 is the exponential rate 
parameter describing the probability that a single organism can survive and initiate infection in 
the host. 𝑁50 is the median infective dose and 𝛼 is the slope parameter for the beta-Poisson 
model. The exponential and the beta-Poisson models both have a mechanistic biological basis and 
exhibit linearity at low dose (Haas et al. 2014).   
 
A Cochran-Armitage test of trend was applied to determine whether there was an association 
between increasing dosages and adverse effects (Haas et al. 2014, Neuhäuser and Hothorn 1999). 
Written formally, the Z-statistic is calculated by 
𝑍𝐶𝐴 =
∑ (𝑥𝑖−?̅?)
𝑘
𝑖=1 𝑝𝑖
√?̅?(1−?̅?) ∑ 𝑛𝑖(𝑥𝑖−?̅?)2
𝑘
𝑖=1
                                                   Eq. 4.3 
where  
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?̅? =
∑ 𝑛𝑖𝑥𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
  and ?̅? =
∑ 𝑝𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
                                                  Eq. 4.4 
with 𝑛𝑖 total subjects and 𝑝𝑖 positive subjects. The null hypothesis of lack of trend is rejected if 
𝑍𝐶𝐴 is above the upper 5
th percentile of the normal distribution, which is 1.64 for a one-tailed test.  
 
If such an association is determined, the data can be modeled. A code written in R programming 
language (www.r-project.org) minimized the deviance (𝑌) of each of these model fits: 
𝑌 = −2 ∑ [𝑝𝑖𝑙𝑛
𝜋𝑖
𝜋𝑖
0 + (𝑛𝑖 − 𝑝𝑖)𝑙𝑛
1−𝜋𝑖
1−𝜋𝑖
0]
𝑘
𝑖=1                                      Eq. 4.5 
The parameters 𝜋𝑖  and 𝜋𝑖
0 are the predicted and observed responses of 𝑝𝑖 positive subjects within 
𝑛𝑖 number of subjects in the set (Haas et al. 2014). Goodness-of-fit was determined by comparing 
minimized deviance from maximum likelihood estimations (MLE) to the critical 2 distribution. 
The optimized deviance has a 2 distribution with m – n degrees of freedom, where m is the 
number of doses and n is the number of model parameters. The dose-response model is rejected if 
𝑌 >  𝑚−𝑛,0.95
2 , at a 95% confidence level. If, however, both models provide acceptable fits, the 
beta-Poisson model could be selected as a best-fit model only if the difference in minimized 
deviances between the beta-Poisson and the exponential model was greater than the critical chi-
square value for a single parameter (one degree of freedom). Confidence intervals of the 
parameters for the models were determined via bootstrapping with 10,000 iterations.  
 
4.4.2.1.1. Pooling 
Pooling between the found datasets was performed to ascertain whether the underlying dose-
response models fitted to the separate datasets did not significantly differ from each other. The 
Giardia species, strain and host different between the two sets, and a positive ability to pool the 
datasets would increase confidence in the dose-response model. The data was pooled using the 
89 
 
 
 
method outlined by Haas et al. (2014). Using this method, two different datasets were combined 
and fit to the dose-response models. Each individual optimized deviance (Y1, Y2) was then 
subtracted from the deviance of the pooled dataset (YT): 
∆= 𝑌𝑇 − (𝑌1 + 𝑌2)                                                             Eq. 4.6 
The Δ was compared to a 𝜒2 distribution with of the degree of freedom represented by  
df = (number of parameters in each dataset) ‒ (total number of parameters)           Eq. 4.7 
The pooled dataset could be accepted if the Δ did not exceed the 2 value for degrees of freedom 
at a 95% confidence.  
 
4.4.2.2. Time-dose-response models 
Traditional models were modiﬁed to incorporate a time dependency due to parasitic 
multiplication by including additional parameters of time post inoculation (TPI). This additional 
time parameter quantifies the time of onset of an effect presumably associated with the kinetics of 
in-vivo bacterial growth. Huang developed eight equations based on time dependency in total 
(Huang et al. 2009, Huang and Haas 2009, 2011). While these dose-response models take the 
form of the traditional dose-response equations, they do not reduce to them as time goes to 
infinity.  
 
Huang’s models were tested to determine if they were true cumulative distribution functions 
(CDFs). The criteria for determining true CDF distributions was that: (i) the function at time zero 
is zero, (ii) the function at time infinity is one, (iii) the functions are monotonic, which means that 
for all 𝑎 and b, 𝑤𝑖𝑡ℎ 𝑎 ≤ 𝑏, 𝐹(𝑎) ≤ 𝐹(𝑏), and (iv) the derivative of the function is greater than or 
equal to zero for all of time. Of these 8 models, only 4 were determined to be true CDFs in time, 
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and are presented in Table 4.1. The models that were not true CDFs were excluded from the 
study.  
 
 
 
Table 4.1 True CDF time-dependent dose-response models. 
Model Name Expression 
Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 
Eq. 4.8 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 4.9 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 4.10 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 4.11 
 
 
The TDR models were ﬁt to the dose-response data, deviances were optimized, and model 
parameters were determined using maximum likelihood estimation (MLE) in the R programming 
language (www.r-project.org, ver. 3.0.3).  
 
The likelihood ratio for the incidence occurring on the jth day with i dose groups is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋
𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1      Eq. 4.12 
where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made, 𝑝𝑖,𝑗 is the number of positive response observed during time 
period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the beginning of time period 𝑗.  The predicted 
response is 𝜋𝑖, and the response for each set based on observations are 𝜋𝑖
°. 
The corresponding deviance is  
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𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1   Eq. 4.13 
This expression is nearly the same as that used in fitting traditional dose-response data in which 
only the long-term endpoint is known (Haas et al. 2014).  Differences between this expression 
and the expression normally used in dose-response modeling is that p is the number of positive 
responses in a time period rather than at the end of observations. 
 
4.4.3. Outbreak model 
The susceptible-infected-recovered (SIR) compartment model was developed by Kermack and 
McKendrick in their seminal papers (Kermack and McKendrick 1927), and has been extensively 
documented since (Anderson and May 1991). A modified SIR model was proposed by Gupta in 
his 1999 thesis (Gupta 1999) and re-derived by the author of this work (Figure 4.2). In this model, 
populations are compartmentalized into groups, with individuals moving through the 
compartments as they become infected. The number of people in the compartments, as well as the 
rates that of transfer are described by a system of differential equations. 
 
 
 
 
Figure 4.2 Modified SIR model proposed by Gupta (Gupta and Haas 2004, Kermack and McKendrick 
1927). 
 
Time-dose-response models 
will be used to determine the 
number of symptomatically ill 
persons on each day of the 
outbreak. 
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In this model, populations are compartmentalized into groups, moving through the compartments 
as they become infected. The number of people in the compartments, as well as the rates that of 
transfer are described by a system of differential equations. The four states in this model are (1) 
the susceptible populations 𝑋(𝑡); (2) latent individuals 𝑌(𝑡) who have been exposed to the 
pathogen and will ultimately become infected; (3) those who become symptomatically ill 𝑍(𝑡); 
and (4) those who have become infected but will remain Asymptomatic 𝐼(𝑡). The force of 
infectivity, 𝛽(𝑡), is the rate of transfer from susceptible to the latent, and 𝑄(𝑡) models the rate of 
newly symptomatic cases. For our purposes, only the symptomatically ill population will be 
considered, since generally data is only available for these groups through epidemic studies. The 
compartment model then reduces to the following equations: 
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), or 
1
𝑋
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)         Eq. 4.14 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡)       Eq. 4.15 
The force of infection 𝛽(t) has units of inverse time, and is a versatile parameter. In the case of a 
rectangular distribution for infectivity, 𝛽(t) would be a constant for the exposure duration. 
However, common source outbreaks are frequently caused by time variable microbial exposures, 
which means that the parameter takes the form of a density distribution, generally of the 
following form: 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)      Eq. 4.16 
where 𝛽(t) is the force of infection; b0 is the background infectivity level, which may account for 
any endemic cases in the population; 𝑔(𝑡) is the ratio of susceptible persons ultimately becoming 
infected at time t; and b1 is the scaling factor for increased infectivity above background. Here, 
𝑔(𝑡) is modeled as a probability density function for the exposure case. The density functions in 
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this case that we have used are the Weibull, gamma, and lognormal, and uniform, all which are 
standard functions which have historically been used to fit observed epidemic curves. Each of 
these density functions have parameter values that determine the shape and scale of the function. 
Integrating Eq. 4.14 gives: 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
   Eq. 4.17 
The rate of newly ill people at any time t is given by the parameter 𝑄(t). At any time t, the 
instantaneous rate of new illnesses can be obtained by the convolution integral: 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
        Eq. 4.18 
where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). The function 𝑓 is a 
probability density function (PDF) which has parameters that need to be estimated.  
 
Substituting Eq. 4.17 into Eq. 4.18 we then obtain: 
𝑑𝑍
𝑑𝑡
= ∫ 𝑋0𝛽(𝜏)exp [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 4.19 
where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the CDF corresponding to the PDF 𝑔(𝑡). Since we are 
using the Weibull, gamma, lognormal and uniform PDFs to model 𝑔(𝑡), we necessarily must use 
the corresponding CDFs for 𝐺(𝑡) in each respective case.  
 
Integrating Eq. 4.19 directly, we can solve for the number of symptomatically ill patients per day 
𝑍(𝑡): 
𝑍(𝑡) = ∬ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑     Eq. 4.20 
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In Eq. 4.20, the exposure time distribution is represented by the expression 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)], 
while the incubation distribution is represented by the expression 𝑓(𝜑 − 𝜏). The incubation 
distribution that will be used here will be the best-fit time-dose-response equation. 
 
4.4.3.1. Matlab model 
The objective function is the likelihood ratio  
−2𝑙𝑛 (
𝐿
?̂?
) = 2 [(𝜂 − 𝑁) − 𝑁𝑙𝑛 (
𝜂
𝑁
)]     Eq. 4.21 
where 𝜂 is the predicted number of new cases and 𝑁 is the observed number of new cases. The 
objective function was minimized by varying the assumed parameters in search of a global 
minimum value. Each unique combination of assumed values corresponds to a calculated value 
for the predicted number of cases per day 𝑍(𝑡), from which a corresponding value for the daily 
likelihood ratio objective function was calculated. An overall objective function is then 
calculated, which is the sum total of all the individual daily objective functions −2𝑙𝑛 (
𝐿
?̂?
) 
throughout the entire outbreak. The routine function ‘fmins,’ which has the ability to minimize 
functions with several parameters and uses a Nelder-Mead simplex, was utilized to fit the dataset. 
 
This entire process was iterative. For each exposure-incubation combination, the following 
process was repeated. A set of assumed parameter values were first input into the simulation 
model, and the corresponding predicted daily ill cases 𝑍(𝑡) was evaluated using the function 
‘quad2d.’ The summation of the daily objective function −2𝑙𝑛 (
𝐿
?̂?
) over the entire duration of the 
outbreak was then calculated. The program varied the initial guesses, and continued to calculate 
the deviance objective function until convergence was assumed, which was assumed to be less 
than 10−3.  
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4.4.4. Incorporation of the Time-Dose-Response into Incubation Distributions of the 
Outbreak Model  
The time-dose-response functions from Table 4.1 cannot be immediately used as incubation 
distributions because they are CDFs. To derive a time dose-response based incubation 
distribution to fit epidemiologic curves, the distributions must be PDFs. To get a PDF from a 
CDF, the derivative must be taken. In the case of the beta-Poisson time dose-response with 
inverse time dependency, we have the following equation:  
𝑅(𝑑, 𝑡) = 1 − [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 4.22 
𝑅(𝑑, 𝑡) is the probability of adverse effect; α is a fitting parameter; θ is a time parameter; 
𝑗0
𝑡
+ 1 
is the dose that elicits a positive response in 50% of the hosts, after infinite time. Taking the first 
partial derivative with respect to time, we get 
𝑟(𝑑, 𝑡) = −𝛼 [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼−1
×𝑑 (2
1
𝛼 − 1)
𝑗0
𝑡2
                      Eq. 4.23 
However, we want that to make sure that our function is a true PDF. Probability density functions 
satisfy the following conditions: 
1. 𝑓(𝑥) ≥ 0 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑥 
2. ∫ 𝑓(𝑥)𝑑𝑥 = 1
∞
−∞
 
 As time goes to infinity, we want the integral of our distribution to be exactly 1.  So we must 
divide by a certain value that ensures that this is true. As 𝑡 → ∞, the maximum response is 
reached for the time dose-response. Then Eq. 4.22 no longer becomes time-dependent, and we 
refer to the TDR dependency equation in Table 4.1, which assumed that 𝑁50 =
𝑗0
𝑡
+ 1. Plugging 
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in 𝑁50 for the expression in the denominator returns us back to the regular beta-Poisson dose-
response model. 
𝑅(𝑑, 𝑡 → ∞) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 4.24 
This expression can be used as the constant for which Eq. 4.23 can be divided. If we divide Eq. 
4.23 by Eq. 4.24, we get the following function: 
𝑓(𝑡|𝑑) =
𝛼[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼−1
×𝑑(2
1
𝛼−1)𝑗0
𝑡2(−1+[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼
)
   Eq. 4.25 
We now have a proper PDF 𝑓(𝑡|𝑑) that characterizes the distribution. This PDF based on the 
beta-Poisson time dose-response function distribution can now be used as a potential incubation 
distribution 𝑓(𝑡) to use in the probability density function used to calculate the number of ill, 
Z(t). The functions used to model the exposure distributions include the Weibull, gamma, 
lognormal and uniform distributions, and the best-fit time-dose-response model will be used as 
the incubation distribution. 
 
To compare the models, the deviance criterion was utilized:  
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 4.26 
The parameters  𝜃?̂? are the values of the full model (observed values), and  𝜃0̂ are the values of 
the predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and, the lowest value 
would suggest the best fit to the model.  
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In this model, we have seven parameters for the number ill, 𝑍(𝑡) in Eq. 4.20, namely the attack 
parameters  𝑏0 and  𝑏1, the two PDF parameters for the attack distribution and two PDF 
parameters for the exposure distribution (Weibull, gamma, lognormal and uniform distributions 
all contain 2 parameters), and the three parameters, 𝛼, 𝑑, and 𝑗0. 
 
It is noted that the parameter values of 𝛼, 𝑑, and 𝑗0 values from the outbreak were used as initial 
guesses for those parameters of the incubation distribution in the optimization routine. In order to 
compare the parameters in the epidemic and dosing parameter studies to see if the differences 
between corresponding parameters were significant, the two-sample Kolmogorov–Smirnov (KS) 
test and the Anderson–Darling (AD) test were utilized. In both tests, we wanted to see if the 
parameters came from the same distribution. The KS test states that 𝐷∗ =
𝑠𝑢𝑝
𝑥
| 𝐹1(𝑥) − 𝐹2(𝑥)|, 
where 𝐹1(𝑥) and 𝐹2(𝑥) are the empirical distribution functions of the two samples respectively, 
and 𝑠𝑢𝑝 is the supremum function (Sheskin 2003). The null hypothesis is rejected if the following 
equation holds true: 𝐷∗ > 𝑐(𝛼)√
𝑛+𝑛1
𝑛𝑛1
. For 𝛼 = 0.05, 𝑐(𝛼) = 1.36. The AD is a refinement of the 
KS test. The statistic that was used was of the form 
𝐴2 = −𝑛 − ∑
2𝑖−1
𝑛
[ln(Φ(𝑌𝑖)) + ln(1 − Φ(𝑌𝑛+1−𝑖))]
𝑛
𝑖=1  (D’Agostino et al. 1986). The parameter 
𝑛 is the number of data points in the sample, and the test statistic measures the distance between 
the hypothesized and empirical. The null hypothesis of normality is rejected if A2 exceeds 0.752 
for α = 0.05. 
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4.5. Results and discussion 
4.5.1. Dose-response  
A literature search was conducted to identify appropriate candidate dose-response datasets for 
Giardia. Two datasets passed the inclusion criteria. The first was a study by Erlandsen et al. 
(1988), in which researchers exposed beavers to different dose levels of Giardia cysts in order to 
determine an infective dose. The administered cysts were obtained from three symptomatic 
patients from a Giardia outbreak in Pittsfield, MA in December 1985. The authors reported the 
viability of the cysts to be 91%. The beavers were live-trapped and examined for 30 days to 
ensure that they were negative for Giardia cysts. Following confirmation, they were subsequently 
inoculated orally at doses levels of 48, 454, 4,460 and 5.5×105 cysts. Infection was determined by 
the presence of fecal cysts. The first day of in which cysts appeared in the feces ranged from 10 to 
30 days post-inoculation.  
 
In a second study by Rendtorff et al. (1954), human volunteers were orally exposed to graded 
doses of Giardia cysts, sourced from the fresh stool samples of human donors. Cysts were 
administered in either a saline or tap water solution. Infection was defined to be the appearance of 
cysts in stool samples. Individuals exposed to doses as low as 10 CFUs were infected, and the 
first day of cyst appearance in the feces was between 6 and 21 days post-inoculation. The adverse 
responses for the beaver and human studies are summarized in Table 4.2.     
  
 
 
 
 
 
 
Table 4.2 Number of beaver and human hosts testing for positive fecal cyst shedding per day after being inoculated with varying doses of Giardia lamblia via 
the oral route. 
    Day post-inoculation  
Case Host No of 
hostsa 
Doseb 1- 5 6 7 8 9 10 11 12 13 14 15 16 17-20 21 22-29 30 Total positive 
hosts 
ERLc Beaver 6 48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
6 454 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 2 
3 4460 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 
3 5.5×105 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 2 
RENd Human 
volunteers 
5 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 10 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 2 
20 25 0 0 0 0 0 0 0 0 1 2 1 1 0 1 0 0 6 
2 1×102 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
3 1×104 0 0 0 2 0 1 0 0 0 0 0 0 0 0 0 0 3 
3 1×105 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 3 
3 3×105 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 3 
2 1×106 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 2 
a Host refers to beavers in the Erlandsen study, and humans in the Rendtorff study 
b Reported in cyst numbers in beaver hosts, and CFUs in human hosts 
c Erlandsen et al. data 
d Rendtorff et al. data 
  
9
9
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Both beaver and human datasets showed positive trends when subjected to the Cochran-Armitage 
test of trend. The Z critical value 𝑍𝑐𝑟, was calculated to be 2.04 for the beaver data set, and 3.14 
for the human data set. Since these values are greater than 1.64 (𝑍𝑐𝑟 > 1.64), the null hypothesis 
of lack of trend is rejected and the data can be further analyzed.  
 
The predictive dose-response model results for the beaver and human trials is provided in Table 
4.3. The beta-Poisson model was the best-fitting mechanistic model for the beaver dose-response 
data set because it was the only one whose minimized deviance of 1.22 was lower than the critical 
chi-square distribution χ2 for 1 degree of freedom, at 3.84. The N50 value was 14601. The 
bootstrapped data set exhibit very wide 95% and 99% confidence intervals, which widen further 
as the dose increases (Figure 4.3a). This may be due to the small number of dose groups 
inoculated for beavers. The scatter plot in Figure 4.3b shows the confidence of the parameter 
values from 90% to 99% confidence levels.  
 
In the human trial study, both the exponential and the beta-Poisson models provide acceptable 
fits, but the best-fitting model was the exponential model because it had both a minimal number 
of parameters and a minimized deviance of 8.37, lower than the critical chi-square distribution χ2 
for 7 degrees of freedom, at 14.1. The fitting parameter k was equal to 0.0199. The bootstrapped 
data set showing the best-fit model and confidence intervals is presented in Figure 4.3c. In this 
case, the 95% and 99% confidence intervals exhibit fairly narrow tight bands. Figure 4.3d shows 
the frequency in which parameter value k is sampled. 
 
The N50 values calculated from the beaver and human datasets varied significantly. The predictive 
dosage in which 50% of human hosts would become ill was estimated to be 35 cysts, much less 
than the 𝑁50 value for the beavers, at 14601. This may be due to variations in the potency of the 
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cysts due to routes of administration, preparation methods, cyst harvesting and sourcing, or 
host/pathogen dynamics. Schaefer et al. (1991) experimentally determined that the 𝑁50 value for 
Giardia cysts in the Mongolian gerbil was 320 cysts for the endpoint of infection, which falls in 
between our estimates here for the beaver and human datasets. 
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Figure 4.3 The top two figures (a and b) correspond to the beaver inoculation data, while the bottom two 
figures (c and d) correspond to the human inoculation data: (a) Best-fit bootstrapped beta-Poisson dose-
response model with confidence intervals for cysts administered orally to beavers; and (b) the 
corresponding bootstrapped beta-Poisson parameters with 10,000 iterations for those confidence intervals 
(Erlandsen et al. 1988). (c) Best-fit bootstrapped exponential model with confidence intervals for cysts 
administered orally to human volunteers via oral route; and (d) the corresponding bootstrapped frequency 
diagram for exponential model parameter 𝐤 with 10,000 iterations (Rendtorff 1954).  
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4.5.1.1. Pooling 
The best-fit model for the pooled Erlandsen et al. beaver and Rendtorff et al. human dataset was 
the beta-Poisson, which had parameter values of α=0.1977 and N50=70.96 with 8 degrees of 
freedom in Table 4.3. The χ2 value for this model was 17.85, while the critical χ2 value for 8 
degrees of freedom is 15.5; therefore, even the best-fit model does not provide an acceptable fit. 
Additionally, the difference in the pooled model’s deviance and the sum of the deviances of the 
individual datasets was 8.26, which exceeded the critical χ2 value (the degrees of freedom equal 
to sum of parameters in individual models minus number of parameters used in pooled model) of 
5.99. By analyzing these two metrics, the pooling for all datasets was determined to be 
unacceptable.  
 
 
 
Table 4.3 Non-time-dependent dose-response modeling results for Giardia inoculation in the beaver 
(Erlandsen et al. 1988) and human (Rendtorff 1954) hosts. 
Dataset Model 
Parameter 
Deviance dfa 𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 Conclusions 
Best fit 
modelc type value 
Dataset 1 
Beaver hosts 
Expd k 5.81×10−6 22.5 3 7.81 Beta-Poisson 
provides 
acceptable fit 
Beta-Poisson 
BPe 
α 0.14 
1.22 2 5.99 
N50 1.46×104 
Dataset 2 
Human hosts 
Expd k 1.99×10−2 8.37 7 14.1 Exp and BP 
provide 
acceptable fit 
Exponential 
BPe 
α 1.48×10−5 
8.37 6 12.5 
N50 34.8 
Pooled 
Datasets 
Expd k 1.09×10−3 133.6 10 19.7 
No acceptable 
fit 
No acceptable 
fit BPe 
α 0.20 
17.9 8 18.3 
N50 71.0 
a df - degrees of freedom for fitted model 
b  Critical values of the chi-squared distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, 
m is the number of doses, n is the number of parameters 
c Best fit model criteria: the lowest deviance of candidate models was chosen compared to the critical values of chi-
squared distribution  
d Exponential Model 
e Beta-Poisson Model 
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4.5.2. Time-Dose-Response  
Table 4.4 summarizes the parameters of the time-dependent dose-response data for the beaver and 
human model fits. The exponential model with exponential-reciprocal time dependency did not 
converge for either the human and beaver datasets. This may be because this time-dependence 
model was not robust enough to provide adequate fitting to the datasets. In the beaver dataset, the 
beta-Poisson model with exponential-reciprocal time dependency and beta-Poisson model with 
exponential time dependency models provided acceptable fits, in which the minimized deviance 
is less than the critical chi-square value for the degree of freedom of the dose-response data at 
𝑝 = 0.05. In the beta-Poisson model with exponential-reciprocal time dependency the minimized 
deviance was determined to be 24.2, less than the critical chi-square value of 27.6 for the degree 
of freedom. In the case of the beta-Poisson model with exponential time dependency, the 
minimized deviance was 22.7, which was slightly lower than the previous model, and still less 
than the critical chi-square value of 27.6. For the beta-Poisson model with inverse time 
dependency model, the minimized deviance was 59.9, much higher than the critical chi-square 
value of 28.9; this model does not provide an acceptable fit to the beaver dataset. In the human 
data set, the only model that provided an acceptable fit for time-dose-response model was the 
beta-Poisson with exponential reciprocal time dependency. The minimized deviance in this case 
was 105.6, less than the critical chi-square value of 116.5. The remaining models did not provide 
acceptable fits. 
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Table 4.4 Time-dose-response (TDR) modeling results for Giardia inoculation in the beaver (Erlandsen et 
al. 1988) and human (Rendtorff 1954) hosts. 
Case Time Dependence Model 
Best fit 
parameters 
Minimized 
deviance 
2
,05.0 df  
Acceptable 
fit? 
Dataset 1 
 
Beaver hosts 
Erlandsen 
 et al. 
 
 
Exponential model with 
exponential-reciprocal time 
dependency 
No convergence n/a n/a n/a 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
α = 0.11 
24.2 27.6 yes j0 = 35.7 
j1 = 9.4 
Beta-Poisson model with 
exponential time 
dependency 
α = 0.13 
22.7 27.6 yes j0 = 0.51 
j1 = 15.7 
Beta-Poisson model with 
inverse time dependencya 
α = 0.013 
59.9 28.9 no 
j0 = 109.2 
Dataset 2 
 
Human hosts 
Rendtorff 
 et al. 
 
Exponential model with 
exponential-reciprocal time 
dependency 
No convergence n/a n/a n/a 
Beta-Poisson model with 
exponential-reciprocal time 
dependenceb 
α = 1.11 
105.6 116.5 yes j0 = 10.4 
j1 = 3.12 
Beta-Poisson model with 
exponential time 
dependency 
α = 5.29 
178.2 116.5 no j0 = 92.0 
j1 = 3.36 
Beta-Poisson model with 
inverse time dependencyd 
α = 1.37 
1.49×103 117.6 no 
j0 = 0.07 
a best-fit model for the beaver dataset (Erlandsen et al. 1988) 
b best-fit model for the human dataset (Rendtorff 1954) 
 
 
 
The time-dose-response model that was ultimately chosen to be used in incubation distribution of 
the Pittsfield, Massachusetts Giardia outbreak was the best-fit model of the human data set, the 
beta-Poisson with exponential reciprocal time dependency. The advantage of using the results of 
the beaver data set was that cysts used to inoculate the animals were sourced from the Pittsfield 
outbreak. However, the human dosing study was considered the most appropriate choice because 
the method of administration was via the oral route, and Giardia outbreaks largely are transmitted 
via this route. Figures 4.4 and 4.5 present the time-dose-response models for each of the 
respective studies.  
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Figure 4.4 Best-fit time-dose-response fits to the beaver dataset (Erlandsen et al. 1988) as modeled by the 
beta-Poisson model with exponential time dependency. Each day is modeled independently, and the arrows 
indicate the direction of the probability of illness from the ﬁrst day to the last. 
 
 
 
Figure 4.5 Best-fit time-dose-response for the human dataset (Rendtorff 1954), as modelled by the beta-
Poisson model with exponential-reciprocal time dependency. The arrows indicate the direction of the 
curves from the ﬁrst day to the last.  
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4.5.3. Giardiasis outbreak model  
While a large number of waterborne and foodborne cases of giardiasis are diagnosed each year, 
less than 1% of cases are associated with an outbreak (Yoder et al. 2012). Of these outbreaks, 
only a few satisfy the criteria for analysis in this study. A Giardia outbreak occurring between 
November 1985 to January 1986 in the city of Pittsfield, MA, was documented by Kent et al. 
(1988) and provided adequate data for the analysis. This outbreak was the largest ever 
documented for a Giardia pathogen. On November 5, a new auxiliary reservoir was brought 
online in Pittsfield to replace water from a main reservoir that was getting a new filtration system 
installed. On November 14, the fraction of water supplied from the auxiliary reservoir increased, 
and residents from various parts of the city complained of cloudy water the same day. Two weeks 
later, health officials in Pittsfield received 70 reports of laboratory-confirmed giardiasis, once 
again from residents throughout the city. Health officials identified the source of the giardiasis 
outbreak, and the auxiliary reservoir was removed from the municipal water supply on December 
21. Although the exposures appear to have spanned a period of over one week, this is still much 
shorter than the length of the outbreak, which spanned the course of 3 months. The exposure 
period is to be modeled with the 4 exposure distributions: Weibull, gamma, lognormal and 
uniform.  
 
Studies conducted in the area suggested that beavers and muskrats had contributed to the 
contamination of the reservoir, but they could have originally been infected from a human source. 
In a susceptible population of about 50,000, a total of 703 laboratory-confirmed cases of 
giardiasis were reported.  
 
The best-fit model from the human feeding trial was the beta-Poisson with exponential reciprocal 
time dependency; this TDR model was therefore chosen to be incorporated into the incubation 
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distribution of the outbreak model. A maximum likelihood approach was used in Matlab to 
predict the number ill 𝑍(𝑡) on each respective day and each of the parameters. Table 4.5 
summarizes the model parameters and the criteria values for the various distribution models, and 
Figure 4.6 summarizes the observed vs. expected curve fits for each PDF convolution.  
 
The 𝑑𝑓 (𝑚 − 𝑛) in this case was 55, the number of data points minus the 8-parameter model. The 
critical chi-square distribution χ2 for 55 degree of freedom is 73.31, so the incubation distribution 
convoluted with the gamma, lognormal, and Weibull distributions all provide acceptable fits 
(Table 4.5). The lognormal exposure distribution is the best fit, which has the lowest deviance 
value of 61.15.
  
 
 
Table 4.5 Parameter, criteria and test statistic values for the outbreak models. 
  Model Parameters  
Criteria 
Value 
Test Statistic 
Exposure 
Distribution 
Incubation 
Distribution 
Attack 
param 
b0 
Attack 
param 
b1 
Attack 
dist – 
PDF 
param 1 
Attack 
dist – 
PDF 
param 2 
Incub 
dist – 
PDF 
param 1 
alpha 
Incub 
distr – 
PDF 
param 2 
dose 
Incub 
distr – 
PDF 
param 3 
j0 
Incub 
distr – 
PDF 
param 4 
j1 
Deviance KSi ADj 
Gamma Beta- 
Poisson with 
Exponential 
Recip Time 
Dependency 
0.010 3.17 25.6a 0.397b 11.4 6.0 13.4 2.4 67.4 1.13 0.52 
Lognormal 0.0030 3.79 3.81c 0.344d 1.39 11.0 7.47 1.68 61.2 0.15 0.27 
Uniform 0.98 0.092 0.166e 0.647f 3.07 3.7 21.8 4.46 106.6 0.32 0.44 
Weibull 0.032 0.244 2.04g 0.66h 2.04 0.66 13.7 18.3 72.1 1.28 0.63 
a mean 
b variance 
c log transform of mean 
d log transform of variance 
e lower endpoint 
f upper endpoint 
g scale parameter 
h shape parameter 
i Kolmogorov–Smirnov test statistic D* 
j Anderson-Darling test statistic A2 
 
  
1
0
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The first and second column of Table 4.5 are the results for the b0 and b1 attack rate values. We 
can here observe general trends in the parameters. From the b0 and b1 attack rate values, we can 
see that there is a low incidence rate of Giardia among this particular susceptible population. The 
third and fourth columns are referred to as “PDF param 1” and “PDF param 2,” and they differ 
according to the distributions used. For the gamma exposure distribution, PDF param 1 and PDF 
param 2 are the mean and variance. In the lognormal distributions, PDF param 1 and PDF param 
2 are the log transform of the mean and variance. In the Weibull distribution, PDF param 1 and 
PDF param 2 are the scale parameter a and shape parameter b in the PDF. The uniform similarly 
follows the Weibull, and uses parameters a and b in the PDF, with a being a lower endpoint 
(minimum) and b being an upper endpoint (maximum). The incubation distribution parameters 
are the parameters from the beta-Poisson with exponential reciprocal time dependency model. 
 
A visual inspection of the model fits of Figure 4.6 shows that the predicted epidemic curve 
provides a reasonable fit for most of the data points. All models were limited by their inability to 
capture the data points in which the number of ill was at its peak, around day 30 of the outbreak. 
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Figure 4.6 Curve fits for (a) gamma, (b) lognormal, (c) uniform, and (d) Weibull exposure functions 
convoluted with the beta-Poisson with exponential reciprocal incubation distribution. 
 
The data was further analyzed by comparing the parameters of the incubation distribution of the 
outbreak model with the human dosing experiment to see if there was a significant difference 
between the parameters of the two models. These parameters that were compared were the 
𝛼, 𝑗0, 𝑗1 of the time-dose-response model with the 𝛼, 𝑗0, 𝑗1 from the outbreak fitting. 
 
The last two columns in Table 4.5 summarize the output of the Kolmogorov–Smirnov and 
Anderson-Darling tests. In each case, the D* value of the KS test is less than the critical 𝜒2 for 
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𝛼 = 0.05, which is 1.36. The AD test, which comes from the KS test, was also positive. The 𝐴2 
values for each distribution scenario were less than the critical 𝜒𝟐 for 𝛼 = 0.05, which is 0.752. 
From these results, it was concluded that there was no significant difference in the parameters of 
the distributions, and they came from the same distribution.  
 
An interesting connection between the beaver trial and the outbreak is that the beavers were 
inoculated with cysts from three symptomatically ill patients from the Pittsfield outbreak. The 
human volunteers, on the other hand, were administered cysts that were sourced from fresh the 
stool samples of human donors. Despite the connection with the original outbreak, the human 
time-dose-response results were ultimately chosen over the beaver results to be incorporated into 
the outbreak model because the human in-vivo response was thought to best model the human 
outbreak.  
 
It is also acknowledged that datasets are limited for the type of modeling performed in this work. 
In both feeding trials, the incubation time is the time between exposure and onset of shedding, 
which is monitored daily for presence of Giardia. However, in the outbreak data, a patient must 
first feel symptomatically ill to go to visit the doctor, who then sends a stool sample to the 
laboratory for analysis. So, there is a time between exposure and onset of symptoms identified by 
the infected individuals themselves. Currently, there is no available data to account for this 
difference. However, the time difference between fecal shedding and onset of symptoms is not 
necessarily significant. The incubation period is estimated to be between 3-25 days, with the 
median number being between 7-10 days (Heyman 2004). The first appearance of cysts in 
beavers was most commonly at 10 days and between 13-14 days. In the human trials, there was a 
much larger spread – between 6 and 17 days, with a mode of 10 days. These numbers are well 
within the incubation period of 3-25 days, and are at the tail end of the median incubation period 
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of 7-10 days. However, to strengthen this model in the future, the value 𝑍(𝑡) could be multiplied 
by another parameter that accounts for this discrepancy. 
 
As with any computer model, the Matlab optimization had challenges in the fitting of the 
datasets. The issue of reliably fitting 8 parameters with a degree of reproducibility, given an 
observed epidemic outbreak, was a concern. To examine this issue, the program was run several 
times, with varying initial guesses. At times, a global minimal for the log-likelihood was not able 
to be reached; instead a local minimum value was calculated. The local min values may suggest a 
substitution effect between the parameters. However, by running the simulations several times 
and allowing them to compute for several hours, these local minimum values were largely able to 
be overcome in favor or global mins. With each run, the models were able to consistently reach 
the same likelihood value with parameter values that were very close to each other. Confidence in 
the model structure could be increased by generating artificial data from the different models and 
testing the ability of the fitting algorithms to recover the parameters. This testing procedure was 
outside of the scope of this work, but could be done as a follow-up study. It would also be useful 
to see confidence interval estimates for at least the favored outbreak model.  These estimates 
could then compare the estimates from those based on the human data.   
 
4.6. Conclusion 
Dose-response and time-dose-response models were generated for Giardia lamblia exposure to 
beaver and human volunteers. An attempt to pool the dose-response models between hosts did not 
yield an acceptable fit, leading to the conclusion that crossing species and routes of 
administration may have prevented pooling of the models. In the human model, the 50% 
predictive infectious dose was estimated to be 35 cysts, while the N50 for the beavers was 14601. 
The best-fit human time-dose-response model was the beta-Poisson with exponential reciprocal 
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dependency, which had a minimized deviance of 105.6; this was chosen to be incorporated into 
the outbreak model. The convolution of this probability distribution with the lognormal 
distribution yielded the best-fit for the model, with a minimized deviance value of 61.2. Analysis 
of the parameters from the dose-response model and the epidemic study showed that the 
parameters were taken from the same distribution, as they passed the AD and KS tests. This work 
suggests that the incorporation of the in-vivo time factor for pathogens may provide an useful 
alternative approach to modelling in which the time-to-infection is considered in the fitting of a 
disease outbreak. 
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Chapter 5: Salmonella Newport and Salmonella Typhimurium4 
 
5.1. Abstract 
A novel method was used to incorporate in-vivo host-pathogen dynamics into a robust outbreak 
model for salmonellosis. Several dose-response and time-dose-response (TDR) models were 
generated for an oral Salmonella Newport exposure to humans and an oral Salmonella 
Typhimurium exposure to young piglets using a maximum likelihood estimation approach. The 
best-fit TDR models from both the S. Newport and S. Typhimurium dosing studies were the beta-
Poisson with inverse time dependency models, which had minimized deviance values of 11.4 and 
8.7, respectively. This best-fit TDR model was then incorporated into the incubation period of 
three separate Salmonella outbreaks and convoluted with exposure density functions. These time-
dependent models were then compared with other models in which time-to-infection was not 
considered. In a primary outbreak of S. Newport caused by lettuce consumption in Northern 
Ireland, the Weibull exposure distribution convoluted with the beta-Poisson with inverse time 
distribution was the best-fit model, with a minimized deviance value of 18.15. In a primary 
outbreak of S. Typhimurium originating from an Oregon salad bar, again the Weibull-beta-
Poisson with inverse time distribution performed the best, with a minimized deviance value of 
26.6. In a secondary outbreak of S. Typhimurium that was initially spread through salami in the 
United Kingdom (U.K.), the uniform exposure convoluted with the gamma distribution 
performed the best, with a minimized deviance value of 1.47. This work shows that the 
incorporation of a time factor into outbreak distributions provides the best fits to modelling and 
can simultaneously provide insight into the in-vivo dynamics of the host-pathogen system.  
  
                                                          
 
4 This chapter is currently under review at Microbial Risk Analysis. 
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5.2. Keywords 
Salmonella, mathematical epidemiology, time-dose-response, outbreak model, in-vivo kinetics, 
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5.3. Introduction 
Salmonellosis, a disease caused by nontyphoid Salmonella (NTS), is an important contributor to 
the global health burden, with symptoms including acute enterocolitis, headaches, abdominal 
pain, diarrhea, nausea and vomiting (Heymann 2008). Salmonellosis transmission occurs when 
organisms are ingested orally, typically from food contaminated by the feces of an infected 
animal or person (Carrasco et al. 2012, Heymann 2008). Animals such as poultry (Akbar and 
Anal 2013, Löfström et al. 2015, Loharikar et al. 2012, Uyttendaele et al. 1998), swine (Abley et 
al. 2013, D'Avino et al. 2014, Gomes-Neves et al. 2012, Haley et al. 2012), and cattle (Khen et al. 
2014) are common reservoirs for the pathogen. Humans may be carriers, as evidenced by the 
numerous cases of person-to-person spread (Craven et al. 1975, Holguin et al. 2014, Loewenstein 
1975, Sharp and Heymann 1976, Steere et al. 1975). An estimated 80.3 million annual cases are 
considered to be foodborne (Majowicz et al. 2010), often traced back to fish, dairy, egg, poultry, 
and meat products (Amagliani et al. 2012, Carrasco et al. 2012, Heymann 2008). NTS has also 
been implicated in gastroenteritis cases stemming from unpasteurized juices and cider (Álvarez-
Ordóñez et al. 2013, Danyluk et al. 2012, Mihajlovic et al. 2013), peanuts (Sheth et al. 2011), and 
raw fruits and vegetables (Angelo et al. 2015, Behravesh et al. 2012, Severi et al. 2012). 
Gastroenteritis infection with Salmonella cannot generally be clinically distinguished from other 
enteric bacterial pathogens, and therefore diagnosis requires isolation of the organisms from feces 
or blood samples, which are then identified in a laboratory through biochemical tests (Giannella 
1996).  
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The incidence of NTS in the United States (U.S.) is estimated to be 1.2 million illnesses annually, 
resulting in 23,000 hospitalizations and 450 deaths (Neidhart 1996, Scallan et al. 2011). In 
immunocompetent individuals, NTS illnesses may be recurrent and can result in diarrheal death, 
which has a fatality rate of approximately 0.1% in the U.S. (Gordon 2008). Bacteremia, a serious 
and potentially fatal complication generally occurring among children and immunosuppressed 
patients, develops from approximately 5% of salmonellosis cases (Acheson and Hohmann 2001). 
In developing countries, the mortality rate due to NTS is estimated to be 24% (Acheson and 
Hohmann 2001). Globally, an estimated 61.8 and 131.6 million cases of gastroenteritis are due to 
Salmonella occur every year, resulting in 39,000 - 303,000 deaths. Estimates, however, vary 
greatly due to a lack of diagnosis and surveillance reporting (Majowicz et al. 2010). Risk factors 
for NTS diarrheal disease include advanced age, antacid treatment, gastrointestinal surgery, 
immunosuppressive treatment and other pressures placed on the immune system such as 
malnutrition or HIV (Acheson and Hohmann 2001, Heymann 2008).  
 
NTS strains have widely differing virulence patterns due to differences in phenotypic diversity 
(Fierer and Guiney 2001), which makes it important to distinguish between serotypes whenever 
data is available. The Kauffman-White scheme (Brenner et al. 2000, Kauffmann 1966, 
Kauffmann and Edwards 1952, Penner 1988, Popoff et al. 2003, 2004) groups the genus 
Salmonella into two species: S. bongori and S. enterica (Brenner et al. 2000, Reeves et al. 1989). 
S. enterica is divided into six subspecies containing 2,557 serotypes. Among these, 1,531 
serotypes are recognized as belonging to subspecies I, also known as Salmonella enterica subsp. 
enterica (Brenner et al. 2000). S. bongori as well as S. enterica subspecies II, IIIa, IIIb, IV, and 
VI are commonly isolated in cold-blooded vertebrates and in the environment, but are rarely 
isolated from clinical gastroenteritis patients (Bopp et al. 2003). S. enterica subsp. enterica 
serotype Typhimurium and S. enterica subsp. enterica serotype Newport rank in the top 
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three Salmonella serotypes associated with foodborne outbreaks in the U.S. (CDC 2014). 
Therefore, in this study, we turn our attention to these two serotypes.  
 
S. Typhimurium is considered to be a highly adapted pathogen with a narrow range of target hosts 
(Jones and Falkow 1996).  In the late 1990s, along with serogroup D, S. Typhimurium serogroup 
B was the most frequently isolated serotype, accounting for approximately 50% of isolates from 
patients in the U.S. (Acheson and Hohmann 2001). Meanwhile, S. Newport outbreaks have 
increased since the mid-1990s, causing at least 100,000 illnesses annually (Cao et al. 2013, CDC 
2014). S. Newport was also responsible for several major outbreaks in developed countries spread 
through the consumption of various food items such as ground beef (Schneider et al. 2011), horse 
meat (Espié et al. 2005), tomatoes (Greene et al. 2008), eggs (Aseffa et al. 1994), mangoes 
(Sivapalasingam et al. 2003), lettuce (Lienemann et al. 2011), ready-to-eat salad vegetables 
(Sagoo et al. 2003), alfalfa sprouts (Van Beneden et al. 1999) and mung bean sprouts (Mohle-
Boetani et al. 2009).  
 
Although Salmonella has been responsible for numerous outbreaks in the past few decades, few 
outbreak models have been generated for the pathogen. Additionally, pathogen populations in the 
host varies with time, which makes incubation a time-dependent process; yet no Salmonella 
outbreak model has considered the effects of in-vivo kinetics of the pathogens on hosts. In 2016, 
Prasad et al. developed an outbreak model that incorporated an infection-time distribution which 
closely modeled the time-to-infection for pathogens (Prasad et al. 2016). The time-dose-response 
(TDR) modeling methodology, which quantifies a relationship between pathogen kinetics and 
host response through the time-to-infection, provides the means in which data from dosing studies 
can be incorporated into the outbreak model (Huang and Haas 2009, 2011). A key research gap 
that remains is whether models that consider the host-pathogen kinetics of Salmonella can 
119 
 
 
 
provide acceptable fits to outbreak data in order to describe public health risk. The purpose of this 
study is to (i) generate and discuss the results stemming from a non-time-dependent dose-
response model for Salmonella Typhimurium and Salmonella Newport; to (ii) determine the best-
fit TDR model for S. Typhimurium and S. Newport; and to (iii) incorporate this model into the 
incubation distribution of an outbreak model. Criteria and parameter values are also investigated.  
 
5.4. Materials and methods 
5.4.1. Datasets for time-dose-response and outbreak models 
5.4.1.1. Dose-response datasets 
A literature search for usable Salmonella datasets for the dose-response models was first 
performed. Our approach was contingent upon finding time-dose-response data in the literature, 
and therefore our inclusion criteria was not limited to any particular strain of Salmonella, animal 
host, route of administration, or endpoint. The inclusion criteria for choosing the time-dose-
response model was that article included: (i) a clear description of dosing methods; (ii) reported 
mode of exposure; (iii) the administered dose to each subject; (iv) the number of subjects that 
experienced adverse effects on each respective day; (v) stated criteria used to define a positive 
endpoint; (vi) detailed descriptions of the pathogen (i.e. source and strain); (vii) at least one 
observation where a fraction of the dosing groups is infected (0 < 𝑝 < 1); and (viii) the time-to-
adverse response for each individual subject (Haas 1999).  
 
5.4.1.2. Outbreak datasets 
The literature was then searched again to find an appropriate dataset that could be fit to our 
outbreak model. The inclusion criteria for selecting an appropriate dataset for the Salmonella 
outbreak model included: (i) that the size of population susceptible to infection was known or 
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could be estimated; (ii) members of this susceptible population who became symptomatically ill 
were confirmed cases; (iii) the beginning and end of the pathogen contamination is known; (iv) 
there is incubation data for the pathogen; (v) the outbreak occurred over a defined period of time; 
(vi) the exposure period is short compared to the length of the outbreak; (vii) each confirmed case 
comes from the original source and there is no secondary spread of disease; or, if there is some 
secondary spread, there is a clear distinction between the primary and secondary spread; and that 
(viii) all outbreak cases that are identified have the same case definition. 
 
5.4.2. Dose-response models 
5.4.2.1. Non-time-dependent dose-response models 
The dosing study datasets were initially modeled using traditional dose-response equations 
widely used in quantitative microbial risk assessment (QMRA), which only considers the extent 
of response and not time of occurrence. Dose-response equations are expressed mathematically, 
often in the form of an exponential or beta-Poisson model (Table 5.1).  
 
 
Table 5.1 The exponential and beta-Poisson non-time-dependent dose-response models. 
Model Expression Eq’n number 
Exponential 𝑃(𝑑) = 1 − 𝑒−𝑘𝑑 Eq. 5.1 
Beta-Poisson 𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 5.2 
 
 
 
The dose-response models are mechanistically based, and assume that (i) the host ingests one or 
more organisms capable of causing an adverse response; and (ii) that only a fraction of these 
pathogens reach a site of infection. Because these models are predictive, we look at the 
probability of adverse response in the host. 𝑃(𝑑) is the probability of adverse response at dose 𝑑, 
and 𝑘 is the exponential rate parameter describing the probability that a single organism can 
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survive and initiate infection in the host. 𝑁50 is the median infective dose and 𝛼 is the slope 
parameter for the beta-Poisson model. 
 
A Cochran-Armitage test of trend was applied to determine whether there was an association 
between increasing dosages and adverse effects. If such a trend was observed, maximum 
likelihood estimations (MLE) was used to fit the models and to obtain deviance and parameter 
values using the R programming language (www.r-project.org, ver. 3.0.3). To test if a more 
complex model with more parameters provides a statistically better fit compared with the original 
one, the improvement to the deviance provided by the additional parameters was compared with 
the chi-squared distribution at 95% confidence level. Conﬁdence intervals for best-ﬁt models 
were determined using bootstrap analysis in R. 
 
5.4.2.2. Dose-response-time models  
Traditional models were modiﬁed to incorporate a time dependency by including additional 
parameters of time-post-inoculation (TPI). This additional time parameter quantifies the time of 
onset of an effect presumably associated with the kinetics of in-vivo bacterial growth. Huang et 
al. (2009) developed eight separate time-dependent equations, and these models were tested to 
determine if they were true cumulative distribution functions (CDFs) (Huang and Haas 2009). 
The criteria for determining true CDF distributions was that: 
1. The function at time zero is zero, and the function at time infinity is one.  
a. 𝐹(𝑡 → 0) = 0 
b. 𝐹(𝑡 → ∞) = 1 
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2. The functions are monotonic, which means that for all 𝑎 and b, with 𝑎 ≤ 𝑏, 𝐹(𝑎) ≤
𝐹(𝑏), and the derivative of the function is greater than or equal to zero for all of time 
(
𝑑𝐹
𝑑𝑡
≥ 0 for all t).  
Of the original eight models, only four were true CDFs, and are presented in Table 5.2. The 
models that were not true CDFs were excluded from the study.  
 
 
 
Table 5.2 True CDF time-dependent dose-response models. 
Model Name Expression Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 Eq. 5.3 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 5.4 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 5.5 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 5.6 
 
 
The TDR models were ﬁt to the dose-response data, deviances were optimized, and model 
parameters were determined using maximum likelihood estimation (MLE) in the R programming 
language (www.r-project.org, ver. 3.0.3).  
 
The likelihood ratio for the incidence occurring on the jth day with i dose groups is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1          Eq. 5.7 
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where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made, 𝑝𝑖,𝑗 is the number of positive response observed during time 
period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the beginning of time period 𝑗.  The predicted 
response is 𝜋𝑖, and the response for each set based on observations are 𝜋𝑖
°. The corresponding 
deviance is  
𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1   Eq. 5.8 
This expression is nearly the same as that used in fitting traditional dose-response data in which 
only the long-term endpoint is known (Haas et al. 2014).  Differences between this expression 
and the expression normally used in dose-response modeling is that p is the number of positive 
responses in a time period rather than at the end of observations. 
 
5.4.3. Outbreak Models 
The standard Susceptible-Infective-Recovered (SIR) model proposed by Kermack and 
McKendrick (1927) is a deterministic model for a closed population of size 𝑁 consisting at time 
𝑡 of 𝑆(𝑡) susceptibles, 𝐼(𝑡) infectives and 𝑅(𝑡) removals, namely individuals who had died, or 
had recovered and were immune. In his 1999 thesis, Gupta proposed a modified SIR model for 
water and foodborne infections (Gupta 1999), which includes a latent period and accounts for 
individuals being either symptomatically or asymptomatically ill (Figure 5.1). The authors further 
developed this model by incorporating the time to infection. 
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Figure 5.1 Modified SIR model proposed by Gupta (Gupta and Haas 2004, Kermack and McKendrick 
1927). 
 
 
 
 
In this model, populations are compartmentalized into groups, moving through the compartments 
as they become infected. The number of people in the compartments, as well as the rates that of 
transfer are described by a system of differential equations. The four states in this model are (1) 
the susceptible populations 𝑋(𝑡); (2) latent individuals 𝑌(𝑡) who have been exposed to the 
pathogen and will ultimately become infected; (3) those who become symptomatically ill 𝑍(𝑡); 
and (4) those who have become infected but will remain Asymptomatic 𝐼(𝑡). The force of 
infectivity, 𝛽(𝑡), is the rate of transfer from susceptible to the latent, and 𝑄(𝑡) models the rate of 
newly symptomatic cases. For our purposes, only the symptomatically ill population will be 
considered, since generally data is only available for these groups through epidemic studies.  
The change in the susceptible population with respect to time 
𝐝𝐗
𝐝𝐭
 is defined: 
𝑑𝑋
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), 𝑜𝑟 
1
𝑋
𝑑𝑋
𝑑𝑡
= −𝛽(𝑡)                                               Eq. 5.9 
𝛽(𝑡) is the force of infectivity, or the transfer rate constant for the movement of individuals from 
the susceptible to infected state. Solving this differential equation yields 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
       Eq. 5.10 
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Similarly, the movement of individuals form infected to ill can also be given by the differential 
equation 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡)𝑌(𝑡)      Eq. 5.11 
Where 𝑄(𝑡) is transfer rate constant for the movement of individuals from the infected to the 
diseased state, and 𝑌(𝑡) is the number of individuals in the latent state. The rate of change of 
latent individuals with respect to time, who will eventually become ill is given by 
 
𝑑𝑌
𝑑𝑡
= 𝛽(𝑡)𝑋(𝑡) − 𝑄(𝑡)𝑌(𝑡)                Eq. 5.12 
Continuous probability density functions can be used for modeling the exposure and incubation 
times of a common source outbreak. The instantaneous rate of new illnesses 
𝑑𝑍
𝑑𝑡
 can also be 
written as the convolution integral 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡)𝑌(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
                                                  Eq. 5.13 
where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). The function 𝑓 is a 
probability density function (PDF) which has parameter values that need to be estimated, and the 
function 𝛽 is defined as follows (with 𝑔 being a PDF with parameters that need to be estimated): 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)        Eq. 5.14 
Substituting Eq. 5.10 into Eq. 5.13 we then obtain: 
𝑑𝑍
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝑋0𝛽(𝜏)𝑒𝑥𝑝 [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 5.15 
where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the cumulative density function (CDF) corresponding to 
the PDF𝑔(𝑡). Integrating Eq. 5.15 directly, we can solve for Z and obtain a direct result: 
𝑍(𝑡) = ∬ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑   Eq. 5.16 
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In this model, we have seven parameters for the number ill, 𝑍(𝑡) in Eq. 5.16, namely the attack 
parameters  𝑏0 and  𝑏1, the two PDF parameters for the attack distribution and two PDF 
parameters for the exposure distribution (Weibull, gamma, lognormal and uniform distributions 
all contain 2 parameters), and the three parameters, 𝛼, 𝑑, and 𝑗0. 
 
Anderson and May described the number of newly infected persons per unit time in a secondary 
infection as 𝛾(𝑡)𝑥(𝑡)𝑧(𝑡) (Anderson et al. 1992). Here, 𝛾(𝑡) is a new parameter that is dependent 
upon the physical properties of a given outbreak, such as the contact rate and dose that is 
transmitted from one contact to another. The inclusion of the individuals in the asymptomatically 
and symptomatically ill states accounts for the fact that they have the ability to transfer infection 
to other susceptible individuals, given the physical parameter value 𝛾(𝑡).  
 
In the specific case of secondary spread, Eq. 5.16 becomes 
𝑍(𝑡) = ∬ 𝛾(𝜏)𝑧(𝜏)[𝑥0 + (𝑦0 − 𝑦(𝜏))]𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑
𝑡
0
                          Eq. 5.17 
Recall that 𝑍(𝑡) is the number of individuals who are symptomatically ill at time 𝑡. For this 
expression, there are functions that not present in the common source outbreak: 𝑦(𝜏), the PDF 
which describes the number of latent individuals at time of infection 𝜏; and 𝑧(𝜏), the PDF which 
describes the number of symptomatically ill individuals at the time of infection 𝜏. These two 
PDFs along with the parameter 𝛾 are components of the exposure distribution, while  𝑓(𝜑 − 𝜏) is 
the density function for the incubation distribution.  
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4.4.3.1. Matlab model 
A computer model was developed in Matlab to best-fit the outbreak dataset. An optimization 
algorithm that evaluated an objective function starting from a set of assumed values for the model 
above-mentioned parameters was used. The objective function is the likelihood ratio  
−2𝑙𝑛 (
𝐿
?̂?
) = 2 [(𝜂 − 𝑁) − 𝑁𝑙𝑛 (
𝜂
𝑁
)]     Eq. 5.18 
where 𝜂 is the predicted number of new cases and 𝑁 is the observed number of new cases. The 
objective function was minimized by varying the assumed parameters in search of a global 
minimum value. Each unique combination of assumed values corresponds to a calculated value 
for the predicted number of cases per day 𝑍(𝑡), from which a corresponding value for the daily 
likelihood ratio objective function was calculated. An overall objective function is then 
calculated, which is the sum total of all the individual daily objective functions −2𝑙𝑛 (
𝐿
?̂?
) 
throughout the entire outbreak. The routine function ‘fmins,’ which has the ability to minimize 
functions with several parameters and uses a Nelder-Mead simplex, was utilized to fit the dataset. 
 
This entire process was iterative. For each exposure-incubation combination, the following 
process was repeated. A set of assumed parameter values were first input into the simulation 
model, and the corresponding predicted daily ill cases 𝑍(𝑡) was evaluated using the function 
‘quad2d.’ The summation of the daily objective function −2𝑙𝑛 (
𝐿
?̂?
) over the entire duration of the 
outbreak was then calculated. The program varied the initial guesses, and continued to calculate 
the deviance objective function until convergence was assumed, which was assumed to be less 
than 10−3.  
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5.4.4. Incorporation of the Time-Dose-Response into Incubation Distributions of the 
Outbreak Model  
The time-dose-response functions from Table 5.2 cannot be immediately used as incubation 
distributions because they are CDFs. To derive a time dose-response based incubation 
distribution to fit epidemiologic curves, the distributions must be PDFs. To get a PDF from a 
CDF, the derivative must be taken. In the case of the beta-Poisson time dose-response with 
inverse time dependency, we have the following equation:  
𝑅(𝑑, 𝑡) = 1 − [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 5.19 
𝑅(𝑑, 𝑡) is the probability of adverse effect; α is a fitting parameter; θ is a time parameter; 
𝑗0
𝑡
+ 1 
is the dose that elicits a positive response in 50% of the hosts, after infinite time. Taking the first 
partial derivative with respect to time, we get 
𝑟(𝑑, 𝑡) = −𝛼 [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼−1
×𝑑 (2
1
𝛼 − 1)
𝑗0
𝑡2
                      Eq. 5.20 
However, we want that to make sure that our function is a true PDF. Probability density functions 
satisfy the following conditions: 
3. 𝑓(𝑥) ≥ 0 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑥 
4. ∫ 𝑓(𝑥)𝑑𝑥 = 1
∞
−∞
 
 As time goes to infinity, we want the integral of our distribution to be exactly 1.  So we must 
divide by a certain value that ensures that this is true. As 𝑡 → ∞, the maximum response is 
reached for the time dose-response. Then Eq. 5.19 no longer becomes time-dependent, and we 
refer to the TDR dependency equation in Table 4.1, which assumed that 𝑁50 =
𝑗0
𝑡
+ 1. Plugging 
in 𝑁50 for the expression in the denominator returns us back to the regular beta-Poisson dose-
response model. 
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𝑅(𝑑, 𝑡 → ∞) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 5.21 
This expression can be used as the constant for which Eq. 5.20 can be divided. If we divide Eq. 
5.20 by Eq. 5.21, we get the following function: 
𝑓(𝑡|𝑑) =
𝛼[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼−1
×𝑑(2
1
𝛼−1)𝑗0
𝑡2(−1+[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼
)
   Eq. 5.22 
We now have a proper PDF 𝑓(𝑡|𝑑) that characterizes the distribution. This PDF based on the 
beta-Poisson time dose-response function distribution can now be used as a potential incubation 
distribution 𝑓(𝑡) to use in the probability density function used to calculate the number of ill, 
Z(t). The functions used to model the exposure distributions include the Weibull, gamma, 
lognormal and uniform distributions, and the best-fit time-dose-response model will be used as 
the incubation distribution. 
 
To compare the results of the outbreak models, deviance, Akaike information criterion (AIC) and 
Bayesian information criterion (BIC) values are examined: 
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 5.23 
𝐴𝐼𝐶 = 2𝑘 − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]                   Eq. 5.24 
𝐵𝐼𝐶 = 𝑘 ∗ 𝑙𝑛(𝑛) − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]           Eq. 5.25 
The parameters 𝜃?̂? are the values of the full model (observed values), and 𝜃0̂ are the values of the 
predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and thus we can see that 
the AIC and BIC is the deviance plus a complexity parameter. BIC penalizes model complexity 
more than AIC does (Ruppert 2011). The outbreak model with the lowest deviance, AIC and BIC 
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are the best-fit. Since some TDR models have extra parameters, they will have higher AIC and 
BIC values. 
 
To compare the parameters in the epidemic and dosing parameter studies to see if the differences 
between corresponding parameters were significant, the two-sample Kolmogorov–Smirnov (KS) 
test and the Anderson–Darling (AD) test were utilized. In both tests, we wanted to see if the 
parameters came from the same distribution. The KS test states that 𝐷∗ =
𝑠𝑢𝑝
𝑥
| 𝐹1(𝑥) − 𝐹2(𝑥)|, 
where 𝐹1(𝑥) and 𝐹2(𝑥) are the empirical distribution functions of the two samples respectively, 
and 𝑠𝑢𝑝 is the supremum function (Sheskin 2003). The null hypothesis is rejected if the following 
equation holds true: 𝐷∗ > 𝑐(𝛼)√
𝑛+𝑛1
𝑛𝑛1
. For 𝛼 = 0.05, 𝑐(𝛼) = 1.36. The AD is a refinement of the 
KS test. The statistic that was used was of the form 
𝐴2 = −𝑛 − ∑
2𝑖−1
𝑛
[ln(Φ(𝑌𝑖)) + ln(1 − Φ(𝑌𝑛+1−𝑖))]
𝑛
𝑖=1  (D’Agostino et al. 1986). The parameter 
𝑛 is the number of data points in the sample, and the test statistic measures the distance between 
the hypothesized and empirical. The null hypothesis of normality is rejected if A2 exceeds 0.752 
for α = 0.05. 
 
5.5. Results and discussion 
5.5.1. Dose-response results 
5.5.1.1. Dose-response datasets 
In the case of S. Newport, a study performed by McCullough et al. (1951) met the inclusion 
criteria for the TDR models. The authors exposed three doses of S. Newport to human volunteers 
orally in order to determine the percentage of people who become ill at each respective dose. The 
adverse responses included abdominal cramping, nausea, and diarrhea. Strains of Salmonella used 
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in this investigation were isolated from market samples of spray-dried egg powder obtained from 
the U.S. Agriculture’s Research Division of the Bureau of Agricultural and Industrial Chemistry. 
For the S. Typhimurium case, a study led by Osterberg and Wallgren (2008) was found. In this 
experiment, 5-week-old piglets were inoculated orally with graded doses of S. Typhimurium and 
monitored for eight weeks for Salmonella presence in the feces. The pathogen was a non-
multiresistant strain that was originally isolated from a Swedish pig herd. Adverse responses for 
these studies are presented in Table 5.3.  
 
For both dose-response datasets, there were positive trends when subjected to the Cochran-
Armitage test of trend. Z critical was greater than 1.64 (𝑍𝑐𝑟 > 1.64), so the null hypothesis of 
lack of trend is rejected and data can be analyzed further.  
  
  
 
 
 
 
 
 
Table 5.3 Number of human and piglet hosts testing for positive fecal cyst shedding per day after being inoculated with varying doses of S. Newport and S. 
Typhimurium (McCullough and Eisele 1951, Osterberg and Wallgren 2008)  
    Day post-inoculation  
Case Host 
No of 
hostsa 
Doseb 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 total 
McC  
Newc 
Human 
volunteers 
6 𝟏. 𝟓𝟐×𝟏𝟎𝟓 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 
8 𝟑. 𝟖𝟓×𝟏𝟎𝟓 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
6 𝟏. 𝟑𝟓×𝟏𝟎𝟔 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 3 
  
OST 
Typd 
Piglets 
6 𝟔. 𝟓×𝟏𝟎𝟐 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 
6 𝟔. 𝟓×𝟏𝟎𝟓 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 
6 𝟔. 𝟓×𝟏𝟎𝟖 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 
a Host refers to human volunteers in the McCullough et al. study, and piglets in the Osterberg et al. study 
b Reported in colony-forming unit (CFU) numbers  
c McCullough et al. data for the Salmonella Newport case 
d Osterberg et al. data for the Salmonella Typhimurium case 
  
1
3
2
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5.5.1.2. Salmonella Newport 
Optimized model results from conventional dose-response studies for S. Newport are provided in 
Figure 5.2 and Table 5.4. The exponential is the best-fitting mechanistic model with a minimized 
deviance of 0.72, lower than the critical chi-square χ2 distribution for 2 degrees of freedom (5.99). 
The beta-Poisson model also provided an acceptable fit for this dataset, with a deviance of 0.69, 
but it has an additional parameter, and the delta ∆𝜒2 value (0.72 − 0.69 = 0.03) is less than the 
critical ∆𝜒2 (5.99 − 3.84 = 2.15), so the exponential is considered best-fit. The bootstrapped 
data set with 10,000 iterations from this murine model is plotted with optimized parameters for 
the exponential model. 
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Figure 5.2 (a) Exponential and beta-Poisson dose-response models fitting human inoculation data from 
McCullough et al. (1951). The best-fitting mechanistic model was the exponential (𝐤 = 𝟓. 𝟐𝟑×𝟏𝟎−𝟕;𝛘𝟐 =
𝟎. 𝟕𝟐). (b) Best-fit bootstrapped exponential model with confidence intervals; and (c) the corresponding 
bootstrapped frequency diagram for exponential model parameter k with 10,000 iterations. 
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Table 5.4 Non-time-dependent dose-response modeling results for S. Newport and S. Typhimurium 
inoculation in the human and piglet hosts. 
 Model 
Parameter 
Deviance dfa 𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 Conclusions 
Best fit 
modelc type value 
Dataset 1 
Human 
Expf k 5.23×10−7 0.72 2 5.99 Both models 
provide 
acceptable fits 
Exponential 
BPg 
α 1.27 
0.69 1 3.84 
N50 1.46×106 
Dataset 2 
Piglet 
Expf k 3.51×10−6 7.01 2 5.99 Beta-Poisson 
provides 
acceptable fit 
Beta-Poisson 
BPg 
α 0.30 
0.26 1 3.84 
N50 7.48×10−4 
a df - degrees of freedom for dataset and model 
b  Critical values of the chi-squared distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, 
m is the number of doses, n is the number of parameters 
c Best fit model criteria - the lowest deviance of candidate models was chosen compared to the critical values of chi-
squared distribution  
d McCullough et al. data for the Salmonella Newport case 
e Osterberg et al. data for the Salmonella Typhimurium case 
f Exponential Model 
g beta-Poisson Model 
  
 
 
The time-dose-response models in Table 5.2 were ﬁtted to the datasets in Table 5.3 using MLE. 
The parameter estimates and the minimized deviances are summarized in the top half of Table 
5.5. The three-parameter beta-Poisson models provided acceptable fits, while the time-dependent 
exponential model did not. Although the beta-Poisson with exponential reciprocal time had the 
lowest deviance, it was only by a margin of 0.2, and had the benefit of an extra parameter. 
Therefore, the best-fit model for the time-dependent data was the beta-Poisson model with 
inverse time dependency because it provided the lowest deviance of 11.4, given the critical chi-
square value of 18.3 for 2 degrees of freedom. Figure 5.3 summarizes the fitted curves. 
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Table 5.5 Time-dose-response (TDR) modeling results for S. Newport and S. Typhimurium inoculation in 
the human and piglet hosts. 
 
Case Time Dependence Model 
Best fit 
parameters 
Minimized 
deviance 
2
,05.0 df  
Acceptable 
fit? 
Dataset 1 
S. Newporta 
 
Human hosts 
McCullough et al. 
 
 
Exponential model with 
exponential-reciprocal time 
dependency 
k0 = 9.21×10-5 27.6 19,7 no 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
α = 4.95 
11.2 16.9 yes j0 = 2.0×10-2 
j1 = 10.64 
Beta-Poisson model with 
exponential time 
dependency 
α = 8.9×10-3 
11.6 16.9 yes j0 = 27.24 
j1 = 56.75 
Beta-Poisson model with 
inverse time dependencyc 
α = 2.86×10-1 
11.4 18.3 yes 
j0 = 2.06×107 
Dataset 2 
S. Typhimuriumb 
 
Piglet hosts 
Osterberg et al. 
 
Exponential model with 
exponential-reciprocal time 
dependency 
k0 = 0.02 18.7 21.0 no 
Beta-Poisson model with 
exponential-reciprocal time 
dependencyd 
α = 0.38 
8.9 18.5 yes j0 = 63.08 
j1 = 52.33 
Beta-Poisson model with 
exponential time 
dependency 
α = 0.38 
9.4 18.5 yes j0 = 2.22 
j1 = 8.55 
Beta-Poisson model with 
inverse time dependencyd 
α = 7.49×10-2 
8.7 22.4 yes 
j0 = 6.59×105 
a McCullough et al. data for the Salmonella Newport case 
e Osterberg et al. data for the Salmonella Typhimurium case 
c Best-fit model for the McCullough et al. dataset 
d Best-fit model for the Osterberg et al. dataset 
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Figure 5.3 Best-fit time-dose-response model for the S. Newport human dataset (McCullough and Eisele 
1951), as modeled by the beta-Poisson model with exponential-reciprocal time dependency. Each day is 
modeled independently, and the arrows indicate the direction of the probability of illness from the ﬁrst day 
to the last. 
 
 
 
5.5.1.3. Salmonella Typhimurium 
The results of the S. Typhimurium non-time-dependent dose-response models are presented in 
Figure 5.4 and the bottom half of Table 5.4. The beta-Poisson is the best-fitting mechanistic 
model, with a minimized deviance of 0.26, lower than the critical chi-square distribution χ2 for 1 
degree of freedom. The exponential model did not provide an acceptable fit for this set of data, as 
the deviance was greater than the χ2 for 1 degree of freedom. The bootstrapped data set with 
10,000 iterations from this pig model is plotted with frequency diagram of model parameters 
𝛼 and 𝑁50.  
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Figure 5.4 (a) Exponential and beta-Poisson dose-response models fitting piglet inoculation data from 
Osterberg et al. (2008). The best-fitting mechanistic model was the beta-Poisson (∝= 𝟎. 𝟑; 𝐍𝟓𝟎 =
𝟕. 𝟒𝟑×𝟏𝟎𝟑; 𝛘𝟐 = 𝟎. 𝟐𝟓𝟓). (b) Best-fit bootstrapped beta-Poisson dose-response model with confidence 
intervals; and (c) the corresponding bootstrapped beta-Poisson parameters with 10,000 iterations for those 
confidence intervals. 
 
 
 
The time-dose-response models were ﬁtted to the S. Typhimurium dataset, and are presented in 
the bottom half of Table 5.5. In this case, the three-parameter beta-Poisson models again provided 
acceptable fits, while the time-dependent exponential model did not. The beta-Poisson model 
with inverse time dependency was chosen as the best-fit for the time-dependent data because it 
provided the lowest deviance of 8.7 (less than the critical chi-square of 22.4), given the 2 degrees 
of freedom.  
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Figure 5.5 Best-fit time-dose-response model for the S. Typhimurium piglet dataset (Osterberg and 
Wallgren 2008), as modeled by the beta-Poisson model with inverse time dependency. Each day is modeled 
independently, and the arrows indicate the direction of the probability of illness from the ﬁrst day to the 
last. 
 
 
 
5.5.2. Outbreak results 
5.4.2.1. Outbreak datasets 
Three total Salmonella outbreaks were modelled here. The outbreak used to model S. Newport 
took place in Northern Ireland between September and October 2004, and was documented by 
Irvine et al. (2009). In this outbreak, salmonellosis caused by S. Newport was confirmed in 130 
people who ate lettuce in a meal outside the home. Two outbreaks were used to model the S. 
Typhimurium dataset. The first was a primary wave outbreak that occurred in restaurant salad 
bars at a commune in The Dalles, Oregon which were intentionally contaminated in September 
and October 1984 (Török et al. 1997). The second outbreak was a person-to-person outbreak that 
lasted from December 1987 to January 1988 in the United Kingdom (U.K.) (Cowden et al. 1989). 
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5.5.2.2. Salmonella Newport 
The outbreak models were fit to the time-dependent dose-response data and non-time dependent 
probability distributions. Since the beta-Poisson with inverse time dependency was the best-fit 
model for the S. Newport case, this was the time dependency kinetic model that was chosen to be 
used in the incubation distributions. The static Weibull, gamma, lognormal and uniform 
distributions were also generated for comparison. Table 5.6 summarizes the model parameters 
and criteria values of all generated models.  
 
The Weibull exposure convoluted with the beta-Poisson has the lowest deviance at 18.15, 
consistent with a qualitative inspection (Figure 5.6). The deviance value reports the best fit 
model, but there may be an issue with overfitting. The AIC and BIC criteria for model selection 
try to resolve this issue by adding a penalty for the number of parameters in the model. Since the 
beta-Poisson has an extra parameter, we find that several other models have lower AIC and BIC 
values, including the Weibull-Weibull, Weibull-gamma, gamma-lognormal, lognormal-Weibull, 
and lognormal-gamma. The model with the lowest AIC and BIC values is the Weibull-gamma 
convolution, with an AIC of 30.32 and BIC of 36.59.  
 
The uniform exposure distributions have the poorest fit for all models, with deviance values of up 
to 27.68. This may indicate that the S. Newport pathogen does not have a uniform exposure 
distribution.   
  
 
 
Table 5.6 Parameter and criteria values for the Salmonella Newport primary outbreak model.  
 
 
 
 
Model Parameters Criteria Values 
Exposure 
Distrib. 
Incubation 
Distrib. 
Expos 
param 
b0 
Expos 
param 
b1 
Expos dist  
PDF 
param 1 
Expos dist  
PDF 
param 2 
Incub dist  
PDF 
param 1 
Incub dist 
PDF 
param 2 
Incub dist 
PDF 
param 3 
Deviance AIC BIC 
Weibull 
Weibull 2.95×10-4 0.24 18.14 1.58 1.49 1.30 n/a 18.39 30.39 36.66 
Gamma 1.35×10-3 1.02 22.73 210.00 1.16 0.62 n/a 18.32 30.32 36.59 
Lognormal 1.68×10-5 0.28 12.79 1.37 1.45 1.34 n/a 24.20 36.20 42.47 
Uniform 3.97×10-3 0.11 14.43 2.27 7.38×10-21 1.98 n/a 20.16 32.16 38.43 
BP with inv 2.15×10-4 0.85 21.80 1.86 1.27 0.58 1.00 18.15 32.15 39.46 
Gamma 
Weibull 1.68×10-3 0.19 15.90 95.12 0.83 4.46 n/a 22.36 34.36 40.63 
Gamma 5.98×10-3 0.05 12.19 11.04 2.09 5.20 n/a 21.56 33.56 39.83 
Lognormal 1.15×10-5 0.36 0.56 1.83 2.98 0.94 n/a 19.02 31.02 37.29 
Uniform 5.91×10-3 0.06 11.24 16.43 0.83 4.11 n/a 20.46 32.46 38.73 
BP with inv 1.35×10-3 1.02 22.73 210.00 1.16 0.62 0.04 18.32 32.32 39.63 
Lognorm 
Weibull 1.77×10-3 0.21 2.78 0.78 0.81 1.63 n/a 19.08 31.08 37.35 
Gamma 2.47×10-3 0.18 2.66 0.70 0.83 1.61 n/a 18.99 30.99 37.26 
Lognormal 1.66×10-4 0.32 2.69 0.98 0.70 1.67 n/a 19.03 31.03 37.30 
Uniform 3.15×10-3 0.17 2.60 0.95 2.17×10-25 5.38 n/a 20.65 32.65 38.92 
BP with inv 2.48×10-2 1.07 351.43 19.14 1.02 0.43 1.62 18.24 32.24 39.55 
Uniform 
Weibull 6.27×10-3 0.06 4.37 25.12 1.73 12.30 n/a 24.49 36.49 42.76 
Gamma 5.98×10-3 0.06 4.85 20.24 1.81 11.67 n/a 20.67 32.67 38.94 
Lognormal 2.54×10-2 0.05 5.00 20.74 1.90 11.73 n/a 24.00 36.00 42.27 
Uniform 7.12×10-3 0.03 6.04 23.83 1.86 3.89 n/a 27.68 39.68 45.95 
BP with inv 3.17×10-2 1.24 10.56 42.03 1.11 0.89 1.34 18.55 32.55 39.86 
  
1
4
1
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Figure 5.6 plots the observed outbreak data (number of ill) as point values and the predicted 
values of the model as the curve fit. In each graph, the abscissa is time in days, and the ordinate is 
the number of cases reported. The TDR-based distribution here seems to fit broadly across many 
of the data points better especially the points on the descending side of the curve.  
 
Figure 5.6 Model fits for the S. Newport primary outbreak. The gamma, lognormal, uniform, and Weibull 
exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, and beta-Poisson with 
reciprocal incubation distributions for a total of 20 data fits. 
 
 
5.5.2.3. Salmonella Typhimurium 
5.5.2.3.1. Primary Spread  
The Oregon salad bar dataset was next fit to the outbreak model. The parameters obtained though 
MLE for the fitted models and criteria values are given in Table 5.7.  
  
 
 
Table 5.7 Parameter and criteria values for the Salmonella Typhimurium primary outbreak model.  
 
 
 
 
 
Model Parameters Criteria Values 
Exposure 
Distrib. 
Incubation 
Distrib. 
Expos 
param 
b0 
Expos 
param 
b1 
Expos dist 
PDF 
param 1 
Expos 
dist 
PDF 
param 2 
Incub dist 
PDF 
param 1 
Incub dist 
PDF 
param 2 
Incub dist 
PDF 
param 3 
Deviance AIC BIC 
Weibull 
Weibull 1.04×10-2 0.65 7.55 9.90 0.97 1.02 n/a 29.88 41.88 46.88 
Gamma 1.03×10-2 0.65 7.52 10.26 0.96 1.02 n/a 28.14 40.14 45.14 
Lognormal 7.89×10-3 0.79 7.24 11.29 1.63×10-3 1.19 n/a 33.85 45.85 50.85 
Uniform 9.32×10-2 2.67×10-2 4.40 22.51 0.85 7.36 n/a 262.22 274.2 279.22 
BP with inv 1.31×10-2 1.00 8.85 7.38 22.66 1.05 1.10×10-2 26.62 40.62 46.45 
Gamma 
Weibull 1.34×10-2 0.69 5.91 1.54 2.50 6.11 n/a 55.65 67.65 72.65 
Gamma 1.30×10-2 0.64 5.87 0.82 2.26 0.77 n/a 31.63 43.63 48.63 
Lognormal 1.06×10-2 0.68 6.38 0.79 0.45 0.59 n/a 33.32 45.32 50.32 
Uniform 9.11×10-2 0.10 7.41 46.07 0.84 7.50 n/a 264.54 276.54 281.54 
BP with inv 1.14×10-2 0.81 8.38 1.97 24.45 1.00 8.48×10-2 30.52 44.52 50.35 
Lognorm 
Weibull 8.91×10-3 0.70 1.97 0.15 1.04 0.90 n/a 32.16 44.16 49.16 
Gamma 4.55×10-1 1.21 4.30×10-5 239.44 6.26 2.98 n/a 122.01 134.01 139.01 
Lognormal 1.21×10-2 0.66 1.77 0.14 0.71 0.46 n/a 30.96 42.96 47.96 
Uniform 1.12×10-3 1.11 1.74 0.93 3.72×10-37 7.07 n/a 193.75 205.75 210.75 
BP with inv 1.16×10-2 0.91 2.12 0.18 5.01 1.81×10-7 1.51×10-2 37.87 51.87 57.70 
Uniform 
Weibull 1.43×10-2 0.55 4.50 8.95 1.24 18.60 n/a 87.25 99.25 104.25 
Gamma 1.67×10-2 0.63 6.51 9.25 0.37 0.23 n/a 57.35 69.35 74.35 
Lognormal 1.75×10-2 0.63 5.41 8.56 0.24 0.26 n/a 57.51 69.51 74.51 
Uniform 1.69×10-2 0.60 6.04 9.10 4.60×10-2 1.30 n/a 61.69 73.69 78.69 
BP with inv 2.33×10-2 0.89 6.72 10.18 4.02 2.32×10-3 1.26×10-2 66.26 80.26 86.09 
 
  14
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As with the S. Newport outbreak, the Weibull exposure convoluted with the beta-Poisson has the 
lowest deviance at 26.62. However, as with the S. Newport case, the AIC and BIC values are not 
the lowest for this model. In this case, the model with the lowest AIC and BIC values is the 
Weibull-gamma function, which has values of 40.14 and 45.14, respectively. Here it seems that 
the models that consistently have the poorest fits are the models with uniform incubation 
distributions. Three out of four of these models have deviance values of over 100. The uniform 
exposure distributions also have poor fits, with most values close to 60, going up to 87. This 
indicates that S. Typhimurium dose not behave in such a way that can be modeled with uniform 
distributions. 
 
Figure 5.7 plots the observed outbreak data (number of ill) as point values and the predicted 
values of the model as the curve fit. In each graph, the abscissa is time in days, and the ordinate is 
the number of cases reported.  
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Figure 5.7 Model fits for the S. Typhimurium primary outbreak. The gamma, lognormal, uniform, and 
Weibull exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, and beta-
Poisson with reciprocal incubation distributions for a total of 20 data fits. 
 
 
5.5.2.3.2. Secondary (person-to-person) spread.  
Attention is now turned to the S. Typhimurium spread in a secondary wave. The parameters and 
criteria values are given in Table 5.8. Interestingly, the model with the lowest deviance, AIC and 
BIC values is the uniform-gamma function, with values of 1.47, 13.47 and 14.65, respectively. 
This is a break from the two primary outbreaks, in which the uniform functions had the worst fits 
to the data. Looking at Figure 5.8, which plots the data for this outbreak, we see that the outbreak 
takes the form of a uniform function: there are single cases spread evenly over several days at the 
beginning of the outbreak, followed by a sharp increase, and then a final sharp decline. This 
figure plots the observed outbreak data (number of ill) as point values and the predicted values of 
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the model as the curve fit. In each graph, the abscissa is time in days, and the ordinate is the 
number of cases reported.  
 
The beta-Poisson models perform well, giving deviances that ranged from 1.69 to 2.13. However, 
with the addition of the extra parameter that comes with these distributions, the AIC and BIC 
values become much higher than the others, with AIC values ranging from 15.69 to 16.13 and 
BIC values ranging from 17.07 to 17.51. From Figure 5.8, the beta-Poisson incubation 
distributions seem to fit broadly across many of the data points better especially the points on the 
descending side of the curve.  
 
 
   
  
 
 
Table 5.8 Parameter and criteria values for the Salmonella Typhimurium secondary outbreak model.  
 
 
 
 
 
Model Parameters Criteria Values 
Exposure 
Distrib. 
Incubation 
Distrib. 
Expos 
param 
b0 
Expos 
param 
b1 
Expos dist 
PDF 
param 1 
Expos 
dist 
PDF 
param 2 
Incub dist 
PDF 
param 1 
Incub dist 
PDF 
param 2 
Incub dist 
PDF 
param 3 
Deviance AIC BIC 
Weibull 
Weibull 1.04×10-2 0.66 7.55 9.90 0.97 1.02 n/a 2.02 14.02 15.20 
Gamma 1.03×10-2 0.65 7.52 10.26 0.96 1.02 n/a 1.86 13.86 15.04 
Lognormal 7.89×10-3 0.79 7.24 11.29 1.63×10-3 1.19 n/a 1.77 13.77 14.95 
Uniform 9.32×10-2 2.67×10-2 4.40 22.51 0.85 7.36 n/a 2.44 14.44 15.62 
BP with inv 1.84×10-2 0.91 21.10 5.87 1.01 1.34 0.17 1.78 15.78 17.16 
Gamma 
Weibull 1.34×10-2 0.69 5.91 1.54 2.50 6.11 n/a 1.95 13.95 15.13 
Gamma 1.30×10-2 0.64 5.87 0.82 2.26 0.77 n/a 1.90 13.90 15.08 
Lognormal 1.06×10-2 0.68 6.38 0.79 0.45 0.59 n/a 2.06 14.06 15.24 
Uniform 9.11×10-2 0.10 7.42 46.07 0.84 7.50 n/a 2.00 14.00 15.18 
BP with inv 3.46×10-3 0.19 19.81 0.92 3.11 0.11 0.58 2.07 16.07 17.45 
Lognorm 
Weibull 8.91×10-3 0.70 1.97 0.15 1.04 0.90 n/a 1.69 13.69 14.87 
Gamma 4.55×10-1 1.21 4.30×10-5 239.44 6.26 2.98 n/a 1.71 13.71 14.89 
Lognormal 1.21×10-2 0.66 1.77 0.14 0.71 0.46 n/a 2.03 14.03 15.21 
Uniform 1.12×10-3 1.11 1.74 0.93 3.70×10-37 7.07 n/a 1.89 13.89 15.07 
BP with inv 2.7×10-3 4.81×10-2 2.85 0.20 2.93 0.22 0.62 1.69 15.69 17.07 
Uniform 
Weibull 1.43×10-2 0.55 4.50 8.95 1.24 18.60 n/a 1.62 13.62 14.80 
Gamma 1.67×10-2 0.63 6.52 9.25 0.37 0.23 n/a 1.47 13.47 14.65 
Lognormal 1.75×10-2 0.63 5.41 8.56 0.24 0.26 n/a 1.99 13.99 15.17 
Uniform 1.69×10-2 0.60 6.04 9.10 4.60×10-2 1.30 n/a 2.19 14.19 15.37 
BP with inv 4.9×10-3 4.69×10-2 15.96 22.09 0.94 6.8×10-3 0.80 2.13 16.13 17.51 
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Figure 5.8 Model fits for the S. Typhimurium secondary outbreak. The gamma, lognormal, uniform, and 
Weibull exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, and beta-
Poisson with reciprocal incubation distributions for a total of 20 data fits. 
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The data was further analyzed by comparing the parameters of the incubation distribution of the 
outbreak models with those from the dosing experiment to see if there was a significant 
difference between the distributions of the two systems. The two-sample Kolmogorov–Smirnov 
(KS) test was utilized towards this end. The KS test states that 𝐷∗ =
𝑚𝑎𝑥
𝑥
| 𝐹1(𝑥) − 𝐹2(𝑥)|, and 
for the null hypothesis to be rejected that samples were drawn from the same distribution, the 
value must be greater than the critical value of 1.36 for 𝛼 = 0.05 (Sheskin 2003). The best-fit 
time-dependent distributions in each outbreak case were taken to see if the parameters in these 
cases were drawn from the same distribution as the dosing experiment administered to humans in 
the S. Newport case and pigs in the S. Typhimurium cases.  
 
The KS value that was calculated for the S. Newport outbreak was between the parameters of the 
beta-Poisson model with reciprocal time dependency and the human dosing challenge, and was 
determined to be 0.58. The null hypothesis cannot be rejected, and it is accepted that the 
parameters from the TDR and outbreak models came from the same distribution. The KS value 
for the Oregon outbreak was also calculated between the parameters of the beta-Poisson model 
with reciprocal time dependency time dependency incubation period and the pig dosing study, 
and was determined to be 1.37. The null hypothesis cannot be rejected, and it is accepted that the 
parameters from the TDR and outbreak models came from the same distribution. Finally, the KS 
value for the salami outbreak in the UK was calculated between the S. Typhimurium time-dose-
response model and the pig dosing study; the value was determined to be 1.19, which indicates 
again that the null hypothesis cannot be rejected. 
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5.6. Conclusion 
Dose-response and time-dose-response models were generated for Salmonella Newport exposure 
to humans via the oral route. A TDR model was incorporated into the incubation period of a S. 
Newport outbreak in order to capture the in-vivo dynamics between pathogen and host. In the 
dose-response model, 50% predictive infectious dose was estimated to be 1.55×106 CFUs, and 
the best-fit time-dose-response model was the beta-Poisson with inverse time dependency, which 
had a minimized deviance of 11.4. This TDR model was incorporated into an outbreak that 
occurred in Northern Ireland, and the Weibull convoluted with the beta-Poisson with inverse time 
distribution was the best-fit model among other generated models, with a minimized deviance 
value of 18.15.  
 
Dose-response and time-dose-response models were then generated for Salmonella Typhimurium 
exposure to pigs via the oral route, and TDR was subsequently incorporated into two S. 
Typhimurium outbreak models: a primary outbreak that occurred Oregon at several salad bars, 
and a secondary outbreak that occurred in the U.K. via a salami food vector. In the Oregon salad 
bar outbreak, again the Weibull-beta-Poisson with inverse time distribution performed the best, 
with a minimized deviance value of 26.6. In the case of the U.K. outbreak, the unifom-gamma 
distribution performed the best, with a minimized deviance value of 1.47.  Analysis of the 
parameters from the dose-response model and the epidemic study showed that the parameters 
were taken from the same distributions. This work suggests that the incorporation of a time factor 
may provide an approach to modelling that adequately describes realistic in-vivo dynamics of the 
host-pathogen system.   
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Chapter 6: Shigella flexneri and Shigella sonnei5 
 
6.1. Abstract 
In this paper, the authors incorporate a time-dose-response (TDR) equation into the incubation 
distribution of Shigella flexneri and Shigella sonnei outbreak models to examine the in-vivo 
kinetics of the pathogen. Dose-response and time-dose-response models were first generated for 
S. flexneri exposure to monkeys.  The TDR equation that best-fit the monkey data was the beta-
Poisson with exponential dependency model. The outbreak model is a probability model that 
convolutes an assumed incubation distribution of the infectious agent with an exposure 
distribution. Since the beta-Poisson with exponential dependency models the time-to-infection 
density distribution, it is input as the incubation distribution. Several density functions, including 
the Weibull, lognormal, gamma, and uniform functions served as exposure distributions. The 
time-dependent probability distribution yielded best-fit results for several outbreak scenarios.  
 
6.2. Keywords 
Dose-response; epidemiology; Shigella flexneri; Shigella sonnei; outbreak model; time-dose-
response 
  
                                                          
 
5 This chapter is currently under review at American Water Works Journal. 
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6.3. Introduction 
Shigellosis, or bacillary dysentery, is an acute enteric infection spread directly or indirectly 
through the fecal-oral route by the genus Shigella (Scallan et al. 2011, Heymann 2008). Shigella 
are Gram-negative, non-motile bacilli belonging to the family Enterobacteriacae (WHO 2005, Jin 
et al. 2002) that includes four species: S. dysenteriae (serogroup A), S. flexneri (serogroup B), S. 
boydii (serogroup C) and S. sonnei (serogroup D) (Bhunia 2007, O'Brien & Holmes 1987). This 
pathogen invades the colonic epithelium, leading to micro-ulcers and inflammation. After an 
incubation period of one to four days, ill patients typically experience loose, bloody stools. These 
stools contain 106-108 organisms per gram, and are often accompanied with mucus (Gaurav et al. 
2013, Bhunia 2007), although some ill patients do have diarrhea without visible blood or mucus 
(Shrotriya 2015, Heymann 2008). Abdominal cramps, tenesmus (unproductive, painful straining), 
fever and anorexia are also common in infections (Shrotriya 2015). Although most patients 
recover within seven to ten days, serious complications may arise, including sepsis, 
hyponatremia, hypoglycemia, seizures and encephalopathy, hemolyticuremic syndrome, 
pneumonia, malnutrition, and death (Shrotriya 2015, Michael 1991).  
 
An estimated 448,240 cases occur in the United States (U.S.) every year, of which approximately 
14,000 are laboratory-confirmed (Pond 2005). Since mild and asymptomatic cases often go 
unreported, the actual number of infections is estimated to be 20 times greater (Pond 2005). Each 
species of Shigella is specific in its predominance in the global theater. S. sonnei occurs more 
frequently than other species in industrialized countries, accounting for about 80% and 90% of 
Shigella infections in the U.S. and the United Kingdom (U.K.), respectively (Nygren et al. 2013, 
Pond 2005). S. flexneri is the second most common species in the United States, accounting for 
18.4% of Shigella isolates submitted to CDC between 1989 to 2002 (Gupta et al. 2004). It is also 
the most predominant species in developing nations (Nygren et al. 2013).  
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Globally, over 164 million cases of shigellosis are reported each year, resulting in 1.1 million 
deaths (Pond 2005). Ninety-nine percent of infections occur in developing countries, with 60% of 
deaths occurring in children less than five years of age (WHO 2005). Those who suffer from 
severe illness and mortality tend to be infants, children who are not breastfed, the 
immunocompromised, the malnourished, and the elderly (WHO 2005). In these patients, 
shigellosis is more likely to require hospitalization than most other forms of diarrheal disease, and 
if left untreated symptoms lingers for an average of seven days, but can last up to a month (WHO 
2005).  
 
Shigella spp. can be spread through a common source, such as contaminated food or water, or 
through direct contact with an infected person, usually through the fecal-oral route. A median 
infectious dose, reported as 200 viable organisms, facilitates person-to-person spread (Paula et al. 
2010). It is not often transferred through animal vectors, and humans and primates are the only 
reservoirs for the pathogen (Paula et al. 2010). Shigellosis is often endemic in areas with 
inadequate sewage disposal or untreated water supplies usually seen in developing nations (Pond 
2005). Once excreted, the organism is very sensitive to environmental conditions and dies 
rapidly, especially when dried or exposed to direct sunlight (Gaurav et al. 2013).  
 
Although Shigella has been responsible for numerous outbreaks in the past decade, no outbreak 
models have been generated for the pathogen. A novel method of modeling outbreaks is to 
assume an infection-time distribution that closely models the actual time to infection for Shigella. 
The time-dose-response (TDR) modeling methodology, which quantifies a relationship between 
pathogen kinetics and host response through the time to infection, provides the means in which 
data from dosing studies can be incorporated into an outbreak model (Huang & Haas 2011, 
Huang & Haas 2009, Huang 2009). Infection is a time-dependent process because pathogen 
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populations in the host vary with time; the investigation of in-vivo kinetic effects on outbreaks 
could therefore be a valuable one.  
 
The purpose of this study is to (i) generate and discuss the results stemming from a TDR model 
for Shigella; and to (ii) incorporate this model into the incubation distribution of an outbreak 
model. The density functions which fit the model best and parameter values are also investigated.  
 
6.4. Materials and methods 
This study is broken down into three parts, each which builds upon the previous step: (i) a 
literature search of time-dose-response and outbreak datasets was performed; (ii) models of time-
dose-response equations were generated using studies from the literature search; and (iii) 
outbreak datasets from the initial literature search were fit using a selected time-dose-response 
equation (and non-time-dependent equations for comparison). This outbreak dataset was modeled 
by convoluting an assumed exposure density function with an incubation density function. The 
exposure density functions that were explored were the Weibull, gamma, lognormal and uniform. 
The incubation density function that was used was the best-fit TDR model (in the form of a 
probability density function), and non-time-dependent Weibull, gamma, lognormal and uniform 
functions. The work builds upon the time-dose-response models developed by Huang et al. 
(Huang & Haas 2011, Huang et al. 2009, Huang & Haas 2009), and the outbreak model 
developed by Gupta et al. (Gupta 1999). 
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6.4.1. Datasets for time-dose-response and outbreak models 
6.4.1.1. Dose-response datasets 
A literature search was conducted to identify and collect appropriate datasets to develop a 
Shigella time dose-response model. The inclusion criteria was not initially limited to any 
particular species of Legionella, animal host, route of administration, or endpoint. The inclusion 
criteria for choosing the time-dose-response model was that article included (i) a clear description 
of dosing methods; (ii) reported mode of exposure; (iii) the administered dose to each subject; 
(iv) the number of subjects that experienced adverse effects on each respective day; (v) stated 
criteria used to define a positive endpoint; (vi) detailed descriptions of the pathogen (i.e. source 
and strain); (vii) at least one observation where a fraction of the dosing groups is infected 
(0 < 𝑝 < 1); and (viii) the time-to-adverse response for each individual subject (Haas 1999).  
 
6.4.1.2. Outbreak datasets 
The literature was then searched to find an appropriate outbreak dataset that could be fit to a 
model. The inclusion criteria for selecting an appropriate outbreak for the Shigella outbreak 
model included (i) that the size of population susceptible to infection was known or could be 
estimated; (ii) members of this susceptible population who became symptomatically ill were 
confirmed cases; (iii) the beginning and end of the pathogen contamination is known; (iv) there is 
incubation data for the pathogen; (v) the outbreak occurred over a defined period of time; (vi) the 
exposure period is short compared to the outbreak; (vii) each confirmed case comes from the 
original source and there is no secondary spread of disease; or, if there is secondary spread, there 
is a clear distinction between the primary and secondary spread; (viii) and that all outbreak cases 
that are identified have the same case definition.  
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6.4.2. Dose-response models 
6.4.2.1. Non-time-dependent dose-response models 
Datasets that met this inclusion criteria were initially modeled using traditional dose-response 
analysis widely used in quantitative microbial risk assessment (QMRA), which neglects the time-
to-infection process. Traditional dose-response predicts the probability of adverse effects, such as 
illness or death, from the infection of a given dose (Haas et al. 2014). Dose-response equations 
are usually expressed mathematically, often in the form of an exponential or beta-Poisson model 
(Haas et al. 2014): 
𝑃(𝑑) = 1 − 𝑒−𝑘𝑑     Eq. 6.1 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 6.2 
The approximate beta-Poisson (Eq. 6.2) was developed from the Exponential (Eq. 6.1) by 
replacing the parameter 𝑘 with a beta distribution (Haas et al. 2014). Both expressions assume 
that (i) a single surviving pathogen is sufficient to initiate infection; (ii) the host ingests one or 
more organisms capable of causing an adverse response; (iii) only a fraction of these pathogens 
reach a site of infection; (iv) individuals ingest a number of microorganisms representing a 
random sample from a Poisson distribution; (v) within the host, the survival of any 
microorganism is independent of the survival of any other microorganism (Haas et al. 2014).  
 
Because these models are predictive models, we look at the probability of adverse response in the 
host. 𝑃(𝑑) is the probability of adverse response at dose 𝑑, and 𝑘 is the exponential rate 
parameter describing the probability that a single organism can survive and initiate infection in 
the host. 𝑁50 is the median infective dose and 𝛼 is the slope parameter for the beta-Poisson 
model. The exponential and the beta-Poisson models both have a mechanistic biological basis and 
exhibit linearity at low dose (Haas et al. 2014).   
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A Cochran-Armitage test of trend was applied to determine whether there was an association 
between increasing dosages and adverse effects (Haas et al. 2014, Neuhäuser and Hothorn 1999). 
Written formally, the Z-statistic is calculated by 
𝑍𝐶𝐴 =
∑ (𝑥𝑖−?̅?)
𝑘
𝑖=1 𝑝𝑖
√?̅?(1−?̅?) ∑ 𝑛𝑖(𝑥𝑖−?̅?)2
𝑘
𝑖=1
                                                   Eq. 6.3 
where  
?̅? =
∑ 𝑛𝑖𝑥𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
  and ?̅? =
∑ 𝑝𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
                                                  Eq. 6.4 
with 𝑛𝑖 total subjects and 𝑝𝑖 positive subjects. The null hypothesis of lack of trend is rejected if 
𝑍𝐶𝐴 is above the upper 5
th percentile of the normal distribution, which is 1.64 for a one-tailed test.  
 
If such an association is determined, the data can be modeled. A code written in R programming 
language (www.r-project.org) minimized the deviance (𝑌) of each of these model fits: 
𝑌 = −2 ∑ [𝑝𝑖𝑙𝑛
𝜋𝑖
𝜋𝑖
0 + (𝑛𝑖 − 𝑝𝑖)𝑙𝑛
1−𝜋𝑖
1−𝜋𝑖
0]
𝑘
𝑖=1                                      Eq. 6.5 
The parameters 𝜋𝑖  and 𝜋𝑖
0 are the predicted and observed responses of 𝑝𝑖 positive subjects within 
𝑛𝑖 number of subjects in the set (Haas et al. 2014). Goodness-of-fit was determined by comparing 
minimized deviance from maximum likelihood estimations (MLE) to the critical 2 distribution. 
The optimized deviance has a 2 distribution with m – n degrees of freedom, where m is the 
number of doses and n is the number of model parameters. The dose-response model is rejected if 
𝑌 >  𝑚−𝑛,0.95
2 , at a 95% confidence level. If, however, both models provide acceptable fits, the 
beta-Poisson model could be selected as a best-fit model only if the difference in minimized 
deviances between the beta-Poisson and the exponential model was greater than the critical chi-
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square value for a single parameter (one degree of freedom). Confidence intervals of the 
parameters for the models were determined via bootstrapping with 10,000 iterations.  
 
6.4.2.2. Time-dose-response models 
Time-dose-response models were developed by Huang et al. (2009) by modifying traditional, 
non-time-dependent exponential and beta-Poisson models to include the time post-inoculation. 
This additional time parameter would quantify the onset time-to-effect presumably associated 
with the kinetics of in-vivo bacterial growth. Huang developed eight separate equations based on 
time dependency in total (Huang & Haas 2011, Huang et al. 2009, Huang & Haas 2009). These 
models have an empirical basis, and were developed from model parameters that were plotted 
against time for various survival dose-response datasets. Of the original 8 models, only 4 were 
true cumulative density functions (CDFs); these are presented in Table 6.1 (Prasad et al. 2016). 
The models that were not true CDFs were excluded from the study (Mendenhall et al. 2012).  
 
 
Table 6.1 True CDF time-dependent dose-response models 
Model Name Expression Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 Eq. 6.6 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 6.7 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 6.8 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 6.9 
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The TDR models in Table 6.1 were ﬁt to the dose-response data, deviances were optimized, and 
model parameters were determined using maximum likelihood estimation (MLE) in the R 
programming language (www.r-project.org, ver. 3.0.3).  
 
The likelihood ratio for the incidence occurring on the jth day with i dose groups is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1      Eq. 6.10 
 
where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made, 𝑝𝑖,𝑗 is the number of positive response observed during time 
period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the beginning of time period 𝑗. The predicted 
response is 𝜋𝑖, and the response for each set based on observations are 𝜋𝑖
°. The corresponding 
deviance is  
𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1       Eq. 6.11 
 
6.4.3. Outbreak model 
The susceptible-infected-recovered (SIR) compartment model was developed by Kermack and 
McKendrick in their seminal papers (Kermack and McKendrick 1927), and has been extensively 
documented since (Anderson and May 1991). A modified SIR model was proposed by Gupta in 
his 1999 thesis (Gupta 1999) and re-derived by the author of this work (Figure 6.1). In this model, 
populations are compartmentalized into groups, with individuals moving through the 
compartments as they become infected. The number of people in the compartments, as well as the 
rates that of transfer are described by a system of differential equations. 
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Figure 6.1 Modified SIR model proposed by Gupta (Gupta and Haas 2004, Kermack and McKendrick 
1927). 
 
 
 
In this model, populations are compartmentalized into groups, moving through the compartments 
as they become infected. The number of people in the compartments, as well as the rates that of 
transfer are described by a system of differential equations. The four states in this model are (1) 
the susceptible populations 𝑋(𝑡); (2) latent individuals 𝑌(𝑡) who have been exposed to the 
pathogen and will ultimately become infected; (3) those who become symptomatically ill 𝑍(𝑡); 
and (4) those who have become infected but will remain Asymptomatic 𝐼(𝑡). The force of 
infectivity, 𝛽(𝑡), is the rate of transfer from susceptible to the latent, and 𝑄(𝑡) models the rate of 
newly symptomatic cases. For our purposes, only the symptomatically ill population will be 
considered, since generally data is only available for these groups through epidemic studies. The 
compartment model then reduces to the following equations: 
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), or 
1
𝑋
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)    Eq. 6.12 
 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡)      Eq. 6.13 
The force of infection 𝛽(t) has units of inverse time, and is a versatile parameter. In the case of a 
rectangular distribution for infectivity, 𝛽(t) would be a constant for the exposure duration. 
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However, common source outbreaks are frequently caused by time variable microbial exposures, 
which means that the parameter takes the form of a density distribution, generally of the 
following form: 
 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)     Eq. 6.14 
 
where 𝛽(t) is the force of infection; b0 is the background infectivity level, which may account for 
any endemic cases in the population; 𝑔(𝑡) is the ratio of susceptible persons ultimately becoming 
infected at time t; and b1 is the scaling factor for increased infectivity above background. Here, 
𝑔(𝑡) is modeled as a probability density function for the exposure case. The density functions in 
this case that we have used are the Weibull, gamma, and lognormal, and uniform, all which are 
standard functions which have historically been used to fit observed epidemic curves. Each of 
these density functions have parameter values that determine the shape and scale of the function. 
Integrating Eq. (6.12) gives: 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
   Eq. 6.15 
The rate of newly ill people at any time t is given by the parameter 𝑄(t). At any time t, the 
instantaneous rate of new illnesses can be obtained by the convolution integral: 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
    Eq. 6.16 
where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). The function 𝑓 is a 
probability density function (PDF) which has parameters that need to be estimated.  
 
Substituting Eq. 6.15 into Eq. 6.16 we then obtain: 
𝑑𝑍
𝑑𝑡
= ∫ 𝑋0𝛽(𝜏)exp [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 6.17 
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where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the CDF corresponding to the PDF 𝑔(𝑡). Since we are 
using the Weibull, gamma, lognormal and uniform PDFs to model 𝑔(𝑡), we necessarily must use 
the corresponding CDFs for 𝐺(𝑡) in each respective case.  
Integrating Eq. 6.17 directly, we can solve for the number of symptomatically ill patients per day 
𝑍(𝑡): 
𝑍(𝑡) = ∬ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑     Eq. 6.18 
In Eq. 6.18, the exposure time distribution is represented by the expression 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)], 
while the incubation distribution is represented by the expression 𝑓(𝜑 − 𝜏). The incubation 
distribution that will be used here will be the best-fit time-dose-response equation. 
 
The time-dose-response functions from Table 6.1 cannot be immediately used as incubation 
distributions because they are in the form of cumulative density functions; probability density 
functions are needed to be input into Eq. 6.18. The derivatives of the functions in Table 6.1 are 
taken so that proper PDFs can be utilized.  
 
For the Weibull, gamma, lognormal and uniform incubation scenarios, we have six parameters for 
𝑍(𝑡): the attack parameters  𝑏0 and  𝑏1, two PDF parameters for the attack distribution, and two 
PDF parameters for the incubation distribution (Weibull, gamma, lognormal and uniform 
distributions all contain 2 parameters). In the case of the beta-Poisson model with inverse time 
dependency, we have seven parameters total, as this model contains three parameters, 𝛼, 𝑑, and 
𝑗0.  
 
Anderson and May described the number of newly infected persons per unit time in a secondary 
infection as 𝛾(𝑡)𝑥(𝑡)𝑧(𝑡) (Anderson et al. 1992). Here, 𝛾(𝑡) is a new parameter that is dependent 
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upon the physical properties of a given outbreak, such as the contact rate and dose that is 
transmitted from one contact to another. The inclusion of the individuals in the asymptomatically 
and symptomatically ill states accounts for the fact that they have the ability to transfer infection 
to other susceptible individuals, given the physical parameter value 𝛾(𝑡).  
 
In the specific case of secondary spread, Eq. 6.18 becomes 
𝑍(𝑡) = ∬ 𝛾(𝜏)𝑧(𝜏)[𝑥0 + (𝑦0 − 𝑦(𝜏))]𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑
𝑡
0
                          Eq. 6.19 
Recall that 𝑍(𝑡) is the number of individuals who are symptomatically ill at time 𝑡. For this 
expression, there are expressions that not present in the common source outbreak: 𝑦(𝜏), the PDF 
which describes the number of latent individuals at time of infection 𝜏; and 𝑧(𝜏), the PDF which 
describes the number of symptomatically ill individuals at the time of infection 𝜏. These two 
PDFs along with the parameter 𝛾 are components of the exposure distribution, while 𝑓(𝜑 − 𝜏) is 
the density function for the incubation distribution.  
 
Like in the common source model case, each of the exposure and incubation can be modeled with 
the Weibull, gamma, lognormal or uniform distributions, which are all 2-parameter models. We 
then have seven parameters in Eq. 6.19 to be determined – the contact rate parameters 𝛾, the four 
parameters in the attack distribution, and the two PDF parameters in the incubation distribution.  
 
To compare the results of the outbreak models, deviance, Akaike information criterion (AIC) and 
Bayesian information criterion (BIC) values are examined: 
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 6.20 
𝐴𝐼𝐶 = 2𝑘 − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]                   Eq. 6.21 
𝐵𝐼𝐶 = 𝑘 ∗ 𝑙𝑛(𝑛) − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]           Eq. 6.22 
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The parameters 𝜃?̂? are the values of the full model (observed values), and 𝜃0̂ are the values of the 
predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and thus we can see that 
the AIC and BIC is the deviance plus a complexity parameter. BIC penalizes model complexity 
more than AIC does (Ruppert 2011). The outbreak model with the lowest deviance, AIC and BIC 
are the best-fit. Since some TDR models have extra parameters, they will have higher AIC and 
BIC values. 
 
In order to compare the parameters in the epidemic and dosing parameter studies to see if the 
differences between corresponding parameters were significant, the two-sample Kolmogorov–
Smirnov (KS) test and the Anderson–Darling (AD) test were utilized. In both tests, we wanted to 
see if the parameters came from the same distribution. The KS test states that 𝐷∗ =
𝑠𝑢𝑝
𝑥
| 𝐹1(𝑥) −
𝐹2(𝑥)|, where 𝐹1(𝑥) and 𝐹2(𝑥) are the empirical distribution functions of the two samples 
respectively, and 𝑠𝑢𝑝 is the supremum function (Sheskin 2003). The null hypothesis is rejected if 
the following equation holds true: 𝐷∗ > 𝑐(𝛼)√
𝑛+𝑛1
𝑛𝑛1
. For 𝛼 = 0.05, 𝑐(𝛼) = 1.36. The AD is a 
refinement of the KS test. The statistic that was used was of the form 
𝐴2 = −𝑛 − ∑
2𝑖−1
𝑛
[ln(Φ(𝑌𝑖)) + ln(1 − Φ(𝑌𝑛+1−𝑖))]
𝑛
𝑖=1  (D’Agostino et al. 1986). The parameter 
𝑛 is the number of data points in the sample, and the test statistic measures the distance between 
the hypothesized and empirical. The null hypothesis of normality is rejected if A2 exceeds 0.752 
for α = 0.05. 
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6.5. Results and discussion 
6.5.1. Dose-response  
A literature search for dose-response datasets was conducted to identify appropriate candidate 
models for Shigella. Several dosing studies have been performed by inoculating animal hosts with 
Shigella pathogens, including guinea pigs (Formal et al. 1958), monkeys (Formal et al. 1967, 
Formal et al. 1966, Formal et al. 1965) and mice (Rodrigues et al. 1996). However, a series of 
studies published by Tasaka et al. was the only study found to meet the inclusion criteria for the 
time-dependent dose-response models (Takasaka et al. 1970, Takasaka et al. 1969, Honjo et al. 
1968, Takasaka 1967, Honjo et al. 1964). The methods of administration were either via the oral 
or injection route. In the oral administration method (published in two separate papers), the 
authors inoculated cynomolgus monkeys (Macaca irus) with varying doses of S. flexneri 2a strain 
5503 to investigate the minimum dose responsible for clinical illnesses (Takasaka et al. 1970, 
Takasaka 1967). The monkeys were from the Philippines, Cambodia or South Vietnam, weighed 
between 1.8 and 3.5 kg, and were dosed between 0.001 and 1000 mg of dysenteric content, 
corresponding to 101 and 109 viable S. flexneri 2a counts (Table 6.2). The number of viable agents 
was estimated by the authors, but since the estimations fluctuated by several orders of magnitude, 
they are presented in as an illustrative measure only.  
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Table 6.2 Cumulative infection percentages of monkeys exposed Shigella (Takasaka 1967). The endpoint 
was clinical illness. 
    Cumulative infection percentage of monkeys per day post-inoculation 
(%) 
Dose 
(mg) 
Viable agent 
counta 
1 2 3 4 5 6 7 8 9 total 
0.001 101 0 0 0 0 0 0 0 0 0 0 
0.01 3.6-3.8 x 106 0 0 0 0 0 0 0 0 0 0 
0.1 103.2-105.0 0 0 0 6 0 0 0 0 19 19 
1 104.8-107.0 0 0 0 19 25 0 0 0 0 25 
20 7.3-7.5 x 109 20 60 0 0 0 0 0 0 0 60 
1000 107.4-109.0 0 8 17 25 0 0 0 0 0 25 
a as estimated by the authors 
 
 
 
Since the dose-response datasets came from two different papers by Takasaka et al. (1970, 1967), 
the data were pooled and tested for lack of fit as described by Haas et al. (2014). The deviance of 
the pooled dataset was then compared with the individual fits. In this case, beta-Poisson of the 
pooled model was the best-fit model, with a deviance value of 6.46 (critical 𝜒0.95,𝑚−𝑛𝑝𝑎𝑟
2 = 9.49). 
However, the summation of the individual deviances was greater than the pooled deviance value 
(∑ 𝑌𝑖 > 𝑌𝑇), so the conclusion was that the datasets could not be pooled. Yet by looking at the 
data, there appeared to be an outlier. This was confirmed because 𝑁50 values were significantly 
higher than other values of S. flexneri previously published in the literature (between 103-104 
CFU) (Crockett 1996).  The pooled dose group was then jackknifed, with the data refit by 
removing a single dose at a time. When the last dose point was removed, the deviance was 
reduced by 5 for the beta-Poisson model, and the 𝑁50 dropped to 10.12 mg, which the authors 
estimate to be approximately 105-107 viable counts (Table 6.3). This is still perhaps at the higher 
end of the previously published values, but much closer than the parameters given before 
removing the outlier.  
 
The higher 𝑁50 value in the Takasaka et al. monkey data could have been for several reasons. In 
their series of experiments, the endpoint was loose stools with a measurable amount of blood and 
mucus. The authors acknowledged that there were monkeys who had loose stools at lower dose 
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groups, but because the stools did not contain blood, they were omitted from what they defined as 
clinical dysentery. A series of experiments using healthy human male subjects determined an 𝑁50 
value of 103-104, with the endpoint being illness characterized by a fever of at least 100°F, severe 
abdominal cramping, diarrhea (at least 2 loose stools in a 24-hr period), severe abdominal 
cramping, or bloody mucoid stools (Crockett 1996). 
 
Dose-response data showed positive trends when subjected to the Cochran-Armitage test of trend. 
The critical Z value was greater than 1.64 (𝑍𝑐𝑟>1.64) at 2.17, so the null hypothesis of lack of 
trend is rejected and data can be analyzed further. Table 6.3 shows the best parameter values of 
the fits and optimization of the pooled datasets, with and without the outlier dose. In the model in 
which the outlier is removed, the beta-Poisson is the best-fitting mechanistic model because it 
was the only model whose minimized deviance of 1.46 was lower than the critical chi-square 
distribution χ2 for 3 degree of freedom, at 7.81. The bootstrapped dataset with 10,000 iterations 
from this monkey model is plotted with optimized parameters for the beta-Poisson model in 
Figure 6.2.  
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Table 6.3 Non-time-dependent dose-response modeling results for Shigella inoculation with and without 
the outlier data point. 
Dose 
Removed 
Model 
Parameter 
Deviance dfa 𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 Conclusions 
Best fit 
modelc type value 
None 
Expd k 1.56×10−3 115.49 5 11.07 
BP provides 
acceptable fit 
Beta-Poisson 
BPe 
α 0.52 
6.46 4 9.49 
N50 3.48×103 
1000 mg 
Expd k 9.44×10−2 19.97 4 9.49 
BP provides 
acceptable fit 
Beta-Poisson 
BPe 
α 0.13 
1.46 3 7.81 
N50 10.12 
a df - degrees of freedom for dataset and model 
b  Critical values of the chi-squared distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, 
m is the number of doses, n is the number of parameters 
c Best fit model criteria - the lowest deviance of candidate models was chosen compared to the critical values of chi-
squared distribution  
d Exponential Model 
e Beta-Poisson Model 
 
 
 
 
 
Figure 6.2 (a) Best-fit bootstrapped beta-Poisson dose-response model with confidence intervals for cysts 
administered orally to beavers; and (b) the corresponding bootstrapped beta-Poisson parameters with 
10,000 iterations for those confidence intervals. 
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6.5.2. Time-Dose-Response  
The time-dose-response models in Table 6.1 were ﬁtted to the survival data presented in Table 
6.2 using maximum likelihood estimation (MLE). The parameter estimates and the minimized 
deviances are summarized in Table 6.4. The one-parameter exponential with exponential-
reciprocal time dependency and the three-parameter beta-Poisson with exponential time 
dependency were found to have acceptable fits to the time-dependent data. The difference in the 
minimized deviance between these two models was 3.81, which was less than the ∆𝜒0.95,𝑑𝑓
2  of 
5.99 for 2 degrees of freedom. Therefore, the best fit for these models is the beta-Poisson with 
exponential time dependency because it provided the lowest deviance, and gave a statistically 
signiﬁcant improvement in ﬁt over the other models. Figure 6.3 plots the best-fit TDR model. 
 
 
 
Table 6.4 Time-dose-response (TDR) modeling results for Shigella inoculation  
Time Dependence Model 
Best fit 
parameters 
Minimized 
deviance 
2
,05.0 df  Acceptable fit 
Beta-Poisson model with 
exponential time 
dependency 
α = 0.79 
37.99 40.1 yes j0 = 0.22 
j1 = 1.88 
Beta-Poisson model with 
exponential-reciprocal 
time dependency 
α = 248.2 
43.8 40.1 no j0 = 3.35 
j1 = 0.95 
Beta-Poisson model with 
inverse time dependency 
α = 3.87×10-5 
55.85 41.3 no 
j0 = 3.07×107 
Exponential model with 
exponential-reciprocal 
time dependency 
k0 = 0.95 41.8 42.6 yes 
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Figure 6.3 Daily cumulative response data fitted by the beta-Poisson model with exponential time 
dependency time-dose-response model. The arrows indicate the direction of the curves from the ﬁrst day to 
the last.  
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6.5.3. Outbreak model 
6.5.3.1. Shigella flexneri outbreak 
S. flexneri was modeled using an outbreak that occurred at an elementary school in Sichuan 
Province, China, where 118 out of 553 students became ill between July 7-16, 2009 (He et al. 
2012). The investigation found S. flexneri type 2b to be the cause of the outbreak, and shigellosis 
was associated with drinking-well water. Environmental investigation showed that the school-
owned wells were located one meter away from a pond, where raw sewage was directly 
discharged. The pond water was then stored in towers and was piped to the school without 
treatment, and students reportedly drank from this frequently. No secondary waves of S. flexneri 
in the literature were found to fit the outbreak criteria.  
 
Since the beta-Poisson with exponential time dependency was the best-fit model, this was the 
time dependency kinetic model that was used as incubation distributions. The non-time-
dependent Weibull, gamma, lognormal and uniform distributions were also generated for 
comparison.  
 
In each case, deviance, AIC and BIC output were compared to determine which convolution of 
distributions best fit the data. In the S. flexneri primary spread case, the gamma-Weibull 
exposure/incubation convolution has the lowest deviance at 4.74 (Table 6.5), consistent with a 
visual inspection (Figure 6.4). The next best-fit models are the lognormal-Weibull at 5.73 and the 
Weibull-Weibull at 6.52. Here, the TDR incubation models did not provide any benefit, given the 
extra parameters, with deviances at 11.73, 12.98, and 13.65 for the Weibull, gamma, and 
lognormal exposure functions. 
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Table 6.5 also summarizes the model parameters for S. flexneri. The first and second column are 
the results for the 𝑏0 and 𝑏1 attack rate values. There is a trend for attack parameter 𝑏0 to be 
small, indicating that there is a low baseline level of this disease in the population before the 
outbreak. The third and fourth columns are referred to as “Exposure Distribution PDF param 1” 
and “Exposure Distribution PDF param 2,” which correspond to the respective exposure 
distributions. For the Weibull distribution, PDF Param 1 and PDF Param 2 refer to the scale 
parameter a, and shape parameter b in the probability distribution function. For the gamma 
exposure distribution, PDF Param 1 and 2 are the mean and variance. In the lognormal 
distributions, PDF Param 1 and PDF Param 2 are the log transform of the mean and variance. The 
uniform distribution refers to parameters a and b in the PDF, with a being a lower endpoint 
(minimum) and b being an upper endpoint (maximum), respectively.  The remaining columns 
correspond to the respective incubation distributions, and follow the same pattern as described 
previously. For the beta-Poisson with exponential time dependency, parameters 5, 6, 7 and 8 refer 
to 𝛼, 𝑗0, 𝑗1, and 𝑑, respectively.  
 
Figure 6.4 plots the observed outbreak data (number ill) and the predicted model for the S. 
flexneri outbreaks in China. Each graph groups the respective incubation periods with the 
corresponding exposure distributions. The abscissa is time in days, and the ordinate is the number 
of cases reported. The graphs exhibit a peak at the height of the outbreak that is characteristic of a 
primary wave in which there are no secondary cases. TPI in the last graph refers to the time-post-
inoculation of the beta-Poisson with exponential model. 
 
  
  
 
 
Table 6.5 Parameter and criteria values for the S. flexneri primary outbreak model. 
  Model Parameters 
 
Criteria Values 
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
para
m 
b1 
Expos 
dist  
PDF 
param 1 
Expos 
dist  
PDF 
param 2 
Incub 
dist  
PDF 
param 1 
Incub dist 
PDF 
param 2 
Incub 
dist 
PDF 
param 3 
Incub 
dist 
PDF 
param 4 
Deviance AIC BIC 
Weibull 
Weibull 1.18×10−2   0.15 3.65a 13.07b 3.14a 4.47b n/a n/a 6.52 18.52 20.34 
Gamma 2.03×10−3   0.24 6.27a 7.31b 1.106c 4.13d n/a n/a 8.58 20.58 22.40 
Lognormal 6.53×10−3        0.59 6.48a 7.54b 1.52e 6.38f n/a n/a 7.04 19.04 20.86 
Uniform 5.35×10−3      0.21 4.05a 4.31b 0.99g 4.71h n/a n/a 19.61 31.61 33.43 
BP with exp 8.90×10−3        0.25 6.79a 8.07b 6.77i 0.92j 1.18k 0.96l 11.73 27.73 30.15 
Gamma 
Weibull 1.22×10−2      0.16 3.30c 0.02d 3.31a 4.31b n/a n/a 4.74 16.74 18.56 
Gamma 9.69×10−3       0.17 3.88c 0.40d 2.54c 0.51d n/a n/a 10.59 22.59 24.41 
Lognormal 8.87×10−3        0.17 4.06c 0.54d 0.83e 0.28f n/a n/a 11.28 23.28 25.10 
Uniform 8.05×10−3        0.17 4.13c 0.46d 0.97h 3.42h n/a n/a 9.48 21.48 23.30 
BP with exp 4.20×10−2       0.32 6.58c 1.89d 2.72i 7.19×10-15 j 1.04k 0.91l 12.98 28.98 31.40 
Lognormal 
Weibull 1.21×10−2        0.17 0.97e 0.03f 3.88a 4.48b n/a n/a 5.73 17.73 19.55 
Gamma 9.89×10−3      0.17 1.33e 0.15f 2.59c 0.56d n/a n/a 10.91 22.91 24.73 
Lognormal 8.90×10−3        0.17 1.38e 0.18f 0.83e 0.29f n/a n/a 11.80 23.8 25.62 
Uniform 8.90×10−8        0.17 1.36e 0.05f 0.72g 3.67h n/a n/a 9.83 21.83 23.65 
BP with exp 9.40×10−3     3.41 2.08e 0.28f 0.74i 0.76j 1.2k 0.98l 13.65 29.65 32.07 
Uniform 
Weibull 9.40×10−3         0.17 2.95g 4.88h 2.68a 3.99b n/a n/a 7.40 19.4 21.22 
Gamma 1.26×10−2        0.14 3.55g 5.27h 2.13c 0.09d n/a n/a 14.42 26.42 28.24 
Lognormal 5.20×10−3      0.21 0.74g 4.27h 1.31e 0.33f n/a n/a 22.14 34.14 35.96 
Uniform 2.28×10−2        0.09 0.84g 0.99h 0.82g 6.44h n/a n/a 60.39 72.39 74.21 
BP with exp 4.60×10−3     0.63 3.85g 9.88h 1.09i 0.25j 0.51k 0.87l 35.49 51.49 53.91 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1
1
7
3
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Figure 6.4 Model fits for the S. flexneri primary outbreak in Sichuan Province, China. The gamma, 
lognormal, uniform, and Weibull exposure functions are convoluted with the gamma, lognormal, uniform, 
Weibull, and beta-Poisson with reciprocal incubation distributions for a total of 20 data fits. Each graph 
groups the respective incubation periods with the corresponding exposure distributions. The abscissa is 
time of symptom onset in days, and the ordinate is the number of cases reported. 
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6.5.3.2. Shigella sonnei outbreak 
Two different outbreaks were used to model S. sonnei. The first was primary wave affecting 148 
villagers in Crete, Greece, which was attributed to a spring water source contaminated with fecal 
coliforms from a nearby sewage facility (Samonis et al. 1994). The authors defined a primary 
case as the first case to develop symptoms of Shigella infection in each household, with 5-6 loose 
stools per day for at least 2 days. This paper additionally contained a well-defined secondary 
outbreak as well, and an attempt was made to utilize model the data, but because the data points 
were scattered, the model gave extremely high deviance value.  
 
A separate secondary wave of S. sonnei was found in which an index case was the source of an 
outbreak in a psychogeriatric ward in December 1985, where a total of 10 patients and 5 staff 
members became symptomatically ill with diarrhea over the course of four weeks (Hunter & 
Hutchings 1987). The cause of the illness in the index patient was undetermined, but Hunter 
(1987) suggests that inadequate personal hygiene in the ward was responsible. The outbreak was 
controlled by closing the ward to new patients on Day 3 and isolating the symptomatically ill 
patients.  
 
Models for fitting S. sonnei outbreak datasets were generated using the same method of 
convoluting distributions. In the primary outbreak case, the uniform-beta Poisson convolution has 
the lowest deviance at 3.45, followed by the Weibull-beta Poisson, Weibull-uniform, and 
Weibull-gamma, respectively, at 7.95, 8.34, and 8.55, respectively (Table 6.6). For these same 
cases, AIC values are 19.45, 23.95, 20.34, and 20.55; BIC values are 23.97, 28.47, 23.73, and 
23.94. Due to the additional parameters of the TDR model, the AIC and BIC values for the TDR 
distributions are larger than for those of the non-time-dependent models. If the AIC and BIC 
values are used as criteria, the uniform-beta Poisson model is the best-fit, followed by Weibull-
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uniform, Weibull-gamma, and gamma-lognormal. In the S. sonnei secondary spread case (Table 
6.7), the models with the lowest deviance were the Weibull-uniform, Weibull-beta Poisson, 
gamma-beta Poisson, and lognormal-beta Poisson, with deviance values of 0.29, 0.54, 0.54, and 
0.55, respectively. The AIC and BIC values for the models were 14.29, 18.54, 18.54, 18.55 and 
15.67, 20.32, 20.32, and 20.33. In this case, if AIC and BIC were used as criteria values, the best-
fit models remain the Weibull-uniform.  
 
Figures 6.5 and 6.6 plot the observed data and predicted models for the primary and secondary S. 
sonnei outbreaks. Each graph groups the respective incubation periods with the corresponding 
exposure distributions. The distinction between the individual models are more prominent here. 
The trend in the exposure distributions appears to be that the uniform gives the flattest peak, 
followed by the lognormal series. The Weibull group are more right-skewed, while the gamma 
seems to be more centered. In the lower graphs, there are more than one peaks in this outbreak, as 
is consistent with secondary spread of pathogens. The uniform-lognormal and the uniform-
uniform seemed to be the only models that captured the second peak at day 16. 
  
 
 
Table 6.6 Parameter and criteria values for the S. sonnei primary outbreak model. 
  Model Parameters 
 
Criteria Values 
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
param 
b1 
Expos 
dist  
PDF 
param 1 
Expos 
dist  
PDF 
param 2 
Incub 
dist  
PDF 
param 1 
Incub dist 
PDF 
param 2 
Incub 
dist 
PDF 
param 3 
Incub 
dist 
PDF 
param 4 
Deviance AIC BIC 
Weibull 
Weibull 2.97×10-3 1.30×10-3 24.39a 17.96b 1.21a 1.13b n/a n/a 9.18 21.18 24.57 
Gamma 3.62×10-3 0.12 23.05a 16.60b 2.43c 0.29d n/a n/a 8.55 20.55 23.94 
Lognormal 2.47×10-3 0.20 24.21a 18.32b 0.68e 2.12f n/a n/a 15.05 27.05 30.44 
Uniform 3.30×10-3 0.13 24.65a 4.31b 0.99g 4.71h n/a n/a 8.34 20.34 23.73 
BP with exp 7.55×10-3 0.27 25.70a 17.34b 3.64i 1.08j 1.18k 0.55l 7.95 23.95 28.47 
Gamma 
Weibull 3.48×10-3 0.12 24.33c 2.60d 0.66a 2.46b n/a n/a 9.04 21.04 24.43 
Gamma 3.42×10-3 0.12 22.50c 1.68d 2.42c 1.13d n/a n/a 9.26 21.26 24.65 
Lognormal 3.55×10-3 0.13 23.77c 2.81d 0.06e 0.17f n/a n/a 8.72 20.72 24.11 
Uniform 1.14×10-6 0.38 0.49c 6.48d 17.74h 27.27h n/a n/a 33.21 45.21 48.60 
BP with exp 1.30×10-2 0.51 25.37c 2.84d 2.46i 1.20j 2.13k 1.20l 8.75 24.75 29.27 
Lognormal 
Weibull 6.00×10-4 0.29 1.17e 8.68f 24.81a 12.38b n/a n/a 13.31 25.31 28.70 
Gamma 3.55×10-4 0.30 1.19e 9.69f 24.18c 8.17d n/a n/a 23.18 35.18 38.57 
Lognormal 8.06×10-8 0.86 10.70e 10.26f 3.17e 0.12f n/a n/a 25.27 37.27 40.66 
Uniform 4.53×10-5 0.20 0.49e 1.57f 17.25g 26.51h n/a n/a 24.74 36.74 40.13 
BP with exp 1.34×10-31 0.43 3.16e 0.12f 0.41i 7.63×10-7 j 0.98k 1.04l 23.11 39.11 43.63 
Uniform 
Weibull 5.10×10-3 0.10 17.34g 21.41h 6.08a 5.94b n/a n/a 10.03 22.03 25.42 
Gamma 1.20×10-4 0.18 15.76g 22.45h 6.19c 13.13d n/a n/a 26.61 38.61 42.00 
Lognormal 1.40×10-3 0.15 0.74g 5.46h 3.06e 0.12f n/a n/a 22.31 34.31 37.70 
Uniform 3.33×10-5 0.17 10.86g 18.14h 5.82g 13.81h n/a n/a 22.71 34.71 38.10 
BP with exp 6.58×10-3 0.17 22.42g 27.30h 7.99i 1.23j 0.71k 1.12l 3.45 19.45 23.97 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1
1
7
7
 
  
 
 
Table 6.7 Parameter and criteria values for the S. sonnei secondary outbreak model. 
   Model Parameters  Criteria Values 
Exposure 
Dist 
Incubation 
Dist 
𝛾 
Expos 
dist 
PDF 
param z1 
Expos 
dist 
PDF 
param 
z2 
Expos 
dist 
PDF 
param 
y1 
Expos 
dist 
PDF 
param 
y2 
Incub 
dist 
PDF 
param 
1 
Incub 
dist 
PDF 
param 
2 
Incub 
dist 
PDF 
param 
3 
Incub 
dist 
PDF 
param 
4 
Dev AIC BIC 
Weibull 
Weibull 3.22×10-3 3.57×10-2 0.94 7.27a 3.28b 2.40a 0.25b n/a n/a 0.61 14.61 15.99 
Gamma 2.60×10-3 1.75×10-2 0.75 6.76a 3.54b 1.15c 0.39d n/a n/a 0.59 14.59 15.97 
Lognormal 2.17×10-3 2.95×10-2 0.47 7.57a 1.44b 0.42e 0.54f n/a n/a 0.79 14.79 16.17 
Uniform 3.73×10-3 7.73×10-3 0.84 5.96a 5.10b 0.82h 1.55h n/a n/a 0.29 14.29 15.67 
BP with exp 2.39×10-2 7.79×10-2 0.38 6.02a 8.71b 0.17i 0.68j 0.65k 0.79l 0.54 18.54 20.32 
Gamma 
Weibull 2.56×10-3 1.74×10-2 0.82 6.55c 3.78d 0.99a 1.52b n/a n/a 0.60 14.60 15.98 
Gamma 2.79×10-3 1.53×10-2 0.94 5.82c 2.65d 1.53c 0.62d n/a n/a 0.68 14.68 16.06 
Lognormal 2.38×10-3 4.10×10-2 1.10 5.85c 10.98d 0.66e 2.05f n/a n/a 0.70 14.70 16.08 
Uniform 2.53×10-3 1.83×10-2 0.28 6.50c 6.76d 0.63g 1.83h n/a n/a 0.63 14.63 16.01 
BP with exp 2.42×10-2 7.98×10-2 0.30 5.63c 0.45d 0.17i 0.68j 0.78k 0.97l 0.54 18.54 20.32 
Lognormal 
Weibull 1.96×10-3 4.19×10-2 1.1 1.04e 1.26 4.90a 1.36b n/a n/a 0.76 14.76 16.14 
Gamma 2.05×10-3 4.10×10-2 0.74 0.72e 1.00 5.58c 21.06d n/a n/a 0.78 14.78 16.16 
Lognormal 1.10×10-3 7.94×10-2 0.88 1.38e 1.22f 1.66e 1.26f n/a n/a 0.79 14.79 16.17 
Uniform 3.52×10-3 3.38×10-2 0.41 5.80e 3.10f 0.72g 2.42h n/a n/a 1.38 15.38 16.76 
BP with exp 2.42×10-2 7.99×10-2 0.28 1.72e 0.12f 0.17i 0.68j 1.77k 0.86l 0.55 18.55 20.33 
Uniform 
Weibull 2.66×10-3 1.47×10-2 0.98 3.15g 9.28h 1.37a 6.47b n/a n/a 0.69 14.69 16.07 
Gamma 2.62×10-3 1.84×10-2 1.79 2.98g 8.54h 1.88c 5.54d n/a n/a 0.68 14.68 16.06 
Lognormal 4.79×10-3 4.43×10-2 0.81 3.33g 9.05h 2.08e 4.82f n/a n/a 0.77 14.77 16.15 
Uniform 4.06×10-3 1.48×10-3 0.17 3.99g 27.67h 1.09g 2.01h n/a n/a 0.95 14.95 16.33 
BP with exp 2.65×10-3 3.50×10-2 0.18 3.95g 17.00h 3.63i 0.11j 1.28k 0.47l 0.98 18.98 20.76 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1 
1
7
8
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Figure 6.5 Model fits for the S. sonnei primary outbreak in Crete, Greece. The gamma, lognormal, 
uniform, and Weibull exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, 
and beta-Poisson with reciprocal incubation distributions for a total of 20 data fits. Each graph groups the 
respective incubation periods with the corresponding exposure distributions. The abscissa is time of 
symptom onset in days, and the ordinate is the number of cases reported. 
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Figure 6.6 Model fits for the S. sonnei secondary outbreak in a psychogeriatric ward. The gamma, 
lognormal, uniform, and Weibull exposure functions are convoluted with the gamma, lognormal, uniform, 
Weibull, and beta-Poisson with reciprocal incubation distributions for a total of 20 data fits. Each graph 
groups the respective incubation periods with the corresponding exposure distributions. The abscissa is 
time of symptom onset in days, and the ordinate is the number of cases reported. 
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6.6. Conclusion 
In this study, a TDR model was incorporated into an incubation distribution and convoluted with 
an exposure distribution. These convoluted distributions are used as input for an SIR 
compartment model to fit outbreak datasets (Gupta & Haas 2004). To this end, dose-response and 
TDR models were generated for Shigella flexneri exposure to monkeys via the oral route, and 
subsequently incorporated into the incubation period of three S. flexneri and S. sonnei outbreaks 
in order to capture the in-vivo dynamics between pathogen and host. In the dose-response model, 
the median infectious dose was estimated to be 10 mg of dysenteric content (approximately 3.7-
3.8×109 viable S. flexneri 2a counts), and the best-fit TDR model was the beta-Poisson with 
exponential dependency, which had a minimized deviance of 37.99.  
 
This TDR model was chosen to be incorporated into three Shigella outbreak models: (i) a primary 
wave of S. flexneri resulting from an outbreak that occurred in China, a (ii) primary wave of S. 
sonnei that broke out in Crete, Greece, and a (iii) secondary S. sonnei wave that swept through a 
psychogeriatric ward. In the primary wave of the S. flexneri outbreak in China, the convolution of 
the gamma exposure distribution with the Weibull incubation distribution was the best-fit for the 
model, with a minimized deviance value of 4.74. In the case of the primary S. sonnei outbreak in 
Greece, the uniform-beta Poisson distribution performed the best, with a minimized deviance 
value of 3.45. In the secondary spread, the Weibull-uniform performed best with a deviance value 
of 0.29.  
 
This work suggests that the incorporation of a time factor into outbreak models may provide an 
approach to modelling that adequately describes realistic in-vivo dynamics of the host-pathogen 
system.  
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Chapter 7: Escherichia coli O157:H76 
 
7.1. Abstract 
A study that integrates in-vivo host-pathogen dynamics into an outbreak of Escherichia coli 
O157:H7 was performed to determine if the incorporation of time dependence fits the outbreak 
data demonstrably better than models that do not take these dynamics into account. Traditional 
non-time-dependent dose-response and time-dose-response models were generated for E. coli 
exposure to infant rabbits via the intragastrical route using a maximum likelihood estimation 
approach. A dose-response exponential model fit the rabbit dataset best, and the best-fit time-
dose-response (TDR) model was found to be the beta-Poisson model with exponential-reciprocal 
time dependency model, which had a minimized deviance 56.8. This TDR and other non-time-
dependent probability distribution functions (PDF) were fit to two outbreak sets: (1) a primary 
outbreak that occurred in rural Missouri between December 1989 and January 1990, and (2) a 
secondary outbreak that occurred at a nursing home in September 1985. The best-fit PDF from 
the primary wave was the convolution of the gamma-Weibull (deviance = 17.13), and the best-fit 
PDF from the secondary wave was the Weibull-BP with exponential-reciprocal time dependency 
(deviance = 16.59). This work shows that the incorporation of a time factor provides acceptable 
fits to modelling pathogen outbreaks.  
 
7.2. Keywords 
Dose-response; epidemiology; Escherichia coli O157:H7; outbreak model; time-dose-response 
  
                                                          
 
6 This chapter is currently under review at Epidemiology and Infection 
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7.3. Introduction 
Escherichia coli and other facultative anaerobes constitute about 0.1% of the human gut flora, 
where they are generally confined; if, however, gastrointestinal barriers are breached, even 
typically benign strains of E. coli can cause illness (Nataro and Kaper 1998). The most common 
route of infection is through fecal-oral transmission (Nguyen and Sperandio 2014). Six strains are 
responsible for causing diarrhea, collectively referred to as diarrheagenic E. coli: (1) 
enterotoxigenic E. coli (ETEC); (2) enteroinvasive E. coli (EIEC); (3) enteropathogenic E. coli 
(EPEC); (4) enteroaggregative E. coli (EAEC); (5) diffuse-adherence E. coli (DAEC); (6) and 
enterohemorrhagic E. coli (EHEC). Each strain has different pathogenesis and mechanism of 
disease (Nataro and Kaper 1998).  
 
EHEC is a subset of Shiga toxin-producing E. coli (STEC). Although some persons infected with 
STEC may be asymptomatic, symptoms may include mild, non-bloody diarrhea, bloody diarrhea, 
hemorrhagic colitis, hemolytic-uremic syndrome (HUS), thrombocytopenia, acute renal 
dysfunction, and death (Heymann 2008). Illness typically begins with abdominal cramping and 
loose stools that become bloody in 70% of cases (Slutsker et al. 1997). The time between 
infection and illness is estimated at 2-10 days, with a median of 3-4 days (Heymann 2008). Fever 
has been documented in 30% of ill patients, and vomiting has been observed in 30-70% of cases 
(Mead and Griffin 1998). Most people with hemorrhagic colitis recover within 7 days, and the 
mean duration of excretion of the pathogen is 10 days, ranging between 4 and 43 days (Mead and 
Griffin 1998). 
 
STEC has been associated with outbreaks worldwide, and in the United States (U.S.), STEC 
outbreaks have only increased since it was first discovered as a human pathogen in 1982, causing 
approximately 265,000 cases of illness and 3,600 hospitalizations (Scallan et al. 2011). The strain 
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of E. coli responsible for the greatest number of cases in the U.S. is O157:H7, which is the 
causative agent for over 96,000 illnesses and 30 deaths (Scallan et al. 2011). Transmission occurs 
primarily through food (52%), with ground beef (21%) being the major contributor; this is 
followed by person-to-person contact (14%); recreational water (6%); animal contact (3%); 
recreational water (3%) (Heiman et al. 2015). Other transmissions routes include pasteurized 
(Upton and Coia 1994) and raw milk (Keene et al. 1997), spinach (Sep 2006), and meats and 
cheeses (Espie et al. 2006). Direct person-to-person transmission occurs in nursing homes 
(Kaplan et al. 1982), day care facilities (Reida et al. 1994), and in families (Chapman et al. 1997). 
Primary and secondary waterborne transmission occurs through exposure to contaminated 
municipal (Swerdlow et al. 1992) and private drinking water supplies (Licence et al. 2001), and 
from recreational waters (Keene et al. 1994).  
 
Although E. coli has been responsible for numerous outbreaks in the past decade, few outbreak 
models have been generated for the pathogen. This method could be further improved upon by 
assuming an infection-time distribution that closely models the actual time to infection for E. coli. 
The time-dose-response (TDR) modeling methodology, which quantifies a relationship between 
pathogen kinetics and host response through the time-to-infection, provides the means in which 
data from dosing studies can be incorporated into the outbreak model (Huang and Haas 2009). 
Infection is a time-dependent process, since pathogen populations in the host vary with time, yet 
no outbreak model has ever considered the effects of in-vivo kinetics of various pathogens on 
hosts to date.  
 
A key research gap that remains is whether models that consider host-pathogen kinetics can 
provide robust fits to outbreak data. The purpose of this study is to utilize data mined from 
published literature to determine the best-fit TDR model for E. coli, and to incorporate this model 
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into the incubation distribution of an outbreak model that gives comparable results to other non-
time-dependent models. 
 
7.4. Materials and methods 
7.4.1. Datasets for time-dose-response and outbreak models 
7.4.1.1. Dose-response datasets 
A literature search was conducted to identify and collect appropriate datasets to develop an E. coli 
time dose-response model. The inclusion criteria for choosing the time-dose-response model was 
that article included (i) a clear description of dosing methods; (ii) reported mode of exposure; (iii) 
the administered dose to each subject; (iv) the number of subjects that experienced adverse effects 
on each respective day; (v) stated criteria used to define a positive endpoint; (vi) detailed 
descriptions of the pathogen (i.e. source and strain); (vii) at least one observation where a fraction 
of the dosing groups is infected (0 < 𝑝 < 1); and (viii) the time-to-adverse response for each 
individual subject (Haas 1999).  
 
7.4.1.2. Outbreak datasets 
The literature was then searched for published outbreak data that met the following criteria: (i) 
the outbreak occurred among a sufficiently large cluster of individuals to mitigate the effects of 
random variation that applies when analyzing small populations; (ii) members of this susceptible 
population who became symptomatically ill were tested for the pathogen; (iii) all outbreak cases 
that are identified have the same case definition; (iv) the beginning and end of the source of 
pathogen contamination is known; (v) all infection comes from a common (primary) source. 
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7.4.2. Dose-response models 
7.4.2.1. Non-time-dependent dose-response models 
Datasets that met this inclusion criteria were initially modeled using traditional dose-response 
analysis widely used in quantitative microbial risk assessment (QMRA), which neglects the time-
to-infection process. Traditional dose-response predicts the probability of adverse effects, such as 
illness or death, from the infection of a given dose (Haas et al. 2014). Dose-response equations 
are usually expressed mathematically, often in the form of an exponential or beta-Poisson model 
(Haas et al. 2014): 
𝑃(𝑑) = 1 − 𝑒−𝑘𝑑     Eq. 7.1 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 7.2 
The approximate beta-Poisson (Eq. 7.2) was developed from the exponential (Eq. 7.1) by 
replacing the parameter 𝑘 with a beta distribution (Haas et al. 2014). Both expressions assume 
that (i) a single surviving pathogen is sufficient to initiate infection; (ii) the host ingests one or 
more organisms capable of causing an adverse response; (iii) only a fraction of these pathogens 
reach a site of infection; (iv) individuals ingest a number of microorganisms representing a 
random sample from a Poisson distribution; (v) within the host, the survival of any 
microorganism is independent of the survival of any other microorganism (Haas et al. 2014).  
distribution; (v) within the host, the survival of any microorganism is independent of the survival 
of any other microorganism (Haas et al. 2014).  
 
Because these models are predictive models, we look at the probability of adverse response in the 
host. 𝑃(𝑑) is the probability of adverse response at dose 𝑑, and 𝑘 is the exponential rate 
parameter describing the probability that a single organism can survive and initiate infection in 
the host. 𝑁50 is the median infective dose and 𝛼 is the slope parameter for the beta-Poisson 
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model. The exponential and the beta-Poisson models both have a mechanistic biological basis and 
exhibit linearity at low dose (Haas et al. 2014).   
 
A Cochran-Armitage test of trend was applied to determine whether there was an association 
between increasing dosages and adverse effects (Haas et al. 2014, Neuhäuser and Hothorn 1999). 
Written formally, the Z-statistic is calculated by 
𝑍𝐶𝐴 =
∑ (𝑥𝑖−?̅?)
𝑘
𝑖=1 𝑝𝑖
√?̅?(1−?̅?) ∑ 𝑛𝑖(𝑥𝑖−?̅?)2
𝑘
𝑖=1
                                                   Eq. 7.3 
where  
?̅? =
∑ 𝑛𝑖𝑥𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
  and ?̅? =
∑ 𝑝𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
                                                  Eq. 7.4 
with 𝑛𝑖 total subjects and 𝑝𝑖 positive subjects. The null hypothesis of lack of trend is rejected if 
𝑍𝐶𝐴 is above the upper 5
th percentile of the normal distribution, which is 1.64 for a one-tailed test.  
 
If such an association is determined, the data can be modeled. A code written in R programming 
language (www.r-project.org) minimized the deviance (𝑌) of each of these model fits: 
𝑌 = −2 ∑ [𝑝𝑖𝑙𝑛
𝜋𝑖
𝜋𝑖
0 + (𝑛𝑖 − 𝑝𝑖)𝑙𝑛
1−𝜋𝑖
1−𝜋𝑖
0]
𝑘
𝑖=1                                      Eq. 7.5 
The parameters 𝜋𝑖  and 𝜋𝑖
0 are the predicted and observed responses of 𝑝𝑖 positive subjects within 
𝑛𝑖 number of subjects in the set (Haas et al. 2014). Goodness-of-fit was determined by comparing 
minimized deviance from maximum likelihood estimations (MLE) to the critical 2 distribution. 
The optimized deviance has a 2 distribution with m – n degrees of freedom, where m is the 
number of doses and n is the number of model parameters. The dose-response model is rejected if 
𝑌 >  𝑚−𝑛,0.95
2 , at a 95% confidence level. If, however, both models provide acceptable fits, the 
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beta-Poisson model could be selected as a best-fit model only if the difference in minimized 
deviances between the beta-Poisson and the exponential model was greater than the critical chi-
square value for a single parameter (one degree of freedom). Confidence intervals of the 
parameters for the models were determined via bootstrapping with 10,000 iterations.  
 
7.4.2.2. Dose-response-time models 
These traditional dose-response models were modiﬁed by Huang et al. to incorporate a time 
dependency by including additional parameters of time post inoculation (TPI) (Huang and Haas 
2009). The additional time parameter would quantify the time of onset of an effect presumably 
associated with the kinetics of in-vivo bacterial growth. Huang developed eight separate time-
dependent equations (Huang et al. 2009), and these models were tested to determine if they were 
true cumulative distribution functions (CDFs). The criteria for determining true CDF distributions 
was that they had the following properties: 
3. The function at time zero is zero, and the function at time infinity is one.  
a. 𝐹(𝑡 → 0) = 0 
b. 𝐹(𝑡 → ∞) = 1 
4. The functions are monotonic, which means that for all 𝑎 and b, 𝑤𝑖𝑡ℎ 𝑎 ≤ 𝑏, 𝐹(𝑎) ≤
𝐹(𝑏), and the derivative of the function is greater than or equal to zero for all of time 
(
𝑑𝐹
𝑑𝑡
≥ 0 for all t).  
Of the original 8 models, only 4 were true CDFs, and are presented in Table 7.1. The models that 
were not true CDFs were excluded from the study (Mendenhall et al. 2012).  
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Table 7.1 True CDF time-dependent dose-response models. 
Model Name Expression Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 Eq. 7.6 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 7.7 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 7.8 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 7.9 
 
 
 
 
The TDR models in Table 7.1 were ﬁt to the dose-response data, deviances were optimized, and 
model parameters were determined using maximum likelihood estimation (MLE) in the R 
programming language (www.r-project.org, ver. 3.0.3). The predicted response is 𝜋𝑖, and the 
response for each set based on observations are 𝜋𝑖
°. The likelihood ratio for the incidence 
occurring on the jth day with i dose groups is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1  Eq. 7.10 
where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made, 𝑝𝑖,𝑗 is the number of positive response observed during time 
period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the beginning of time period 𝑗.  The 
corresponding deviance is  
𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1   Eq. 7.11 
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7.4.3. Outbreak model 
The susceptible-infected-recovered (SIR) compartment model was developed by Kermack and 
McKendrick in their seminal papers (Kermack and McKendrick 1927), and has been extensively 
documented since (Anderson and May 1991). A modified SIR model was proposed by Gupta in 
his 1999 thesis (Gupta 1999) and re-derived by the author of this work (Figure 7.1). In this model, 
populations are compartmentalized into groups, with individuals moving through the 
compartments as they become infected. The number of people in the compartments, as well as the 
rates that of transfer are described by a system of differential equations. 
 
 
 
 
Figure 7.1 Modified SIR model proposed by Gupta (Gupta and Haas 2004, Kermack and McKendrick 
1927). 
 
 
In this model, populations are compartmentalized into groups, moving through the compartments 
as they become infected. The number of people in the compartments, as well as the rates that of 
transfer are described by a system of differential equations. The four states in this model are (1) 
the susceptible populations 𝑋(𝑡); (2) latent individuals 𝑌(𝑡) who have been exposed to the 
pathogen and will ultimately become infected; (3) those who become symptomatically ill 𝑍(𝑡); 
and (4) those who have become infected but will remain Asymptomatic 𝐼(𝑡). The force of 
infectivity, 𝛽(𝑡), is the rate of transfer from susceptible to the latent, and 𝑄(𝑡) models the rate of 
newly symptomatic cases. For our purposes, only the symptomatically ill population will be 
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considered, since generally data is only available for these groups through epidemic studies. The 
compartment model then reduces to the following equations: 
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), or 
1
𝑋
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)    Eq. 7.12 
 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡)      Eq. 7.13 
The force of infection 𝛽(t) has units of inverse time, and is a versatile parameter. In the case of a 
rectangular distribution for infectivity, 𝛽(t) would be a constant for the exposure duration. 
However, common source outbreaks are frequently caused by time variable microbial exposures, 
which means that the parameter takes the form of a density distribution, generally of the 
following form: 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)     Eq. 7.14 
 
where 𝛽(t) is the force of infection; b0 is the background infectivity level, which may account for 
any endemic cases in the population; 𝑔(𝑡) is the ratio of susceptible persons ultimately becoming 
infected at time t; and b1 is the scaling factor for increased infectivity above background. Here, 
𝑔(𝑡) is modeled as a probability density function for the exposure case. The density functions in 
this case that we have used are the Weibull, gamma, and lognormal, and uniform, all which are 
standard functions which have historically been used to fit observed epidemic curves. Each of 
these density functions have parameter values that determine the shape and scale of the function. 
Integrating Eq. (7.12) gives: 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
   Eq. 7.15 
The rate of newly ill people at any time t is given by the parameter 𝑄(t). At any time t, the 
instantaneous rate of new illnesses can be obtained by the convolution integral: 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
    Eq. 7.16 
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where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). The function 𝑓 is a 
probability density function (PDF) which has parameters that need to be estimated.  
 
Substituting Eq. 7.15 into Eq. 5.16 we then obtain: 
𝑑𝑍
𝑑𝑡
= ∫ 𝑋0𝛽(𝜏)exp [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 7.17 
where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the CDF corresponding to the PDF 𝑔(𝑡). Since we are 
using the Weibull, gamma, lognormal and uniform PDFs to model 𝑔(𝑡), we necessarily must use 
the corresponding CDFs for 𝐺(𝑡) in each respective case.  
 
Integrating Eq. 7.17 directly, we can solve for the number of symptomatically ill patients per day 
𝑍(𝑡): 
𝑍(𝑡) = ∬ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑     Eq. 7.18 
In Eq. 7.18, the exposure time distribution is represented by the expression 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)], 
while the incubation distribution is represented by the expression 𝑓(𝜑 − 𝜏). The incubation 
distribution that will be used here will be the best-fit time-dose-response equation. 
 
Anderson and May described the number of newly infected persons per unit time in a secondary 
infection as 𝛾(𝑡)𝑥(𝑡)𝑧(𝑡) (Anderson et al. 1992). Here, 𝛾(𝑡) is a new parameter that is dependent 
upon the physical properties of a given outbreak, such as the contact rate and dose that is 
transmitted from one contact to another. The inclusion of the individuals in the asymptomatically 
and symptomatically ill states accounts for the fact that they have the ability to transfer infection 
to other susceptible individuals, given the physical parameter value 𝛾(𝑡).  
 
In the specific case of secondary spread, Eq. 7.18 becomes 
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𝑍(𝑡) = ∬ 𝛾(𝜏)𝑧(𝜏)[𝑥0 + (𝑦0 − 𝑦(𝜏))]𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑
𝑡
0
                          Eq. 7.19 
Recall that 𝑍(𝑡) is the number of individuals who are symptomatically ill at time 𝑡. For this 
expression, there are functions that not present in the common source outbreak: 𝑦(𝜏), the PDF 
which describes the number of latent individuals at time of infection 𝜏; and 𝑧(𝜏), the PDF which 
describes the number of symptomatically ill individuals at the time of infection 𝜏. These 2 PDFs 
along with the parameter 𝛾 are components of the exposure distribution, while  𝑓(𝜑 − 𝜏) is the 
density function for the incubation distribution.  
 
Like in the common source model case, each of the exposure and incubation can be modeled with 
the Weibull, gamma, lognormal or uniform distributions, which are all 2-parameter models. We 
then have seven parameters in Eq. 7.14 to be determined – the contact rate parameters 𝛾, the four 
parameters in the attack distribution, and the two PDF parameters in the incubation distribution. 
In the case of the beta-Poisson model with inverse time dependency, we have eight parameters 
total, as this model contains three parameters, 𝛼, 𝑑, and 𝑗0.  
 
The time-dose-response functions from Table 7.1 cannot be immediately used as incubation 
distributions because they are CDFs. To derive a time dose-response based incubation 
distribution to fit epidemiologic curves, the distributions must be PDFs. To get a PDF from a 
CDF, the derivative must be taken. In the case of the beta-Poisson time dose-response with 
inverse time dependency, we have the following equation:  
𝑅(𝑑, 𝑡) = 1 − [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 7.20 
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𝑅(𝑑, 𝑡) is the probability of adverse effect; α is a fitting parameter; θ is a time parameter; 
𝑗0
𝑡
+ 1 
is the dose that elicits a positive response in 50% of the hosts, after infinite time. Taking the first 
partial derivative with respect to time, we get 
𝑟(𝑑, 𝑡) = −𝛼 [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼−1
×𝑑 (2
1
𝛼 − 1)
𝑗0
𝑡2
                      Eq. 7.21 
However, we want that to make sure that our function is a true PDF. Probability density functions 
satisfy the following conditions: 
1. 𝑓(𝑥) ≥ 0 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑥 
2. ∫ 𝑓(𝑥)𝑑𝑥 = 1
∞
−∞
 
 As time goes to infinity, we want the integral of our distribution to be exactly 1. So, we must 
divide by a certain value that ensures that this is true. As 𝑡 → ∞, the maximum response is 
reached for the time dose-response. Then Eq. 7.20 no longer becomes time-dependent, and we 
refer to the TDR dependency equation in Table 7.1, which assumed that 𝑁50 =
𝑗0
𝑡
+ 1. Plugging 
in 𝑁50 for the expression in the denominator returns us back to the regular beta-Poisson dose-
response model. 
𝑅(𝑑, 𝑡 → ∞) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 7.22 
This expression can be used as the constant for which Eq. 7.21 can be divided. If we divide Eq. 
7.21 by Eq. 7.22, we get the following function: 
𝑓(𝑡|𝑑) =
𝛼[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼−1
×𝑑(2
1
𝛼−1)𝑗0
𝑡2(−1+[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼
)
   Eq. 7.23 
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We now have a proper PDF 𝑓(𝑡|𝑑) that characterizes the distribution. This PDF based on the 
beta-Poisson time dose-response function distribution can now be used as a potential incubation 
distribution 𝑓(𝑡) to use in the probability density function used to calculate the number of ill, 
Z(t). The functions used to model the exposure distributions include the Weibull, gamma, 
lognormal and uniform distributions, and the best-fit time-dose-response model will be used as 
the incubation distribution. 
 
To compare the results of the outbreak models, deviance, Akaike information criterion (AIC) and 
Bayesian information criterion (BIC) values are examined: 
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 7.24 
𝐴𝐼𝐶 = 2𝑘 − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]                   Eq. 7.25 
𝐵𝐼𝐶 = 𝑘 ∗ 𝑙𝑛(𝑛) − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]           Eq. 7.26 
The parameters 𝜃?̂? are the values of the full model (observed values), and 𝜃0̂ are the values of the 
predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and thus we can see that 
the AIC and BIC is the deviance plus a complexity parameter. BIC penalizes model complexity 
more than AIC does (Ruppert 2011). The outbreak model with the lowest deviance, AIC and BIC 
are the best-fit. Since some TDR models have extra parameters, they will have higher AIC and 
BIC values. 
 
It is noted that the parameter values of 𝛼, 𝑑, and 𝑗0 values from the outbreak were used as initial 
guesses for those parameters of the incubation distribution in the optimization routine. In order to 
compare the parameters in the epidemic and dosing parameter studies to see if the differences 
between corresponding parameters were significant, the two-sample Kolmogorov–Smirnov (KS) 
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test and the Anderson–Darling (AD) test were utilized. In both tests, we wanted to see if the 
parameters came from the same distribution. The KS test states that 𝐷∗ =
𝑠𝑢𝑝
𝑥
| 𝐹1(𝑥) − 𝐹2(𝑥)|, 
where 𝐹1(𝑥) and 𝐹2(𝑥) are the empirical distribution functions of the two samples respectively, 
and 𝑠𝑢𝑝 is the supremum function (Sheskin 2003). The null hypothesis is rejected if the following 
equation holds true: 𝐷∗ > 𝑐(𝛼)√
𝑛+𝑛1
𝑛𝑛1
. For 𝛼 = 0.05, 𝑐(𝛼) = 1.36. The AD is a refinement of the 
KS test. The statistic that was used was of the form 
𝐴2 = −𝑛 − ∑
2𝑖−1
𝑛
[ln(Φ(𝑌𝑖)) + ln(1 − Φ(𝑌𝑛+1−𝑖))]
𝑛
𝑖=1  (D’Agostino et al. 1986). The parameter 
𝑛 is the number of data points in the sample, and the test statistic measures the distance between 
the hypothesized and empirical. The null hypothesis of normality is rejected if A2 exceeds 0.752 
for α = 0.05. 
 
7.5. Results and discussion 
7.5.1. Dose-response  
A study performed by Pai et al. (1986) was found to meet the inclusion criteria for the time-
dependent dose-response models. The authors exposed graded doses of E. coli O157:H7 to infant 
rabbits intragastrically with 1.0 ml of bacterial suspension through a catheter tube passed into the 
stomach through the mouth in order to determine illness rates. The strains were obtained from 
clinical isolates in the U.S. The rabbits were 3 days old, and were administered dosages between 
105 to 1010 CFU. Of the mice that received 105 and 106 CFUs, 33% and 40% had diarrhea, 
respectively. The adverse reaction rates for the remaining groups were 92% or 100% (Table 7.2). 
The incubation period was longer for the smaller inoculum doses, in that it took longer for 
symptoms to manifest in the host.  
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Table 7.2 Cumulative infection percentages of rabbits exposed to E. coli O157:H7 via oral exposure (Pai et 
al. 1986). 
 Day  
Dose (CFU) 1 2 3 4 5 6 10 
Total 
percentage 
𝟏𝟎𝟓 0 0 33 33 33 33 33 33 
𝟏𝟎𝟔 0 0 20 20 20 20 40 40 
𝟏𝟎𝟕 0 20 40 100 100 100 100 100 
𝟏𝟎𝟖 38 38 46 54 85 92 92 92 
𝟏𝟎𝟗 40 60 10 100 100 100 100 100 
𝟑𝒙𝟏𝟎𝟗 10 10 10 100 100 100 100 100 
𝟏𝟎𝟏𝟎 10 10 10 100 100 100 100 100 
 
   
 
Haas et al. (2000) modeled the same E. coli O157:H7 Pai et al. (1986) dataset using the 
traditional dose-response models. The parameters and deviance from those models were 
reproduced in this work. The survival data in Table 7.2 was fitted to the non-time-dependent 
dose-response models using MLE, and is summarized in Table 7.3.  
 
Table 7.3 Non-time-dependent dose-response modeling results for E. coli O157:H7 inoculation.  
Model 
Parameter 
Deviance dfa 𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 Conclusions Best fit modelc 
type value 
Expd k 7.33×10−7 64.1 6 12.59 
BP provides 
acceptable fit 
Beta-Poisson 
BPe 
α 0.49 
3.12 5 11.07 
N50 5.97×105 
a df - degrees of freedom for dataset and model 
b  critical values of the chi-squared distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, 
m is the number of doses, n is the number of parameters 
c Best fit model criteria - the lowest deviance of candidate models was chosen compared to the critical values of chi-
squared distribution  
d Exponential Model 
e beta-Poisson Model 
 
 
 
The beta-Poisson model is the only one to have deviance values less than the critical 𝜒2values 
(Exp: dev=64.1, 𝜒0.95,𝑑𝑓
2 = 12.59; BP: dev=3.12, 𝜒0.95,𝑑𝑓
2 = 11.07). Therefore, the beta-Poisson 
is the best-fitting mechanistic model here.  Figures 7.2 plots both dose-response models. Figure 
7.3 plots best-fit bootstrapped beta-Poisson model with bootstrapped confidence intervals. 
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Figure 7.2 Dose-response data by Pai et al. (1986) on CFUs administered to rabbits via the oral route 
generated into predictive exponential and beta-Poisson model results. The best-fitting mechanistic model 
was the exponential (𝐍𝟓𝟎 = 𝟓. 𝟗𝟕×𝟏𝟎
𝟓, α =0.49; 𝛘𝟐 = 𝟑. 𝟏𝟐). 
 
 
 
 
Figure 7.3 Dose-response data and best-fit bootstrapped exponential model with confidence intervals for 
CFUs administered to rabbits via the oral route (Table 7.2), along with the frequency diagram of beta-
Poisson model parameters 𝐍𝟓𝟎 and α.  
 
199 
 
 
 
EHEC is unethical to test on human subjects because of its severity, so infective dose values for 
O157:H7 is difficult to find, but is cited to be 10-100 CFUs (Food and Drug Administration 
2012). However, several animal studies have been performed. Cornick and Helgerson found the 
infectious dose of O157:H7 for 3 and 4-month-old pigs to be approximately 6×103 CFU 
(Cornick and Helgerson 2004). Infectious doses for calves was similar, at 5×103 to 9 ×103 CFU 
(Besser et al. 2001). In the cases of mature cattle, doses were much higher, on the order of 107 
CFUs (Cray and Moon 1995), while the infectious dose for sheep was 105 CFU (Cornick et al. 
2000). The lowest infectious dose in the Pai et al. dataset is 105 CFUs, which makes a third of the 
rabbits ill; through extrapolation, it can be deduced that the lowest infectious dose would be much 
lower than 105 CFUs. Kothary and Babu reviewed infective dose values in human volunteers 
from 24 separate EPEC, ETEC, and EHEC experiments administered orally with milk, 
bicarbonate or meals. The infectious dose range was found to be between 108 and 1010 CFUs 
(Kothary and Babu 2001), which is eight orders of magnitude greater than the O157:H7 infective 
dose of 10-100 CFUs (Food and Drug Administration 2012). Therefore, only species-specific 
values can be compared with each other.  
 
Estimates for LD50 values were calculated from the traditional dose-response models. The 
infectious dose LD50 (the number of organisms needed to infect 50% of individuals) at the lower 
bound of the 95th percentile confidence interval was determined to be  6.31×104 CFUs, and  
2.63×106 CFUs at the upper bound. Teunis et al. (2004) generated dose-response curves for E. 
coli O157:H7 based on an outbreak that occurred in Japan in September 1996. The LD50 values 
from those models were between 3 ×103 CFUs, and 6×105, which are one order of magnitude 
below the LD50 values generated in this model, but still comparable. 
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7.5.2. Time-Dose-Response  
The time-dose-response models in Table 7.1 were ﬁtted to the survival data using MLE. The 
parameter estimates and the minimized deviances are summarized in Table 7.4.  
 
 
 
Table 7.4 Time-dose-response (TDR) modeling results for E. coli O157:H7 inoculation  
Time Dependence Model 
Best fit 
parameters 
AIC 
Minimized 
deviance 
2
,05.0 df  Acceptable fit 
Beta-Poisson model with 
exponential time 
dependency 
α = 2.80 
62.3 56.3 62.8 Yes j0 = -0.14 
j1 = 12.41 
Beta-Poisson model with 
exponential-reciprocal 
time dependency 
α = 0.24 
56.8 50.8 62.8 Yes j0 = -5.31 
j1 = 14.19 
Beta-Poisson model with 
inverse time dependency 
α = 0.30 
61.9 57.9 64.0 Yes 
j0 = 2.1x103 
Exponential model with 
exponential-reciprocal 
time dependency 
k0 = 2.27x10-9 109.3 107.3 65.2 No 
 
 
The 3-parameter beta-Poisson with exponential reciprocal time dependency was found to be the 
best-fit model for the time-dependent data, with a minimized deviance value of 50.8, less than the 
critical chi-square value at its degree of freedom (χ0.95,df
2 ), of 62.8. It provided the lowest 
deviance, and gave a statistically signiﬁcant improvement in ﬁt over the other models. Two other 
models provided acceptable fits as well – the beta-Poisson model with exponential time 
dependency (χ2 = 56.3) and beta-Poisson model with inverse time dependency (χ2 = 57.9). The 
1-parameter exponential model with exponential-reciprocal time dependency gave a fitting that 
was not acceptable, with a minimized deviance of 107.3, which was less than the critical chi-
square value at its degree of freedom (χ0.95,df
2 ), of 56.9. The AIC accounts for the additional 
parameters, but despite the total of 3 parameters, the AIC of the beta-Poisson model with 
exponential-reciprocal time dependency is still model with the best fit. This model was therefore 
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chosen as the time-dependent model to fit the incubation distribution of the E. coli O157:H7 
outbreaks. Figure 7.4 plots the fitted data points.  
 
 
 
Figure 7.4 Daily cumulative response data fitted by the best-fit time-dose-response model, the beta-Poisson 
model with exponential-reciprocal.  
 
 
7.5.3. Outbreak model 
Two datasets were chosen for the outbreak models. The first study was the December 
1989/January 1990 outbreak in a rural Missouri township documented by Swerdlow et al (1992). 
In this outbreak, E. coli O157:H7 was confirmed in 243 people who visited Cabool, MO and 
drank the municipal water. This was the largest outbreak of E. coli O157:H7, and was transmitted 
through water. The outbreak was likely caused by sewage contamination of the water distribution 
system, either due to backflow in two water main breaks, or through a single slow-flow of water 
that contained high levels of the pathogen.  
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A persom-to-person outbreak occurred in a Nebraska nursing home in September 1985, when an 
outbreak of E. coli O157:H7 enteritis sickened 55 of 169 residents and 18 of 137 staff members 
(Carter et al. 1987). The outbreak consisted of a primary wave that was associated with a 
contaminated sandwich, and a secondary wave from person-to-person transmission.  This 
outbreak caused a high level of morbidity and mortality: 12 residents (22%) developed HUS, and 
11 of these HUS patients (92%) died. In total, nineteen (35%) symptomatically ill patients died. 
Here, we focus on the secondary wave, in which 8 of the 55 residents and 11 of the 18 staff 
members became symptomatically ill. The authors concluded that the secondary wave of 
pathogen spread was likely transmitted from residents to staff members, and then from 
contaminated staff back to the residents. Among staff members, the average duration of diarrhea 
was 6 days, with a median of 7 days and a range between 1 and 15 days.   
 
Since the beta-Poisson with exponential reciprocal time dependency was the best-fit TDR model, 
this was the time dependent kinetic model that was chosen to be used in the incubation function. 
The static Weibull, gamma, lognormal and uniform distributions were also generated for 
comparison. To determine which distribution convolution fit the data best, deviance, AIC and 
BIC output were compared. Table 7.5 presents the results of the model fit to the primary Missouri 
waterborne outbreak. 
  
  
 
 
Table 7.5 Parameter and criteria values for the E. coli primary outbreak model. 
  Model Parameters  Criteria Values 
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
param 
b1 
Expos 
dist 
PDF 
param 1 
Expos 
dist 
PDF 
param 2 
Incub dist 
PDF param 
1 
Incub 
dist 
PDF 
param 2 
Incub dist 
PDF param 
3 
Incub 
dist 
PDF 
param 4 
Dev AIC BIC 
Weibull 
Weibull 3.60×10−3 0.232 20.5a 4.44b 0.864a 1.09b n/a n/a 25.91 37.91 42.55 
Gamma 3.68×10−3 0.239 20.7a 4.55b 0.665c 1.19d n/a n/a 25.93 37.93 42.57 
Lognormal 7.60×10−3 0.133 16.2a 48.2b 1.04e 0.817f n/a n/a 17.48 29.48 34.12 
Uniform 3.37×10−3 0.238 20.5a 4.34b 2.84×10−2g 1.69h n/a n/a 25.36 37.36 42.00 
BP exp recip 9.20×10−3 1.34 24.2a 4.66b 2.30i 1.17j 5.43×10−2 k 1.24l 26.03 42.03 48.21 
Gamma 
Weibull 7.31×10−3 0.141 16.4c 0.112d 4.16a 1.21b n/a n/a 17.13 29.13 33.77 
Gamma 5.75×10−3 0.165 18.1c 11.7d 1.85c 0.336d n/a n/a 25.14 37.14 41.78 
Lognormal 7.41×10−3 0.143 16.4c 0.452d 0.952e 0.955f n/a n/a 17.67 29.67 34.31 
Uniform 6.76×10−3 0.146 17.2c 9.95d 1.57h 3.77h n/a n/a 25.35 37.35 41.99 
BP exp recip 1.33×10−2 5.91 33.3c 126.0d 1.59i 0.999 j 9.18×10−3 k 1.02l 26.16 42.16 48.34 
Lognormal 
Weibull 6.29×10−3 0.148 2.89e 0.114f 1.33a 0.736b n/a n/a 24.17 36.17 40.81 
Gamma 6.50×10−3 0.207 2.96e 0.167f 0.580c 1.66d n/a n/a 25.94 37.94 42.58 
Lognormal 8.89×10−3 0.237 2.91e 0.110f 1.48×10−3e 4.16f n/a n/a 24.05 36.05 40.69 
Uniform 5.06×10−8 0.462 2.45e 0.991f 1.02×10−3g 18.3h n/a n/a 35.94 47.94 52.58 
BP exp recip 7.10×10−3 0.267 3.00e 0.191f 3.15i 0.024j 1.10×10−3 k 0.615l 26.93 42.93 49.11 
Uniform 
Weibull 5.61×10−3 0.184 9.75g 21.4h 4.34a 1.24b n/a n/a 28.76 40.76 45.40 
Gamma 4.98×10−3 0.201 9.04g 23.2h 3.27c 6.09d n/a n/a 30.74 42.74 47.38 
Lognormal 4.40×10−3 0.225 9.05g 25.4h 0.460e 1.06f n/a n/a 32.78 44.78 49.42 
Uniform 6.54×10−3 0.162 9.39g 20.3h 0.856g 8.55h n/a n/a 27.66 39.66 44.30 
BP exp recip 1.82×10−2 1.01 15.4g 28.6h 0.442i 0.198j 7.09×10−2k 0.452l 23.92 39.92 46.10 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1
2
0
3
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Based on the criteria values from Table 7.5, the models with the lowest deviance for each of the 
distributions were as follows: the gamma-Weibull (deviance = 17.13), the Weibull-lognormal 
(deviance = 17.48); the gamma-lognormal (deviance = 17.67); and the uniform-BP with exp-recip 
time dep (deviance = 23.92). The non-time-dependent distributions fit the outbreak dataset 
sufficiently well, while the time-dependent models performed moderately well. Although the 
uniform-BP with exp-recip time dep exposure/incubation convolution has the fourth lowest 
deviance, it has the benefit of having 2 additional parameter in the model, with 8 total parameters. 
The distributions that gave well was the poorest fits were the lognormal-uniform (deviance = 
35.94), and the uniform-lognormal (deviance = 32.78), followed by the uniform-gamma 
(deviance = 30.74) and uniform-uniform (deviance = 27.66). 
 
The criteria values are consistent with a visual inspection, as seen in Figure 7.5. All of the fits 
were distinct from one another close to one another. Each graph is grouped by their incubation 
distribution: Weibull, gamma, lognormal, uniform and time-post-inoculation models, specifically 
in this case the beta-Poisson model with exponential reciprocal time dependency. The observed 
outbreak data (number ill) are represented as point values and the predicted values of the models 
as the curve fit. The abscissa is time in days, and the ordinate is the number of cases reported.  
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Figure 7.5 Model fits for the E. coli O157:H7 primary outbreak. The gamma, lognormal, uniform, and 
Weibull exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, and beta-
Poisson with reciprocal incubation distributions for a total of 20 data fits. Each graph groups the respective 
incubation periods with the corresponding exposure distributions. The abscissa is time of symptom onset in 
days, and the ordinate is the number of cases reported. 
 
  
 
206 
 
 
 
The Nebraska nursing home outbreak was similarly modeled with the beta-Poisson exponential-
reciprocal time model. Additionally, Weibull, gamma, lognormal and uniform distributions were 
used. 
 
Table 7.6 summarizes the criteria values of the secondary wave in the nursing home outbreak. 
Here, the Weibull-BP with exponential-reciprocal time dependency exposure/incubation 
convolution has the lowest deviance at 16.59. The others that fit the dataset best were: lognormal-
lognormal (deviance=18.19); gamma-BP with exponential-reciprocal time dependency 
(deviance=18.30); uniform-Weibull (deviance=18.78). Again, due to the additional 2-parameters 
of the TDR model, the AIC and BIC are slightly larger than they are in the non-TDR models. If 
using the AIC and BIC as metrics for best fit, the lognormal-lognormal performed best 
(AIC=30.19; BIC=34.83). Here, the uniform-uniform distribution has the poorest fit for all cases, 
at 19.88, followed by the lognormal-uniform distribution (deviance=19.74); gamma-Weibull 
(deviance=19.71); Weibull-uniform (deviance=19.58). Figure 7.6 plots the observed cumulative 
number ill as point values and the predicted values of the model as the curve fit.  
 
In Tables 7.5 and 7.6, the first and second column are the results for the 𝑏0 and 𝑏1 attack rate 
values. There is a trend for attack parameter 𝑏0 to be small, indicating that there is a low baseline 
level of this disease in the population before the outbreak. The third and fourth columns are 
referred to as “Exposure Distribution PDF param 1” and “Exposure Distribution PDF param 2,” 
which correspond to the respective exposure distributions. For the gamma exposure distribution, 
PDF Param 1 and 2 are the mean and variance. In the lognormal distributions, PDF Param 1 and 
PDF Param 2 are the log transform of the mean and variance. In the Weibull distribution, PDF 
Param 1 and PDF Param 2 refer to the scale parameter a, and shape parameter b in the probability 
distribution function. The uniform distribution refers to parameters a and b in the PDF, with a 
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being a lower endpoint (minimum) and b being an upper endpoint (maximum), respectively.  The 
remaining columns correspond to the respective incubation distributions, and follow the same 
pattern as described previously. For the beta-Poisson with exponential-reciprocal time 
dependency, Parameters 3, 4, 5 and 6 refer to 𝛼, 𝑗0, 𝑗1, and 𝑑, respectively. The gamma exposure 
distribution gives a mean 𝜇 range of 11-14 days. This is on the higher end of the assumed 
incubation distribution of 2-10 days.  
 
 
 
  
  
 
 
Table 7.6 Parameter and criteria values for the E. coli secondary outbreak model. 
  Model Parameters  Criteria Values 
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
param 
b1 
Expos 
dist 
PDF 
param 1 
Expos dist 
PDF param 
2 
Incub dist 
PDF param 
1 
Incub 
dist 
PDF 
param 2 
Incub dist 
PDF param 
3 
Incub 
dist 
PDF 
param 4 
Dev AIC BIC 
Weibull 
Weibull 1.56×10−3 0.134 18.9a 1.83b 1.40a 1.47b n/a n/a 19.34 31.34 35.98 
Gamma 7.20×10−4 0.169 20.5a 1.75b 0.980c 0.566d n/a n/a 19.35 31.35 35.99 
Lognormal 3.41×10−3 8.69×10−2 12.3a 2.06b 0.959e 1.41f n/a n/a 19.17 31.17 35.81 
Uniform 2.51×10−3 9.44×10−2 17.7a 2.17b 3.00×1015g 1.93h n/a n/a 19.58 31.58 36.22 
BP exp recip 2.53×10−2 0.120 9.99a 34.1b 9.98×10−2i 0.293j 1.62×10−2k 1.24l 16.59 32.59 38.77 
Gamma 
Weibull 3.44×10−3 6.30×10−2 14.0c 32.4d 0.894a 1.13b n/a n/a 19.71 31.71 36.35 
Gamma 3.30×10−3 6.97×10−2 14.5c 37.5d 0.918c 1.09d n/a n/a 19.36 31.36 36.00 
Lognormal 3.82×10−3 6.14×10−3 11.3c 25.4d 0.715e 1.10f n/a n/a 19.05 31.05 35.69 
Uniform 4.26×10−3 4.08×10−3 11.4c 22.9d 0.820h 4.08h n/a n/a 19.49 31.49 36.13 
BP exp recip 2.86×10−2 0.119 9.79c 1.10d 9.04×10−2i 0.337j 8.42×10−2 k 0.454l 18.30 34.30 40.48 
Lognormal 
Weibull 2.05×10−3 0.125 2.83e 0.645f 0.804a 1.46b n/a n/a 18.85 30.85 35.49 
Gamma 1.68×10−3 0.159 2.95e 0.747f 0.757c 1.32d n/a n/a 18.80 30.80 35.44 
Lognormal 4.08×10−3 6.86×10−2 2.35e 0.433f 0.862e 1.46f n/a n/a 18.19 30.19 34.83 
Uniform 2.08×10−3 0.163 3.03e 0.957f 1.65×10−2g 3.40h n/a n/a 19.74 31.74 36.38 
BP exp recip 5.31×10−2 0.159 13.5e 2.81×10−2f 6.53×10−2i 0.465j 9.23×10−4k 1.57l 19.40 35.40 41.58 
Uniform 
Weibull 4.31×10−3 3.91×10−2 7.08g 18.8h 2.22a 1.88b n/a n/a 18.78 30.78 35.42 
Gamma 3.89×10−3 7.02×10−2 5.11g 19.7h 3.00c 34.1d n/a n/a 19.49 31.49 36.13 
Lognormal 4.95×10−3 3.76×10−2 5.26g 11.4h 0.850e 1.42f n/a n/a 18.86 30.86 35.50 
Uniform 4.19×10−3 4.32×10−2 4.80g 18.8h 0.857g 5.40h n/a n/a 19.88 31.88 36.52 
BP exp recip 3.19×10−2 0.151 4.40g 20.1h 8.82×10−2 i 0.382j 1.34×10−2k 0.58l 19.06 35.06 41.24 
 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1 
2
0
8
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Figure 7.6 Model fits for the E. coli O157:H7 secondary outbreak. The gamma, lognormal, uniform, and 
Weibull exposure functions are convoluted with the gamma, lognormal, uniform, Weibull, and beta-
Poisson with reciprocal incubation distributions for a total of 20 data fits. Each graph groups the respective 
incubation periods with the corresponding exposure distributions. The abscissa is time of symptom onset in 
days, and the ordinate is cumulative number of cases reported. 
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7.6. Conclusion 
This study incorporated a TDR model into the incubation distribution and convoluted it with an 
exposure distribution. Dose-response and TDR models were generated for E. coli O157:H7 
exposure to rabbits via the oral route, and the TDR model was subsequently incorporated into the 
incubation period of primary and secondary wave outbreaks in order to capture the in vivo 
dynamics between pathogen and host. In the dose-response model, the median infectious dose 
was estimated to be 5.97×105 CFUs, and the best-fit TDR model was the beta-Poisson with 
exponential reciprocal dependency, which had a minimized deviance of 56.8. This TDR model 
was chosen to be incorporated into two E. coli outbreak models: a primary outbreak that occurred 
in a rural Missouri township due to a contaminated municipal water system, and a secondary 
spread that occurred in a Nebraska nursing home. In the Missouri outbreak, the convolution of the 
gamma-Weibull was the best-fit for the model, with a minimized deviance value of 17.13. In the 
case of the secondary nursing home outbreak, the Weibull-beta-Poisson with exponential-
reciprocal time dependency distribution performed the best, with a minimized deviance value of 
16.59. This work suggests that the incorporation of a time factor into outbreak models may 
provide an approach to modelling that adequately describes realistic in vivo dynamics of the host-
pathogen system.  
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Chapter 8: Campylobacter jejuni7 
 
8.1. Abstract 
A study that integrates in vivo host-pathogen dynamics into an outbreak of Campylobacter jejuni 
was performed. Traditional non-time-dependent dose-response and time-dose-response models 
were generated for C. jejuni exposure to chickens via the oral route using a maximum likelihood 
estimation approach. A dose-response exponential model fit the chicken data set best, and the 
best-fit time-dose-response (TDR) model was found to be the beta-Poisson with exponential time 
dependency model, which had a minimized deviance 44.3. This TDR and other non-time-
dependent probability distribution functions (PDF) were fit to an outbreak that occurred at an 
army obstacle course in Finland. The best-fit outbreak PDF was the convolution of the Weibull-
beta-Poisson with exponential time, which had a minimized deviance value of 0.94 This time-
dependent distribution was tested against other incubation distributions in the Finland outbreak, 
and outperformed them. This work shows that the incorporation of a time factor provides 
acceptable fits to modelling pathogen outbreaks.  
 
8.2. Keywords 
Campylobacter jejuni, mathematical epidemiology, time-dose-response 
 
  
                                                          
 
7 This chapter is currently under review at Risk Analysis. 
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8.3. Introduction 
Campylobacter bacteria are spiral, motile, non–spore-forming, Gram-negative rods (Garrity et al. 
2006), and are the causative agents of campylobacteriosis, a disease of varying intensities 
characterized by gastroenteritis. Symptoms include loose bloody stools, abdominal pain, malaise, 
fever, nausea and vomiting (Heymann 2008, Ketley and Konkel 2005). Less commonly, exposure 
to Campylobacter spp. is also responsible for triggering disorders such as Guillain-Barré 
syndrome (GBS) (Allos 1997, Rees et al. 1995), an autoimmune disease that inflames the 
peripheral nerves (Pithadia and Kakadia 2010), and has an incidence rate of 1 in 1000 patients 
following Campylobacter infection (Allos 1997). The incubation period following exposure is 1-3 
days with a range from 18 hours to 8 days (Blaser and Engberg 2008). Gastroenteritis generally 
persists for 6 days, although prolonged illnesses may occur (Man 2011). Unless treated with 
antibiotics, infected persons will continue to excrete the bacteria in their feces for several weeks 
after symptoms no longer persist (Blaser and Engberg 2008). While ill persons generally will 
recover, approximately 100 people in the United States (U.S.) die each year from complications 
(Heymann 2008). Persons with AIDS are at increased risk of acquiring Campylobacter infections 
(Angulo and Swerdlow 1995). Of the 17 species and 6 subspecies (Silva et al. 2011), C. jejuni 
(and to a much lesser extent C. coli), account for 90% of all reported cases (Wagenaar et al. 
2015). 
 
Campylobacteriosis is one of the most widespread and commonly reported infectious diseases of 
the last century (Kaakoush et al. 2015). However, monitoring of campylobacteriosis is largely 
limited to developed countries, and varying reports make it difficult to estimate the number of 
symptomatically ill patients worldwide. A United Kingdom (U.K.) study listed Campylobacter as 
the most common agent in gastroenteritis cases in the country; the illness rate was 9.3 cases per 
1,000 person-years, with an estimated total of 500,000 cases annually (Tam et al. 2012). In the 
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U.S., the National Outbreak Reporting System reported 56 confirmed and 13 suspected outbreaks, 
causing 1,550 illnesses and 52 hospitalized cases between 2009 and 2010 (Hall 2013). Batz et al. 
(2012) estimates the annual number of food-acquired campylobacteriosis cases to be 845,024 
cases, resulting in 8,463 hospitalizations and 76 deaths based on outbreak data and expert 
elicitation. Other studies estimated the number of campylobacteriosis cases to be 1.3 million in 
the U.S. in 2011 (Scallan et al. 2011), and 9.2 million in the European Union in 2009 (Havelaar et 
al. 2013, Wagenaar et al. 2014). Reportable campylobacteriosis incidents increased 14% in 2012 
from 2006, while the reports of other common gastro-pathogens such as Cryptosporidium, 
Listeria, Salmonella, Shigella, Shiga-toxigenic Escherichia coli (STEC) O157, and Yersinia 
infections decreased over the same period (CDC 2013a).  
 
The epidemiology of Campylobacter infection in developed countries is notably different than 
that of the developing world (Kaakoush et al. 2015). In developed countries, Campylobacter 
illnesses are sporadic, having seasonal variability and low numbers of asymptomatic ill patients 
(Olson et al. 2008). Campylobacter spp. are generally contracted through ingestion of 
contaminated food and water, or through contact with infected pets and farm animals (Domingues 
et al. 2012). Undercooked or raw meat (Lee 2016), particularly poultry (Bryan and Doyle 1995, 
Corry and Atabay 2001, Harris et al. 1986, Skarp et al. 2016), is recognized as a primary source 
of food-acquired Campylobacter. An estimated 71% of Swiss campylobacteriosis cases between 
2001 and 2012 were attributed to chicken consumption (Wei et al. 2015). Cases due to raw milk 
ingestion (Davis 2016, Korlath et al. 1985, Peterson 2003) has increased in recent years. Animal 
reservoirs for the pathogen are frequently live poultry and cattle (Boysen et al. 2014, Stanley and 
Jones 2003, Wesley et al. 2000), as well as pets such as dogs (Chaban et al. 2010, Gras et al. 
2013, Skirrow 1981), cats (Baker et al. 1999, Shen et al. 2001), and birds (Mohan 2015). 
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Campylobacter may also be found in untreated water sources (Brown and McDermott 1982, 
Clark et al. 2003, Mughini-Gras et al. 2016, Rogol et al. 1983) contaminated with animal feces.  
 
Outbreak data from developing nations, however, are scarce. Campylobacteriosis has a lower 
incidence and seasonality is likely absent. The disease is often endemic in the population, with 
asymptomatic infections being common (Platts-Mills et al. 2014). Campylobacter are discovered 
to be the causative agent in gastroenteritis 3-4 times more frequently than Salmonella or E. coli 
(Olson et al. 2008). A study that monitored patients in a Kolkata hospital reported that 16% of 
diarrhea stool samples were positive for Campylobacter (Sinha et al. 2013). Campylobacter is 
most prevalent among children under the age of 5 in this region, and is isolated in 10% of 
diarrheal cases (Mukherjee et al. 2013). This is significant because diarrhea is the second leading 
cause of death in children less than 5 years old, resulting in 1.336 million child deaths annually; 
of these, 18% of these deaths occur in India (Black et al. 2010). Platt-Mills et al. reported that in 
138 Tanzanian children, C. jejuni and C. coli were detected in 34.8% of gastroenteritis cases and 
30.4% of controls, while and other Campylobacter species were found in 47.8% of gastroenteritis 
cases and 42.0% of controls (Platts-Mills et al. 2014). Campylobacter diarrhea is less commonly 
reported in adults (Platts-Mills et al. 2014). Serological studies suggest that since most 
individuals are exposed to the organism by 20 years of age (Ang et al. 2011, Wagenaar et al. 
2014), this can lead to protective immunity, which may the cause of the low reportable numbers 
despite regular exposure (Havelaar et al. 2013, Wagenaar et al. 2014).  
 
Although Campylobacter has been responsible for millions of cases in the past decade, few 
outbreak models have been generated for the pathogen. The time-dose-response (TDR) modeling 
methodology, which quantifies a relationship between pathogen kinetics and host response 
through the time to infection, provides the means in which data from dosing studies can be 
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incorporated into the outbreak model (Huang et al. 2009, Huang and Haas 2009, 2011). Infection 
is a time-dependent process, yet no outbreak model has ever considered the effects of in-vivo 
kinetics of this pathogen on hosts. Models that consider host-pathogen kinetics have provided 
robust fits to outbreak data in the case of Legionella (Prasad et al. 2016), but a TDR analysis has 
not yet been generated for Campylobacter, nor has a dosing study-based incubation distribution 
been incorporated into an outbreak model. The purpose of this study is to determine the best-fit 
TDR model for C. jejuni, and to incorporate this model into the incubation distribution of an 
outbreak model. 
 
8.4. Materials and methods 
8.4.1. Datasets for time-dose-response and outbreak models 
8.4.1.1. Dose-response datasets 
A thorough search for available dose-response data in the published literature was conducted to 
identify appropriate candidate models for C. jejuni. The inclusion criteria for choosing the time-
dose-response model was that article included: (i) a clear description of dosing methods; (ii) 
reported mode of exposure; (iii) the administered dose to each subject; (iv) the number of subjects 
that experienced adverse effects on each respective day; (v) stated criteria used to define a 
positive endpoint; (vi) detailed descriptions of the pathogen (i.e. source and strain); (vii) at least 
one observation where a fraction of the dosing groups is infected (0 < 𝑝 < 1); and (viii) the 
time-to-adverse response for each individual subject (Haas 1999).  
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8.4.1.2. Outbreak datasets 
The inclusion criteria for selecting an appropriate outbreak for the C. jejuni outbreak model 
included: (i) that the size of population susceptible to infection was known or could be estimated; 
(ii) members of this susceptible population who became symptomatically ill were confirmed 
cases; (iii) the beginning and end of the pathogen contamination is known; (iv) there is incubation 
data for the pathogen; (v) the outbreak occurred over a defined period of time; (vi) the exposure 
period is short compared to the length of the outbreak; (vii) each confirmed case comes from the 
original source and there is no secondary spread of disease; or, if there is some secondary spread, 
there is a clear distinction between the primary and secondary spread; and that (viii) all outbreak 
cases that are identified have the same case definition. 
 
8.4.2. Dose-response models 
8.4.2.1. Non-time-dependent dose-response models 
The dosing study dataset was initially modeled using traditional dose response analysis widely 
used in quantitative microbial risk assessment (QMRA), which only considers extent of response 
and not time of occurrence (Haas et al. 2014). Traditional dose-response predicts the probability 
of adverse effects, such as illness or death, from the infection of a given dose (Haas et al. 2014). 
Dose-response equations are usually expressed mathematically, often in the form of an 
exponential or beta-Poisson model (Haas et al. 2014) (Table 8.1). 
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Table 8.1 Exponential and beta-Poisson dose-response models. 
Model Expression Eq’n number 
Exponential 𝑃(𝑑) = 1 − 𝑒−𝑘𝑑 8.1 
Beta-Poisson 𝑃(𝑑) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
 8.2 
 
 
These expressions assume that (1) the host ingests one or more organisms capable of causing an 
adverse response; and (2) that only a fraction of these pathogens reach a site of infection. Because 
these models are predictive models, we look at the probability of adverse response in the host. 
P(d) is the probability of response at dose d, and k is the exponential rate parameter describing the 
probability that a single organism can survive and initiate infection in the host. 𝑁50 is the median 
infective dose and 𝛼 is the slope parameter for the beta-Poisson model. The exponential model 
and the beta-Poisson model both have a mechanistic biological basis and exhibit linearity at low 
dose (Haas et al. 2014).   
 
A Cochran-Armitage test of trend was applied to determine whether there was an association 
between increasing dosages and adverse effects (Haas et al. 2014, Neuhäuser and Hothorn 1999). 
Written formally, the Z-statistic is calculated by 
𝑍𝐶𝐴 =
∑ (𝑥𝑖−?̅?)
𝑘
𝑖=1 𝑝𝑖
√?̅?(1−?̅?) ∑ 𝑛𝑖(𝑥𝑖−?̅?)2
𝑘
𝑖=1
                                                   Eq. 8.3 
where  
?̅? =
∑ 𝑛𝑖𝑥𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
  and ?̅? =
∑ 𝑝𝑖
𝑘
𝑖=1
∑ 𝑛𝑖
𝑘
𝑖=1
                                                  Eq. 8.4 
with 𝑛𝑖 total subjects and 𝑝𝑖 positive subjects. The null hypothesis of lack of trend is rejected if 
𝑍𝐶𝐴 is above the upper 5
th percentile of the normal distribution, which is 1.64 for a one-tailed test.  
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If such an association is determined, the data can be modeled. A code written in R programming 
language (www.r-project.org) minimized the deviance (𝑌) of each of these model fits: 
𝑌 = −2 ∑ [𝑝𝑖𝑙𝑛
𝜋𝑖
𝜋𝑖
0 + (𝑛𝑖 − 𝑝𝑖)𝑙𝑛
1−𝜋𝑖
1−𝜋𝑖
0]
𝑘
𝑖=1                                      Eq. 8.5 
The parameters 𝜋𝑖  and 𝜋𝑖
0 are the predicted and observed responses of 𝑝𝑖 positive subjects within 
𝑛𝑖 number of subjects in the set (Haas et al. 2014). Goodness-of-fit was determined by comparing 
minimized deviance from maximum likelihood estimations (MLE) to the critical 2 distribution. 
The optimized deviance has a 2 distribution with m – n degrees of freedom, where m is the 
number of doses and n is the number of model parameters. The dose-response model is rejected if 
𝑌 >  𝑚−𝑛,0.95
2 , at a 95% confidence level. If, however, both models provide acceptable fits, the 
beta-Poisson model can be selected as a best-fit model only if the difference in minimized 
deviances between the beta-Poisson and the exponential model was greater than the critical chi-
square value for a single parameter (one degree of freedom). Confidence intervals of the 
parameters for the models were determined via bootstrapping with 10,000 iterations.  
 
8.4.2.2. Dose-response-time models 
These traditional dose-response models were modiﬁed by Huang and Haas (2009) to incorporate 
a time dependency by including additional parameters of time-post-inoculation (TPI). The 
additional time parameter quantifies the time of onset of the effect associated with the kinetics of 
in-vivo pathogen growth. Huang developed eight separate time-dependent equations (Huang et al. 
2009, Huang and Haas 2009, 2011); of the original eight models, only four were true cumulative 
density functions (CDFs). These models are presented in Table 8.2. The models that were not true 
CDFs were excluded from the study.  
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Table 8.2 True CDF time-dependent dose-response models. 
Model Name Expression Eq’n 
number 
Exponential model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − 𝑒−𝑒
(
−𝑘0
𝑡 )𝑑, where 𝑘0 > 0 Eq. 8.6 
Beta-Poisson model with 
exponential-reciprocal time 
dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
𝑒
(
𝑗0
𝑡+𝑗1
)
× (2
1
𝛼 − 1)]
−𝛼
 
𝑤ℎ𝑒𝑟𝑒𝑗0 ≫ 𝑗1 
Eq. 8.7 
Beta-Poisson model with 
exponential time dependency 𝑃(𝑑) = 1 − [1 +
𝑑
𝑒(𝑗0×𝑡+𝑗1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 8.8 
Beta-Poisson model with inverse 
time dependency 
𝑃(𝑑) = 1 − [1 +
𝑑
(
𝑗0
𝑡 + 1)
× (2
1
𝛼 − 1)]
−𝛼
 Eq. 8.9 
 
 
 
The TDR models were ﬁt to the dose-response data, deviances were optimized, and model 
parameters were determined using maximum likelihood estimation (MLE) in the R programming 
language (www.r-project.org, ver. 3.0.3). The predicted response is 𝜋𝑖, and the response for each 
set based on observations are 𝜋𝑖
°. 
 
The likelihood ratio for the incidence occurring for 𝑖 dose groups on day 𝑗 is 
𝐿𝑅 = ∏ ∏
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)𝜋𝑖,𝑗
𝑝𝑖,𝑗
(1−𝜋𝑖,𝑗)
𝑛𝑖,𝑗−𝑝𝑖,𝑗
(
𝑛𝑖,𝑗
𝑝𝑖,𝑗
)(𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗(1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1 = ∏ ∏ (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° )
𝑝𝑖,𝑗
(
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )
𝑛𝑖,𝑗−𝑝𝑖,𝑗𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1            Eq. 8.10 
where 𝑚𝑑𝑜𝑠𝑒𝑠 is the total number of dose groups and 𝑚𝑡𝑖𝑚𝑒𝑠 is the number of time periods during 
which observations were made, 𝑝𝑖,𝑗 is the number of positive response observed during time 
period 𝑗, and 𝑛𝑖,𝑗 is number of surviving animals at the beginning of time period 𝑗.   
 
The corresponding deviance is  
𝑌 = −2 ln 𝐿𝑅 = −2 ∑ ∑ [𝑝𝑖,𝑗 ln (
?̂?𝑖,𝑗
𝜋𝑖,𝑗
° ) + (𝑛𝑖,𝑗 − 𝑝𝑖,𝑗) ln (
1−?̂?𝑖,𝑗
1−𝜋𝑖,𝑗
° )]
𝑚𝑑𝑜𝑠𝑒𝑠
𝑖=1
𝑚𝑡𝑖𝑚𝑒𝑠
𝑗=1  Eq. 8.11 
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8.4.3. Outbreak model 
The standard Susceptible-Infective-Recovered (SIR) compartment model proposed by Kermack 
and McKendrick in 1927 is a deterministic model for a closed population of size 𝑁 consisting of 
𝑆(𝑡) susceptibles, 𝐼(𝑡) infectives and 𝑅(𝑡) removals, namely individuals who had died, or had 
recovered and were immune at time 𝑡 (Kermack & McKendrick 1927). In his 1999 thesis, Gupta 
proposed a modified SIR model for water and foodborne infections (Gupta 1999), which includes 
a latent period and accounts for individuals being either symptomatically or asymptomatically ill 
(Figure 8.1).  
 
 
 
 
Figure 8.1 Modified SIR model proposed by Gupta (Gupta and Haas 2004, Kermack and McKendrick 
1927). 
 
 
 
In this model, populations are compartmentalized into groups, moving through the compartments 
as they become infected. The number of people in the compartments, as well as the rates that of 
transfer are described by a system of differential equations. The four states in this model are (1) 
the susceptible populations 𝑋(𝑡); (2) latent individuals 𝑌(𝑡) who have been exposed to the 
pathogen and will ultimately become infected; (3) those who become symptomatically ill 𝑍(𝑡); 
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and (4) those who have become infected but will remain Asymptomatic 𝐼(𝑡). The force of 
infectivity, 𝛽(𝑡), is the rate of transfer from susceptible to the latent, and 𝑄(𝑡) models the rate of 
newly symptomatic cases. For our purposes, only the symptomatically ill population will be 
considered, since generally data is only available for these groups through epidemic studies. The 
compartment model then reduces to the following equations: 
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)𝑋(𝑡), or 
1
𝑋
𝑑𝑋(𝑡)
𝑑𝑡
= −𝛽(𝑡)    Eq. 8.12 
𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡)      Eq. 8.13 
The force of infection 𝛽(t) has units of inverse time, and is a versatile parameter. In the case of a 
rectangular distribution for infectivity, 𝛽(t) would be a constant for the exposure duration. 
However, common source outbreaks are frequently caused by time variable microbial exposures, 
which means that the parameter takes the form of a density distribution, generally of the 
following form: 
𝛽(𝑡) = 𝑏0 + 𝑏1𝑔(𝑡)     Eq. 8.14 
where 𝛽(t) is the force of infection; b0 is the background infectivity level, which may account for 
any endemic cases in the population; 𝑔(𝑡) is the ratio of susceptible persons ultimately becoming 
infected at time t; and b1 is the scaling factor for increased infectivity above background. Here, 
𝑔(𝑡) is modeled as a probability density function for the exposure case. The density functions in 
this case that we have used are the Weibull, gamma, and lognormal, and uniform, all which are 
standard functions which have historically been used to fit observed epidemic curves. Each of 
these density functions have parameter values that determine the shape and scale of the function. 
Integrating Eq. (8.12) gives: 
𝑋(𝑡) = 𝑋0𝑒𝑥𝑝[−𝐵(𝑡)], where 𝐵(𝑡) =  ∫ 𝛽(𝑢)𝑑𝑢
𝑡
0
   Eq. 8.15 
The rate of newly ill people at any time t is given by the parameter 𝑄(t). At any time t, the 
instantaneous rate of new illnesses can be obtained by the convolution integral: 
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𝑑𝑍(𝑡)
𝑑𝑡
= 𝑄(𝑡) = ∫ 𝛽(𝜏)𝑋(𝜏)𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
    Eq. 8.16 
where 𝑓(𝑡 − 𝜏) is the density function having incubation period of (𝑡 − 𝜏). The function 𝑓 is a 
probability density function (PDF) which has parameters that need to be estimated.  
 
Substituting Eq. 8.15 into Eq. 8.16 we then obtain: 
𝑑𝑍
𝑑𝑡
= ∫ 𝑋0𝛽(𝜏)exp [−𝐵(𝜏)]𝑓(𝑡 − 𝜏)𝑑𝜏
𝑡
0
     Eq. 8.17 
where 𝐵(𝑡) = 𝑏0𝑡 + 𝑏1𝐺(𝑡) and 𝐺(𝑡) is the CDF corresponding to the PDF 𝑔(𝑡). Since we are 
using the Weibull, gamma, lognormal and uniform PDFs to model 𝑔(𝑡), we necessarily must use 
the corresponding CDFs for 𝐺(𝑡) in each respective case.  
 
Integrating Eq. 8.17 directly, we can solve for the number of symptomatically ill patients per day 
𝑍(𝑡): 
𝑍(𝑡) = ∬ 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)]
𝑡
0
𝑓(𝜑 − 𝜏)𝑑𝜏𝑑𝜑     Eq. 8.18 
In Eq. 8.18, the exposure time distribution is represented by the expression 𝛽(𝜏)𝑋0𝑒𝑥𝑝[−𝐵(𝜏)], 
while the incubation distribution is represented by the expression 𝑓(𝜑 − 𝜏). The incubation 
distribution that will be used here will be the best-fit time-dose-response equation. 
 
The time-dose-response functions from Table 8.2 cannot be immediately used as incubation 
distributions because they are in the form of cumulative density functions; probability density 
functions are needed to be input into Eq. 8.18. The derivatives of the functions in Table 8.2 are 
taken so that proper PDFs can be utilized (Prasad et al. 2016). In the case of the beta-Poisson time 
dose-response with inverse time dependency, we have the following equation:  
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𝑅(𝑑, 𝑡) = 1 − [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 8.19 
𝑅(𝑑, 𝑡) is the probability of adverse effect; α is a fitting parameter; θ is a time parameter; 
𝑗0
𝑡
+ 1 
is the dose that elicits a positive response in 50% of the hosts, after infinite time. Taking the first 
partial derivative with respect to time, we get 
𝑟(𝑑, 𝑡) = −𝛼 [1 +
𝑑
𝑗0
𝑡
+1
× (2
1
𝛼 − 1)]
−𝛼−1
×𝑑 (2
1
𝛼 − 1)
𝑗0
𝑡2
                      Eq. 8.20 
However, we want that to make sure that our function is a true PDF. Probability density functions 
satisfy the following conditions: 
1. 𝑓(𝑥) ≥ 0 𝑓𝑜𝑟 𝑎𝑙𝑙 𝑥 
2. ∫ 𝑓(𝑥)𝑑𝑥 = 1
∞
−∞
 
 As time goes to infinity, we want the integral of our distribution to be exactly 1. So, we must 
divide by a certain value that ensures that this is true. As 𝑡 → ∞, the maximum response is 
reached for the time dose-response. Then Eq. 8.19 no longer becomes time-dependent, and we 
refer to the TDR dependency equation in Table 8.2, which assumed that 𝑁50 =
𝑗0
𝑡
+ 1. Plugging 
in 𝑁50 for the expression in the denominator returns us back to the regular beta-Poisson dose-
response model. 
𝑅(𝑑, 𝑡 → ∞) = 1 − [1 +
𝑑
𝑁50
× (2
1
𝛼 − 1)]
−𝛼
    Eq. 8.21 
This expression can be used as the constant for which Eq. 8.20 can be divided. If we divide Eq. 
8.20 by Eq. 8.21, we get the following function: 
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𝑓(𝑡|𝑑) =
𝛼[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼−1
×𝑑(2
1
𝛼−1)𝑗0
𝑡2(−1+[1+
𝑑
𝑗0
𝑡
+𝑗1
×(2
1
𝛼−1)]
−𝛼
)
   Eq. 8.22 
We now have a proper PDF 𝑓(𝑡|𝑑) that characterizes the distribution. This PDF based on the 
beta-Poisson time dose-response function distribution can now be used as a potential incubation 
distribution 𝑓(𝑡) to use in the probability density function used to calculate the number of ill, 
Z(t). The functions used to model the exposure distributions include the Weibull, gamma, 
lognormal and uniform distributions, and the best-fit time-dose-response model will be used as 
the incubation distribution. 
 
For the Weibull, gamma, lognormal and uniform incubation scenarios, we have six parameters for 
𝑍(𝑡): the attack parameters  𝑏0 and  𝑏1, two PDF parameters for the attack distribution, and two 
PDF parameters for the incubation distribution (Weibull, gamma, lognormal and uniform 
distributions all contain 2 parameters). In the case of the beta-Poisson model with inverse time 
dependency, we have seven parameters total, as this model contains three parameters, 𝛼, 𝑑, and 
𝑗0.  
 
To compare the results of the outbreak models, deviance, Akaike information criterion (AIC) and 
Bayesian information criterion (BIC) values are examined: 
𝐷(𝑦) = −2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]       Eq. 8.23 
𝐴𝐼𝐶 = 2𝑘 − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]                   Eq. 8.24 
𝐵𝐼𝐶 = 𝑘 ∗ 𝑙𝑛(𝑛) − 2 [log (𝑝(𝑦|𝜃0̂)) − log (𝑝(𝑦|𝜃?̂?))]           Eq. 8.25 
The parameters 𝜃?̂? are the values of the full model (observed values), and 𝜃0̂ are the values of the 
predicted model, 𝑘 is the number of parameters, and 𝑛 is the number of observations (Ruppert 
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2011). The equation for deviance is simply the −2×(𝑙𝑜𝑔 ∙ 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) and thus we can see that 
the AIC and BIC is the deviance plus a complexity parameter. BIC penalizes model complexity 
more than AIC does (Ruppert 2011). The outbreak model with the lowest deviance, AIC and BIC 
are the best-fit. Since some TDR models have extra parameters, they will have higher AIC and 
BIC values. 
 
To compare the parameters in the epidemic and dosing parameter studies to see if the differences 
between corresponding parameters were significant, the two-sample Kolmogorov–Smirnov (KS) 
test and the Anderson–Darling (AD) test were utilized. In both tests, we wanted to see if the 
parameters came from the same distribution. The KS test states that 𝐷∗ =
𝑠𝑢𝑝
𝑥
| 𝐹1(𝑥) − 𝐹2(𝑥)|, 
where 𝐹1(𝑥) and 𝐹2(𝑥) are the empirical distribution functions of the two samples respectively, 
and 𝑠𝑢𝑝 is the supremum function (Sheskin 2003). The null hypothesis is rejected if the following 
equation holds true: 𝐷∗ > 𝑐(𝛼)√
𝑛+𝑛1
𝑛𝑛1
. For 𝛼 = 0.05, 𝑐(𝛼) = 1.36. The AD is a refinement of the 
KS test. The statistic that was used was of the form 
𝐴2 = −𝑛 − ∑
2𝑖−1
𝑛
[ln(Φ(𝑌𝑖)) + ln(1 − Φ(𝑌𝑛+1−𝑖))]
𝑛
𝑖=1  (D’Agostino et al. 1986). The parameter 
𝑛 is the number of data points in the sample, and the test statistic measures the distance between 
the hypothesized and empirical. The null hypothesis of normality is rejected if A2 exceeds 0.752 
for α = 0.05. 
 
8.5. Results and discussion 
8.5.1. Dose-response  
Several Campylobacter dosing studies have been performed on animals, including pigs 
(Babakhani et al. 1993, Lambert et al. 1987, Maridor et al. 2008), hamsters (Humphrey et al. 
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1985), rabbits (Caldwell et al. 1983), monkeys (Fitzgeorge et al. 1981, Flores et al. 1990, Russell 
et al. 1989), mice (Baqar et al. 1996, Blaser et al. 1983, Hodgson et al. 1998, Stanfield et al. 
1987) and humans (Black et al. 1988). Chickens (Kazwala et al. 1992, Li et al. 1996, Ringoir et 
al. 2007, Ruiz-Palacios et al. 1981, Shanker et al. 1990, Welkos 1984) have been of particular 
interest as hosts since they are well-established as carriers of the pathogen.  
 
The dosing study that contained the criteria required for dose-response modelling was carried out 
by Ringoir et al (2007), who dosed 2- and 14-day-old Ross breed chickens with C. jejuni 
pathogens at dosing levels between 5×101 to 5×107 CFUs. Strain 331 from the Royal 
Melbourne Institute of Technology University (RMIT) was cultured on Columbia agar 
supplemented with 5% horse blood and antibiotics, and incubated for 48-72 hours at 42°C in a 
90% N2 atmosphere. The newly-hatched chicks were then inoculated with this strain via an oral 
route. Each chicken was tested for the presence of Campylobacter cells daily after inoculation by 
cloacal swabs. The minimum C. jejuni count required to colonize 14-day-old chickens was 
5×104 cells, and that for 2-day-old chickens was 5×103. Table 8.3 provides the cumulative 
infection percentages of the chickens who first showed signs of infection. 
 
 
 
 
Table 8.3 Cumulative infection percentages of chickens exposed to varying doses of Campylobacter. 
Day 
Doseb 1 2 3 5 7 10 23 total 
𝟓×𝟏𝟎𝟏 0 0 0 0 0 0 0 0 
𝟓×𝟏𝟎𝟐 0 0 0 15 15 15 25 25 
𝟓×𝟏𝟎𝟑 0 10 15 40 55 55 70 70 
𝟓×𝟏𝟎𝟒 40 45 60 80 100 100 100 100 
𝟓×𝟏𝟎𝟓 50 75 80 100 100 100 100 100 
𝟓×𝟏𝟎𝟔 80 95 95 100 100 100 100 100 
𝟓×𝟏𝟎𝟕 90 100 100 100 100 100 100 100 
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The Ringoir et al. data set was initially modeled using traditional dose response methods. Dose 
response data showed positive trends when subjected to the Cochran-Armitage test of trend. Z 
critical was greater than 1.64 (𝑍𝑐𝑟 > 1.64), so the null hypothesis of lack of trend is rejected and 
data can be analyzed using R. The responses for the data set was best fit by the exponential dose-
response model. Predictive model results from conventional dose response studies are provided in 
Figures 8.2, 8.3 and Table 8.4. 
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Figure 8.2 Dose-response model generated to fit data provided by Ringoir et al. of Campylobacter jejuni 
orally administered to chicks with the endpoint as cloacal presence (Ringoir et al. 2007). The best-fit 
mechanistic model was the exponential (𝐤 = 𝟑. 𝟏𝟗×𝟏𝟎−𝟒;𝛘𝟐 = 𝟐. 𝟑𝟑). 
 
 
 
 
Figure 8.3 Dose-response data and best-fit bootstrapped exponential model with confidence intervals for 
CFUs administered orally to chicks via the oral route (Table 8.3), along with the frequency diagram of 
exponential model parameter 𝒌.  
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Table 8.4 Non-time-dependent dose-response modeling results for Campylobacter jejuni inoculation.  
Model 
Parameter 
Deviance dfa 
Critical
𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 𝒃 
Conclusions Δ 
Critical 
𝝌𝟎.𝟗𝟓,𝟏
𝟐  
Best fit 
modelc type value 
Expd k 3.19×10−4 2.33 6 12.59 Both models 
provide 
acceptable 
fit 
0.68 3.84 Exp 
BPe 
α 2.21 
1.65 5 11.07 
N50 1.83×103 
a df - degrees of freedom for dataset and model 
b  critical values of the chi-squared distribution at a 95% confidence level (df = m-n), where df is the degree of freedom, 
m is the number of doses, n is the number of parameters 
c Best fit model criteria - the lowest deviance of candidate models was chosen compared to the critical values of chi-
squared distribution  
d Exponential Model 
e beta-Poisson Model 
 
 
 
Both the exponential and beta-Poisson models have deviance values less than the critical 
𝜒2values (Exp: dev=2.33, 𝜒0.95,𝑑𝑓
2 = 12.59; BP: dev=1.65, 𝜒0.95,𝑑𝑓
2 = 11.07). The difference in 
the minimized deviance (Δ = 2.33-1.65) between two models is compared to the critical chi-
square value for 1 degree of freedom.  Since the Δ difference is less than the critical chi-square 
estimate, the 1-parameter (exponential model) provides the best fit.  The exponential is the best-
fitting mechanistic model here.  
 
The infectious dose of C. jejuni for humans appears to be low. The lowest infectious dose in this 
dataset is 500 CFUs, which is supported in the literature. Robinson experimented by personally 
swallowing 500 C. jejuni organisms dissolved in 180 ml of pasteurized milk, and reported a 
subsequent illness, including diarrhea and abdominal cramps (Robinson 1981).  
 
Estimates for LD50 values were calculated from the traditional dose-response models. The LD50 
value at the lower bound of the 95th percentile confidence interval was determined to be 
1.24×103 CFUs, and 3.60×103 CFUs at the upper bound. Human volunteer studies conducted 
by Black et al. (1988) showed that half the subjects became infected after ingesting 8.00×103 
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organisms, the lowest dose tested (Black et al. 1988). This value is slightly higher than the beta-
Poisson model generated by the authors, but of the same magnitude. Line et al. (2008) devised a 
study that compared an individually-housed chick model to a group-housed chick model in order 
to estimate the number of C. jejuni microbes necessary to infect 50% of broiler chicks inoculated. 
They estimated an N50 of about 524 CFU for C. jejuni RM1221 in the individually-housed chick 
model, which is about half the N50 that was determined by our model. It should be noted however, 
that being previously exposed to the Campylobacter pathogen provides a degree of immunity to 
the host (Wagenaar et al. 2014). It could be possible that high rates of illness follow low doses in 
these scenarios (Teunis et al. 2005), and that large discrepancies in attack rates could reflect 
variety in host immunity.  
 
Chen et al. (Chen et al. 2006) modeled two dosing studies for chickens that were done by 
Cawthraw et al. (1996). The N50, the dose needed to achieve a 50% infection probability, was 
calculated to be 2.30×103 (logN50 = 3.361) for fresh isolates, and 6.65×105 (logN50 = 5.823) for 
lab-stored isolates. Conlan et al. (2011) also furthered Chen et al.’s model considering the 
transmission of Campylobacter in chickens but did not report any parameter values in his study. 
 
Medema et al. (1996) and Teunis et al. (1999) each separately reported dose-response 
relationships for C. jejuni using a study performed on healthy human volunteers performed by 
Black et al. in 1988 (Black et al. 1988). Both studies used a modified beta-Poisson equation that 
modeled the probability of infection to be 𝑃(𝑑) = 1 − [1 +
𝐷
𝛽
]
−𝛼
. The parameters that both sets 
of authors reported were 𝛼 = 0.15, 𝛽 = 7.9, with a deviance value of 2.4. Rose and Gerba (1991) 
published best-fit beta Poisson parameter values for C. jejuni, based on a human volunteer study 
by Cooper et al. (1986) (a = 0.039; j = 55), and calculated the probability of infection from 
exposure to 1 organism to be 7×10−3. Although modeling a different dataset, our beta-Poisson 
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model performed better here, with a deviance of 1.65. Medema et al. further reported an 
exponential parameter 𝑘 = 3.52×10−6, with a deviance value of 108, which was higher than 
their critical 𝜒0.95,𝑑𝑓
2 , and considered to be an unacceptable fit.  
 
8.5.2. Time-Dose-Response  
The time-dose-response models in Table 8.2 were ﬁtted to the survival data presented in Table 
8.3 using maximum likelihood estimation (MLE). Figure 8.4 summarizes the fitted curves. The 
parameter estimates and criterion values are summarized in Table 8.5. The 3-parameter beta-
Poisson with exponential time dependency was found to be the best-fit model for the time-
dependent data, with a minimized deviance value of 44.3, less than the critical chi-square value at 
its degree of freedom (𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 ), of 54.6. It provided the lowest deviance, and gave a statistically 
signiﬁcant improvement in ﬁt over the other models. Two other models provided acceptable fits 
as well – the beta-Poisson model with exponential-reciprocal time dependency and exponential 
model with exponential-reciprocal time dependency. Of the 2-parameter models, the beta-Poisson 
model with exponential-reciprocal time dependency had a slightly higher deviance, at 52.2 
compared with 44.3. The 1-parameter exponential model with exponential-reciprocal time 
dependency gave a good fitting, with a minimized deviance of 54.1, which was less than the 
critical chi-square value at its degree of freedom (𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐 ), of 56.9. Although this deviance was 
higher than our best-fit model, it had the advantage of being a 1-parameter model, whereas our 
best-fit model is a 3-parameter model. So we look to the Akaike information criterion (AIC), 
which accounts for the additional parameters. Despite the addition of 2 parameters, the AIC of the 
beta-Poisson model with exponential time dependency is still lower than the AIC of the 
Exponential model with exponential-reciprocal time dependency. The 2-parameter beta-Poisson 
model with inverse time dependency did not give an acceptable fit. The best-fit model, the beta-
232 
 
 
 
Poisson with exponential time dependency, was chosen as the time-dependent model to fit the 
incubation distribution of the Finland C. jejuni outbreak.  
 
It is noted that although in the traditional dose-response models, the exponential model provided 
the best fit, while in the time-dose-response model set, the Beta-Poisson model with inverse time 
dependency provided the best fit. There was no correlation between whether a traditional 
exponential or beta-Poisson model could predict the best-fit time-dependent model.  
 
 
 
Table 8.5 Time-dose-response (TDR) modeling results for C. jejuni inoculation   
Time Dependence Model 
Best fit 
parameters 
AIC 
Minimized 
deviance 
Critical 
𝝌𝟎.𝟗𝟓,𝒅𝒇
𝟐  
Acceptable 
fit 
Beta-Poisson model with 
exponential time 
dependency 
α = 0.6 
50.3 44.3 54.6 Yes j0 = -0.9 
j1 = 15 
Beta-Poisson model with 
exponential-reciprocal 
time dependency 
α = 1.2 
58.2 52.2 54.6 Yes j0 = 10.5 
j1 = 5.5 
Beta-Poisson model with 
inverse time dependency 
α = 0.082 
124.1 120.1 55.8 No 
j0 = 2.07×107 
Exponential model with 
exponential-reciprocal 
time dependency 
k0 = 7.14×10-4 56.1 54.1 56.9 Yes 
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Figure 8.4 Best-fit TDR model, the beta-Poisson model with exponential time dependency, fit to dosing 
study data.  
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8.5.3. Outbreak model  
Several studies report primary spread stemming from Campylobacter. Common-source outbreaks 
caused by Campylobacter are not as frequently reported as isolated campylobacteriosis cases. It 
may be because unlike other gastroenteritis-inducing pathogens such as Salmonella, 
Campylobacter does not tolerate exposure to atmospheric oxygen or to drying, nor does it 
multiply on foods left out for many hours (Blaser et al. 1981). Most species prefer a micro-
aerobic atmosphere containing 3-10% oxygen for growth (Kaakoush et al. 2015). The 
environmental sensitivity could explain the why large outbreaks of Campylobacter with respect to 
foods are seldom documented (Franco 1988).  
 
Contaminated water has been responsible for a number of Campylobacter outbreaks (Denis et al. 
2011, Miller and Mandrell 2005, Palmer et al. 1983, Taylor et al. 1983).  The study used to model 
the outbreak was one that occurred in Utti, Finland in July 1987 (Aho et al. 1989). In this 
outbreak, diarrhea, abdominal pain, malaise and fever caused by heat-stable C. jejuni serotype 
3/43/59 was confirmed in 75 out of 88 soldiers who completed an outdoor infantry drill on July 
22nd. The soldiers were all men 18-22 years of age and in excellent physical condition. Two days 
later, over 60 soldiers became sick with campylobacterosis, which lasted between 1-10 days 
(median 2-7 days). C. jejuni serotype 3/43/59 was isolated on two occasions from surface water, 
which was presumed to be the source of the outbreak. It is known that wild animals, particularly 
wild birds, are potential reservoirs of Campylobacter species. (In one study, 35% of the cecal 
contents harvested from 445 wild ducks from tested positive for C. jejuni (Yogasundram et al. 
1989). Investigations found that eight common teals (Anas crecca) and seven mallards (Anas 
platyrhynchos) were shot on August 15-16 by a hunting club at a pond 30 km north of the swamp; 
of these birds, Campylobacter jejuni was isolated from one teal (Aho et al. 1989).  
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Secondary spread is thought to be relatively uncommon (Blaser 1997), but some evidence has 
been documented (Ethelberg et al. 2004, Mughini-Gras et al. 2014, Rotariu et al. 2010) to support 
the theory that person-to-person spread does indeed occur either through the fecal-oral route or 
via fomites. The Health Protection Agency in the U.K. found that person-to-person transmission 
was the cause in 3% of campylobacteriosis cases from 1992 to 2009 (Little et al. 2010). Ribiero et 
al. and Blaser et al. each reported a family outbreak of cryptosporidiosis in which the index case 
was acquired from the environment and subsequently spread to their respective families (Blaser et 
al. 1981, Ribeiro and Palmer 1986). Gordon et al. investigated an outbreak of gastroenteritis 
occurred in a retirement facility in the San Francisco Bay area from March 20 through April 15, 
1988; the authors reported that the risk of becoming ill one or two days after a roommate became 
ill was significantly greater than that of becoming ill at other times during the outbreak, indicating 
the possibility of person-to-person transmission (Gordon et al. 1990). Despite the prevalence of 
outbreaks published in the literature, data from these studies were too scattered to be usedin this 
model. Therefore, only the primary outbreak was modeled. 
 
Since the beta-Poisson model with exponential time dependency was the best-fit TDR model, this 
was the time dependent kinetic model that was chosen to be modeled. The static Weibull, gamma, 
lognormal and uniform distributions were also generated for comparison. To determine which 
distribution convolution fit the data best, deviance, AIC and BIC output were compared (Table 
8.6). Based on the criteria values, the models with the lowest deviances for each of the 
distributions were as follows: the Weibull-BP with exponential time dep (deviance = 0.94), the 
Weibull-Gamma (deviance = 0.96); the Gamma-Gamma (deviance = 0.97); and the Uniform-BP 
with exponential time dep (deviance = 0.98).  
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Although the Weibull-BP with exponential time dep exposure/incubation convolution has the 
lowest deviance, it has the benefit of having 1 additional parameter in the model, with 7 total 
parameters. Therefore, along with the deviance, the AIC and BIC were calculated. Both AIC and 
BIC contain the deviance in their formulas, but both have the additional benefit of also 
considering the number of parameters. Looking solely at the AIC and BIC criteria values only, 
the best-fit distributions are follows: Weibull-gamma (AIC = 12.96; BIC = 14.78); the gamma-
gamma (AIC = 12.97; BIC = 14.79); Weibull-lognormal (AIC = 13.00; BIC = 14.82); and 
Weibull-Weibull (AIC = 13.10; BIC = 14.92) was tied with lognormal-Weibull (AIC = 13.10; 
BIC = 14.92). So, although the time distributions provide a better fit, it comes with the cost of an 
additional parameter. The non-time-dependent distributions fit the outbreak dataset sufficiently as 
well. The distributions that gave well was the poorest fits were the gamma-Weibull (deviance = 
2.14), and the uniform-uniform (deviance = 2.04), followed by the lognormal-uniform (deviance 
= 1.59). 
 
The parameter values can also provide some insight into the outbreak. The first and second 
column are the results for the 𝑏0 and 𝑏1 attack rate values. There is a trend for attack parameter 𝑏0 
to be small, indicating that there is a low baseline level of this disease in the population before the 
outbreak. The third and fourth columns are referred to as “Exposure Distribution PDF param 1” 
and “Exposure Distribution PDF param 2,” which correspond to the respective exposure 
distributions. In the Weibull distribution, PDF Param 1 and PDF Param 2 refer to the scale 
parameter a, and shape parameter b in the probability distribution function. For the Gamma 
exposure distribution, PDF Param 1 and 2 are the mean and variance. In the Lognormal 
distributions, PDF Param 1 and PDF Param 2 are the log transform of the mean and variance. The 
Uniform distribution refers to parameters a and b in the PDF, with a being a lower endpoint 
(minimum) and b being an upper endpoint (maximum), respectively.  The remaining columns 
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correspond to the respective incubation distributions, and follow the same pattern as described 
previously. For the beta-Poisson with exponential time dependency, Parameters 3, 4, 5 and 6 refer 
to 𝛼, 𝑗0, 𝑗1, and 𝑑, respectively. 
 
The criteria values are consistent with a visual inspection, as seen in Figure 8.5. All of the fits 
were very close to one another, so the fits may appear largely indistinguishable from each other. 
Each graph is grouped by the incubation distribution – gamma, Weibull, lognormal, uniform and 
TDR models, specifically in this case the beta-Poisson model with exponential time dependency. 
The observed outbreak data (number ill) are represented as point values and the predicted values 
of the models as the curve fit. The abscissa is time in days, and the ordinate is the number of 
cases reported.   
  
 
 
Table 8.6 Parameter and criterion values for the C. jejuni primary outbreak model. 
  Model Parameters 
 
Criterion Values 
Exposure 
Dist 
Incubation 
Dist 
Expos 
param 
b0 
Expos 
para
m 
b1 
Expos dist  
PDF param 
1 
Expos dist  
PDF param 
2 
Incub dist  
PDF param 
1 
Incub dist 
PDF param 
2 
Incub 
dist 
PDF 
param 3 
Incub 
dist 
PDF 
param 4 
Dev AIC BIC 
Weibull 
Weibull 3.00×10−3      0.145       2.64a 6.76b 0.507a 1.08b n/a n/a 1.10 13.10 14.92 
Gamma 3.09×10−3 0.145       1.63a 2.59b 1.49c 3.78×10−2d n/a n/a 0.96 12.96 14.78 
Lognormal 2.99×10−3     0.155    8.43×10−3a 3.35b 1.05e 0.242f n/a n/a 1.00 13.00 14.82 
Uniform 3.08×10−3      0.147       1.14a 2.02b 1.31g 2.52h n/a n/a 1.01 13.01 14.83 
BP with exp 7.09×10−3      0.295      2.82a 7.95b 1.00i 6.73×10−2j 0.971k 1.00l 0.94 14.94 17.06 
Gamma 
Weibull 2.39×10−21      0.405      2.83c 0.340d 3.94×10−2a 0.115b n/a n/a 2.14 14.14 15.96 
Gamma 3.12×10−3      0.145      1.54c 0.232d 1.40c 0.169d n/a n/a 0.97 12.97 14.79 
Lognormal 2.93×10−3    0.151     6.15×10−2c 9.11×10−3d 1.02e 0.230f n/a n/a 1.45 13.45 15.27 
Uniform 3.02×10−3     0.146       1.16c 0.250d 1.09h 2.46h n/a n/a 1.04 13.04 14.86 
BP with exp 6.19×10−3      0.268       2.71c 0.233d 1.22i 3.20×10−3 j 0.297k 1.22l 0.99 14.99 17.11 
Lognormal 
Weibull 3.01×10−3      0.146     3.78×10−2e 0.402f 1.98a 4.60b n/a n/a 1.10 13.10 14.92 
Gamma 9.76×10−4     0.345      0.798e 14.3f 2.83c 0.373d n/a n/a 1.45 13.45 15.27 
Lognormal 3.00×10−3   0.147     0.107e 0.349f 0.523e 0.286f n/a n/a 1.42 13.42 15.24 
Uniform 6.29×10−7      0.314       1.00e 8.20f 1.83g 3.57h n/a n/a 1.59 13.59 15.41 
BP with exp 6.20×10−3    0.269    0.980e 0.181f 1.22i 1.00×10−4 j 0.684k 1.42l 1.07 15.07 17.19 
Uniform 
Weibull 3.07×10−3    0.145      1.04g 3.06h 1.03a 4.27b n/a n/a 1.84 13.84 15.66 
Gamma 3.04×10−3    0.144       1.11g 2.57h 1.10c 0.216d n/a n/a 1.10 13.10 14.92 
Lognormal 2.94×10−3    0.149    1.99×10−2g 0.683h 0.913e 0.245f n/a n/a 1.38 13.38 15.20 
Uniform 3.10×10−3       0.146     0.177g 1.73h 1.13g 2.79h n/a n/a 2.04 14.04 15.86 
BP with exp 7.00×10−3    0.321       1.74g 3.39h 0.996i 3.40×10−2j 1.03k 0.87l 0.98 14.98 17.10 
a scale parameter  
b shape parameter 
c shape parameter 
d scale parameter 
e log mean  
f log variance  
g lower endpoint  
h upper endpoint  
i alpha 
j dose 
k 𝑗0 
l 𝑗1
2
3
8
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Figure 8.5 Curve fits for the Exposure/Incubation distribution models of the Finland outbreak. The 
abscissa is time of symptom onset in days, and the ordinate is the number of cases reported. 
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8.6. Conclusion 
Dose-response and TDR models were generated for Campylobacter jejuni exposure to young 
chicks via the oral route, and TDR was subsequently incorporated into the incubation period of a 
C. jejuni outbreak in order to capture the in-vivo dynamics between pathogen and host. In the 
dose-response model, the median infectious dose was estimated to be 1.83×103 CFUs, and the 
best-fit TDR model was the beta-Poisson with exponential dependency, which had a minimized 
deviance of 44.3. A C. jejuni outbreak dataset that occurred at a military training site in Finland 
was used to fit the models. Among all the fitted models, the Weibull-BP with exponential time 
distribution performed the best, with a minimized deviance value of 0.94. However, due to the 
extra parameter in this convolution, AIC and BIC calculations were made. Looking at AIC and 
BIC values, the Weibull-gamma convolution performed the best (AIC = 12.96; BIC = 14.78). 
This work suggests that the incorporation of a time factor into outbreak models may provide an 
approach to modelling that adequately describes realistic in-vivo dynamics of the host-pathogen 
system.  
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Chapter 9: Conclusion 
 
In this work, the fundamental knowledge of dose response behavior was used to predict disease 
transmission dynamics in a population. 
 
9.1. Objective 1 
The first objective to reach this end was to construct a model of the disease transmission process 
that integrated time-dose-response (TDR) equations into a compartment outbreak model. Indeed, 
a dynamic disease model was developed that utilized dose-response equations to fit epidemic data 
from reported outbreaks found in literature. A computer model for the outbreak was written in 
Matlab that had the flexibility to allow for exposure and incubation periods to be modeled as 
defined probability distribution functions (PDFs).  
 
9.1.1. Hypothesis I 
It was hypothesized that the TDR models developed by Huang et al. (2009) could provide 
acceptable fits to the dose-response datasets of several pathogens responsible for common source 
and person-to-person outbreaks (Hypothesis I). A literature search was required for usable 
pathogen datasets. Dosing studies for Giardia, Legionella, Salmonella, E. coli, Shigella, and 
Campylobacter were found that included incubation time data. This TDR framework proposed 
was applied successfully to six pathogens.  
 
9.2. Objective 2 
The second objective was to apply the derived outbreak compartment from Objective 1 to 
common source and person-to-person outbreaks. Outbreak datasets for Giardia, Legionella, 
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Salmonella, E. coli, Shigella, and Campylobacter were found through literature searches, and 
were individually fitted to the Matlab computer model.  
 
9.2.1. Hypothesis II  
It was hypothesized that for a common source outbreak, incorporating TDR into the incubation 
distribution of an outbreak model provides a better fit to the outbreak data than models that do not 
take time-based distributions into account (Hypothesis II). The incubation period was modeled 
using TDR equations which quantified the relationship between the administered dose of a 
particular pathogen with the probability of adverse reaction with respect to time. The Weibull, 
gamma, lognormal and uniform PDFs were also used to model the incubation period in order to 
compare the results of the time-dependent model with these models that had no time-dependent 
basis. The Weibull, gamma, lognormal and uniform functions were used as the exposure 
distributions. 
 
The results of this hypothesis are mixed. Generally, the outbreak models that contain the TDR 
equations in the incubation period perform very well, with deviance values that are quite low. 
Among the exposure-incubation combinations outlined above, the TDR incubation models are 
usually either the best-fit model, or close to it. However, the TDR models have the benefit of 
extra parameters compared with the other models, so the Akaike information criterion (AIC) and  
Baysian information criterion (BIC) are utilized to examine the effect of the extra parameters on 
the models. When the AIC and BIC criteria were examined, generally the non-time-dependent 
models had the lower values.  
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9.2.2. Hypothesis III  
It was hypothesized that for the onset of a propagated (person-to-person) outbreak, in which 
the onset of secondary cases is clearly distinguishable from primary waves, incorporating TDR 
dependency into the incubation distribution of the full outbreak model predicts the behavior of the 
secondary wave that is comparable with non-time-dependent models (Hypothesis III). The 
pathogens considered in the secondary spread are Legionella, Salmonella, E. coli, Shigella, all of 
which have well-documented routes of transmission. 
 
As with Hypothesis II, the incubation period of these outbreaks was modeled using TDR 
equations, Weibull, gamma, lognormal and uniform PDFs. The Weibull, gamma, lognormal and 
uniform functions were used to model the exposure distributions. The results of this hypothesis 
had results that were similar to the common source outbreaks, in that the TDR-incubation 
outbreak models fit the data generally well, but when the AIC and BIC criteria were examined, 
the non-time-dependent models had the lower values.  
 
9.3. Objective 3 
The third objective was to determine outbreak model parameters that define exposure and 
incubation distributions. These parameter values were obtained through maximum likelihood 
estimation in the Matlab code. There was a certain degree of commonality among the studied 
parameters, particularly with the exposure parameters 𝑏0 and  𝑏1 parameters, which tended to be 
very low, indicating a low level of the disease in the population before the first reported case. The 
two parameters from the exposure distributions tended to correspond to a pathogen exposure of a 
few days. Since these pathogens have different incubation times, the incubation parameters varied 
widely throughout. 
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9.4. Limitations 
The strength of this work is that models were successfully fit to several different pathogens with 
very different pathogenesis. This indicates that the models are robust and flexible enough to 
predict the infection processes of several microorganisms, and can do so more accurately in a way 
that other traditional compartment models cannot. Additionally, due to the inclusion of the host-
pathogen exposure and incubation distribution functions, these models can better predict for 
variations in infectivity and can be used to determine how certain vulnerable at-risk populations 
are affected by pathogen outbreaks. 
 
However, there are several sources of uncertainty in this work. Examples of structural uncertainty 
include the outbreak model forms. The choice of a particular TDR model used in the incubation 
distribution over another, potentially better one is a case of structural uncertainty. Experimental 
uncertainty may arise from the dosing studies due to the variability in taking measurements, 
especially as it pertains to categorizing certain subjects symptomatically ill or not. Sources of 
epistemic uncertainty (caused by lack of knowledge or data) include reporting biases, surveillance 
errors, and unreported or undocumented cases.  
 
Aleatory uncertainty includes the inherent variability of the parameters within the model itself.  
As with any computer model, the Matlab optimization had challenges in the fitting of the 
datasets. The issue of reliably fitting 8 parameters with a degree of reproducibility, given an 
observed epidemic outbreak, was a concern. To examine this issue, the program was run several 
times, with varying initial guesses. At times, a local minimum value was calculated, which may 
suggest a substitution effect between the parameters. Confidence in the model structure could be 
increased by generating artificial data from the different models and testing the ability of the 
fitting algorithms to recover the parameters. This testing procedure was outside of the scope of 
245 
 
 
 
this work, but could be done as a follow-up study. It would also be useful to see confidence 
interval estimates for at least the favored outbreak model.  These estimates could then compare 
the estimates from those based on the human data.   
 
Many of the parameters in the model are subject to inherent variability. Outbreaks are subject to 
the pathogenicity (ability to cause disease), which in turn depends on the features of the host 
immune system such as immunity, and the features of the pathogen, such as replication and 
spread. Infectivity, virulence factors, drug sensitivity and route of transmission may also play a 
role in this variability. Other variables include the seasonal variability of certain diseases, which 
may play a role in the price, demand and subsequent use of vaccines.  
 
Another limitation of the outbreak model is that there is a danger of overfitting the datasets. The 
model has at least 6 parameters, and in the case of a small outbreak, may overfit the data. This is 
most relevant in person-to-person outbreaks. For these outbreaks, it was difficult to find datasets 
that passed our inclusion criteria, so the number of data points was often small. One improvement 
to this model would be to solely apply it to large-scale models.  
 
This work indicates that the incorporation of TDR functions into the incubation distribution of the 
outbreak model provides adequate fits to the outbreak data, especially compared to models that 
don’t include time-dependency factors. This method of modelling disease outbreaks using time-
to-infection was a novel variation to the compartmental modeling approach.  
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9.5. Future research 
The TDR-based model showed success in incorporating the pathogen incubation period into 
outbreak models. The biggest limitation to this system was that outbreak models that contained 
TDR in the incubation period had the benefit of extra parameters compared to other 2-parameter 
functions. If the time-dose-response equations were re-worked so that they contain fewer 
parameters, this would lead to a TDR-based outbreak model that contained less parameters. A key 
aspect of future work would be to include confidence limits to the outbreak fits and parameter 
estimates. This would give more confidence to the conclusion that the TDR-based outbreak 
models gave the best fits to the data.  
 
In this work, incubation time was the primary focus of the outbreak model. Further studies can be 
conducted in which other aspects of the outbreaks are investigated. For example, a model could 
consider the various effects on the exposure function, including routes of transmission, the 
frequency of interaction between population groups in a person-to-person spread, and pathogen 
survival in the environment. Throughout the course of an outbreak, the infectivity of the pathogen 
itself might change, due to seasonality, pathogen adaptations, or vaccinations.  
 
A model that considers changes in infectivity in such pathogens may especially be useful for 
public health officials who are searching for control strategies. Communications with local public 
health agencies is an essential part of predictive disease modelling, and outbreak models which 
reflect the result of different control measures could be generated using several different 
combinations of exposures and incubation functions. By studying these predictive models, a best-
case control strategy could be selected, and public health officials could make informed decisions 
regarding disease control strategies.  
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One additional improvement that could be made would be choosing TDR and outbreak datasets 
that have the same endpoint. In some of the pathogens of interest studied in this work, the 
endpoints of the dose-response differed due to lack of available data. The closer that the outbreak 
parameters are to the dose-response-time models, the less uncertainty is built into the modelling 
system. Future studies could also include pathogens that are more diverse than the ones examined 
in this work. Here, pathogens that caused gastroenteritis were generally used. However, other 
microorganisms that have other endpoints could be modeled. Huang (2010) generated TDR 
models for Bacillus anthracis (anthrax), Yersinia pestis (plague), Francisella tularensis 
(tularemia), and Scrapie agent. Outbreak models for these, and other agents of interest could be 
generated.  
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Appendix A: R source code for dose-response model fitting 
 
erlandsen giardia regular DR.txt: 
dose pos neg 
48 0 6  
454 2 4 
4460 1 2 
5.5E5 2 1 
 
 
DR_Data <- read.table("erlandsen giardia regular DR.txt",header=TRUE) 
dose <- DR_Data$dose 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
oprob <- pos/(pos+neg) 
 
## load("monkey_data.Rdata") 
## datafilename=monkey_data 
## attach(datafilename) 
require(stats4) 
require(boot) 
 
##******************************************************************************* 
## Define the dose response models. 
##    expntl ---> exponential 
##    betapoisson ---> beta Poisson 
##    lp ---> log probit 
## 
 
expntl.dr <- function(k,dose) 1 - exp(-k*dose) 
betapoisson.dr <- function(alpha,N50,dose) 1-(1+dose*(2^(1/alpha)-1)/N50)^(-alpha) 
lp.dr <- function(q1, q2, dose) pnorm(((1/q1) * log((dose/q2)))) 
 
##******************************************************************************** 
## Define functions for deviances of dose-response model fits to experimental data 
## 
deviance.expntl <- function(obspos, obsneg, logk, dose) { 
      eps <- 1e-15; 
      k <- exp(logk) 
      pred <- expntl.dr(k,dose); 
      obs <- obspos/(obspos + obsneg);} 
       
 
deviance.bp <- function(obspos,obsneg,logalpha,logN50,dose) { 
 eps=1e-15; 
 alpha=exp(logalpha); 
 N50=exp(logN50); 
 predf=betapoisson.dr(alpha,N50,dose); 
 obsf=obspos/(obspos+obsneg); 
 t1=-sum(obspos*log(predf/(obsf+eps))); 
 t2=-sum(obsneg*log((1-predf+eps)/(1-(obsf-eps)))); 
 return(1*(t1+t2))} #NOTE - don't include factor of 2 
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results2<-mle(deviance.bp, start=list(logalpha=0.8,logN50=3.4),  
    method = 'BFGS',fixed = list(obspos=pos,obsneg=neg,dose=dose)) 
#print(summary(results2)) 
j<-coef(results2) 
logalpha=j["logalpha"] 
logN50=j["logN50"] 
#print(logalpha) 
#print(logN50) 
 
iterations=3000 
bootparms<-matrix(nrow=iterations,ncol=3) 
for (iter in 1:iterations) { 
  
## bootdataframe=datafilename 
      bootdataframe=DR_Data 
 total=bootdataframe$pos+bootdataframe$neg 
 fobs=bootdataframe$pos/total 
 bootpos<-rbinom(0+fobs,total,fobs) # draw randome sample 
 bootdataframe$pos<-bootpos          # replace and form bootstrap sample 
 results_boot<-mle(deviance.bp,  
          start=list(logalpha=-.2,logN50=9), method = 'BFGS', 
      fixed = list(obspos=bootdataframe$pos, 
          obsneg=total-bootdataframe$pos,dose=bootdataframe$dose)) 
 L<-logLik(results_boot) 
 L<-2*L[[1]] 
 jb<-coef(results_boot) 
 bootparms[iter,1]<-jb["logalpha"] 
 bootparms[iter,2]<-jb["logN50"] 
 bootparms[iter,3]<-L 
## print(iter) 
}     
 
par(font=3) 
plot(bootparms[,1], bootparms[,2], xlab=expression(italic(alpha)),ylab=expression(italic(N[50])),log="xy") 
colnames(bootparms)<-c("logalpha","logN50","neg_2_ln_L") 
bootparms<-data.frame(bootparms) 
print(bootparms) 
 
## 
## plot the best fit model with confidence intervals 
## 
 
X11() 
ndiv <- 400 
alphalist <- exp(bootparms[,1]) 
N50list <- exp(bootparms[,2]) 
dmin <- min(dose)/100 
ldmin <- log10(dmin) 
dmax <- max(dose)*10 
ldmax <- log10(dmax) 
diff <- (ldmax - ldmin)/ndiv 
bestfit<-matrix(nrow=ndiv+1,ncol=1) 
plot01<-matrix(nrow=ndiv+1,ncol=1) 
plot05<-matrix(nrow=ndiv+1,ncol=1) 
plot95<-matrix(nrow=ndiv+1,ncol=1) 
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plot99<-matrix(nrow=ndiv+1,ncol=1) 
plotdose <- matrix(nrow=ndiv+1,ncol=1) 
 
for (iter in 0:ndiv+1) { 
   pdose <- 10^(ldmin + (iter-1)*diff) 
   plotdose[iter] <- pdose 
   bestfit[iter] <- betapoisson.dr(exp(logalpha),exp(logN50),pdose) 
   spread<- betapoisson.dr(alphalist,N50list,pdose) 
   CIs <- quantile(spread,probs=c(0.01,0.05,0.95,0.99))  
   plot01[iter] <- CIs[1] 
   plot05[iter] <- CIs[2] 
   plot95[iter] <- CIs[3] 
   plot99[iter] <- CIs[4]} 
par(cex=1.2,cex.lab=1.4,mai=c(0.95,0.95,0.1,0.15), 
    cex.axis=1.1,mgp=c(2.5,0.75,0))  
plot(dose,pos/(pos+neg),log="x",xlab="Dose", 
     ylab="Response",ylim=c(0,1),pch=17, xlim=c(dmin,dmax)) 
 
## plot(dose,pos/(pos+neg),log="x",xlab="Dose",ylab="Response") 
lines(plotdose,bestfit,lwd=2) 
lines(plotdose,plot01,lty=2,lwd=2) 
lines(plotdose,plot05,lty=3,lwd=2) 
lines(plotdose,plot95,lty=3,lwd=2) 
lines(plotdose,plot99,lty=2,lwd=2) 
legend(dmin,1.0,legend=c("best fit model","95% confidence","99% confidence"), 
     lty=c(1,3,2),bty="n",y.intersp=1.4) 
 
     
## detach(datafilename)  
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Appendix B: R source code for bootstrap dose-response model fitting 
 
DR_Data <- read.table("Campy DR raw data tot.txt",header=TRUE) 
dose <- DR_Data$dose 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
oprob <- pos/(pos+neg) 
 
## load("monkey_data.Rdata") 
## datafilename=monkey_data 
## attach(datafilename) 
require(stats4) 
require(boot) 
X11() 
 
##******************************************************************************* 
## Define the dose response models. 
##    expntl ---> exponential 
##    betapoisson ---> beta Poisson 
##    lp ---> log probit 
## 
 
expntl.dr <- function(k,dose) 1 - exp(-k*dose) 
betapoisson.dr <- function(alpha,N50,dose) 1-(1+dose*(2^(1/alpha)-1)/N50)^(-alpha) 
lp.dr <- function(q1, q2, dose) pnorm(((1/q1) * log((dose/q2)))) 
 
##******************************************************************************** 
## Define functions for deviances of dose-response model fits to experimental data 
## 
deviance.expntl <- function(obspos, obsneg, logk, dose) { 
      eps = 1e-15; 
      k = exp(logk) 
      obsf = obspos/(obspos + obsneg); 
      pred = expntl.dr(k,dose); 
      y1 = sum(obspos*log(pred/(obsf+eps))); 
      y2 = sum(obsneg*log((1-pred+eps)/(1-obsf+eps))) 
      return(-1*(y1+y2)) 
} 
       
 
deviance.bp <- function(obspos,obsneg,logalpha,logN50,dose) { 
 eps=1e-15; 
 alpha=exp(logalpha); 
 N50=exp(logN50); 
 predf=betapoisson.dr(alpha,N50,dose); 
 obsf=obspos/(obspos+obsneg); 
 t1=-sum(obspos*log(predf/(obsf+eps))); 
 t2=-sum(obsneg*log((1-predf+eps)/(1-(obsf-eps)))); 
 return(1*(t1+t2))} #NOTE - don't include factor of 2 
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results2<-mle(deviance.expntl, start=list(logk=-13.001),  
    method = 'BFGS',fixed = list(obspos=pos,obsneg=neg,dose=dose)) 
print(summary(results2)) 
j<-coef(results2) 
logk=j["logk"] 
print(logk) 
 
iterations=3000 
bootparms<-matrix(nrow=iterations,ncol=2) 
for (iter in 1:iterations) { 
## bootdataframe=datafilename 
        bootdataframe=DR_Data 
 total=bootdataframe$pos+bootdataframe$neg 
 fobs=bootdataframe$pos/total 
 bootpos<-rbinom(0+fobs,total,fobs)  # draw random sample 
 bootdataframe$pos<-bootpos          # replace and form bootstrap sample 
 results_boot<-mle(deviance.expntl,start=list(logk=-13), method = 'Nelder-Mead', 
               fixed = list(obspos=bootdataframe$pos, 
               obsneg=total-bootdataframe$pos, 
               dose=bootdataframe$dose)) 
        results_boot 
 L<-logLik(results_boot) 
 L<-2*L[[1]] 
 jb<-coef(results_boot) 
 bootparms[iter,1]<-jb["logk"] 
 bootparms[iter,2]<-L 
## print(iter) 
}     
 
##  plot(bootparms[,1], bootparms[,2],  
##       xlab=expression(italic(alpha)), 
##       ylab=expression(italic(N[50]))) 
par(font=3) 
par(cex=1.4,mai=c(1.2,1.2,0.1,0.15),font.lab=3) 
hhplot <- hist(bootparms[,1],breaks=20,plot=TRUE,xlab="ln(k)",main=" ") 
hhplot 
 
 
## colnames(bootparms)<-c("logalpha","logN50","neg_2_ln_L") 
## bootparms<-data.frame(bootparms) 
## print(bootparms) 
 
## 
## plot the best fit model with confidence intervals 
## 
 
X11() 
ndiv <- 700 
klist <- exp(bootparms[,1]) 
dmin <- min(dose)/100 
ldmin <- log10(dmin) 
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dmax <- max(dose)*10 
ldmax <- log10(dmax) 
diff <- (ldmax - ldmin)/ndiv 
bestfit<-matrix(nrow=ndiv+1,ncol=1) 
plot01<-matrix(nrow=ndiv+1,ncol=1) 
plot05<-matrix(nrow=ndiv+1,ncol=1) 
plot95<-matrix(nrow=ndiv+1,ncol=1) 
plot99<-matrix(nrow=ndiv+1,ncol=1) 
plotdose <- matrix(nrow=ndiv+1,ncol=1) 
 
for (iter in 0:ndiv+1) { 
   pdose <- 10^(ldmin + (iter-1)*diff) 
   plotdose[iter] <- pdose 
   bestfit[iter] <- expntl.dr(exp(logk),pdose) 
   spread<- expntl.dr(klist, pdose) 
   CIs <- quantile(spread,probs=c(0.005,0.025,0.975,0.995))  
   plot01[iter] <- CIs[1] 
   plot05[iter] <- CIs[2] 
   plot95[iter] <- CIs[3] 
   plot99[iter] <- CIs[4]} 
##par(cex=0.9,font.lab=1.3,mai=c(0.6,0.55,0.1,0.15), 
##    cex.axis=0.8,mgp=c(2,0.5,0),font.lab=2) 
par(cex=1.2,cex.lab=1.4,mai=c(0.95,0.95,0.1,0.15), 
    cex.axis=1.1,mgp=c(2.5,0.75,0))  
plot(dose,pos/(pos+neg),log="x",xlab="Dose", 
     ylab="Response (cloacal presence)",ylim=c(0,1),pch=17, xlim=c(dmin,dmax)) 
lines(plotdose,bestfit,lwd=2) 
lines(plotdose,plot01,lty=2,col="black", lwd=2) 
lines(plotdose,plot05,lty=3, col="black", lwd=2) 
lines(plotdose,plot95,lty=3, col="black", lwd=2) 
lines(plotdose,plot99,lty=2, col="black", lwd=2) 
legend(1e4,0.4, 
    legend=c("best fit model","95% confidence","99% confidence","data"), 
    lty=c(1,3,2,0),lwd=c(2,2,2,0), pch=c(-1,-1,-1,17), 
    bty="n",y.intersp=1.1, col=c("black","black","black","black")) 
 
     
## detach(datafilename)  
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Appendix C: R source code for time-dose-response model fitting 
 
C.1. Beta-Poisson with exponential reciprocal time dependency 
leg.txt 
dose pos neg TPI 
1E+03 0 10 1 
1E+04 0 10 1 
1E+05 0 10 1 
1E+06 0 10 1 
1E+07 0 10 1 
1E+08 0 10 1 
1E+09 0 10 1 
1E+03 0 10 2 
1E+04 0 10 2 
1E+05 0 10 2 
1E+06 0 10 2 
1E+07 0 10 2 
1E+08 4 6 2 
1E+09 8 2 2 
1E+03 0 10 3 
1E+04 0 10 3 
1E+05 0 10 3 
1E+06 0 10 3 
1E+07 2 8 3 
1E+08 6 0 3 
1E+09 2 0 3 
1E+03 0 10 4 
1E+04 0 10 4 
1E+05 1 9 4 
1E+06 5 5 4 
1E+07 8 0 4 
1E+08 0 0 4 
1E+09 0 0 4 
1E+03 0 10 5 
1E+04 0 10 5 
1E+05 3 6 5 
1E+06 3 2 5 
1E+07 0 0 5 
1E+08 0 0 5 
1E+09 0 0 5 
1E+03 0 10 6 
1E+04 3 8 6 
1E+05 5 1 6 
1E+06 2 0 6 
1E+07 0 0 6 
1E+08 0 0 6 
1E+09 0 0 6 
1E+03 0 10 7 
1E+04 0 8 7 
279 
 
 
 
1E+05 0 1 7 
1E+06 0 0 7 
1E+07 0 0 7 
1E+08 0 0 7 
1E+09 0 0 7 
1E+03 0 10 8 
1E+04 0 8 8 
1E+05 0 1 8 
1E+06 0 0 8 
1E+07 0 0 8 
1E+08 0 0 8 
1E+09 0 0 8 
1E+03 0 10 9 
1E+04 0 8 9 
1E+05 0 1 9 
1E+06 0 0 9 
1E+07 0 0 9 
1E+08 0 0 9 
1E+09 0 0 9 
1E+03 0 10 10 
1E+04 0 8 10 
1E+05 0 1 10 
1E+06 0 0 10 
1E+07 0 0 10 
1E+08 0 0 10 
1E+09 0 0 10   
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require(stats4) 
 
DR_Data <- read.table("leg.txt",header=TRUE) 
DR_Data$tot <- DR_Data$pos + DR_Data$neg 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
dose <- DR_Data$dose 
TPI <- DR_Data$TPI 
 
# 
#  Define dose response function.  
#  This program uses only the approximate beta-Poisson (abp) 
#  modified to account for time-post-inoculation (TPI) 
#  
 
# Approximate beta-Poisson 
abp.dr<-function(alpha,N50,d) 1-(1+d*(2^(1/alpha)-1)/N50)^(-alpha) 
 
# power exponential model for N50 
N50model <- function(j0,TPI) {((j0/TPI))} 
 
controllist=list(trace=1,maxit=300,reltol=1e-12); 
opos=pos;   # observed positive responses 
oneg=neg;   # observed negative responses 
d=dose; # estimated dose 
 
#Define the deviance function and output the value of the deviance that 
#will latter be used in the minimization to find the minimum deviance 
#with the parameters for the different dose response models 
#Y signifies the deviance then syntax is .(dose response model used) 
 
dev.abp <-function(opos,oneg,alpha,j_0,d,TPI) { 
 eps=1e-16; 
      TPIM <- TPI - 1 + eps 
      kk1 <- N50model(j_0,TPIM)   # j_2*exp(j_0*TPI)  
      kk2 <- N50model(j_0,TPI)   # kmodel(r,alpha,TPI) 
      for (i in 1:length(d)) { 
         kk1[i] <- max(eps,kk1[i]); 
         kk2[i] <- max(eps,kk2[i]);} 
      pred=abs(abp.dr(alpha,kk1,d) - abp.dr(alpha,kk2,d))/ 
          (1-abp.dr(alpha,kk1,d)+eps); 
 obs=opos/(opos+oneg+eps); 
 opos=pos; 
 oneg=neg; 
 d=dose; 
 y1=sum(opos*log(pred/(obs+eps))); 
 y2=sum(oneg*log((1-pred+eps)/(1-(obs-eps)))); 
 return(-1*(y1+y2)) } 
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#  Estimate d-r model parameters via maximu likelihood. 
#  Deviance function (dev.abp) is optimized via built-in  
#  optimization routines  
print(",______________________________________________________,") 
print("|Optimization for the deviance of the beta-Poisson TPI Model|") 
print("|______________________________________________________|") 
 
results_abp<-mle(dev.abp,  
            start=list(alpha=0.2231168,j_0=2.065900e+07),  
            method = 'BFGS',control=controllist,  
            fixed = list(opos=pos,oneg=neg,d=dose,TPI=TPI)) 
 
#  print parameters and deviance from the maximum likelihood estimation 
 
print(summary(results_abp)) 
length(dose) 
lnnz <- length(DR_Data$tot[DR_Data$tot > 0.1]) 
qchisq(0.95,lnnz-4,lower.tail=TRUE) 
 
j<-coef(results_abp) # gives the parameter estimates 
alpha=j["alpha"]  
j_1=j["j_1"] 
print(list(alpha,j_1)) 
  
#  
# Plot results 
#  
 
AllT <- unique(TPI); 
L_AllT <- length(AllT); 
AllN50 <- N50model(j_0,AllT); 
 
d=dose; 
dmin <- min(d) 
dmax <- max(d) 
dminl <- log10(dmin)-5 
dmaxl <- log10(dmax)+2 
dl <- seq(dminl,dmaxl,by=0.05) 
dp <- 10^dl 
 
TPIP <- unique(DRP$TPI); 
LTPIP <- length(TPIP); 
XC <- rainbow(LTPIP,start=0,end=0.75) 
 
predPlot <- abp.dr(alpha,AllN50[1],dp) 
par(mai=c(1.1,1.1,0.2,0.2)) 
plot(dp,predPlot,log="x",type="l",ylim=c(0,1),xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
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DRP <- read.table("leg_Cumulative.txt",header=TRUE)  
DRP$Tot <- DRP$pos / (DRP$pos + DRP$neg); 
 
for(i in 1:LTPIP) { 
   points(DRP$dose[DRP$TPI==TPIP[i]], 
          DRP$Tot[DRP$TPI==TPIP[i]],col=XC[LTPIP+1-i], 
          pch=16,cex=1.4) } 
xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
 
 
C.2. Beta-Poisson with exponential time dependency 
require(stats4) 
 
DR_Data <- read.table("leg.txt",header=TRUE) 
DR_Data$tot <- DR_Data$pos + DR_Data$neg 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
dose <- DR_Data$dose 
TPI <- DR_Data$TPI 
 
# 
#  Define dose response function.  
#  This program uses only the approximate beta-Poisson (abp) 
#  modified to account for time-post-inoculation (TPI)  
#  
 
# Approximate beta-Poisson 
abp.dr<-function(alpha,N50,d) 1-(1+d*(2^(1/alpha)-1)/N50)^(-alpha) 
 
#  power exponential model for N50 
N50model <- function(j0,j1,TPI) {exp(j0*TPI+j1)} 
 
controllist=list(trace=1,maxit=200000,reltol=1e-12); 
#reltol=1e-12); 
opos=pos;   # observed positive responses 
oneg=neg;   # observed negative responses 
d=dose; # estimated dose 
 
#Define the deviance function and output the value of the deviance that 
#will latter be used in the minimization to find the minimum deviance 
#with the parameters for the different dose response models 
#Y signifies the deviance then syntax is .(dose response model used) 
 
dev.abp <-function(opos,oneg,alpha,j_0,j_1,d,TPI) { 
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 eps=1e-16; 
      TPIM <- TPI - 1 + eps 
      kk1 <- N50model(j_0,j_1,TPIM)   # j_2*exp(j_0*TPI)  
      kk2 <- N50model(j_0,j_1,TPI)   # kmodel(r,alpha,TPI) 
      for (i in 1:length(d)) { 
         kk1[i] <- max(eps,kk1[i]); 
         kk2[i] <- max(eps,kk2[i]);} 
      pred=abs(abp.dr(alpha,kk1,d) - abp.dr(alpha,kk2,d))/ 
          (1-abp.dr(alpha,kk1,d)+eps); 
 obs=opos/(opos+oneg+eps); 
 opos=pos; 
 oneg=neg; 
 d=dose; 
 y1=sum(opos*log(pred/(obs+eps))); 
 y2=sum(oneg*log((1-pred+eps)/(1-(obs-eps)))); 
 return(-1*(y1+y2)) } 
  
 
#  Estimate d-r model parameters via maximu likelihood. 
#  Deviance function (dev.abp) is optimized via built-in  
#  optimization routines  
print(",______________________________________________________,") 
print("|Optimization for the deviance of the beta-Poisson TPI Model|") 
print("|______________________________________________________|") 
 
results_abp<-mle(dev.abp,  
            start=list(alpha=5,j_0=0.10,j_1=0.0001),  
            method = 'BFGS',control=controllist,  
            fixed = list(opos=pos,oneg=neg,d=dose,TPI=TPI)) 
 
#  print parameters and deviance from the maximum likelihood estimation 
 
print(summary(results_abp)) 
length(dose) 
lnnz <- length(DR_Data$tot[DR_Data$tot > 0.1]) 
qchisq(0.95,lnnz-4,lower.tail=TRUE) 
 
j<-coef(results_abp) # gives the parameter estimates 
alpha=j["alpha"]  
j_0=j["j_0"]  
j_1=j["j_1"] 
print(list(alpha,j_0,j_1)) 
  
#  
# Plot results 
#  
 
AllT <- unique(TPI); 
L_AllT <- length(AllT); 
AllN50 <- N50model(j_0,j_1,AllT); 
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d=dose; 
dmin <- min(d) 
dmax <- max(d) 
dminl <- log10(dmin)-2 
dmaxl <- log10(dmax)+2 
dl <- seq(dminl,dmaxl,by=0.05) 
dp <- 10^dl 
 
TPIP <- unique(DRP$TPI); 
LTPIP <- length(TPIP); 
XC <- rainbow(LTPIP,start=0,end=0.75) 
 
predPlot <- abp.dr(alpha,AllN50[1],dp) 
par(mai=c(1.1,1.1,0.2,0.2)) 
plot(dp,predPlot,log="x",type="l",xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
 
DRP <- read.table("leg_Cumulative.txt",header=TRUE)  
DRP$Tot <- DRP$pos / (DRP$pos + DRP$neg); 
 
for(i in 1:LTPIP) { 
   points(DRP$dose[DRP$TPI==TPIP[i]], 
          DRP$Tot[DRP$TPI==TPIP[i]],col=XC[LTPIP+1-i], 
          pch=16,cex=1.4) }  
 
 
 
C.3. Beta-Poisson with exponential time dependency 
require(stats4) 
 
DR_Data <- read.table("leg.txt",header=TRUE) 
DR_Data$tot <- DR_Data$pos + DR_Data$neg 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
dose <- DR_Data$dose 
TPI <- DR_Data$TPI 
 
# 
#  Define dose response function.  
#  This program uses only the approximate beta-Poisson (abp) 
#  modified to account for time-post-inoculation (TPI)  
#  
 
# Approximate beta-Poisson 
abp.dr<-function(alpha,N50,d) 1-(1+d*(2^(1/alpha)-1)/N50)^(-alpha) 
 
# Power exponential model for N50 
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N50model <- function(j0,TPI) {((j0/TPI))} 
 
controllist=list(trace=1,maxit=300,reltol=1e-12); 
opos=pos;   # observed positive responses 
oneg=neg;   # observed negative responses 
d=dose; # estimated dose 
 
#Define the deviance function and output the value of the deviance that 
#will latter be used in the minimization to find the minimum deviance 
#with the parameters for the different dose response models 
#Y signifies the deviance then syntax is .(dose response model used) 
 
dev.abp <-function(opos,oneg,alpha,j_0,d,TPI) { 
 eps=1e-16; 
      TPIM <- TPI - 1 + eps 
      kk1 <- N50model(j_0,TPIM)   # j_2*exp(j_0*TPI)  
      kk2 <- N50model(j_0,TPI)   # kmodel(r,alpha,TPI) 
      for (i in 1:length(d)) { 
         kk1[i] <- max(eps,kk1[i]); 
         kk2[i] <- max(eps,kk2[i]);} 
      pred=abs(abp.dr(alpha,kk1,d) - abp.dr(alpha,kk2,d))/ 
          (1-abp.dr(alpha,kk1,d)+eps); 
 obs=opos/(opos+oneg+eps); 
 opos=pos; 
 oneg=neg; 
 d=dose; 
 y1=sum(opos*log(pred/(obs+eps))); 
 y2=sum(oneg*log((1-pred+eps)/(1-(obs-eps)))); 
 return(-1*(y1+y2)) } 
  
 
#  Estimate d-r model parameters via maximu likelihood. 
#  Deviance function (dev.abp) is optimized via built-in  
#  optimization routines  
print(",______________________________________________________,") 
print("|Optimization for the deviance of the beta-Poisson TPI Model|") 
print("|______________________________________________________|") 
 
results_abp<-mle(dev.abp,  
            start=list(alpha=0.2231168,j_0=2.065900e+07),  
            method = 'BFGS',control=controllist,  
            fixed = list(opos=pos,oneg=neg,d=dose,TPI=TPI)) 
 
#  print parameters and deviance from the maximum likelihood estimation 
 
print(summary(results_abp)) 
length(dose) 
lnnz <- length(DR_Data$tot[DR_Data$tot > 0.1]) 
qchisq(0.95,lnnz-4,lower.tail=TRUE) 
 
j<-coef(results_abp) # gives the parameter estimates 
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alpha=j["alpha"]  
j_1=j["j_1"] 
print(list(alpha,j_1)) 
  
#  
# Plot results 
#  
 
AllT <- unique(TPI); 
L_AllT <- length(AllT); 
AllN50 <- N50model(j_0,AllT); 
 
d=dose; 
dmin <- min(d) 
dmax <- max(d) 
dminl <- log10(dmin)-5 
dmaxl <- log10(dmax)+2 
dl <- seq(dminl,dmaxl,by=0.05) 
dp <- 10^dl 
 
TPIP <- unique(DRP$TPI); 
LTPIP <- length(TPIP); 
XC <- rainbow(LTPIP,start=0,end=0.75) 
 
predPlot <- abp.dr(alpha,AllN50[1],dp) 
par(mai=c(1.1,1.1,0.2,0.2)) 
plot(dp,predPlot,log="x",type="l",ylim=c(0,1),xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
 
DRP <- read.table("leg_Cumulative.txt",header=TRUE)  
DRP$Tot <- DRP$pos / (DRP$pos + DRP$neg); 
 
for(i in 1:LTPIP) { 
   points(DRP$dose[DRP$TPI==TPIP[i]], 
          DRP$Tot[DRP$TPI==TPIP[i]],col=XC[LTPIP+1-i], 
          pch=16,cex=1.4) } 
xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
 
 
 
287 
 
 
 
C.4. Exponential with exponential time dependency 
require(stats4) 
 
DR_Data <- read.table("leg.txt",header=TRUE) 
DR_Data$tot <- DR_Data$pos + DR_Data$neg 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
dose <- DR_Data$dose 
TPI <- DR_Data$TPI 
 
# 
#  Define dose response function.  
#  This program uses only the approximate beta-Poisson (abp) 
#  modified to account for time-post-inoculation (TPI) 
#  
 
# Approximate beta-Poisson 
abp.dr<-function(alpha,N50,d) 1-(1+d*(2^(1/alpha)-1)/N50)^(-alpha) 
 
# Power exponential model for N50 
N50model <- function(j0,j1,TPI) {exp((j0/TPI)+j1)} 
 
controllist=list(trace=1,maxit=30,reltol=1e-12); 
opos=pos;   # observed positive responses 
oneg=neg;   # observed negative responses 
d=dose; # estimated dose 
 
#Define the deviance function and output the value of the deviance that 
#will latter be used in the minimization to find the minimum deviance 
#with the parameters for the different dose response models 
#Y signifies the deviance then syntax is .(dose response model used) 
 
dev.abp <-function(opos,oneg,alpha,j_0,j_1,d,TPI) { 
 eps=1e-6; 
      TPIM <- TPI - 1 + eps 
      kk1 <- N50model(j_0,j_1,TPIM)   # j_2*exp(j_0*TPI)  
      kk2 <- N50model(j_0,j_1,TPI)   # kmodel(r,alpha,TPI) 
      for (i in 1:length(d)) { 
         kk1[i] <- max(eps,kk1[i]); 
         kk2[i] <- max(eps,kk2[i]);} 
      pred=abs(abp.dr(alpha,kk1,d) - abp.dr(alpha,kk2,d))/ 
          (1-abp.dr(alpha,kk1,d)+eps); 
 obs=opos/(opos+oneg+eps); 
 opos=pos; 
 oneg=neg; 
 d=dose; 
 y1=sum(opos*log(pred/(obs+eps))); 
 y2=sum(oneg*log((1-pred+eps)/(1-(obs-eps)))); 
 return(-1*(y1+y2)) } 
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#  Estimate d-r model parameters via maximu likelihood. 
#  Deviance function (dev.abp) is optimized via built-in  
#  optimization routines  
print(",______________________________________________________,") 
print("|Optimization for the deviance of the beta-Poisson TPI Model|") 
print("|______________________________________________________|") 
 
results_abp<-mle(dev.abp,  
            start=list(alpha=3.5,j_0=5.3,j_1=0.0001),  
            method = 'BFGS',control=controllist,  
            fixed = list(opos=pos,oneg=neg,d=dose,TPI=TPI)) 
 
#  print parameters and deviance from the maximum likelihood estimation 
 
print(summary(results_abp)) 
length(dose) 
lnnz <- length(DR_Data$tot[DR_Data$tot > 0.1]) 
qchisq(0.95,lnnz-4,lower.tail=TRUE) 
 
j<-coef(results_abp) # gives the parameter estimates 
alpha=j["alpha"]  
j_0=j["j_0"]  
j_1=j["j_1"] 
print(list(alpha,j_0,j_1)) 
  
#  
# Plot results 
#  
 
AllT <- unique(TPI); 
L_AllT <- length(AllT); 
AllN50 <- N50model(j_0,j_1,AllT); 
 
d=dose; 
dmin <- min(d) 
dmax <- max(d) 
dminl <- log10(dmin)-2 
dmaxl <- log10(dmax)+2 
dl <- seq(dminl,dmaxl,by=0.05) 
dp <- 10^dl 
 
TPIP <- unique(DRP$TPI); 
LTPIP <- length(TPIP); 
XC <- rainbow(LTPIP,start=0,end=0.75) 
 
predPlot <- abp.dr(alpha,AllN50[1],dp) 
par(mai=c(1.1,1.1,0.2,0.2)) 
 
plot(dp,predPlot,log="x",type="l 
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require(stats4) 
 
DR_Data <- read.table("leg.txt",header=TRUE) 
DR_Data$tot <- DR_Data$pos + DR_Data$neg 
pos <- DR_Data$pos 
neg <- DR_Data$neg 
dose <- DR_Data$dose 
TPI <- DR_Data$TPI 
 
# 
#  Define dose response function.  
#  This program uses only the approximate beta-Poisson (abp) 
#  modified to account for time-post-inoculation (TPI 
#  
 
# Approximate beta-Poisson 
abp.dr<-function(alpha,N50,d) 1-(1+d*(2^(1/alpha)-1)/N50)^(-alpha) 
 
# Power exponential model for N50 
N50model <- function(j0,j1,TPI) {exp((j0/TPI)+j1)} 
 
controllist=list(trace=1,maxit=30,reltol=1e-12); 
opos=pos;   # observed positive responses 
oneg=neg;   # observed negative responses 
d=dose; # estimated dose 
 
#Define the deviance function and output the value of the deviance that 
#will latter be used in the minimization to find the minimum deviance 
#with the parameters for the different dose response models 
#Y signifies the deviance then syntax is .(dose response model used) 
 
dev.abp <-function(opos,oneg,alpha,j_0,j_1,d,TPI) { 
 eps=1e-6; 
      TPIM <- TPI - 1 + eps 
      kk1 <- N50model(j_0,j_1,TPIM)   # j_2*exp(j_0*TPI)  
      kk2 <- N50model(j_0,j_1,TPI)   # kmodel(r,alpha,TPI) 
      for (i in 1:length(d)) { 
         kk1[i] <- max(eps,kk1[i]); 
         kk2[i] <- max(eps,kk2[i]);} 
      pred=abs(abp.dr(alpha,kk1,d) - abp.dr(alpha,kk2,d))/ 
          (1-abp.dr(alpha,kk1,d)+eps); 
 obs=opos/(opos+oneg+eps); 
 opos=pos; 
 oneg=neg; 
 d=dose; 
 y1=sum(opos*log(pred/(obs+eps))); 
 y2=sum(oneg*log((1-pred+eps)/(1-(obs-eps)))); 
 return(-1*(y1+y2)) } 
  
 
#  Estimate d-r model parameters via maximu likelihood. 
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#  Deviance function (dev.abp) is optimized via built-in  
#  optimization routines  
print(",______________________________________________________,") 
print("|Optimization for the deviance of the beta-Poisson TPI Model|") 
print("|______________________________________________________|") 
 
results_abp<-mle(dev.abp,  
            start=list(alpha=0.01,j_0=5,j_1=0.01),  
            method = 'BFGS',control=controllist,  
            fixed = list(opos=pos,oneg=neg,d=dose,TPI=TPI)) 
 
#  print parameters and deviance from the maximum likelihood estimation 
 
print(summary(results_abp)) 
length(dose) 
lnnz <- length(DR_Data$tot[DR_Data$tot > 0.1]) 
qchisq(0.95,lnnz-4,lower.tail=TRUE) 
 
j<-coef(results_abp) # gives the parameter estimates 
alpha=j["alpha"]  
j_0=j["j_0"]  
j_1=j["j_1"] 
print(list(alpha,j_0,j_1)) 
  
#  
# Plot results 
#  
 
AllT <- unique(TPI); 
L_AllT <- length(AllT); 
AllN50 <- N50model(j_0,j_1,AllT); 
 
d=dose; 
dmin <- min(d) 
dmax <- max(d) 
dminl <- log10(dmin)-2 
dmaxl <- log10(dmax)+2 
dl <- seq(dminl,dmaxl,by=0.05) 
dp <- 10^dl 
 
TPIP <- unique(DRP$TPI); 
LTPIP <- length(TPIP); 
XC <- rainbow(LTPIP,start=0,end=0.75) 
 
predPlot <- abp.dr(alpha,AllN50[1],dp) 
par(mai=c(1.1,1.1,0.2,0.2)) 
plot(dp,predPlot,log="x",type="l",ylim=c(0, 1),xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
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DRP <- read.table("leg_Cumulative.txt",header=TRUE)  
DRP$Tot <- DRP$pos / (DRP$pos + DRP$neg); 
 
for(i in 1:LTPIP) { 
   points(DRP$dose[DRP$TPI==TPIP[i]], 
          DRP$Tot[DRP$TPI==TPIP[i]],col=XC[LTPIP+1-i], 
          pch=16,cex=1.4) } 
xlab="Dose (CFU)",ylab="Response", 
     col=XC[1],cex.lab=1.2) 
for(i in 2:L_AllT) { 
   predPlot <- abp.dr(alpha,AllN50[i],dp) ; 
   lines(dp,predPlot,col=XC[i]); } 
 
DRP <- read.table("leg_Cumulative.txt",header=TRUE)  
DRP$Tot <- DRP$pos / (DRP$pos + DRP$neg); 
 
for(i in 1:LTPIP) { 
   points(DRP$dose[DRP$TPI==TPIP[i]], 
          DRP$Tot[DRP$TPI==TPIP[i]],col=XC[LTPIP+1-i], 
          pch=16,cex=1.4) } 
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Appendix D: Matlab source code for outbreak model fitting 
 
fitdriver.m 
 
%driver to do the fitting 
global bestQ bestcoeffs intfuncevals convcriteria 
intfuncevals=1000*1;  %max integration intervals in quad2d.  start at 1000 
convcriteria=[0.001 1e-2]/(10^0);  %{abs rel} convergence criteria for quad2d (start at 10^0) 
  
%time start time end    cases 
  
%Samonis/Shigella Gupta model 
%data=[17    18  2 
%    18  19  2 
%    20  21  2 
%    21  22  2 
%    22  23  9 
%    23  24  11 
%    24  25  14 
%    25  26  9 
%    26  27  16 
%    27  28  3 
%    28  29  2 
%    29  30  1 
%    30  31  2]; 
  
% Melbourne Egan data 
data=[1     2    4 
2  3   3 
3  4   7 
4  5   10 
5  6   16 
6  7   10 
7  8   8 
8  9   12 
9  10  13 
10 11  12 
11 12  11 
12 13  7 
13 14  5 
14 15  3 
15 16  1 
16 17  1 
17 18  1]; 
  
%  params(1): b0 - attack param         b0 
%  params(2): b1 - attack param         b1 
%  params(3): pdfparam1 (attack distr)  param1 
%  params(4): pdfparam2 (attack distr)  param2 
%  params(5): pdfparam3 (attack distr)   k0 
%  params(6): pdfparam2 (incub distr)   theta 
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%  params(7): pdfparam3 (incub distr)   dose 
  
%0.053103    -0.50314      6.3239  3.3252e-05      1.5807     -0.2539      3.3696 
%0.4518   -1.5454    2.5668    2.0699    0.1324   -0.3313    2.0174 
%0.39522      0.6143      1.6147      1.7471    0.078993     0.58718     0.71556 
  
guesses=([0.207     -1.2456       1.376      1.4886     0.11506     0.60354     0.73565      1.0307]);  
   
other.exposuredist='lognorm'; 
other.incubdist='tpi3'; 
  
other.N0=514; 
  
bestQ=inf;bestcoeffs=[]; 
OPTIONS= optimset('TolX',1e-15,'display','iter','PlotFcns',{@optimplotfval,@optimplotfunccount},... 
    'DiffMinChange',convcriteria(2)); 
OPTIONSps= psoptimset('TolX',1e-15,'display','iter','InitialMeshSize',0.1,'CompletePoll','on',... 
    'SearchMethod',{@searchlhs,500,9},'Cache','on','CacheSize',1000,'CacheTol',1e-5,... 
    'ScaleMesh','on'); 
  
ga_increment=0.2; 
LB=guesses-ga_increment;UB=guesses+ga_increment; 
OPTIONSga=gaoptimset('Display','iter'); 
warning('off','MATLAB:quad2d:maxFunEvalsPass'); %disable maxiter warnings if integration is OK 
while bestQ>1, 
      [bestfit,bestf]=fminsearch(@(x) obj_func(x,data,other),guesses,OPTIONS); 
%     [bestfit,bestf]=fminunc(@(x) obj_func(x,data,other),guesses,OPTIONS); 
%     [bestfit,bestf]=patternsearch(@(x) obj_func(x,data,other),guesses,[],[],[],[],[],[],[],OPTIONSps); 
%     [bestfit,bestf]=ga(@(x) obj_func(x,data,other),length(guesses),[],[],[],[],LB,UB,[],OPTIONSga) 
%      [bestfit,bestf]=lsqcurvefit(@(x) obj_func(x,data,other),guesses,data(:,2),data(:,3)); 
    guesses=bestfit; 
end; 
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NumberIll.m 
 
function [ ill,errbnd ] = NumberIll( params,exposuredist,incubdist,t1,t2,N0,convcriteria ) 
global intfuncevals 
%This evaluates the total ill between t1 and t2 in a simple disease transmission model by 
%direct double integration 
  
[ill errbnd]=quad2d(@(tout,tin) integrand(tout,tin,params,N0,exposuredist,incubdist),t1,t2,0,t2,... 
    'RelTol',convcriteria(2),'AbsTol',convcriteria(1),'MaxFunEvals',intfuncevals,'Singular',true); 
  
end 
  
function I = integrand(touter,tinner,params,N0,attackpdf,incubationpdfname) 
[betaval B]=occurrence(attackpdf,tinner,params(1),params(2),params(3),params(4)); 
tmp1=betaval.*N0.*exp(-B); 
    if (touter<=tinner) 
        tmp2=0; 
    else 
       tmp2=incubationpdf(incubationpdfname,touter-tinner,params(5),params(6),params(7),params(8)); 
    end 
I=tmp1.*tmp2; 
end 
  
function [betaval,B]=occurrence(pdfname,time,b0,b1,pdfparam1,pdfparam2); 
  
%returns beta and integral of beta - attack rate (exposure) 
switch lower(pdfname) 
    case('gamma') 
%       param1=mean; param2=var; 
        a=(pdfparam1^2)/pdfparam2; 
        b=pdfparam2/pdfparam1; 
        betaval=b0+b1*gampdf(time,a,b); 
        B=b0*time+b1*gamcdf(time,a,b); 
    case('lognorm') 
%       param1=norm(log); param2=log(sd) 
        betaval=b0+b1*lognpdf(time,pdfparam1,pdfparam2); 
        B=b0*time+b1*logncdf(time,pdfparam1,pdfparam2); 
    case('weibull') 
        betaval=b0+b1*wblpdf(time,pdfparam1,pdfparam2); 
        B=b0*time+b1*wblcdf(time,pdfparam1,pdfparam2); 
    case('uniform') 
        betaval=b0+b1*unifpdf(time,pdfparam1,pdfparam2); 
        B=b0*time+b1*unifcdf(time,pdfparam1,pdfparam2); 
end   
end 
  
  
%function [f] = incubationpdf(pdfname,time,pdfparam1,pdfparam2,pdfparam3) 
function [f] = incubationpdf(pdfname,time,pdfparam1,pdfparam2,pdfparam3,pdfparam4) 
%returns incubationpdf f(t) 
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switch lower(pdfname) 
    case('gamma') 
        a=(pdfparam1^2)/pdfparam2; 
        b=pdfparam2/pdfparam1; 
        f=gampdf(time,a,b); 
    case('lognorm') 
        f=lognpdf(time,pdfparam1,pdfparam2); 
    case('weibull') 
        f=wblpdf(time,pdfparam1,pdfparam2); 
    case('uniform') 
        f=unifpdf(time,pdfparam1,pdfparam2); 
    case('tpi1') 
        k0=pdfparam1; 
        theta=pdfparam2; 
        dose=pdfparam3; 
        if time<=1e-15 
            f=2.*exp((k0./time)+theta).*exp(-exp((k0./time)+theta).*dose)./(k0.*dose.*(1-exp(-
exp(theta).*dose)).*(1+dose.*exp((k0./time)+theta))); 
        else f=k0.*dose.*exp((k0./time)-theta).*exp(-exp((k0./time)-theta).*dose)./((time.^2).*(1-exp(-exp(-
theta).*dose))); 
        end 
     case('tpi2') 
        k0=pdfparam1; 
        theta=pdfparam2; 
        dose=pdfparam3; 
        f=k0.*dose.*exp((k0.*time)+theta).*exp(-exp((k0.*time)+theta).*dose); 
     case('tpi3') 
        alpha=pdfparam1; 
        d=pdfparam2; 
        j0=pdfparam3; 
        j1=pdfparam4; 
        f=alpha.*d.*j0.*(1+d.*2.^(-(-1+alpha)./alpha)).^alpha.*(exp(-
j0./(time+j1)).*(exp(j0./(time+j1))+d.*2.^(1./alpha)-d)).^(-alpha).*(2.^(1./alpha)-
1)./((time+j1).^2.*((1+d.*2.^(-(-1+alpha)./alpha)).^alpha-1).*(exp(j0./(time+j1))+d.*2.^(1./alpha)-d)); 
         
end 
end 
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obj_func.m 
 
function [ Y ] = obj_func( coeffs,data,otherparams ) 
%computes deviance 
global bestQ bestcoeffs convcriteria 
%coeffs=exp(coeffs);  %invert log transform 
Npred=0*data(:,1); 
coeffs; 
for i=1:size(data,1), 
    Npred(i)=NumberIll( coeffs,otherparams.exposuredist,otherparams.incubdist... 
        ,data(i,1),data(i,2),otherparams.N0,convcriteria ); 
   
end;     
  
  
%compute deviance 
Q=-2*((data(:,3)-Npred(:))-data(:,3).*log(data(:,3)./Npred(:))); 
if min(Npred)<0, 
    i=find(Npred<0); 
    Y=length(i)*1e50; 
else     
    Y=sum(Q); 
end;     
if Y<bestQ, 
    bestQ=Y; 
    bestcoeffs=coeffs; 
    tm=(data(:,1)+data(:,2))/2; 
     figure(1); 
     plot(tm,data(:,3),'ko',tm,Npred,'k-'); 
    pause(0.01); 
    cc=reshape(coeffs,1,length(coeffs)); 
    A=num2str([cc]); 
    A=['                   -----' A]; 
    disp(A); 
end;     
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Appendix E: Outbreak datasets for pathogens 
 
Table E.1 Legionella pneumophila outbreak data (Epidemic data): Okada et al. 2005 
 
Time Start Time End Cases 
1 2 1 
3 4 2 
4 5 2 
5 6 1 
7 8 1 
11 12 2 
12 13 3 
13 14 2 
14 15 8 
15 16 8 
16 17 8 
17 18 11 
18 19 10 
19 20 11 
20 21 17 
21 22 6 
22 23 11 
23 24 8 
24 25 11 
25 26 9 
26 27 10 
27 28 15 
28 29 11 
29 30 15 
30 31 11 
31 32 10 
32 33 16 
33 34 7 
34 35 15 
35 36 6 
36 37 6 
37 38 2 
38 39 5 
39 40 1 
40 41 3 
43 44 1 
44 45 2 
46 47 1 
51 52 1 
53 54 2 
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Table E.2 Legionella pneumophila outbreak data (Epidemic data): Greig et al. 2004 
 
 
Time Start Time End Cases 
1 2 4 
2 3 3 
3 4 7 
4 5 10 
5 6 16 
6 7 10 
7 8 8 
8 9 12 
9 10 13 
10 11 12 
11 12 11 
12 13 7 
13 14 5 
14 15 3 
15 16 1 
17 18 1 
19 20 1 
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Table E.3 Giardia lamblia outbreak data (Epidemic data): Kent et al. 1988 
 
Time Start Time End Cases 
1 2 3 
5 6 1 
6 7 2 
7 8 1 
9 10 1 
11 12 3 
12 13 1 
13 14 1 
14 15 3 
15 16 9 
16 17 1 
17 18 4 
18 19 3 
19 20 4 
20 21 9 
21 22 7 
22 23 7 
23 24 10 
24 25 10 
25 26 17 
26 27 15 
27 28 19 
28 29 61 
29 30 51 
30 31 29 
31 32 31 
32 33 32 
33 34 14 
34 35 23 
35 36 19 
36 37 11 
37 38 17 
38 39 12 
39 40 20 
40 41 10 
41 42 14 
42 43 19 
43 44 14 
44 45 10 
45 46 11 
46 47 7 
47 48 4 
48 49 11 
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Table E.3 (continued) Giardia lamblia outbreak data (Epidemic data): Kent et al. 1988  
 
49 50 4 
50 51 7 
51 52 2 
52 53 5 
53 54 5 
54 55 3 
55 56 7 
56 57 2 
58 59 1 
59 60 1 
60 61 1 
61 62 2 
62 63 2 
63 64 1 
64 65 1 
65 66 1 
67 68 2 
69 70 2 
75 76 1 
78 79 1 
80 81 1 
88 89 1 
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Table E.4 Salmonella Newport outbreak data (Epidemic data): Irvine et al. 2009 
 
Time Start Time End Cases 
1 2 1 
2 3 1 
4 5 1 
5 6 3 
7 8 5 
8 9 1 
10 11 7 
11 12 3 
12 13 3 
13 14 6 
14 15 2 
15 16 6 
16 17 3 
17 18 2 
18 19 4 
19 20 7 
20 21 5 
21 22 12 
22 23 10 
23 24 15 
24 25 6 
25 26 8 
26 27 4 
27 28 8 
28 29 10 
29 30 11 
30 31 5 
31 32 5 
32 33 5 
33 34 6 
34 35 6 
35 36 7 
36 37 6 
37 38 6 
38 39 3 
39 40 4 
40 41 2 
41 42 2 
42 43 3 
43 44 5 
44 45 4 
46 47 3 
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Table E.4 (continued) Salmonella Newport outbreak data (Epidemic data): Irvine et al. 2009  
 
 
47 48 4 
48 49 2 
49 50 1 
50 51 2 
51 52 2 
52 53 4 
53 54 2 
56 57 2 
57 58 1 
58 59 3 
60 61 2 
61 62 2 
62 63 1 
64 65 4 
65 66 3 
66 67 1 
68 69 4 
70 71 2 
71 72 2 
72 73 1 
75 76 1 
76 77 1 
78 79 3 
83 84 1 
85 86 3 
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Table E.5 Salmonella Typhimurium primary outbreak data (Epidemic data): Torok et al. 1997 
 
 
Time Start Time End Cases 
1 2 2 
2 3 3 
3 4 5 
4 5 3 
5 6 23 
6 7 31 
7 8 98 
8 9 57 
9 10 33 
10 11 11 
11 12 11 
12 13 2 
13 14 8 
14 15 2 
16 17 2 
17 18 2 
18 19 4 
 
 
 
 
Table E.6 Salmonella Typhimurium secondary outbreak data (Epidemic data): Cowden et al. 1989 
 
Time Start Time End Cases 
1 2 1 
4 5 1 
5 6 1 
9 10 1 
11 12 1 
12 13 3 
13 14 1 
17 18 3 
24 25 1 
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Table E.7 Shigella flexneri outbreak data (Epidemic data): He et al. 2012 
 
Time Start Time End Cases 
1 2 1 
2 3 1 
3 4 4 
4 5 14 
5 6 19 
6 7 41 
7 8 19 
8 9 4 
9 10 6 
10 11 4 
 
 
 
 
Table E.8 Shigella sonnei primary outbreak data (Epidemic data): Samonis et al. 1994 
 
Time Start Time End Cases 
17 18 2 
18 19 2 
20 21 2 
21 22 2 
22 23 9 
23 24 11 
24 25 14 
25 26 9 
26 27 16 
27 28 3 
28 29 2 
29 30 1 
30 31 2 
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Table E.9 Shigella flexneri secondary outbreak data (Epidemic data): Hunter, Hutchings. 1987 
 
Time Start Time End Cases 
1 2 1 
4 5 2 
6 7 3 
9 10 2 
10 11 2 
13 14 1 
16 17 2 
18 19 1 
23 24 1 
 
 
Table E.10 Escherichia coli O157:H7 primary outbreak data (Epidemic data): Swerdlow et al. 1992 
 
Time Start Time End Cases 
1 2 1 
2 3 1 
4 5 3 
5 6 2 
6 7 3 
7 8 2 
8 9 1 
9 10 4 
10 11 5 
11 12 5 
12 13 6 
13 14 2 
14 15 4 
15 16 4 
16 17 8 
17 18 19 
18 19 11 
19 20 9 
20 21 8 
21 22 10 
22 23 3 
23 24 9 
24 25 4 
26 27 5 
27 28 4 
28 29 3 
30 31 2 
31 32 1 
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Table E.11 Escherichia coli O157:H7 secondary outbreak data (Epidemic data): Carter et al. 1987 
 
Time Start Time End Cases 
1 2 1 
2 3 1 
4 5 2 
6 7 3 
7 8 2 
8 9 2 
9 10 4 
10 11 6 
11 12 7 
12 13 2 
13 14 2 
14 15 4 
15 16 1 
16 17 3 
17 18 4 
18 19 2 
19 20 6 
20 21 1 
21 22 3 
22 23 1 
23 24 4 
26 27 3 
27 28 1 
28 29 3 
29 30 2 
30 31 1 
31 32 2 
32 33 1 
 
 
Table E.12 Campylobacter jejuni outbreak data (Epidemic data): Aho et al. 1989 
 
Time Start Time End Cases 
1 2 5 
2 3 37 
3 4 27 
4 5 5 
5 6 1 
6 7 2 
7 8 2 
8 9 1 
9 10 1 
10 11 1 
307 
 
 
 
Vita 
 
 
 
 
Bidya Prasad was born in Patna, India. She earned her Bachelor of Science degree (B.S.) in 
Chemical and Biochemical Engineering from Rutgers University in New Brunswick, NJ in 2006. 
During this time, she interned as a Chemist in the Formulations Group at Unilever in Edgewater, 
NJ and as an Engineer in the Quality Control group at Hewlett-Packard in San Diego, CA. After 
graduation, she worked as an Engineer for PepsiCo, developing international Tropicana and 
Gatorade products in Valhalla, NY. Bidya returned to Rutgers in 2008 to continue her academic 
pursuits by earning a Master of Science (M.S.) degree in Chemical Engineering, after which she 
began her tenure at Drexel University in Philadelphia, PA to pursue a Doctor of Philosophy 
(Ph.D.) degree in Environmental Engineering. Her research focused on incorporating time-dose-
response equations into the incubation period of outbreak data to model the effects of in vivo 
kinetics between pathogens and hosts. 
 
Publications and Proceedings 
1. Prasad B, Hamilton K, Haas C.N. (2016). Incorporating time-dose-response in Legionella 
outbreak models. Risk Analysis. 
2. Prasad, B., Haas, C.N., Ryan, M. (2017). A method for incorporating a time-dose-response 
model into a Giardia lamblia outbreak. Journal of Water and Health, in press. 
3. Prasad, B., Haas, C.N. (2017). Incorporating time-dose-response models into Salmonella 
outbreaks. (Under review) 
4. Prasad, B., Haas, C.N. (2017). Incorporating time-dose-response models into Shigella 
outbreaks. (Under review) 
5. Prasad, B., Haas, C.N. (2017). Incorporating time-dose-response models into Escherichia coli 
O157:H7 outbreaks. (Under review) 
6. Prasad, B., Haas, C.N. (2017). Incorporating time-dose-response models into a 
Campylobacter jejuni outbreak. (Under review) 
7. Prasad, B., Sungar, N., Lennon, E., Haas, C. “A Risk Model for Inhaled Toxins Associated 
with Spores of Stachybotrys Chartarum” Society for Risk Assessment Conference, 2013. 
8. Gurian, P.L. Aminto, A., Bennett, J., De Sousa, R., Jackson, E., Prasad, B., Vernet, J.D. 
“Service Learning for Small System Support.” American Water Works Association Annual 
Conference and Exhibition, 2012.  
9. Yu, K., Prasad, B., Shapley, N. “Rheology and Complex Flow of a Concentrated Bimodal 
Suspension.” American Institute of Chemical Engineers Conference, 2012.   
 
 
 
 
 
 
 
